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ABSTRACT OF THE DISSERTATION 
Dissection of Affective Catecholamine Circuits Using Traditional and Wireless Optogenetics  
by 
Jordan Gary McCall 
Doctor of Philosophy in Biology and Biomedical Sciences 
Neurosciences 
Washington University in St. Louis, 2015 
Professor Michael R. Bruchas, Chair 
 
 Parsing the complexity of the mammalian brain has challenged neuroscientists for 
thousands of years. In the early 21st century, advances in materials science and neuroscience 
have enabled unprecedented control of neural circuitry. In particular, cell-type selective 
manipulations, such as those with optogenetics and chemogenetics, routinely provide answers to 
previously intractable neurobiological questions in the intact, behaving animal.  
 In this two-part dissertation, I first introduce new minimally invasive, wireless 
technology to perturb neural activity in the ventral tegmental area dopaminergic system of freely 
moving animals. I report a series of novel devices for studying and perturbing intact neural 
systems through optogenetics, microfluidic pharmacology, and electrophysiology. Unlike 
optogenetic approaches that rely on rigid, glass fiber optics coupled to external light sources, 
these novel devices utilize flexible substrates to carry microscale, inorganic light emitting diodes 
(µ-ILEDs), multimodal sensors, and/or microfluidic channels into the brain. Each class of device 
can be wirelessly controlled, enabling studies in freely behaving mice and achieving previously 
untenable control of catecholamine neural circuitry.  
xix 
 In the second part of this dissertation, I apply existing cell-type selective approaches to 
dissect the role of the locus coeruleus noradrenergic (LC-NE) system in anxiety-like and 
aversive behaviors. The LC-NE system is one of the first systems engaged following a stressful 
event. While LC-NE neurons are known to be activated by many different stressors, the 
underlying neural circuitry and the role of this activity in generating stress-induced anxiety has 
not been elucidated until now. I demonstrate that increased tonic activity of LC-NE neurons is 
both necessary and sufficient for stress-induced anxiety; a behavior which is driven by LC 
projections to the basolateral amygdala. Furthermore, this activity and behavior is elicited by 
corticotropin releasing hormone-containing afferent inputs into the LC from the central 
amygdala. These studies position the LC-NE system as a critical mediator of acute stress-induced 
anxiety and offer a potential intervention for preventing stress-related affective disorders. 
 Together these two objectives provide a rich technological toolbox for neuroscientists 
and yield important knowledge of how small catecholamine structures with widespread forebrain 
innervation can selectively mediate higher order behaviors.
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Introduction 
 
 
 
 
 
 
 
 
 
2 
INTRODUCTION 
 The living mammalian brain is a soft, squishy entanglement of millions of different cells. 
This declarative statement is the impetus for the following work. That single sentence captures 
two of the greatest challenges faced in neuroscience. The soft nature of the brain limits how we, 
as scientists trying to understand its functions, can interact with its intact form. The complex 
arrangement of the cells in the tissue poses incredible hurdles in understanding the anatomical 
and functional organization of the organ as a whole. These two challenges are not new, 
neuroscientists and anatomists have been tackling them for thousands of years, but only recently 
has our mastery of materials and genetics converged to allow increasingly detailed understanding 
of the soft, squishy entanglement we know as the brain. The following dissertation will introduce 
new tools for studying the intact circuitry of the living brain and apply a battery of existing 
techniques towards understanding the role of the locus coeruleus noradrenergic (LC-NE) system 
in complex negative affective behaviors. 
The power of cell-type selective neural manipulations 
  The complex nature of the brain has long puzzled those who sought to understand its 
function. As early as 1700 B.C., observations were recorded documenting the observable 
structure of brain anatomy (Risse, 1972). While these early observations remained as such for 
many hundreds of years, ever-diligent anatomists slowly began to establish the gross anatomy of 
the human brain (Arráez-Aybar et al., 2015; Schmitt, 2009). However, the ability to evaluate the 
function of brain anatomy remained elusive. One of the first major insights into how the nervous 
system functions came in 1791 when Luigi Galvani discovered that electricity could be used to 
stimulate nerve fibers in dissected frog legs (Parent, 2004). What is now considered a simple 
3 
observation (indeed one regularly taught in undergraduate physiology courses around the world) 
was at the time a paradigm-shifting discovery: electrical stimulation can be used to exogenously 
elicit function from neural tissues. Over the next two hundred years, the electrical nature of the 
central nervous system was exploited to an elegant degree both in understanding the cellular 
properties of the neuron (Hodgkin and Huxley, 1945) and the functional organization of the 
cortex (Rasmussen and Penfield, 1947a). In the latter case, very early studies using electrical 
stimulation gave functional information to the previously established anatomy (Penfield, 1947; 
Rasmussen and Penfield, 1947a, 1947b). However, the more sophisticated neurochemical and 
genetic tools became, the more complex the brain appeared to be. So much so that harnessing the 
power of electricity now seemed too limiting in scope to perturb and observe neuronal function. 
This limitation arises in large part due to the non-selective nature of exogenously applied current. 
When a stimulating microelectrode is placed in the brain, the current delivered to the probe 
agnostically perturbs all of the electrically excitable membranes near it (Figure 1.1). These 
excitable membranes could be neuronal cell bodies, passing axons, axon terminal or dendrites. 
For gross functional anatomy mapping (i.e. can x brain region elicit y behavioral response?) and 
some therapeutic approaches (Clark, 2015; Giugni and Okun, 2014) this approach proved 
sufficient, however to understand the complex circuitry of the mammalian brain, more selective 
tools would be necessary.  
 By the early 21st century, the need for tools that could selectively modulate particular 
genetically defined neuronal subtypes became clear and numerous groups provided potential 
answers (Adamantidis et al., 2007; Arenkiel et al., 2007; Armbruster et al., 2007; Banghart et al., 
2004; Güler et al., 2012; Lima and Miesenböck, 2005; Zemelman et al., 2002, 2003). Though a 
complete review of the possible solutions presented is outside the scope of this introduction, it is 
4 
important to note that two major solutions emerged from this challenge: one using photons to 
target exogenously expressed channels, pumps, and receptors (optogenetics) (Yizhar et al., 2011) 
and one using highly selective ligands to target exogenously expressed channels and receptors 
(chemogenetics) (Sternson and Roth, 2014). In both such schemes, advances in viral gene 
delivery enabled, for the first time, cell-type selective targeting of neurons and their projections 
(Adamantidis et al., 2007; Arenkiel et al., 2007; Krashes et al., 2011). These approaches now 
enable dynamic control of various types of cellular activity including stimulation (Arenkiel et al., 
2007), inhibition (Berndt et al., 2014), modulation (Airan et al., 2009; Siuda et al., 2015), 
intracellular signaling (Zhang and Cui, 2015) and gene expression (Konermann et al., 2013; 
Polstein and Gersbach, 2015). Perhaps the most powerful application of these tools is in awake, 
behaving animals where new fundamental insights into neural function are being made at an 
extraordinary rate (Tye and Deisseroth, 2012).    
The ventral tegmental area dopamine system as a model for progress in neuroscience 
 In the age of cell-type selective neural manipulations, few brain systems have received as 
much scientific attention as the ventral tegmental area dopamine (VTA-DA) system (for review 
see Britt and Bonci, 2013; Ikemoto and Bonci, 2014; Lammel et al., 2014; Nieh et al., 2013; 
Stamatakis and Stuber, 2012; Tye and Deisseroth, 2012; Walsh and Han, 2014). The VTA-DA 
system is one of the main sources of dopamine for the forebrain (Björklund and Dunnett, 2007). 
The VTA-DA system has long been known for its critical role in reward processing (Bozarth and 
Wise, 1981; Hollerman and Schultz, 1998; Miliaressis and Cardo, 1973; Wise, 1984), but it was 
not until the rise of optogenetics that the true complexity of this system was revealed. Diverse 
heterogeneity of cell-types (Tan et al., 2012; Yamaguchi et al., 2015; van Zessen et al., 2012),  
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Figure 1.1 Schemes for in vivo manipulation of neural circuitry. (A) Electrical 
microstimulation stimulates all cells, terminals, and fibers of passage near the electrode. (B) 
Optogenetics can selectively target genetically-defined cell-types, such as the red cells here. 
Only cells expressing the opsin (depicted as green outline) will be sensitive to photostimulation. 
(C) Chemogenetics also selectively targets genetically-defined cell-types, but uses a selective 
ligand (here as CNO), rather than light, to perturb neural activity. Figure 1.1 layout inspired by 
(Carter and de Lecea, 2011). 
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afferent inputs (Lammel et al., 2012; Watabe-Uchida et al., 2012), and efferent projections with 
non-canonical neurotransmission (Lammel et al., 2011; Root et al., 2014; Stamatakis et al., 2013; 
Zhang et al., 2015)regulates and contributes to motivation, reward, and emotional regulation with 
elegant detail.  
 One of the first studies implementing optogenetics in vivo answered a fundamental 
question about the VTA-DA system (Tsai et al., 2009): how do different phasic or tonic firing 
patterns contribute to reward-related behaviors? Not only did this study demonstrate that 
photostimulation could be used to manipulate affective neural circuitry, but it showed that 
modulation of firing profiles specific cell-types of neurons could be used to drive different 
behaviors. Several groups have carried on from these findings to clearly define the role of phasic, 
but not tonic, VTA-DA activity as a neural substrate of reward (Kim et al., 2012b; Lammel et al., 
2011; Tan et al., 2012; Witten et al., 2011; van Zessen et al., 2012).  
 The rich literature of the VTA-DA system provides a model for this two-part dissertation. 
First, we will utilize our existing knowledge of the VTA-DA system as a testing ground for new 
technology. The implementation of new technology that interfaces with neural tissue must 
functionally demonstrate that it can achieve results consistent with what is understood about the 
brain. Ideally new neural interface technologies will also expand our knowledge of neural 
function. In Part 1 of this dissertation, I report a series of novel devices for studying and 
perturbing intact neural systems through optogenetics, microfluidic pharmacology, and 
electrophysiology. This technology will be demonstrated with proof-of-principle experiments in 
the VTA-DA system. 
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 Though the VTA-DA system has been well characterized with modern tools, the same 
cannot be said for other major monoamine structures such as the dorsal raphe (5-
hydroxytryptamine/serotonin) or locus coeruleus (norepinephrine). Recent work has begun to 
unravel the circuit-level details of the dorsal raphe serotonergic system in motivation and 
affective procressing (Bruchas et al., 2011; Cohen et al., 2015; McDevitt et al., 2014; Miyazaki 
et al., 2014; Ogawa et al., 2014; Qi et al., 2014), but very limited work has focused modern tools 
on the role of locus coeruleus noradrenergic (LC-NE) system (Carter et al., 2010, 2012; Hickey 
et al., 2014; Vazey and Aston-Jones, 2014) and no so far in these such behaviors. Part 2 of this 
dissertation will focus on understanding the role of tonic activity of the LC-NE system in the 
mediation of stress-induced and stress-related behaviors such as anxiety-like and aversive 
behaviors. The experimental approaches used by the VTA-DA field will provide a template for 
how to proceed in dissecting this important catecholamine brain system. 
Motivation for the development of flexible, wireless devices for manipulation of intact 
mammalian neural circuitry  
 Though much progress can and has been made with traditional approaches to 
optogenetics (i.e. fiber optics implanted directly into the brain), there remain limitations to the 
implementation of these approaches in freely behaving animals. An immediate concern is that 
light delivery with traditional fiber optic approaches requires the animal to be tethered to an 
external laser or LED light source (Zhang et al., 2010). While this limitation does not prevent 
study in awake, behaving animals it does limit the scope and type of behaviors one can assess. 
Interrogation of endogenous neural function is best done in the context of natural behaviors. Any 
handling or tethering of mice disrupts their natural behavior (Sorge et al., 2014), an observation 
that can be clearly made from any actogram of behavior following a cage change (Aton et al., 
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2005). Furthermore, any obstrusive headstage or cabling would more than likely cause a 
significant confound in the study of social behavior (Shah et al., 2013). Therefore a conscious 
effort should be made towards reducing both experimenter and technical interference during the 
study of animal behavior. To achieve this goal wireless systems present a promising alternative 
to tethered designs. Wireless observation of neural activity has been achieved by a number of 
groups (Bertrand, 2015; Harrison et al., 2010; Szuts et al., 2011; Yin et al., 2014), but at the 
outset of the work presented here no one had yet achieved wireless photostimulation. 
 Another crucial limitation of traditional fiber optic implants is in controlling the path of 
light. While there now exist a few options for guiding light at different angles and points along 
the dorsal-ventral axis of a brain structure (Tye et al., 2011; Zorzos et al., 2010, 2012), basic 
fiber implants can only deliver light dorsal to the brain structure of interest. This can be 
problematic when a brain structure is oriented vertically in the dorsal-ventral plane of the brain 
(i.e. the locus coeruleus) as illuminating the entire structure would either require implanting 
deeper or increasing the power of the light source. Both of these solutions can cause excess 
damage to tissue (Yizhar et al., 2011). Therefore developing implantable light sources that can 
approach brain structures from multiple and unique angles can greatly empower functional 
dissection of the intact living brain. 
 The need in the neuroscience community for untethered devices with modular angles of 
light delivery comes at time when the materials science community has begun to solve many of 
these issues. Wirelessly powered devices traditionally rely on battery-powered operation, 
however, batteries traditionally pose two immediate challenges to integration into electronics for 
small mammals: 1) the batteries must be changed and 2) the batteries add weight to whatever 
device the animal is required to support. In answer to these challenges, electrical engineers have 
9 
devised power harvesting strategies that convert ambient energy into usable electrical energy 
(Anton and Sodano, 2007). While these strategies are often seen as alternative renewable energy 
sources, the same approach can be used with purposefully broadcasted radiofrequency (RF) 
signals used to increase the ambient RF energy available for scavenging (Anton and Sodano, 
2007; Olgun et al., 2010; Sample and Smith, 2009). This strategy is one that we employ in 
Chapter 2 & 3 to create fully untethered devices for wireless photostimulation. These battery-
free devices can be powered in most environments without the need to contact the animal. 
 A second key advance in materials science has been the development of micro-scale 
light-emitting diodes (µ-ILEDs) (Kim et al., 2010, 2012c). These light sources are small enough 
that they can readily be transferred to flexible materials (Kim et al., 2012a) which provide ideal 
material properties for interfacing with biological tissue. µ-ILED technology presents as an 
excellent solution for spatial targeting in optogenetics. µ-ILEDs can be made that are on the size 
scale of a few individual cell bodies (as small as 625 µm2) (Kim et al., 2012c) and while the light 
from these devices spreads further than a single cell, localized activation within a brain structure 
is an attainable goal. Importantly, µ-ILEDs are extremely efficient (i.e. they convert electrical 
energy into light without losing too much energy to heating) which is critical for implanting 
electronics into neural tissue. Chapter 2 details experiments and modeling (the latter done by 
collaborators) to ensure that these implanted light sources do not deleteriously heat the tissue. 
Finally, because of the flexible nature of the fabrication of these µ-ILEDs, they can be implanted 
on ultrathin substrates that cause substantially less damage to the soft tissue of the brain than 
conventional implants.  
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 The devices introduced in Chapters 2 & 3 serve as first generation prototypes of 
technology that can be used to observed physiology (electrical, optical, and thermal properties) 
or wirelessly perturb physiology (electrical or optical). These devices lack, however, an interface 
for delivery of fluids such as viral vectors, therapeutic drugs, or other pharmacological agents. 
Chapter 4 presents a new generation of device that maintains the ability to wirelessly 
photostimulate, but adds fluid delivery capabilities. These optofluidic neural probes represent 
one of many different possible second generation wireless µ-ILED devices and will serve as a 
powerful tool for further dissection of neural circuitry. 
Motivation for understanding the role of the LC-NE system in negative affective behavior 
 Anxiety is the manifestation of a complex set of behavioral and physiological responses 
that can be either beneficial or detrimental to an individual. Under a state of stress and fear, 
anxiety helps to maintain the arousal and vigilance required to maintain attention and accomplish 
necessary tasks. After prolonged stress, however, anxiety can become pathological, interfering 
with an individual’s ability to function normally (Gross and Hen, 2004). This neuropsychiatric 
form of anxiety affects nearly 20% of the U.S. population during their lifetime and leads to 
significant economic impacts, including loss of productivity and increased health care costs. Part 
2 of this dissertation seeks to establish a greater understanding of the neurobiological basis of 
anxiety and stress-induced behavioral disorders. 
Norepinephrine, stress, and anxiety 
 The LC-NE system is a small, tightly packed pontine brain region that sends numerous 
projections to the forebrain and spinal cord. This system is involved in a broad number of 
physiological functions including arousal, memory, cognition, and stress reactivity (Berridge and 
Waterhouse, 2003; Snyder et al., 2012; Valentino and Van Bockstaele, 2008). NE acts at 
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postsynaptic (Gs-coupled ! and Gq-coupled "1) and presynaptic (Gi-coupled "2) adrenergic 
receptors throughout the forebrain (Figure 1.2) (Berridge and Waterhouse, 2003). The LC-NE 
system is known to increase activity in response to a wide array of environmental stressors 
including social and predator stress (Berridge and Waterhouse, 2003; Bingham et al., 2011; 
Cassens et al., 1981; Curtis et al., 2012; Francis et al., 1999; Snyder et al., 2012; Valentino and 
Van Bockstaele, 2008). The response of the LC-NE system to stress is particularly important in 
the context of stress-induced human neuropsychiatric disorders such as posttraumatic stress 
disorder (PTSD). Noradrenergic neurons within the LC-NE system exhibit three distinct 
activation profiles: low tonic, high tonic, and phasic activity. It is believed that these neurons 
function differently in determining behavioral flexibility to various environmental challenges. 
Low tonic LC discharge (1-2 Hz) is thought to be consistent with an awake state (Aston-Jones 
and Bloom, 1981a; Carter et al., 2010, 2012), whereas phasic burst activity results from distinct 
sensory stimuli (Aston-Jones and Bloom, 1981b). Stress and stress-related neuropeptide release 
(such as corticotrophin-releasing hormone, CRH) is thought to shift LC activity towards a high 
tonic mode of firing (3-8 Hz) while simultaneously decreasing phasic firing events, whereas 
endogenous opioid transmission is thought to return tonic firing to baseline (Curtis et al., 2012; 
Snyder et al., 2012; Valentino and Foote, 1988). Taking a cue from the VTA-DA system, the 
first study into LC-NE function in affective behaviors will examine different activity profiles of 
these neurons (Tsai et al., 2009). Chapter 5 will focus on examining the effects stress-induced 
and optogenetically-evoked high tonic activity of LC-NE neurons. 
Amygdala-LC circuitry and the modulation of stress-induced anxiety-like behavior 
 There is some evidence that neuropeptidergic inputs to the LC from the central nucleus of 
the amygdala (CeA), including those containing CRH, may become activated in response to 
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stressors (Figure 1.2) (Curtis et al., 2012; Francis et al., 1999; Valentino et al., 1992). Recent 
anatomical data further support this notion using tract tracing studies and electron microscopy to 
confirm that CRH containing amydalar monosynaptic projections from the CeA terminate in the 
LC (Valentino et al., 1992). Given the importance of CRH in stress-induced behavioral responses 
these projections are situated to significantly impact LC neuronal activity, yet their functional 
consequences remain unresolved. Engagement of the CRH system has been implicated in stress-
induced depression, anxiety, and negative affective responses including dysphoria (Bruchas et 
al., 2009). Taken together, the prior body of work strongly implicates CeA-LC neural circuit 
activation in mediating the stress response of the LC-NE system, emphasizing the need for 
continued dissection of these circuits and systems. The second half of Chapter 5 focuses on 
CRH-containing afferent inputs to the LC from the CeA. These studies demonstrate that CRH 
neurotransmission increases tonic LC-NE activity and drives anxiety-like and aversive 
behaviors. 
Downstream effectors of LC-mediated negative affective behaviors 
 The LC-NE system has rich and complex combination of receptor and anatomical 
projection targets. There are at least nine different adrenergic receptors and most have had some 
implication in anxiety-like behaviors (Brunner et al., 2014; Dixit et al., 2014; Hanke et al., 2012; 
Kuteeva et al., 2008; Le Maître et al., 2013; Mantsch et al., 2010; Raskind et al., 2007; Wohleb 
et al., 2011). Furthermore, the LC has a widespread projection network throughout the 
mammalian forebrain and spinal cord (Berridge and Waterhouse, 2003; Sara, 2009). Of 
particular interest are the dense projections to the basolateral amygdala, a critical structure in  
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Figure 1.2 Simplified, putative LC-NE system involved in negative affective behaviors. The 
diagram illustrates CeA neurons terminating in the LC to release CRH and drive increased tonic 
LC-NE firing causing release of NE into the BLA to drive possibly drive anxiety-like behaviors. 
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generating negative affect (Berridge and Waterhouse, 2003; Davis, 1992; Valentino and Aston-
Jones, 2010). While the anatomical projections from the LC and their cell types have beenstudied 
for several years, the precise mechanisms by which the LC generates its influence over 
basolateral amygdala (BLA) function remain undefined. Chapter 6 will focus on how the LC-
BLA projection induces affective behavioral responses via specific receptor systems and cell 
activity. Understanding the next substrates beyond LC activity will be important for a clear 
comprehension of how this system produces certain behaviors.  
 Together, Part 1 and Part 2 provide a novel series neural interfacing devices for 
neuroscientists and off important insight of how small, widely projecting catecholamine 
structures selectively mediate affective behaviors. 
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SUMMARY 
 Successful integration of advanced semiconductor devices with biological systems will 
accelerate basic scientific discoveries and their translation into clinical technologies. In 
neuroscience generally, and in optogenetics in particular, an ability to insert light sources, 
detectors, sensors and other components into precise locations of the deep brain could yield 
versatile and important capabilities. Here, we introduce an injectable class of cellular-scale 
optoelectronics that offers such features, with examples of unmatched operational modes in 
optogenetics, including completely wireless and programmed complex behavioral control over 
freely moving animals. The ability of these ultrathin, mechanically compliant, biocompatible 
devices to afford minimally invasive operation in the soft tissues of the mammalian brain 
foreshadow applications in other organ systems, with potential for broad utility in biomedical 
science and engineering. 
INTRODUCTION 
Electronic systems that integrate with the body provide powerful diagnostic and 
therapeutic capabilities for basic research and clinical medicine. Recent research establishes 
materials and mechanical constructs for electronic circuits, light-emitting diodes (LEDs), 
sensors, and other components that can wrap the soft, external surfaces of the brain, skin and 
heart, for diverse functions in analytical measurement, stimulation and intervention (Kim et al., 
2010, 2011; Mannsfeld et al., 2010; Ordonez et al., 2012; Qing et al., 2010; Sekitani and 
Someya, 2012; Sekitani et al., 2009; Takeuchi et al., 2004; Tian et al., 2010; Viventi et al., 
2010). A significant constraint in operating these devices, however, follows from their surface-
mounted configurations and inability to provide direct interaction into the volumetric depths of 
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the tissues. Passive penetrating electrodes or optical fibers with interconnections to externally 
located electronic control and/or acquisition systems or light sources can be valuable in many 
contexts, particularly in neuroscience, engineering, and surgery (Anikeeva et al., 2011; Kim and 
Romero-Ortega, 2012; Mattis et al., 2012; Ordonez et al., 2012; Stark et al., 2012; Takeuchi et 
al., 2004). Direct biological integration is limited by challenges from tissue lesions during 
insertion, persistent irritation, and engineering difficulties in thermal management, 
encapsulation, scalable interconnection, power delivery, and external control. Many of these 
issues constrain attempts to insert conventional, bulk LEDs into brain tissue (Cao et al., 2013) 
and to use semiconductor nanowire devices as cellular probes or active, in vitro tissue scaffolds 
(Tian et al., 2010, 2012). In optogenetics, engineering limitations of conventional, tethered fiber 
optic devices restrict opportunities for in vivo use and widespread biological application. As a 
solution, we developed mechanically compliant, ultrathin multifunctional optoelectronic systems 
that mount on releasable injection needles for insertion into the depths of soft tissue. These 
wireless devices incorporate cellular-scale components ranging from independently addressable 
multicolored microscale, inorganic light-emitting diodes (µ-ILEDs) to colocated, precision 
optical, thermal, and electrophysiological sensors and actuators.  
RESULTS 
A scanning electron micrograph (SEM) of an isolated gallium nitride (GaN) µ-ILED, as a 
constituent component of these systems, is presented in Figure 2.1A, as well as an epifluorescent 
image of a device among cultured human embryonic kidney (HEK293) cells, to illustrate the 
similar sizes. Each such “cellular-scale” µ-ILED (6.45 µm thick, 50x50 µm2) uses high-quality 
epitaxial material grown on sapphire, processed to establish contacts (15x15 µm2 square pads in 
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the corners, and an L-shaped current spreading layer for the p-contact) and then released, to 
allow transfer printing onto narrow, thin plastic strips. The µ-ILEDs are less than one-thousandth 
the size of conventional LEDs (typically 100 µm thick, with lateral dimensions of 1 mm2) and 
fiber optic probes, as discussed below (Kim et al., 2012b). The small sizes of µ-ILEDs allow for 
spatially precise, cellular-scale delivery of photons, highly effective thermal management, 
reduced tissue damage, and minimized inflammation for prolonged use in vivo.  
Combining µ-ILEDs with electronic sensors and actuators yields multifunctional 
integrated systems that can be configured in single or multilayer formats. The latter option is 
illustrated in Figure 2.1B and C, in which the sensors and/or actuators include a Pt 
microelectrode for electrophysiological recording or electrical stimulation (Layer #1; a 20x20 
µm2 exposure defines the active area), a microscale inorganic photodetector (µ-IPD) based on an 
ultrathin silicon photodiode (Layer #2; 1.25 µm thick, 200x200 µm2), a collection of four µ-
ILEDs connected in parallel (Layer #3) and a precision temperature microsensor or microheater 
(Layer #4; Pt serpentine resistor) (more details in Figure 2.2-2.4). Each layer is processed on 
separate substrates shaped to match a releasable, photolithographically-defined epoxy 
microneedle (Figure 2.5). A thin layer (~500 nm) of epoxy joins each of the layers in a precisely 
aligned, stacked configuration. The microneedle bonds to the bottom layer with a thin, bio-
resorbable adhesive based on a film of purified silk fibroin, which enables removal of the 
microneedle after implantation (Figure 2.1D and Figure 2.6). The microelectrodes measure 
extracellular voltage signals in the direct vicinity of illumination and can also be used for 
stimulation (Figure 2.15H). The temperature sensors determine the degree of local heating, with 
a precision approaching ~1 mK, and can also be used as microheaters. The µ-IPD can measure 
the intensity of light from the µ-ILEDs while implanted deep in brain tissue and/or can enable 
28 
basic spectroscopic evaluations of absorption, fluorescence, diffuse scattering, and so on (for 
detailed information see Figure 2.7 and 2.8.  
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Figure 2.1 Injectable, cellular-scale semiconductor devices, with multifunctional operation 
in stimulation, sensing and actuation. (A) Left, colorized SEM (left) of a GaN µ-ILED (~6.45 
µm thick, and 50x50 µm2; contacts – gold; spreading layer – red). Right, fluorescent image of a 
!-ILED (blue) with cultured HEK293 cells that express an eYFP tagged transmembrane protein 
(green). (B) A multifunctional, implantable optoelectronic device, in a tilted exploded view 
layout illustrating various components. The system includes layers for electrophysiological 
measurement (#1; Pt contact pad, microelectrode), optical measurement (#2; silicon µ-IPD), 
optical stimulation (#3; µ-ILED array), and temperature sensing (#4; serpentine Pt resistor), all 
bonded to a releasable structural support for injection (microneedle). (C) Top view of the 
integrated device shown in (B). (D) Process of injection and release of the microneedle. After 
insertion, aCSF (center) dissolves the external silk-based adhesive. The microneedle is removed 
(right) leaving only the active device components in the brain. (E) SEM of an injectable array of 
µ-ILEDs. The total thickness is 8.5 µm. Inset shows rigid device before coating with a 
passivation layer. (F) Integrated system wirelessly powered with RF scavenging. Insets show a 
connectorized device unplugged (top) and plugged into (bottom) the wireless power system. (G) 
Healthy, freely-moving mice with lightweight, flexible (left) and rigid (right) wireless systems 
powering GaN µ-LED arrays in the VTA.  
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Figure 2.2 Schematic illustration of steps for fabrication (A) thin (2.5 or 6.0 µm thick) 
microneedle-shaped polymeric template laminated on a PDMS coated substrate, (B) µ-ILEDs 
integrated by transfer printing, (C) patterned passivation layers and interconnects, and (D) 
removal of the device from the PDMS coated substrate and transfer printing onto a releasable, 
injection microneedle substrate. 
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Figure 2.3 Schematic illustration of a printed multifunctional µ-ILED system. 
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Figure 2.4 Photograph of µ-ILED layout 
Photograph of four printed µ-ILEDs next to the tip of a ballpoint pen (right), to set the scale. 
Each µ-ILED has lateral dimensions of 100 x100 µm2, with two 25x25 µm2 metal pads for 
contacts and an L-shape current spreader. 
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Figure 2.5 Images of injection microneedles 
Images of injection microneedles defined photolithographically using a UV-curable epoxy (250 
µm thick, SU-8 100). (A) Photolithographic patterning of epoxy on a pre-patterned glass 
substrate (B) microneedles delaminated by mechanical force from the glass substrate. (C) Tilted 
optical microscopic image of a single microneedle.   
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Figure 2.6 Demonstration of silk as an adhesive for injection microneedles 
Demonstration of silk as a water soluble, bio-resorbable, releasable adhesive for injection 
microneedles. (A) Image of a device at the initial stages of silk dissolution, after 3 min and (B) 
after full dissolution and mechanical separation, after 15 min.    
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Figure 2.7 Relationship between temperature and resistance of temperature sensors 
(A) Change in resistance with temperature. (B) Fractional change in resistance as a function of 
temperature, for three different devices. 
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Figure 2.8 Current-voltage (I-V) characteristics of a µ-IPD 
Current-voltage (I-V) characteristics of a µ-IPD exposed to different light intensities generated 
by operation of four µ-ILEDs.  Electrical DC input powers into the µ-ILEDs were 0, 6.0, 9.5, 
13.5 mW.  
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Injection of such flexible devices into the brain follows steps shown in Figure 2.1D. The 
injected multifunctional optoelectronic systems, have a total thickness of ~20 µm. This 
exceptionally thin geometry, low bending rigidity, and high degree of mechanical flexibility 
(Figure 2.1E and 2.1F) allow for minimally invasive operation. Wired control schemes use 
standard transistor-transistor logic (TTL) and are therefore compatible with any readily available 
electrical commutator. Details on wired powering strategies and demonstration of wired 
optogenetic functionality in rodent behavioral assays are presented in Figures 2.9, 2.10, and 
2.11. Implementation of a wireless power module based on radiofrequency (RF) scavenging is 
shown in Figure 2.1F. A custom flexible polyimide film-based lightweight (~0.7 g) power 
scavenger or a rigid printed circuit board-based scavenger (~2.0 g) (Figure 2.1G and Figure 
2.12) can be temporarily mounted on freely moving animals for short-term experimentation 
without constraint in natural animal behavior (Figure 2.1G). The entire system consists of a 
wireless power transmitter and RF signal generator; an RF source (910 MHz; power output 
between 0.02 and 0.1 mW); a power supply; an RF power amplifier (gain of 49 dB at 910 MHz; 
power output between 1.6 and 7.9 W); and a panel antenna (gain of 13 dBi), as in Figures 2.12 
and 2.13. The low-frequency signal generator provides user-controlled amplitude modulation for 
programmed operation. The RF power that reaches the animals, under normal operating 
conditions at a distance of ~1 m, is between 0.15 and 0.77 mW/cm2, which is substantially 
smaller than the maximum permissible exposure limits (3.03 mW/cm2) for humans in controlled 
environments. Wireless control allows access to complex and ethologically relevant models in 
diverse environmental settings, including social-interactions, homecage behaviors, wheel 
running, complex maze navigation tasks, and many other behavioral outputs (Figure 2.1G and 
2.14). 
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Figure 2.9 Images of connection between power supplies and µ-ILED systems 
Images of the plug-in geometry of the connection between power supplies and penetrating µ-
ILED systems, for the case of a wired supply (A) and RF wireless units (B and C). 
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Figure 2.10 !-ILED devices drive a conditioned place preference using standard TTL 
signals. To demonstrate wired functionality, we selectively targeted ChR2(H134)-eYFP to VTA-
DA neurons (Figure 2.26A) and tested that phasic activation (20, 5 ms pulses every minute) of 
cells with a !-ILED device is sufficient to drive robust place preference behavior without a 
change in locomotor activity. Animals were conditioned over three days for 30 minutes. !-ILED 
devices were powered and controlled using standard function generator (Tektronix, AFG3022B 
or AMPI, Master-9). (A) Left, Diagram of three-chambered conditioned place preference 
apparatus. Right, representative heat maps of activity during the post-test, hotter colors represent 
longer duration at every location in the apparatus. (B) Place preference scores, calculated as post-
test minus pre-test on the light stimulation-paired side (n = 4-6/group; *p<0.05 t test compared to 
AAV5-DIO-eYFP controls). (C) Total activity during the pre- and post-tests shows no difference 
between the two groups. All bars represent means ± SEM. 
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Figure 2.11 Real-time assessment of reward seeking or aversion 
Real-time assessment of reward seeking or aversion is possible by pairing an animal’s behavioral 
response with self-triggered stimulation or inhibition (Figure 2.19-2.21). Real-time conditioning, 
animals allowed free access to the apparatus from fig. S18A learn to self-trigger stimulations 
when 10, 5 ms pulses at 20 Hz light is delivered contingent on entry into the paired chamber. (A) 
Animals did not express either a real-time or conditioned place preference under this 
experimental design. (B) AAV5-DIO-ChR2 mice, however, did have increased numbers of 
passive, entry-triggered self-stimulations. (C) Passive self-stimulation is learned over the course 
of each trial. (D) Importantly, this difference is not due to a change in activity between the two 
groups (n = 3/group, **p<0.01 t test compared to AAV5-DIO-eYFP controls). (E) Animals 
could receive subsequent stimulations if they remained in the stimulus-paired chamber for 60 
seconds. ChR2 mice did not learn to remain in the chamber for these subsequent stimulations. 
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Figure 2.12 Circuit diagrams and pictures if RF powering scavenger 
Circuit diagrams for each RF powering scavenger and pictures of RF powering scavenger (left) 
and RF antenna (right), in a miniaturized PCB layout (A) and on polyimide film (B). The RF 
power scavenger contains a RF antenna that works at 910 MHz, an impedance matching 
inductor, a voltage multiplexer with cascaded combination of Schottky diodes and capacitors, 
and blue LEDs. The circuit of the RF power scavenger for (A) is on two stacked PCB boards that 
are connected with each other by a PCB connector. For RF power scavenger for (B), Au pre-
patterned PI film supports all of components connected by silver epoxy.   
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Figure 2.13 Key components for wireless operation using RF power delivery 
(A) Photo and diagram explaining the components of the system and demonstrating wireless 
power. Headstage antennas on PCB board (B) and on bent PI (C). (D) A mouse with a 
chronically implanted device. The nature of the interconnect allows for temporary coupling to 
either form of headstage antenna or a wired power source. (E,F,G) Mice with acutely mounted 
headstage antennas. 
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Figure 2.14 Demonstration of wireless capabilities 
For all panels the same environment is shown with wireless lit !-ILEDs (left) and wirelessly 
stimulated mice (right). (A) Wireless mice can explore circular environments with no need for 
commutators or adaptations to the behavioral apparatus. (B) RF modulation can be used to power 
devices through covered arenas as seen here with a mouse in a traditional homecage 
environment. (C) Multiple wireless devices can be controlled using a single antenna. Here, two 
implanted mice are receiving identical optical stimulation simultaneously on a standard rotarod- 
a rotating wheel that provides numerous barriers for use with tethered animals.  
The electrical, optical, and thermal characteristics of the devices when operated in 
biological environments are important for optogenetics and other biomedical applications. The 
B!
A!
C!
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total optical power density of the four µ-ILEDs in this device as a function of electrical input 
power is shown in Figure 2.15A (more details in Figure 2.16 and 2.17. This performance is 
comparable to similarly designed, state-of-the-art conventional GaN LEDs (Kim et al., 2012b). 
Many optogenetic constructs can be activated with ~1 mW/mm2, at wavelengths near 450 nm 
(Mattis et al., 2012). These conditions are well matched to the output of the GaN µ-ILEDs. Input 
power of ~1.0 to 1.5 mW (Figure 2.15A) is sufficient for both activation of the 
channelrhodopsin-2 [ChR2(H134)] ion channel and precise control of intracellular signaling 
[adenosine 3’5’-monophosphate (cAMP and extracellular signal-regulated kinase (ERK 1/2)] via 
an optically sensitive heterotrimeric guanine nucleotide-binding (G-protein)-coupled receptor 
(OPTO-!2) (Airan et al., 2009) (Figure 2.23C and D, Figure 2.18 and 2.19). Wirelessly, at a 
distance of 1 m, the RF scavenger puts out 4.08 mW of electrical power resulting in a 7 
mW/mm2 optical power density. Other wavelengths are possible using different types of µ-
ILEDs, either in multicolored or uniform arrays. An example of the latter, with blue and red 
(GaAs) µ-ILEDs, and the former, with green devices (produced using fluorescein sodium salt 
phosphor on a blue GaN µ-ILED) are shown in Figure 2.15B.  
µ-ILED induced changes in temperature determined by infrared imaging and by 
analytical calculation, respectively, are shown in Figure 2.15, C and D. The µ-ILEDs were 
implanted 0.3 mm into an explanted piece of brain tissue held at 37 oC. The time-averaged 
temperatures measured at light-pulse (10 ms) frequencies of 3, 5, 10, and 20 Hz with peak light 
output of 17.7 mW/mm2 are 37.17º, 37.22º, 37.31º, and 37.46oC, respectively. These results are 
similar to calculated time-averaged temperatures of 37.20º, 37.34º, 37.68º, and 38.37oC, 
respectively. Note that, the input power used in these tests is 10 times what is necessary to 
activate many optogenetic constructs (Mattis et al., 2012). The cellular-scale dimensions of the 
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µ-ILEDs enable high rates of passive thermal spreading, and the brain tissue itself operates as an 
efficient heat sink. The latter is apparent in studies of the dependence of operating temperature 
on tissue thickness, operating power, and frequency (Figure 2.15E). As in Figure 2.15D, the 
experiment and theory agree remarkably well in spite of the indirect correlation between infrared 
imaging results and temperature at the location of the devices (details appear in Figure 2.20 and 
2.21. Perfusion in living tissue further increases the efficacy of these biological heat sinks. 
Changes in temperature measured in vivo using an integrated temperature sensor (Figure 2.7) 
compared with calculated results are shown in Figure 2.15F. Collectively, these results indicate 
that changes in temperature associated with operation of µ-ILEDs can be less than 0.10 oC for 
pulse frequencies less than 20 Hz, typical of many neuronal firing rates. These values are much 
lower than those that occur in human deep brain stimulation (DBS) regulation, ~2oC (Elwassif et 
al., 2006). Furthermore, in wireless operation, there is no appreciable change in temperature 
associated with operation at the headstage antenna or the skull (Figure 2.22). 
Other components of this multifunctional platform exhibit similarly good characteristics.  
To demonstrate functionality of the silicon µ-IPD, Figure 2.15G shows photocurrents generated 
by different intensities of light from µ-ILEDs at different pulse frequencies. Finally, the Pt 
microelectrode has a 400 µm2 exposure site with ~1.0 M$ impedance at 1 kHz capable of 
measuring extracellular potentials on the microvolt scale necessary to distinguish individual 
action potentials (Figure 2.15H), as demonstrated with clear clustering in the principal 
component analysis of spike data (Figure 2.15I). 
46 
 
 
 
E!
G 
H 
18
0 
!V
 
500 ms 
PC1 
PC2 I 
off?off? off?off?5 Hz?3 Hz? 20 Hz?10 Hz?
40 oC!37! 39!38!
37.17! 37.22 ! 37.31! 37.46!
5 mm!
C 
D 
37.20 ! 37.34! 37.68! 38.37!
3 Hz 5 Hz 10 Hz 20 Hz 
B!
1 mm!
20 Hz?
10 Hz?
5 Hz?
3 Hz?
F on? off?
56 60 64 68
0.00
0.04
0.08
0.12
Time (s)
on?off? off?
0 10 20 30 40
0
10
20
30
40
Electrical input power (mW)
Li
gh
t o
ut
pu
t d
en
si
ty
 (m
W
/m
m
2 )A!
20 mW 3 mW 40 mW 
Op
tic
al 
po
we
r d
en
sit
y 
0 2 4 6 8
-1500
-1000
-500
0
Time (s)
Cu
rer
nt 
(nA
)
21.9 mW/mm2
16.2 mW/mm2
5.0 mW/mm2
0 5 10 15 20
100
35
40
45
50
Frequency (Hz)
Tis
su
e t
em
pe
rat
ure
 (º
C) 2 mm
1 mm
0.3 mm
DC
23.5 mW/mm2
17.7 mW/mm2
23.5 mW/mm2
17.7 mW/mm2
23.5 mW/mm2
17.7 mW/mm2
50 100 150 200 250
0.00
0.04
0.08
0.12
Time (s)
! T
em
pe
rat
ure
 (º
C)
47 
Figure 2.15. Optical, thermal, and electrophysiological studies with corresponding 
theoretical analyses. (A) Total optical power density as a function of electrical input power 
applied to an array of four GaN µ-ILEDs; optical images show operation at 3, 20 and 40 mW. 
(B) A single device has one 675 nm GaAs !-ILED and four 450 nm GaN !-ILEDs that can be 
activated independently (upper left and upper right) or concurrently (lower left). The same 
device is coated in a fluorescein sodium salt phosphor for 530 nm light (lower right). (C) 
Measured and (D) calculated temperatures in explanted brain tissue near implanted µ-ILEDs at a 
depth of 0.3 mm and operated at 17.7 mW/mm2 of light output power. (E) Temperatures in a 
system similar to that of (C, D), as a function of duty cycle in the operation of the µ-ILEDs and 
at three different implantation depths (0.3, 1.0, 2.0 mm) and two different light output powers 
(17.7, 23.5 mW/mm2). (F) Change in brain temperature as a function of time, measured using an 
integrated temperature sensor co-located with an array of four µ-ILEDs in a lightly anesthetized 
mouse. Results evaluated at a peak input electrical power of 8.65 mW, in 3, 5, 10, and 20 Hz 
pulses (10 ms duration). The vertical dashed lines indicate onset (at 60 s) and offset (at 240 s) of 
the µ-ILEDs. Colored dashes lines correspond to theoretical models for the temperature. The 
right frame shows the time dynamics as the device is powered. (G) Change in photocurrent as a 
function of time, measured using an integrated µ-IPD, for three different light output powers to 
an array of µ-ILEDs: 5.0 mW/mm2 (blue trace), 16.2 mW/mm2 (red trace), and 21.9 mW/mm2 
(black trace) at different pulse frequencies (10 ms pulses at 3, 5, 10, and 20 Hz). (H) 5 s 
extracellular voltage trace of spontaneous neuronal activity gathered using the integrated Pt 
microelectrode. (I) The same data is filtered and sorted using principal components analysis to 
identify single units. 
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Figure 2.16 Electrical and optical properties of an array of four µ-ILEDs connected in 
parallel. (A) Current-Voltage (I-V) characteristics, (B) light output power and radiant efficiency 
as a function of electrical input power, and (C) light emission intensity as a function of 
wavelength. 
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Figure 2.17 Information related to tests of light penetration depth 
(A) Schematic illustration of the experimental scheme, (B) light output-current and voltage 
(LIV) results collected using slabs of brain tissue with various thicknesses (0.5, 1, 2, 3, 4, 5 mm) 
and (C) their light transmission through the thickness of the tissue. (D) Light extraction through 
2 mm thick slabs of brain tissue at various applied powers. 
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Figure 2.18 !-ILED-induced activation of cAMP and ERK phosphorylation in Opto!2 
expressing cells. (A) Opto!2 cells co-expressing pGlo show a rapid and transient increase in 
cAMP following light (450 nm, 5 sec, 0.5 W/cm2 pulse) stimulation (n=3). HEK293 cells 
expressing pGlo show no response to the same light stimulation (n=3). Data are expressed as 
mean ± sem. (B). Representative pERK and actin Western Blots for Opto!2 and HEK293 cells 
following light (450 nm, 1 min, 0.5 W/cm2 pulse) stimulation (n=3).  (C). Quantitation of pERK 
normalized to actin in light stimulated Opto!2 and HEK293 cells. (*p<0.05, unpaired, two-tailed 
t-test). 
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Figure 2.19 !-ILED-induced modulation of in vivo neuronal activity in the VTA via 
ChR2(H134)-eYFP expressing neurons. (A) Representative peri-light raster plot and histogram 
demonstrating increased cell firing within 20 ms of onset of a 450 nm, 0.5 W/cm2 light pulse. (B) 
Raster plot showing activity from the same neuron (A) time locking with various frequencies of 
light delivery. Each light pulse is centered at 0 ms, the effects of prior and subsequent pulses are 
apparent in each line of the 2000 ms raster plot. 
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Figure 2.20 Surface temperature of µ-LEDs on an injection microneedle, during operation 
at various power levels in open air. (A) Measured (dots) and calculated (lines) temperatures of 
µ-ILEDs at various pulse duty cycles and at DC power levels.  All calculated temperatures 
(lines) are obtained by time-average results at 37 oC background temperature.  The duration time 
(width) for all pulsed cases is 10 msec.  (B) Measured (left) and calculated (right) temperatures 
at 15 and 10 mW applied power.  The measured (calculated) temperatures are 37.44 (39.31) and 
36.15 (38.54) oC, respectively, with a 3 Hz pulse. (C) Measured (left) and calculated (right) 
temperature at 15 and 10 mW DC applied power. The measured temperatures (calculated) are 
84.01 (86.95) and 86.31 (70.30) oC, respectively, with a 3 Hz pulse. 
 
 
53 
 
 
 
Figure 2.21 Thermal imaging with a calibrated IR camera. (A) Schematic illustration and (B) 
pictures of the IR camera stage and µ-ILED devices injected in brain tissue. (C) Measured and 
(D) calculated tissue temperature with µ-ILEDs injected into a 0.3 mm thick slab of tissue, 
evaluated at the surface for the case of 10 mW DC input power.  Measured and calculated 
temperatures are 42.09 and 43.82 oC, respectively. 
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Figure 2.22 IR images of a phantom skin sample and the surrounding environment during 
prolonged exposure to RF radiation. IR images (left) and extracted average temperatures 
(right) of a phantom skin sample and the surrounding environment during prolonged exposure to 
RF radiation, starting at time=0 s.  The results indicate no observable effects of heating due to 
RF. The temperature variations in the phantom skin are small, and mostly due to variations in the 
environment, without any observable effect, even under constant RF power (B) IR images (left) 
of a RF power scavenger circuit during exposure to constant RF radiation for various times. The 
images show changes in temperature when RF power is applied, and the µ-ILEDs are turned on, 
for 0 (left), 60 (right, top), and 120 (right, bottom) min. Spatially averaged changes in 
temperature (right) of the RF power scavenger circuit and connector during prolonged exposure 
to constant RF radiation, starting at time=0 s.  The temperature change is less than 0.5ºC during 
this 2 hr period. (C) IR images (left) of a thin, lightweight flexible RF power scavenger circuit 
during exposure to pulsed (10 Hz) RF radiation for various times: 1 (left), 30 (middle), and 60 
(right) min. There is no temperature change (right) in the thin, lightweight flexible RF power 
scavengers (near the antenna and the connectors) during prolonged exposure to pulsed RF 
radiation at 10 Hz. 
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For use in optogenetics, such devices eliminate the need for lasers, bulk LEDs, fiber 
coupling systems, tethers, and optomechanical hardware used in conventional approaches 
(Figure 2.9). Furthermore, the fundamental optics of µ-ILEDs are very different from typical 
fiber optic implants. Absorbing and reflecting structures around the emissive areas of the µ-
ILEDs enable precise delivery of light to cellular sub-regions. Figure 2.23A and B compare 
relative size and the different patterns of light emission from µ-ILEDs to fiber optic probes. 
Fiber optics typically approach brain structures dorsally. This approach preferentially illuminates 
cells in the dorsal portion of the targeted region with greater light intensity near the point of light 
escape (Aravanis et al., 2007) (Figure 2.23B left, & Figure 2.24). Targeting ventral cell bodies 
or terminals requires lesion of dorsal regions or the use of substantially greater, and potentially 
phototoxic (Yizhar et al., 2011), amounts of light to the site of interest. Neither option protects 
the intact architecture of a complete brain locus. Although recent advances have spatially 
restricted light from implanted fiber optics (Tye et al., 2011; Zorzos et al., 2012), these 
approaches require the use of invasive metal cannulae (Figure 2.23E) or rely on sophisticated 
and sensitive optomechanical engineering that may limit their use in awake, behaving animals. 
The architecture of the !-ILEDs enables light delivery medial or lateral to the intended target 
brain region. Native light escape from !-ILEDs is nearly omni-directional (Figure 2.23B, 
center) but can be restricted to a wide range of angles with absorbing or reflective structures on 
the device (Figure 2.23B, right).  
We implanted both µ-ILEDs and fiber optics into animals expressing ChR2(H134)-eYFP 
(fused with enhanced yellow fluorescent protein) in the locus coeruleus (LC) (Figure 2.24). One 
hour of output-matched photostimulation induced c-fos expression (Carter et al., 2010), a 
biochemical marker of neuronal activation, in both groups of ChR2(H134)-eYFP-expressing 
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mice that was not seen in green fluorescent protein (GFP) expressing controls (Figure 2.23C 
and D). The spatial distribution of c-fos expression, however, differed markedly between the 
fiber optic and !-ILED groups. !-ILED devices produced significantly greater activation in the 
ventral LC (Figure 2.23D). 
The physical sizes and mechanical properties of the µ-ILED systems reduce lesioning, 
neuronal loss, gliosis, and immunoreactivity. Glial responses are biphasic with an early phase 
featuring widespread activation of astrocytes and microglia and a late, prolonged phase 
hallmarked by restriction of the gliosis to the area closest to the implanted substrate (Szarowski 
et al., 2003). The µ-ILED devices produced substantially less glial activation and caused smaller 
lesions than metal cannulae and fiber optics, at both early (2 weeks) and late (4 weeks) phases 
(Figure 2.23E). Furthermore, 
the brain tolerates the thin, 
flexible devices better than 
rigid structures (Figure 
2.23E), consistent with 
reports on passive electrode 
devices (Kozai and Kipke, 
2009).  Finally, we examined 
the chronic functionality of 
the devices and demonstrated 
that they are well tolerated in 
freely moving animals with 
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encapsulated sensors and µ-ILEDs, which maintain function over several months (Figure 2.25). 
Figure 2.23 !-ILED devices improve spatial targeting and reduce gliosis. (A) Colorized 
SEM (left) of a !-ILED mounted on a standard 200 !m fiber optic implant. (B) Left, a dorsal-
ventral oriented light cone (outlined in white) from a 200 !m bare fiber implant (blue dash) 
emitting 465 nm light in 30 !M fluorescein water. Center, near omnidirectional light escape 
from a !-ILED device (blue dash) with four 450 nm !-ILEDs. Right, lateral light escape 
(outlined in white) from a modified !-ILED device (blue dash) to allow unique spatial targeting 
including flanking positions along the dorsal-ventral axis of brain loci. (C) Confocal 
fluorescence images of 30 !m brainstem slices containing the LC show staining for tyrosine 
hydroxylase (TH) and c-fos in control (left), fiber optic implanted (center), and !-ILED device 
implanted (right) animals following 1 hour 3 Hz photostimulation (15 ms pulses, 5 mW output 
power). Scale bar = 100 !m.  (D) Fiber optic and !-ILED treatments specifically increase co-
immunoreactivity. Ventral portions of the LC the !-ILED devices express a higher proportion of 
tyrosine hydroxylase (TH, blue) and c-fos (red) co-immunoreactive neurons than fiber optic or 
control groups (n = 3 slices per brain from 3 brains for each group; Two-way ANOVA with 
Bonferroni post-hoc; All error bars represent means ± SEM; *p < 0.05, **p < 0.01). (E) 
Confocal fluorescence images of 30 !m striatal slices show staining for astrocytes (GFAP, red) 
and activated microglia (Iba1, green) at the ventral tip of each implanted device (dashed outline). 
Gliosis is smallest with the µ-ILED device at both two- and four-week time points. 
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Figure 2.24 Cartoon depicting the experimental strategy used in Fig. 3B & 3C. !-ILED 
devices allow for unique spatial targeting of brain structures (here the locus coeruleus) to provide 
consistent illumination along the entire dorsal-ventral plane of the structure. 
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Figure 2.25 The durability of the devices and the constituent 
component following chronic implantation. (A) Survival curve 
showing viability of !-ILEDs, fully passivated sensors 
(temperature and !-IPD), and animals following device injection. 
!-ILEDs were considered viable if the all !-ILEDs in each array 
were still emitting sufficient light to activated ChR2. Sensors were 
considered viable if performance was within 1% of original 
performance. Components performed reliably within the two-
three week timespan of a normal behavioral experiment and often 
well beyond that range. Detailed information on each point of 
attrition or censorship is available in Table 2.1. (B) The !-ILED 
devices are robust and capable of functioning properly months 
after implantation. Working devices one (top), three (center), and 
six (bottom) months after chronic implantation into freely moving 
mice. 
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Table 2.1 Detailed information on the attrition and censoring of devices from Figure 2.25A. 
The last working day after implantation was recorded as 0 if the damage occurred prior to or 
during implantation. 
Device ID Reason for attrition/censor Last working day after implantation 
S1 Testing period ended, sensor working 21 
S2 Testing period ended, sensor working 21 
S3 Testing period ended, sensor working 21 
S4 Testing period ended, sensor working 21 
S5 Testing period ended, sensor working 21 
S6 Testing period ended, sensor working 220 
S7 Interconnect failure 0 
S8 Testing period ended, sensor working 7 
L1 Structural damage during implantation 0 
L2 Testing period ended, !-ILEDs working 220 
L3 Animal died, device damaged on removal 183 
L4 Testing period ended, !-ILEDs working 220 
L5 Testing period ended, !-ILEDs working 220 
L6 Testing period ended, !-ILEDs working 220 
L7 Testing period ended, !-ILEDs working 220 
L8 Testing period ended, !-ILEDs working 220 
L9 Testing period ended, !-ILEDs working 220 
L10 Testing period ended, !-ILEDs working 220 
L11 Testing period ended, !-ILEDs working 220 
L12 Testing period ended, !-ILEDs working 30 
L13 Animal died, device damaged on removal 164 
L14 One or more !-ILED failure 186 
L15 Testing period ended, !-ILEDs working 90 
L16 Testing period ended, !-ILEDs working 90 
L17 One or more !-ILED failure 220 
L18 One or more !-ILED failure 220 
L19 One or more !-ILED failure 220 
L20 One or more !-ILED failure 220 
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We next implemented a fully wireless system for dissecting complex neurobiology and 
behavior. Phasic neuronal firing of ventral tegmental area (VTA)-dopaminergic (VTA-DA) 
neurons encodes salient stimuli and is sufficient for behavioral conditioning (Adamantidis et al., 
2011; Kim et al., 2012a; Tsai et al., 2009; Witten et al., 2011). We selectively targeted 
ChR2(H134)-eYFP to VTA-DA neurons (Figure 2.26A) and tested whether mice would engage 
in wireless, optical self-stimulation (20 5-ms pulses every nose poke) of their dopamine reward 
pathway. To increase the contextual salience of the stimulation and to demonstrate wireless 
function of the µ-ILED devices, the mice were free to explore a complex environment (Figure 
2.27A-C). In the absence of physical reward, the same stimulation of VTA-DA neurons that 
drives a traditional conditioned place preference (Figure 2.10) (Adamantidis et al., 2011; Tsai et 
al., 2009) is actively sought with a cued nose poke when paired within a discrete environmental 
context. ChR2(H134)-eYFP mice learned to self-stimulate their dopamine neurons (Figure 
2.26B and C) and, furthermore, developed a robust place preference (Figure 2.26D and E) for 
the environmental context containing the active nose poke for VTA-DA stimulation. 
ChR2(H134)-eYFP animals showed strong correlation (r = 0.8620, p = 0.0272) between the 
number of active nose pokes and the magnitude of conditioned place preference that was absent 
in eYFP controls (Figure 2.26F and Figure 2.27E). In addition, we examined the effects of 
wireless tonic stimulation of VTA-DA neurons on anxiety-like behavior. Tonic stimulation (at 5 
Hz) reduced anxiety-like behavior, whereas phasic activation of VTA-DA neurons did not have 
an effect on anxiety-like behavior (Figure 2.28). These findings are consistent with the 
anxiolytic actions of nicotine on VTA-DA neurons, as well as the behavioral phenotypes seen in 
the Clock%19 mice that have increased tonic firing of VTA-DA neurons (Coque et al., 2011; 
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McGranahan et al., 2011) and further establish the utility of wireless optogenetic control in 
multiple environmental contexts.  
 Figure 2.26. Wirelessly powered !-ILED devices operantly drive conditioned place 
preference. (A) Cell-type specific expression of ChR2(H134)-eYFP (green) in dopaminergic, 
TH (red) containing neurons of the VTA. For clarity, inset shows TH channel alone. All scale 
bars = 100 !m. (B) Operant learning curve on the active (left) and inactive (right) nose poke 
devices over 5 days of 1-hour trials in the Y-maze. Active pokes drive 1 s of 20 Hz light (5 ms 
pulses) from the !-ILED device on a fixed-ratio-1 schedule (n = 6-8 mice/group; Two-way 
ANOVA with Bonferroni post-hoc; **p < 0.01). (C) Mean number of nose pokes ± SEM across 
all five conditioning sessions. (*p < 0.05 One-way ANOVA with Bonferroni post-hoc) (D) Heat 
maps of activity during the post-test, hotter colors represent longer duration in a location in that 
part of the apparatus. (E) Left, place preference scores calculated as post-test minus pre-test in 
the active nose poke-paired context. Five days of self-stimulation significantly conditioned a 
place preference that developed over the course of the training sessions and remained during the 
post-test (right; *p < 0.05 t-test compared to controls; *p < 0.05 Two-way ANOVA with 
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Bonferroni post-hoc). All error bars represent means ± SEM (F) Scatter plot demonstrating 
positive correlation (r = 0.8620, p = 0.0272) between post-test preference and total number of 
active nose pokes during training in the ChR2(H134)-eYFP group.  
 
 
Figure 2.27 Wireless !-ILED devices drive an operantly conditioned place preference.  (A) 
Cartoon and (B) photo of Y-Maze with contexts and nose poke devices, red zones were not 
accessible during pre/post-tests. (C) Timeline of experimental approach. (D) Total activity 
during the conditioning shows increase in total ambulation of the ChR2 mice during the first four 
days of training. (E) Scatter plot demonstrating no correlation (r=-0.1707, p=0.6861) between 
post-test preference and total number of active nose pokes during training in the AAV-DIO-
eYFP injected controls.  
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Figure 2.28 Tonic, not phasic, activation of VTA-DA neurons induces anxiolytic-like 
behavior. (A) 5 Hz activation of VTA-DA neurons induces an anxiolytic-like behavioral 
response in an elevated zero maze independent of (B) locomotor effects (n=6-9; *p<0.05 t test 
compared to AAV5-DIO-eYFP controls). (C) Phasic (20, 5 ms pulses of 20 Hz light every 
minute) stimulation does not influence anxiety-like behavior or (D) locomotor activity in the 
open field test (n=6-8/group). 
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DISCUSSION 
These experiments demonstrate that these devices can be readily used in optogenetic 
experiments. Future possible uses are in closed-loop operation, where actuators (e.g. heat, light, 
and electrical) operate in tandem with sensors (e.g. temperature, light, and potential) for altering 
light stimulation in response to physiological parameters, such as single-unit activity, pH, blood 
oxygen or glucose levels, or neurochemical changes associated with neurotransmitter release. 
Many of the device attributes that make them useful in optogenetics suggest strong potential for 
broader use in biology and medicine. The demonstrated compatibility of silicon technology in 
these injectable, cellular-scale platforms foreshadows sophisticated capabilities in electronic 
processing and biological interfaces. Biocompatible deep-tissue injection of semiconductor 
devices and integrated systems, such as those reported here, will accelerate progress in both basic 
science and translational technologies. 
MATERIALS AND METHODS 
Preparation of µ-ILEDs 
The fabrication began with epitaxially grown GaN on a sapphire wafer (500 µm thick 
double polished sapphire with 2” diameter, Cermet Inc.).  The GaN stack layers consisted of 
undoped GaN (3.8 µm), n-type GaN (2 µm), spacer (0.4 µm), MQW (0.14 µm), and p-type GaN 
(0.2 µm).  Residual metal ions and GaN oxide on the surface were removed by rinsing with 
diluted HCl (33 %). L-shaped current spreading layers of Ni (15 nm) and Au (15 nm) were 
formed by sputter deposition (AJA ATC 2000), followed by annealing at 500 oC for 5 min in an 
oxygen and nitrogen atmosphere to form an ohmic contact.  After exposing n-type regions 
defined using photolithography (40 x 40 µm2 recessive square with thick AZ 2035, Microchem 
Inc) and etched using chorine based-inductively coupled plasma reactive ion etching (ICP RIE, 
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Plasmatherm, SLR-770), both n- and p- contact pads, each 25 x25 µm2 in dimension, of 15 nm of 
Cr and 300 nm of Au were deposited by electron beam evaporation (Temescal, FC-1800). To 
define the lateral dimensions of the devices (100x100 µm2), chorine based ICP RIE was used to 
remove GaN down to the sapphire substrate, with negative tone photoresist as an etching mask 
(AZ 2070, Micorchem Inc).  
After deposition of a passivation layer of SiNx (200 nm) by plasma enhanced chemical 
vapor deposition (PECVD; STS, Mesc Multiple) the processed substrate was bonded to a silicon 
wafer using a layer of palladium (Pd)-indium (In) chemical alloy, followed by laser lift off (KrF, 
intensity,~0.9 J/cm2) to remove the sapphire from the µ-ILEDs. Here, the laser light triggered 
thermal decomposition at the GaN-sapphire interface, allowing easy mechanical removal of 
sapphire substrate upon heating to 70 oC on a hotplate. Wet etching with 5 wt% diluted HCl 
selectively removed the underlying unalloyed In layer, leaving residual porous structures of In-
Pd alloy that served as anchors to tether the µ-ILEDs to the silicon wafer.  In this configuration, 
the devices were easily lifted onto the surfaces of microstructured (3 µm in diameter, 1.2 µm in 
height, and 5 µm in space) slabs of poly(dimethylsiloxane) (PDMS; Sylgard 184, Dow Corning) 
via the action of van der Waals forces.  Etching the exposed unalloyed Pd and passivation layer 
(SiNx) removed all of residual metal on the µ-ILEDs.  The result was an array of µ-ILEDs on 
microstructured PDMS, suitable for manipulation by transfer printing, for integration onto 
microneedles. 
 
Fabrication of releasable, injection microneedles 
To fabricate penetrating polymeric microneedles, suitable shapes were first defined in layers 
of Cr (15 nm) and Au (300 nm) deposited on a glass slide (5 x 3.5 cm2) by photolithography and 
wet etching. Photo-curable epoxy (SU-8 100, Microchem Inc) was then spin cast (1100 rpm for 
67 
250 µm and 1800 rpm for 150 µm thickness) on the slide, and ultraviolet light was passed (380 
mJ/cm2) through the backside to define a pattern of exposure in the epoxy, with the geometry of 
the microneedle.  Developing away the unexposed regions followed by thermal annealing (150 
oC for 10 min) defined and fully cured the epoxy to complete the fabrication of microneedles, 
typically in array geometries. Poor adhesion between the glass and the epoxy allowed easy 
mechanical removal of the microneedles, with tweezers, stamps or other implements. The left 
image of Figure 2.6 shows an array of epoxy microneedles on glass.  The left and right three 
microneedles were removed before this image was collected.  
To fabricate 6 µm thick (or 2.5 µm thick for µ-ILED) polyester device substrates (Mylar® 
film, Chemplex® industries) with similar microneedle layouts, the films were first laminated on a 
PDMS coated substrate. Patterns of Cr (100 nm thickness) in microneedle geometries were used 
as etching masks for oxygen plasma RIE (March polymer RIE) of the exposed regions of the 
films.  Wet etching of the Cr completed the fabrication.   
 
Fabrication of sensors 
For microelectrodes and temperature sensors, 6 µm thick, patterned polyester films on 
PDMS coated glass, formed according to procedures described above, were used.  To fabricate 
the electrophysiological sensor, 100 µm wide and 100 nm thick lines of Pt were formed on the 
needle by photolithography and lift-off using negative tone resist (AZ 2070, Microchem Inc).  To 
measure electrophysiological signals from a single neuron, an epoxy passivation layer (SU-8 2, 
Microchem Inc.) defined 20 x 20 µm2 openings to the underlying Pt, as the sensing locations. For 
temperature sensors, 20 nm thick and 20 µm wide Pt serpentine structures served as resistors, 
connected by Au electrodes at both ends.   
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 For the photodetectors, the top silicon layer of an silicon on insulator (SOI) wafer (1.25 
µm thick silicon on a 400 nm thick layer of silicon dioxide on a silicon substrate, Soitec) was p- 
and n- doped sequentially through masking layers of silicon dioxide (900-nm thick) deposited by 
plasma-enhanced chemical vapor deposition and patterned by photolithography and etching. For 
p-doping, the sample was exposed to a boron source for 30 min at 1000 oC in an N2 environment. 
The n- doping used a phosphorous source under the same conditions for 10 min. A single cell 
had a size of 200 µm x 200 µm including p- and n- doped parts with 200 µm x 40 µm (active 
area: 200 µm x 120 µm), isolated by reactive ion etching through the silicon layer in a geometry 
patterned by photolithography. The buried oxide layer of the SOI wafer was partially etched to 
slightly undercut slicon layer. Next, photolithography defined photoresist structures at the four 
corners of each square cell to hold the silicon layers to the underlying silicon wafer during 
complete removal of the silicon dioxide layer with HF. 
 
Measurements on µ-IPD 
The current responses of µ-IPDs at different current injection levels (0 to 9 mA) into four 
blue µ-ILEDs, in an array, were measured at biases of -5V to 5V. For time-dependent light 
response measurements, AC current with four different frequencies (i.e., 3, 5, 10, and 20 hz) 
were applied to the µ-ILEDs using a pulse generator (Global Specialities®). The current resonse 
of the µ-IPDs at a bias of -3V were measured for 8 s with a sampling rate of 160 Hz. 
 
Impedance measurements on microelectrode 
Impedance was measured using a potentiostat (Gamry instruments, reference 600) with 
phoshate buffered saline (PBS, Sigma-Aldrich). The PBS solution was diluted in 1 liter 
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deionized water for 0.01 M, pH 7.4 at 25 oC. To measure impedance, we appied frequency 
ranging from 11.0 KHz to 1 KHz.  
 
Fabrication of µ-ILED arrays and interconnects on microneedles  
1. A PDMS stamp with posts (100 & 100 µm and heights of 100 µm) was positioned 
above µ-ILEDs on a structured PDMS slab and then used to remove an µ-ILED, one at a time, 
for integration onto a thin UV curable adhesive coated on a 2.5 µm thick microneedle shaped 
substrate (patterned polyester film on PDMS coated glass, fabricated using steps similar to those 
described above for the sensors).  The printing was performed using a modified mask aligner 
(Karl Suss, MJB).  To form interconnected arrays of µ-ILEDs, the SiNx passivation layer was 
first removed by reactive ion etching (RIE; Plasmatherm 790).  Coating with an adhesion 
promoter (Dow, AP3000) and then a layer of photosensitive benzocyclobutene (6 µm thick; 
BCB) prepared the devices for backside exposure to ultraviolet light, through the transparent 
substrate.  This light exposed the BCB in all regions except those above the opaque n-, and p- 
contact pads. Developing away the unexposed BCB (Advanced Developer, DS2100) and 
blowing with a stream of N2 removed the residual developer, to complete the patterning process 
for via holes.  After fully curing the BCB in an Ar atomosphere in a glove box at 210 oC for 3 hr, 
remaining BCB residues on the contacts were removed by oxygen RIE.  To form metallization 
lines to the contacts, 15 nm of Cr and 300 nm of Au were sputter deposited, and then wet etched 
through a photopatterned layer of photoresist.  Finally, an epoxy layer (2 µm thick, SU-8 2 
Microchem) was spin cast and cured to form insulating coatings on the electrodes. 
 
Forming multi-functional µ-ILED systems on releasable injection microneedles 
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Separately fabricated thermal and electrophysiological sensors and printed µ-ILEDs, each 
on polyester thin film substrates, were stacked in an aligned configuration on a penetrating epoxy 
microneedle substrate using a modified mask aligner (Karl Suss, MJB).  A thin layer of UV 
curable epoxy (SU-8 2) served as an adhesive for bonding the sensors and the µ-ILEDs.  For 
bonding the entire stack to the penetrating microneedle, a thin layer of purified silk (7 wt%) was 
used, to allow release of after implantation. After curing or drying, the adhesives in all cases 
have thicknesses of a few hundred nanometers.  
 
Characterization of optical and thermal properties  
Optical measurements of the emission spectra and light output were obtained with a 
spectrometer (HR4000 and FOIS-1 fiber optics integrating sphere, Ocean Optics). Thermal 
measurements were performed using a MWIR-based InDb thermal imager (InfraScope, GFI) 
with a base temperature of 37oC.  
 
Wired powering 
µ-ILED devices were connected to a function generator (AMPI, Master-9 or Tektronix, 
AFG3022B) and TTL modulation (low 0V, high 4V) was used to power the !-ILEDs at the 
stated frequencies and pulse widths.   
 
Wireless powering and RF powering scavenger 
The wireless power transmitter includes a low-frequency signal generator, an RF signal 
generator, a power supply, a RF power amplifier, and a panel antenna.  The low-frequency signal 
generator outputs an amplitude modulation signal to modulate the RF power generator.  The RF 
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power amplifier that is powered by the power supply enlarges the modulated RF signal from the 
RF signal generator.  The RF power is then transmitted from the panel antenna on 75 µm thick 
polyimide layer or commercialized PCB board. The RF signal generator has a power output from 
-10 to -17 dBm at 910 MHz, which corresponds to a power ranging from 0.1 mW to 0.02 mW.  
The power amplifier has a gain of 49 dB, thus the power output from the power amplifier is from 
1.6 to 7.9 W.  Under an antenna gain of 13 dBi and at a distance that is approximately 1 meter 
away from the antenna, the RF power that reaches the mice is approximately 4 mW, given an 
exposure area of the mice of ~32 cm2. Mice with chronically implanted µ-ILED devices were 
acutely connected to the headstage antenna immediately prior to any wireless photostimulation. 
 
Numerical modeling of temperature in the µ-ILEDs 
A three dimensional (3D) model was established to study the temperature distributions in 
the system in  the pulsed mode and DC mode.  Eight-node, hexahedral brick elements in the 
finite element software ABAQUS were used to discretize the geometry.  The µ-ILEDs are 
modeled as heat sources.  The bottom surface of device was set as a constant temperature, while 
the other surfaces are free heat convection boundary with the convection heat transfer coefficient 
25 W/(m2'K).  The initial temperature of the device was set as the environmental temperature 
.  The dimensions and layout of the device can be found in the main text.  The 
microelectrodes and the sensors were neglected in the finite element simulations due to their 
small thickness (~300 nm) compared to that of other layer (~6 µm).  The thermal conductivity, 
density and thermal capacity are 317 W/(m'K), 19300 kg/m3 and 130 J/(kg'K) for Au, 0.2 
W/(m'K), 1190 kg/m3 and 1200 J/(kg'K) for epoxy (Solano et al., 2008), 0.15 W/(m'K), 1050 
kg/m3 and 1270 J/(kg'K) for polyester (Mattsson et al., 2007), 230 W/(m'K), 2330 kg/m3 and 
T!
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700 J/(kg'K) for µ-ILEDs (Kim et al., 2012b), and 0.29 W/(m'K), 1050 kg/m3 and 2180 J/(kg'K) 
for BCB (Modafe et al., 2005).  
Figure 2.18A shows the time-average temperature of µ-ILEDs operated in pulsed modes 
(3, 10, and 20 Hz) and DC mode at 5, 10, 15 and 20 mW input power when the background 
temperature is = 37 oC.  The finite element results (line) agree well with the experimental 
measurements (dot).  Figure 2.18B and C show the surface temperature distribution from 
experiments and finite element simulations.  They agree reasonably well with each other and the 
discrepancy is due to the assumption of heat source only for µ-ILEDs since other parts (e.g., Au 
interconnect) may also serve as heat sources. 
Analytical modeling of temperature in the tissue 
An analytical model was established to obtain the steady temperature in the tissue when the 
device is inserted into the mouse brain tissue.  The µ-ILED is modeled as a disk heat source with 
a radius r0= corresponding to the same area of µ-ILED (L&L) and a heat generation of 
Q(t).  Since the thickness of tissue (~4 mm) is much larger than that of device (~100 µm), we 
ignore the device structure in the analytical modeling. Once we have the temperature due to a 
single µ-ILED, the temperature due to four µ-ILEDs can be obtained by the superposition 
theorem.   
The heat transfer equation in cylindrical coordinate with the origin as the center of µ-ILED 
is  
                                                      (1) 
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where k is thermal conductivity of tissue,  is density of tissue, c is specific heat capacity of 
tissue.  The thermal diffusivity of tissue is .  By setting , where  is the 
remote temperature, the above equation becomes 
 
                 
                                        (2) 
Boundary conditions involve the adiabatic condition on the top surface (z=-h0) and a constant 
temperature = 37 oC on the bottom surface (z=h1).  At the µ-ILED interface (z=0), 
discontinuous heat flow Q(t) is assumed as a means to introduce the input pulsed power.  Let’s 
consider a unit pulsed power P(t) for time between 0 an t0 with a period T, which can be 
expanded into Fourier Series 
                             (3) 
where .  For each 
cos(nwt) [or sin(nwt)] in the power expression of Eq. (3), we can assume the solution of Eq. (2) 
to be .  Equation (2) then becomes 
 
                 
                                (4) 
where .  Equation (4) can be solved by applying the Hankel transformation.  For 
, we obtain the solution as       
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where . 
The temperature increase due to the power of cos(nwt) [or sin(nwt)] is then equal to  
 [or ] where .  The 
temperature due to the power P(t) in Eq. (3) is given by 
 (6) 
The temperature due to the four µ-ILEDs with total power Q(t)=Q0*P(t)/4 can then be given by 
                                          
                                                   (7) 
In vitro experiments, the thermal conductivity k of the issue is 0.6 W/(m'K), the density  is 
1040 Kg/m3, the specific heat c is 3650 J/(kg'K)(Elwassif et al., 2006). The predicted surface 
temperature (z=-h0) agrees well with experimental measurement as shown in Figure 2.19 and 
Figure 2.15D and E.   In vivo experiments, there is a heat loss due to blood flow and we fit an 
effective power to be 0.62 mW at 3Hz.  Then the predicted the time-averaged temperature at the 
location of temperature sensor (z=-6 µm) agrees very well with that in experiments at other 
frequencies with ~5% error.  To further verify the analytical solution in Eq. (7), a full 3D finite 
element model for the device/tissue system is also established.  The time history of average 
temperature in Figure 2.15F shows a good agreement between finite element simulation and 
experimental measurement.     
Preparation of phantom skin and IR measurement of RF scavenger 
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 The potential localized heating effect of RF power is characterized using a phantom skin 
sample that is placed in the RF field. The phantom skin (Esler et al., 2010; Ito et al., 2001) is a 
gelatin-based material that is made of the combination of water, agar, polyethylene, sodium 
chloride, sodium azide (Sigma-Aldrich Co.), and TX 151 (Oil Center Research), and has similar 
electrical properties as animal skin at the RF range. The thermal imaging is taken using an 
infrared camera (A655sc, FLIR Systems, Inc.), which has high resolution and a measurement 
accuracy at ±2% of the reading value.  
Experimental subjects  
Adult (25–35 g) male C57BL/6J and TH::IRES-Cre backcrossed to C57BL/6J mice were 
group-housed, given access to food pellets and water ad libitum (except where noted) and 
maintained on a 12 h:12 h light:dark cycle (lights on at 7:00 AM). All animals were held in a 
facility in the lab 1 week prior to surgery, post-surgery and throughout the duration of the 
behavioral assays to minimize stress from transportation and disruption from foot traffic.  All 
procedures were approved by the Animal Care and Use Committee of Washington University 
and conformed to US National Institutes of Health guidelines.  
Viral preparation 
 Plasmids coding pAAV-EF1a-DIO-EFYP, pAAV-EF1a-double floxed-hChR2(H134R)-
EYFP-WPRE-HGHpA, and pLenti-EF1a-hChR2(H134R)-EYFP-WPRE were obtained from 
Addgene (Addgene.org) originally from the Deisseroth Laboratory at Stanford University. The 
DNA was amplified with a Maxiprep kit (Promega) and packaged into AAV5 serotyped viruses 
by the WUSTL Hope Center Viral Core. LV-PGK-GFP was provided by the WUSTL viral core 
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facility. The final viral concentration was 2-5 x 1012 genome vg/mL for the adeno-associated 
viruses and 1.1-1.3 x 108 IU/ml for all the lentivirus used. 
Table 2.2 
Plasmid Source Packaged by Serotype Titer 
pAAV-EF1a-
DIO-EFYP 
Deisseroth 
Laboratory 
(Stanford) 
WUSTL Hope 
Center Viral 
Core 
AAV5 5 x 10^12 vg/ml 
pAAV-EF1a-
double floxed-
hChR2(H134R)-
EYFP-WPRE-
HGHpA 
Deisseroth 
Laboratory 
(Stanford) 
WUSTL Hope 
Center Viral 
Core 
AAV5 2 x 10^13 vg/ml 
pLenti-EF1a-
hChR2(H134R)-
EYFP-WPRE 
Deisseroth 
Laboratory 
(Stanford) 
WUSTL Hope 
Center Viral 
Core 
N/A 1.1 x 108 IU/ml 
pRRLsinPGK-
GFPppt 
Sands 
Laboratory 
(WUSTL) 
WUSTL Hope 
Center Viral 
Core 
N/A 1.3 x 108 IU/ml 
 
Stereotaxic surgery  
 After the animals were acclimatized to the holding facility for seven to nine days, they 
were anaesthetized in an induction chamber (4% Isolflurane) and placed in a stereotaxic frame 
(Kopf Instruments, Model 1900) where they were maintained at 1-2% isoflurane. A craniotomy 
was performed and mice were injected with 1ul of AAV5-DIO-ChR2 or AAV5-DIO-eYFP, LV-
Ef1"-ChR2-eYFP, or LV-Ef1"-GFP unilaterally into the VTA (stereotaxic coordinates from 
bregma: -3.20 anterior-posterior (AP), +/(0.50 medial-lateral (ML), (4.90 mm dorsal-ventral 
(DV)), LC (-5.45 AP, +/- 1.25 ML, -4.00 DV), or the ventral striatum (1.3 AP, +/- 1.0 ML, -4.00 
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DV). Mice were then implanted with metal cannula (PlasticsOne; coordinates adjusted from viral 
injection 0.00 AP, +/- 0.25 ML, +1.00 DV), fiber optic implants (coordinates adjusted from viral 
injection 0.00 AP, +/- 0.25 ML, +1.00 DV)(Sparta et al., 2011), or a !-ILED device (same 
coordinates as viral injection). Custom adapters (WUSTL Instrument Machine Shop) for the 
Kopf cannula holder (Model 1966) were used to implant the fiber optics and the !-ILED devices. 
For biodissolvable samples, the device was implanted at the desired target, ACSF was applied to 
the portion of the device that remained outside of the skull to facilitate dissolution of the 
adhesive, and then the epoxy needle was removed after a delay of 15 minutes. The implants were 
secured using two bone screws (CMA, 743102) and affixed with TitanBond (Horizon Dental 
Products) and dental cement (Lang Dental). Mice were allowed to recover for 3-5 weeks prior to 
behavioral testing; this interval also permitted optimal AAV expression and Cre recombinase 
activity.  
Immunohistochemistry  
 Immunohistochemistry was performed as described (Bruchas et al., 2011). Briefly, mice 
were anesthetized with pentobarbital and intracardially perfused with ice-cold 4% 
paraformaldehyde in phosphate buffer (PB). Brains were dissected, post-fixed for 24 hr at 4 ºC 
and cryoprotected with solution of 30% sucrose in 0.1M PB at 4ºC for at least 24 hr, cut into 30 
!m sections and processed for immunostaining. 30 !m brain sections were washed three times in 
PBS and blocked in PBS containing 0.5% Triton X-100 and 5 % normal goat serum. Sections 
were then incubated for ~16 hr at room temperature in rabbit anti c-fos antibody (1:20000, 
Millipore), guinea pig anti-GFAP (1:500, Synaptic Systems), rabbit anti-Iba1 (1:300, Wako 
Chemicals) and/or chicken anti-TH (1:2000, Aves Labs). Following incubation, sections were 
washed three times in PBS and then incubated for 2 hr at room temperature in Alexa Fluor 488 
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goat anti-mouse IgG (1:500, Invitrogen), Alexa Fluor 594 goat anti-rabbit IgG (1:500, 
Invitrogen-), goat anti-chicken Alexa Fluor 633(1:500, Invitrogen) and/or goat anti-guinea pig 
Alexa Fluor 546(1:500, Invitrogen) were then washed three times in PBS and followed by three 
10-min rinses in PB and mounted on glass slides with Vectashield (Vector Labs) and sealed with 
nail polish for microscopy. All sections were imaged on both epifluorescent (Olympus BX61) 
and confocal (Olympus Fluoview 500) microscopes. Gain and exposure time were constant 
throughout, and all image groups were processed in parallel using Adobe Photoshop CS5 (Adobe 
Systems). 
Table 2.3 
Antibody Species Dilution Source 
GFAP Guinea Pig 1:500 Synaptic Systems 
Iba1 Rabbit 1:300 Wako Chemicals 
TH Chicken 1:2000 Aves Labs 
c-fos Rabbit 1:20,000 Millipore 
Alexa Fluor 488 anti-
mouse IgG 
Goat 1:500 Invitrogen 
Alexa Fluor 594 anti-
rabbit IgG 
Goat 1:500 Invitrogen 
Alexa Fluor 633 anti-
chicken IgG 
Goat 1:500 Invitrogen 
Alexa Fluor 546 anti-
guinea pig IgG 
Goat 1:500 Invitrogen 
Alexa Fluor 594 anti-
chicken IgG 
Goat 1:500 Invitrogen 
 
Cell culture and transfection of NOPR-YFP expressing, HEK293 Cells 
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 A single 50 x 50 x 6.45 !m !-ILED was printed onto a standard glass coverslip 
(Fisherbrand, 12-545-80). The glass was coated with Poly-L-lysine (Sigma-Aldrich, P4707) to 
facilitate cell adhesion. Stable HEK293 cells expressing pcDNA3 containing nociceptin opioid 
peptide receptor-YFP (NOPR-YFP) were generated as previously described (Zhang et al., 2012). 
The NOPR-YFP expressing cells were grown on the coverslip in a 24-well plate and placed in a 
37 °C 5% CO2 incubator. Cells were washed three times with PBS and then fixed in 4% 
paraformaldehyde for 20 min, washed in PBS, washed in 0.1 M PB, and mounted using 
VECTASHIELD (Vector Laboratories) and sealed with clear nail polish. Images were captured 
using Metamorph 7.6 (Molecular Devices) and processed with ImageJ 1.44o (NIH). 
cAMP Assay 
 HEK293 cells were co-transfected with Opto!2 (Airan et al., 2009) (pGloSensor-22F 
cAMP plasmid (Promega E2301) in 96-well format. Using a SynergyMx microplate reader 
(BioTek; VT, USA), baseline luminescence recordings were taken.  In the presence of 9-cis 
retinal (1!M), cells were exposed to !-ILED light (450 nm, 5 sec, 0.5 W/cm2 pulse) and relative 
luminescent units taken every 2 sec using GloSensor cAMP Assay (Promega). Relative 
luminescent units were normalized to an initial 1 min recording of baseline. Data are expressed 
as ± S.E.M. 
Immunoblotting 
 Western blots for phospho-MAPKs were performed as described previously (Zhang et 
al., 2012). Briefly, Opto!2 expressing HEK293 cells were serum-starved 4-6 h prior to treatment. 
Cells were light treated (450 nm, 1 min, 0.5 W/cm2 pulse),  lysed in 70 µl of lysis buffer (50 mM 
Tris-HCl, 300 mM NaCl, 1 mM EDTA, 1 mM Na3VO4, 1 mM NaF, 10% glycerol, 1% Nonidet 
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P-40, 1:100 of phosphatase inhibitor mixture set 1 (Calbiochem), and 1:100 of protease inhibitor 
mixture set 1 (Calbiochem)), sonicated for 20 s, centrifuged for 15 min (14000 x g, 4 °C).  50 µg 
of total protein was loaded onto non-denaturing 10% bisacrylamide precast gels (Invitrogen) and 
run at 150 V for 1.5 h. Blots were transferred to nitrocellulose (Whatman, Middlesex, UK) for 
1.5 h at 30 mV, blocked in TBS/5% bovine serum albumin for 1 hr, incubated overnight at 4 °C 
with a 1:1000 dilution of goat-anti- rabbit phospho-ERK 1/2 (Thr-202/Tyr-204) antibody (Cell 
Signaling) and mouse actin (1:20,000, AbCam). Following overnight incubation, membranes 
were washed 4 x 15 min in TBST (Tris- buffered saline, 1% Tween 20) and then incubated with 
IRDye 800- and 700 conjugated affinity-purified anti-rabbit or anti-mouse IgG at a dilution of 
1:5000 (pERK) or 1:20,000 (actin) in a 1:1 mixture of 5% milk/TBS and Li-Cor blocking buffer 
(Li-Cor Biosciences, Lincoln, NE) for 1 h at room temperature, washed 3 x 10 min in TBST, 1 x 
10 min in TBS and analyzed using the Odyssey infrared imaging system (Li-Cor Biosciences). 
Band intensity was measured using Odyssey software following background subtraction and 
integrated band density in high-resolution pixels calculated. All subtypes of ERK (1 and 2) were 
quantified together. All pERK bands were normalized to actin, as an equal protein loading 
control and plotted using GraphPad (GraphPad Prism 5.0) software. Statistical significance was 
taken as * p < 0.05 as determined by unpaired two-tailed t-test. 
In vivo electrophysiology 
 To demonstrate the ability of the incorporated electrode, spontaneous cellular activity 
was monitored in the deep midbrain (Figure 2.15H). For light modulated responses, an array of 
16 (35-µm tungsten wires, 150-µm spacing between wires, 150-µm spacing between rows, 
Innovative Physiology) was epoxied to a rigid !-ILED device and lowered into the VTA of a 
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lightly (~1% isoflurane) anesthetized, TH-Cre mouse expressing ChR2(H134)-eYFP in the VTA 
(Figure 2.17). Two skull screws were arbitrarily placed anterior to bregma on either side of the 
midline and used to ground the electrode array. In either approach, voltage readings from each 
electrode were bandpass-filtered with activity between 250 and 8,000 Hz analyzed as spikes. The 
signal was amplified and digitally converted using commercially available hardware and 
software (Omniplex and PlexControl, Plexon). Spikes were sorted using principal component 
analysis and/or evaluation of t-distribution with expectation maximization (Offline sorter, 
Plexon).  
Light path visualization 
 A 200 !m, 0.48 NA diameter fiber optic coupled to a 465 nm blue LED (Plexon) or 
devices with four, 100 x 100 x 6.45 !m 450 nm blue !-ILEDs were adjusted to have the same 
(~280 !W) light output. The light sources were submerged in 30 !M fluorescein sodium salt 
(Sigma-Aldrich, F6377) (Tye et al., 2011) in deionized water and the photos were taken in a dark 
room with an exposure of 1/1000 s and an f-number of 5.6 from ~50 cm away for all images. 
Each photo was cropped using Photoshop (Adobe Systems), but no other processing was used. 
c-fos expression 
 C57BL/6J mice were injected with LV-Ef1"-ChR2-eYFP or LV-PGK-GFP into the LC 
as described above. Three weeks later, animals were anesthetized, mounted on the stereotaxic 
instrument, and fiber optics or !-ILED devices were acutely implanted to target the LC. 5 mW, 3 
Hz blue light stimulation was delivered for 1 hour (Carter et al., 2010), animals were perfused 
immediately following, and immunohistochemistry was performed as above. Slices from the LC 
originated from approximately -5.45 mm caudal to bregma were mounted and imaged. For 
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quantification, the LC was divided into three  (dorsal, central, and ventral) 100 x 100 !m 
compartments. TH and c-fos labeled channels were separated, the compartment mask was 
applied, an exclusive threshold was set and positive staining for each channel was counted in a 
blind-to-treatment fashion using Metamorph. The counts from each channel were then overlaid 
and percent TH+ cells expressing c-fos were reported.  
Immuno-glial response in implanted tissues 
 C57BL/6J mice (n=16) were implanted with devices into the ventral striatum and allowed 
to recover for either 2 or 4 weeks before perfusion. Immunohistochemistry was performed as 
described.  
Conditioned Place Preference 
 VTA injected (AAV5-DIO-eYFP or AAV5-DIO-ChR2-eYFP; n=4-6/group) mice were 
trained in an unbiased, balanced three- compartment conditioning apparatus as described 
(Bruchas et al., 2011). Briefly, mice were pre-tested by placing individual animals in the small 
central compartment and allowing them to explore the entire apparatus for 30 min. Time spent in 
each compartment was recorded with a video camera (ZR90; Canon) and analyzed using 
Ethovision 8.5 (Noldus). Mice were randomly assigned to light and no-light compartments and 
received no light in the morning and light (20, 5 ms pulses every minute) in the afternoon at least 
4 h after the morning training on three consecutive days. CPP was assessed on day 5 by allowing 
the mice to roam freely in all three compartments and recording the time spent in each. Scores 
were calculated by subtracting the time spent in the light stimulus-paired compartment post-test 
minus the pre-test. 
Real-time Place Preference 
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 VTA injected (AAV5-DIO-eYFP or AAV5-DIO-ChR2-eYFP; n=3/group) TH-Cre mice 
were trained in an unbiased, balanced three-compartment conditioning apparatus as described 
(Lammel et al., 2012; Stamatakis and Stuber, 2012; Tan et al., 2012). Mice were trained in the 
same conditioning apparatus as described above, and the pretesting phase (day 1) was identical. 
However, on days 2–4, mice were still allowed to freely roam all three compartments. On these 
conditioning days, entry into one compartment was paired with 20, 5 ms pulses of light that 
would repeat every minute the animal remained in the light-paired chamber. On day 5, the post-
testing was identical as the above. Scores were calculated by subtracting the time spent in the 
light stimulus-paired compartment each day minus the pre-test. 
Operantly Conditioned Place Preference 
 VTA injected (AAV5-DIO-eYFP or AAV5-DIO-ChR2-eYFP; n=6-8/group) TH-Cre 
mice were prepared for nose poke training by mildly restricting daily food to four grams to 
stabilize body weight and facilitate behavioral responding. Mice were trained in an unbiased, 
balanced three-compartment Y-Maze. Each arm of the Y-Maze was 50 cm by 10 cm, a 50 cm2 
equilateral triangle connected all three arms (for a total area of 1550 cm2), and each arm was 
outfitted with a unique context (white, horizontal black stripes, or vertical black stripes). At the 
distal end of each of the striped arms a nose poke device (Med Associates, ENV-313M). On day 
1, the headstage antenna was attached and mice were pre-tested by placing individual animals in 
the intersection of the three arms and allowing them to explore the entire apparatus for 30 min. 
During the pre-test and post-test sessions, a wall was placed to prohibit access to the nose poke 
apparatus and the final 15 cm of each arm. On days 2-6, the headstage antenna was attached and 
mice were allowed access to the entire Y-Maze for 1 hour. During these conditioning sessions a 
cue light was on to indicate a stimulation could be achieved nose poke and turned off for 500 ms 
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following a poke on either device. A nose poke on the active device triggered an optical 
stimulation (20 pulses, 20 Hz, 5 ms pulse duration) on a fixed ratio-1 schedule, while a poke on 
the inactive device resulted in the cue light turning off for 500 ms. Nose pokes were recorded 
using a Med Associates TTL-I/O Interface connected to the Noldus Ethovision I/O Box. On day 
7, the post-testing was conducted in an identical manner as the pre-test. All activity and position 
data was recorded using Ethovision and analyzed using Microsoft Excel and GraphPad Prism 
5.0. Place preference scores were calculated by subtracting the time spent in the active nose 
poke-paired compartment each day minus the pre-test. 
Open Field Test 
 OFT testing was performed in a sound attenuated room maintained at 23ºC. Lighting was 
measured and stabilized at 200 lux, and performed in the afternoon between 13:00–1600 hrs. The 
open field was a 55 x 55 cm square enclosure and was cleaned with 70% ethanol between testing 
trials. For testing, VTA injected (AAV5-DIO-eYFP or AAV5-DIO-ChR2-eYFP; n=6-8/group) 
TH-Cre mice were connected to cables coupled to a function generator and placed in the center 
of the open field and allowed to roam freely for 15 min. During the entire trial, animals received 
20, 5 ms pulses of photostimulation. Movements were video- recorded and analyzed using 
Ethovision. The center was defined as a square comprised of 50% the total area of the OFT. 
Time in the center expressed as percentages total time was the primary measure of anxiety-like 
behaviors.  
Elevated Zero Maze 
 EZM testing was performed in a sound attenuated room maintained at 23ºC. Lighting was 
200 lux, and performed in the afternoon between 13:00–1600 hrs. The EZM (Harvard 
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Apparatus) was made of grey plastic (Dimensions: 200 cm in circumference comprised of four 
50 cm sections: two opened, two closed. The maze was elevated 50 cm above the floor and had a 
path width of 4 cm with a 0.5 cm lip on each open section) and was cleaned with 70% ethanol 
between trials. For testing, VTA injected (AAV5-DIO-eYFP or AAV5-DIO-ChR2-eYFP; n=6-
9/group) TH-Cre mice were connected to the headstage antenna and placed at the threshold of a 
closed section facing the open section and allowed to roam freely for 9 min. For the first and the 
final 3 minutes of each trial there was no photostimulation. For minutes 4-6, animals received 5 
Hz, 5 ms width stimulation. Movements were video- recorded and analyzed using Ethovision 
(Noldus). Open section times expressed as percentages total time the primary measures of 
anxiety-like behaviors.  
Data Analysis/Statistics 
 Data are expressed as means ± SEM. Data were normally distributed, and differences 
between groups were determined using independent t-tests or one-way ANOVA, or two-way 
ANOVAs followed by post hoc Bonferroni comparisons if the main effect was significant at p < 
0.05. Statistical analyses were conducted using Prism 5.0 (GraphPad). 
Genotyping of mouse lines  
  DNA was isolated from tail tissue obtained from weanling mice (21-28 days of age), and 
PCR screening was performed using the following primers: Cre recombinase (forward: 5’- GCA 
TTA CCG GTC GAT GCA ACG AGT GAT GAG-3’ and reverse: 5’- GAG TGA ACG AAC 
CTG GTC GAA ATC AGT GCG-3’) yielding a 400-bp PCR product in Cre positive animals. 
Fatty acid-binding protein intestinal primers (forward: 5’- TGG ACA GGA CTG GAC CTC 
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TGC TTT CCT AGA-3’ and reverse: 5’- TAG AGC TTT GCC ACA TCA CAG GTC ATT 
CAG-3’) were used as positive controls and yield a 200-bp PCR product. 
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SUMMARY 
 The rise of optogenetics provides unique opportunities to advance materials and 
biomedical engineering as well as fundamental understanding in neuroscience. This protocol 
describes the fabrication of optoelectronic devices for studying intact neural systems. Unlike 
optogenetic approaches that rely on rigid fiber optics tethered to external light sources, these 
novel devices utilize flexible substrates to carry wirelessly powered microscale, inorganic light-
emitting diodes (µ-ILEDs) and multimodal sensors inside the brain. We describe the technical 
procedures for construction of these devices, their corresponding radiofrequency power 
scavengers, and their implementation in vivo for experimental application. In total, the timeline 
of the procedure, including device fabrication, implantation, and preparation to begin in vivo 
experimentation, can be completed in approximately 3–8 weeks. Implementation of these 
devices allows for chronic (tested up to six months), wireless optogenetic manipulation of neural 
circuitry in animals navigating complex natural or homecage environments, interacting socially, 
and experiencing other freely-moving behaviors. 
INTRODUCTION 
 Optogenetics is a relatively new field of neuroscience that gives researchers the ability to 
control cellular signaling and neural activity in a cell-type selective manner. In vivo applications 
of optogenetics have rapidly aided in the understanding of neural circuit function in behavioral 
models (Adamantidis et al., 2007; Carter et al., 2010; Fenno et al., 2011; Jennings et al., 2013; 
Kim et al., 2013a; Lammel et al., 2012; Stuber et al., 2011; Tye et al., 2011; Yizhar et al., 2011; 
Zhang et al., 2010). Despite the success of these studies, tethered fiber optic approaches have 
restricted opportunities for the study of more complex, ethologically relevant behavioral 
paradigms such as enclosed homecage behavior, spontaneous pain, wheel-running, and freely-
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moving social interactions. Here we present a protocol for the fabrication of flexible devices that 
carry wirelessly powered microscale, inorganic light-emitting diodes (µ-ILEDs) and multimodal 
sensors to study neural circuitry in awake, freely moving animals. The devices described in this 
protocol are robust, self-contained, multifunctional, and capable of wireless operation with 
conventional electronics and power supplies. These fully electronic systems eliminate the need 
for high-powered light sources, fiber coupling fixtures and optomechanical hardware for in vivo 
optogenetic experiments. The following protocol is based on technology and approaches 
developed jointly in our two laboratories (See Chapter 2) (Al-Hasani et al., 2013; Kim et al., 
2010a, 2012a, 2012b, 2013b; Li et al., 2013).  
 
Development of the protocol and comparison with traditional light sources 
 This protocol is the result of advances in material science that have led to the 
development of flexible electronics, biodissolvable adhesives, microscale sensors, and high 
efficiency µ-ILEDs (See Chapter 2) (Hwang et al., 2012; Kim et al., 2010a, 2012a, 2012b; Tao et 
al., 2012). While other groups have successfully implemented wireless schemes and LEDs for 
optogenetics (Cao et al., 2013; Iwai et al., 2011; Wentz et al., 2011; Zhao et al., 2009), the 
protocol described here provides a completely customizable approach for combining various 
materials engineering approaches to design and implement devices that can be optimized for an 
individual laboratory’s experimental needs.  
 The current standard in neuroscience for light delivery into the depth of the brain is to use 
chronically implanted fiber optics (Sparta et al., 2011), which offer substantial advantages over 
acute delivery of fibers via metal cannulae (See Chapter 2) (Kim et al., 2013b; Zhang et al., 
2010). These chronic implants, however, have their own limitations. Principally, light from fiber 
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optic implants can only escape from the tip of the implant to illuminate ventral brain structures. 
While adaptations to this ventral light delivery are possible (Tye et al., 2011; Zorzos et al., 2010, 
2012) (available commercially at www.doriclenses.com), the range of customizability can be 
limited and often restricts the user to only delivering light without the capability of observing 
physiology. Furthermore, µ-ILEDs create opportunities to restrict or expand spatial targeting by 
selecting from a range of sizes (625-10,000 µm2), altering the number and arrangement of µ-
ILEDs, and using reflective materials to direct light. This protocol provides a basis from which 
any combination of µ-ILEDs and sensors can direct light within the brain and measure 
physiological function without the restriction of enforced light trajectory. 
 Various strategies have been employed for delivering multiple wavelengths of light into 
the same animal (Stark et al., 2012; Zorzos et al., 2010, 2012). These approaches require 
establishing an extensive network of optics and tethered optical equipment external to the 
behaving animal. Depending on the laboratory behavioral space, such setups can restrict 
experimental possibilities and requires advanced experience with optics to maintain optimal 
conditions. This protocol may require access to external facilities for some labs, but the end 
result is a device that can be operated with basic laboratory equipment already likely to be 
present in most neuroscience laboratories. Furthermore, the rescue and recycling of these devices 
for re-use is relatively easy, meaning that these devices can be used for several rounds of 
behavioral experimentation with different sets of animals. For light-evoked activation of 
channelrhodopsin-2 [ChR2 (H134)], optically sensitive seven-transmembrane domain receptors 
(i.e. OPTO-"1, OPTO-!2,), and other blue light-sensitive optogenetic constructs, GaN µ-ILEDs 
are appropriate (See Chapter 2) (Airan et al., 2009; Kim et al., 2013b; Yizhar et al., 2011). A 
device utilizing these 450 nm-emitting µ-ILEDs will be the focus of this protocol. However, it is 
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important to note that µ-ILEDs emitting at other relevant wavelengths are also possible to 
fabricate for use in other contexts (See Chapter 2) (Kim et al., 2013b; Park et al., 2009) . The 
combination of µ-ILEDs of different wavelengths provides the user with access to activation 
spectra of multiple optogenetic constructs with a single implanted, electronic device. 
Furthermore, the electronic nature of these devices ensures that they can be operated wirelessly. 
Wireless optogenetic manipulation of neural circuitry has been achieved by other means (Iwai et 
al., 2011; Wentz et al., 2011), but these approaches can restrict behaviors accessible to study 
because the animal is required to remain in a fixed environment. By utilizing radiofrequency 
(RF) power scavenging, the devices and approaches contained in this protocol free the user of 
constraints on behavioral assays, thereby allowing for experimental testing in any space. 
 
Applications of the protocol  
 While the focus of this protocol is on the creation of devices engineered to deliver µ-
ILEDs into the brain for optogenetic applications, this same protocol can be used to fabricate 
devices to measure electrophysiological, thermal, and other properties of intact brain tissue (See 
Optional Section 3.1 for details). The flexible nature of these devices provides the potential to 
extend their application into other intact tissues such as the peripheral nervous system and the 
circulatory system/cardiac tissue of larger organisms. 
 
Experimental design 
Subjects. This protocol and these devices have been optimized for use in adult (25–35 g) male 
C57BL/6J mice and mutant mice backcrossed to the C57BL/6J mouse strain. However, as the 
optogenetic toolbox expands to other mammals (Cavanaugh et al., 2012; Diester et al., 2011; 
95 
Gerits and Vanduffel, 2013; Han et al., 2009; Ruiz et al., 2013; Witten et al., 2011) these devices 
will likely have broader utility in other animal models. Specifically, larger organisms such as rats 
and non-human primates will tolerate the ~700 mg wireless antenna with greater ease than mice. 
Unlike animals with polished fiber optic implants, animals with chronically implanted µ-ILEDs 
can be housed with other animals, as the metal pin connectors cannot be damaged by cage mates. 
Prior to beginning this protocol, all the procedures described herein should be approved by the 
Animal Care and Use Committee of the investigating institution and conform to US National 
Institutes of Health guidelines regarding animal research. For this protocol, all procedures were 
approved by the Animal Care and Use Committee of Washington University and conformed to 
US National Institutes of Health guidelines. 
 
Controls As noted elsewhere (See Chapter 2) (Kim et al., 2013b; Sparta et al., 2011; Yizhar et 
al., 2011), the proper controls for in vivo optogenetics are mice that express genetically-encoded 
fluorescent reporters in the absence of an opsin. These control mice will account for any 
disturbance from viral injection, device implantation, heating confounds from light delivery, and 
fluorophore fluorescence within the brain. Another important confound to consider when 
conducting light-evoked single-unit electrophysiological experiments is the potential for 
generating neural activity downstream of retinal stimulation. These devices prevent the external 
light escape that is common with fiber optic implants, but activity from the visual system has the 
potential to activate the retina and retinal ganglion cells from within the brain, depending on the 
brain region (Kravitz et al., 2013). Recordings performed with an external light stimuli can 
control for these effects. Additionally, properly counter-balanced within-subject experimental 
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designs are possible with these devices by withholding power to the devices during the 
behavioral testing period.  
Limitations While these devices offer numerous advantages over traditional fiber optic 
implants; the technology is not intended to replace protocols that work well to manipulate neural 
circuitry in vivo (Sparta et al., 2011; Zhang et al., 2010). The greatest limitation associated with 
this procedure is the accessibility to the facilities and the technical skill required to fabricate 
these devices and their scavenging antennas. That being said, subsequent recovery and re-
fabrication of the devices is straightforward and accessible to any laboratory. Once the protocol 
is followed there are few considerations when designing behavioral experiments. First, 
depending on the panel antenna employed, the signal can be polarized. In current designs, both 
the panel antenna and the antenna on the scavenger are directional with linear polarization. A 
maximum efficiency of power transmission and reception is achieved when the polarizations of 
both antennas are aligned. The power transmitted by the panel antenna can typically be adjusted 
to accommodate mismatches that can occur in most practical situations. Such issues can be 
avoided entirely by use of a transmission antenna with circular polarization or multiple panel 
antennas. Care should also be taken to ensure that the animal’s surroundings do not interfere with 
the RF signal by powering a free-standing device in the behavioral context (See Chapter 2) (Kim 
et al., 2013b). Wireless control of these devices is compatible with a wide-range of behavioral 
assays. In our hands, the devices have performed well in tests of anxiety-like behavior (open 
field test, elevated zero maze), reward-related behavior (conditioned place preference, operant 
behaviors, and self-stimulation), social behaviors (social defeat stress and social aversion), pain 
behaviors (Hargreaves test), and homecage behaviors11. In our experience, commonly used 
materials for behavioral apparatus (wood, polyvinyl chloride (PVC), Poly(methyl methacrylate) 
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(PMMA; Plexiglass/Perspex) and the metal from cage lids) do not interfere with the RF signal, 
but can reduce the overall power if they are positioned between the panel antenna and the 
headstage scavenger (see Table 3.1).  
Second, the current protocol only provides wireless access to power the µ-ILEDs and not 
to receive information from the sensors. This backwards data stream restriction is largely one 
based on the weight that an animal can endure on the headstage. For a mouse, 
electrophysiological, temperature, and photo sensors currently require a wired connection. For 
larger mammals, the devices can be integrated with existing telemetry setups, provided they do 
not interfere with the RF signal (Harrison et al., 2010; Szuts et al., 2011) (commercially available 
at www.plexon.com). Finally, independent control of individual µ-ILEDs is also possible with 
these devices, but the described protocol has not been optimized for these conditions in a 
wireless control mode. If independent control is a desired feature, it is recommended that smaller 
connections featuring a number of channels are employed over the pin connectors that we 
present here (many options commercially available at www.omnetics.com).  
Upon completion of the protocol presented here, users can expect to have devices with 4 
?-ILEDs that can be wirelessly powered with suitable light output from two meters away. In our 
experience, more ?-ILEDs can be added to a single device with relative ease (the maximum we 
have tested is 25 (5 x 5) ?-ILEDs from a single power scavenger). Furthermore, the 
radiofrequency power scavenging approach is appropriately suited for powering multiple ?-
ILED devices (presumably in multiple animals) using a different power scavenging headstage 
antenna for each device. The upper limit on the number of simultaneously powered devices is 
primarily dependent on the spatial constraints of the experimental space and apparatus to achieve 
equal powering to all devices. 
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Notes on the materials and equipment used in this protocol: Accurate injection of these 
devices into brain tissue requires an stereotaxic adapter for standard cannula holders. The basic 
principle of this adapter is that the µ-needle can mounted in-line with the existing stereotaxic 
system. The dimensions of such an adapter will vary by stereotaxic alignment system make and 
model, but most university machine shops should be able to fashion such an adapter. The adapter 
presented in this protocol was specifically designed for use with the KOPF Single Cannula 
Holder (Model 1966). It is also possible that other commercially available electrode holders may 
be capable of accurately targeting the devices (e.g. KOPF Model 1768). More detailed 
information on the machining and dimensions of the adapter for the KOPF Model 1966 can be 
found in (Figure 3.6). 
 In order to deliver pulse trains of light, the devices can be controlled using a traditional 
function generator to drive amplitude modulation of the wireless powering equipment. 
Amplitude modulation is an internal function available on most RF generators. This function 
allows an internally or externally supplied modulating signal to control the amplitude of the 
output RF signal. The internal modulating signal is usually a sinusoidal waveform with a much 
lower frequency compared to that of the RF output. For the positive region of the sinusoidal 
signal, the RF generator can output an RF signal whose amplitude is modulated by the low 
frequency sinusoidal signal, and change from 0 to the maximum set power and then back to 0. 
For the negative region of the modulating signal, the output RF signal maintains at 0. An external 
TTL modulating signal is preferable in terms of modulating the amplitude of the output RF 
signal.  Here, the high state of the TTL causes the RF generator to output a constant set power, 
while in the low state of the TTL, the RF generator outputs 0 power. Thus, the TTL modulating 
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method is more suitable for generating constant light intensity during the high state of the TTL. 
The pulse width and frequency of photostimulation should be determined and based on 
physiologically relevant conditions (Adamantidis et al., 2011; Jennings et al., 2013; Sparta et al.; 
Tye and Deisseroth, 2012; Tye et al., 2011)  
 Post-mortem rescue of the devices for reuse is a delicate, but straightforward process. 
The dental cement presented here (Lang Dental) allows for such rescue. Other cements and 
bonding agents can inhibit the process and destroy internal components. It may be necessary to 
use a stronger bonding agent in some scenarios (see Table 3.1).  In such cases, the re-usability 
might be compromised. 
MATERIALS 
Reagents 
Preparation of releasable polymer template 
• UV curable epoxy (SU-8 2 & 100 photoresist, Microchem) ! CAUTION Partially cured 
or uncured epoxy needle can induce excess chemical contamination in the brain.  
• SU-8 developer (Microchem)  
• Isopropyl alcohol (IPA) !CAUTION Isopropyl alcohol is flammable. 
• Acetone !CAUTION Acetone is flammable. 
• Silk adhesive (Details are shown in other papers (Hwang et al., 2012; Kim et al., 2010a; 
Tao et al., 2012), see REAGENT SETUP).  
• BCB (Benzocyclobutene, DS-4022 35, Dow corning) 
• BCB developer (Advanced Developer, DS2100, Dow corning) 
• Water soluble tape (3M) 
• Photoresists (AZ 1518, AZ 2070, Capital Scientific) 
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• AZ 300 MIF developer (Capital Scientific) 
• Hydrofluoric acid (HF) !CAUTION HF is extremely corrosive. Wear gloves and use eye 
protectionwhen using HF.  
• Chrome (Cr) etchant, gold (Au) etchant, palladium (Pd) etchant (Transene Inc.) 
• Polydimethylsiloxane (PDMS, Sylgard184, Dow corning) 
• Polyethylene terephthalate (PET, polyester film, 2.5 and 6 µm thick, Mylar? film, 
Chemplex? Inc.) 
Preparation of µ-ILEDs 
• Gallium nitride (GaN) LED epitaxial materials grown on sapphire substrates (Cermet 
Cop.)  
Injection of virus and µ-ILEDs into targeted brain structure 
• Isoflurane, USP (Isothesia, Butler Schein, cat. no. 029405)! CAUTION Prior to 
beginning this protocol, the Animal Care and Use Committee of the investigating 
institution should approve all procedures and conform to US National Institutes of Health 
guidelines regarding animal research. ! CAUTION Ensure proper ventilation and gas 
scavenging methods are in place to prevent potential inhalation of excess isolflurane. 
• Betadine solution (Purdue Products, cat. no. 67618015017) 
• Ethanol (Sigma-Aldrich, cat. no. 362808) ! CAUTION Ethanol is flammable.  
• Hydrogen peroxide, 3% USP (Select Medical Products, cat. no. 117) 
• Lidocaine ointment USP, 5% (Fougera) 
• Ophthalmic ointment (Altalube Ophthalmic Product) 
• Adhesive Luting Cement (C&B-Metabond, Parkell Inc., cat. no. S380) ! CAUTION 
• Light cured bonding adhesive (VLC One Step Prime & Bond Adhesive, cat. no. 305-006-
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030) ! CAUTION 
• Dental cement (Jet Denture Repair, Lang Dental, cat. no.1223, see REAGENT SETUP) ! 
CAUTION Methyl Methacrylate Monomer, Stabilized is a flammable liquid. It may also 
cause skin irritation; avoid contact with skin, eyes, and clothing. Use with adequate 
ventilation. 
• 0.9% Sodium Chloride Inj., USP ((9 mg/ml NaCl), Hospira, cat. no. RL-0497(9/04)) 
• Enroflaxin (Baytril, Bayer, cat. no. R30901) 
• Antibiotic ointment (Neosporin, Johnson & Johnson, cat. no. 174-73087Q) 
• Viruses of interest (Adeno-associated virus and lentiviruses are available from the 
WUSTL Hope Center Viral Core , https://hopecenter.wustl.edu/?page_id=99 and/or the 
University of North Carolina Viral Vector Core, 
http://genetherapy.unc.edu/services.htm), Herpes Simplex Viruses are available from the 
MIT Viral Core, http://mcgovern.mit.edu/technology/viral-vector) ! CAUTION Follow 
the appropriate safety precautions pertaining to the particular virus in use. It may be 
necessary to obtain a higher Biosafety Level certification prior to use. 
• Artificial cerebral spinal fluid (ACSF; Tocris, cat. no. 3525 or custom, see REAGENT S
ETUP (2011; Zhang et al., 2010) 
• Animal(s) to be injected with µ-ILED device. The procedure describes how to use a µ-IL
ED device with a mouse, as previously described (See Chapter 2) (Kim et al., 2013b). ! C
AUTION Prior to beginning this protocol, the Animal Care and Use Committee of the in
vestigating institution should approve all procedures and conform to US National Institut
es of Health guidelines regarding animal research. 
Behavioral procedures using RF power scavenging 
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• Thermal grease (Wakefield Solutions, cat. no. 120-2) 
EQUIPMENT 
Preparation for µ-ILEDs and Multifunctional Sensors  
• Sputter ((AJA international, ATC 200) metal deposition for Au (gold), Ni (nickel), Pt 
(platinum), etc.)  
• Rapid thermal annealing (RTA) !CAUTION High temperature, semi-transparent L-
shaped current spreading layer on p-side on GaN LED should be used in thin metal layers 
(15/15 nm Ni/Au) followed by 500oC annealing.  
• Mask aligner (Karl Suss, MJB) 
• Inductively coupled plasma (ICP) etcher (PlasmaTherm SLR-700, etching for GaN) 
• Reactive ion etcher (RIE, PlasmaTherm 790, etching for SiNx) 
• Plasma enhancement-chemical vapor deposition (PE-CVD, STS mixed frequency nitride 
deposition system)   
• Wafer bonder (Electronic Visions, EV501) 
• Laser lift off (LLO, Krypton Fluoride (KrF)(0.9 J/cm2, 248 nm wavelength, IPG 
Photonics (http://www.ipgphotonics.com/microprocessing.htm)) or Yttrium aluminum 
garnet (YAG):Nd laser (0.3 J/cm2, 266 nm Single pulse with 5 ns exposure, Sandia 
National Lab) ! CAUTION Avoid eye contact with the laser. Always wear eye 
protection.  
• Digital multimeter (Fluke 115 or other commercially available multimeter) 
• Printed circuit board (PCB) for headstage connection (General Circuits Co.) 
• Male pins for headstage PCB (2.54 mm spacing male pins (Sunlight Inc, P2540-H254-
S180). 
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Measurement of µ-ILED 
• Ocean Optics (Ocean Optics HR4000) (for measuring wavelength spectrum, light output 
power)  
• Probe station (Agilent 4155) (current-voltage (I-V) characteristics). 
• Pulse generator (Global specialties, 4001)  
• Oscilloscope (Agilent , DSOX2004A, 70 MHz) 
• IR camera (QFI InfraScope II)  
 
Injection of virus and µ-ILEDs into targeted brain structure 
• Stereotaxic alignment system (KOPF Model1900) ! CAUTION Prior to beginning this 
protocol, the Animal Care and Use Committee of the investigating institution should 
approve all procedures and conform to US National Institutes of Health guidelines 
regarding animal research. 
• Stereotaxic alignment indicator (KOPF Model 1905) 
• 40X Centering Microscope (KOPF 1915) 
• Stereotaxic drill (KOPF Model 1911) and #66 drill bit (KOPF cat. no. 8669) 
• Stereotaxic single cannula holder (KOPF Model 1966) 
• Stereotaxic adapter for cannula holder (See Figure 3.6), WUSTL Machine Shop or other) 
• Anchoring screws (CMA Microdialysis, cat. no. 7431021) 
• Needles (Becton-Dickinson, cat. no. 305111) 
• Micro-injection syringes (Hamilton, cat. no. 88011) 
• Infusion pump and controller (UltraMicroPump III, World Precision Intstruments, cat. 
nos. UMP3 and UNC4) 
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• Forceps (Miltex, cat. no. 6-100) 
• Surgical scissors (Miltex, cat. no. 18-1430) 
• Hemostats (Miltex, cat. no. MH7-26) 
• Microspatula (Chemglass, cat. no. CG-1982-12) 
• Electric clippers (Wahl, cat. no. 8064-900) 
 
Behavioral procedures using RF power scavenging 
• RF generator (Agilent, N5181 MXF) 
• Function generator with standard transistor-transistor logic (TTL) (AMPI Master-9 or 
other) 
• RF amplifier (Empower RF systems Inc. 1100/BBM2E4AJP) 
• RF antenna (ARC wireless solutions, ARC-PA0913B01, ARC 902-928 MHz 12.5dBi, 
Flat Panel)  
• DC power supply (Mastech, cat. no. HY5005E-2) 
• Relevant behavioral assay apparatus (university machine shops, MED Associates, 
Harvard Apparatus or other) 
• Wireless headstage antenna (see PROCEDURE) 
• Printed circuit board (PCB) for wireless headstage antenna (General Circuits Co.) 
• Ceramic antenna (W3012, Pulse Electronics) 
• Schottky diode (Digi-Key, cat. no. MMDL301T1G) 
• Power meter (Bird Electronic Corp.,Thruline 43) 
• Two SMA Male to N Male Precision cables (Pasternack, cat. no. PE304-120) 
• Fan-cooled heat sink (Fischer Elektronik, cat. no. LA 17/200 24V) 
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Behavioral procedures using a wired connection 
• Animal(s) with injected µ-ILED device ! CAUTION Prior to beginning this protocol, the 
Animal Care and Use Committee of the investigating institution should approve all 
procedures and conform to US National Institutes of Health guidelines regarding animal 
research. 
• Relevant behavioral assay apparatus (university machine shops, MED Associates, 
Harvard Apparatus or other) 
• Function generator for standard transistor-transistor logic (TTL) (AMPI Master-9 or 
other) 
• BNC cables (Cables to Go, various lengths and catalog numbers) 
• Electrical rotary joint (Moog, cat. no. SRA-73683 (du Hoffmann et al., 2011)) 
• BNC-to-banana plug adapter (Fluke BP881 or other) 
• Wire (30 gauge wire, Artistic Wire) and female connector (Single modality devices: TE 
Connectivity, cat. no. AMP 3-640441-2; Multimodal devices or independent µ-ILED 
control: TE Connectivity, cat. no. AMP 87631-4)   
REAGENT SETUP 
Silk adhesive Boil cocoons of the Bombyx mori silkworm for 30 minutes in a solution of 0.02M 
Na2CO3 to remove the sericin protein. Rinse the extracted fibroin with distilled water and dry in 
ambient air for 12 hours. After drying, dissolve the fibroin in a 9.3M LiBr solution at 60 ?C for 
4 hours, yielding a 20 wt.% aqueous solution, and subsequently dialyze the solution against 
distilled water using a dialysis cassette at room temperature for 48 hours until the solution 
reaches a concentration of 8 wt.%. 
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Dental cement The dental cement can be prepared as described elsewhere (Sparta et al., 2011) 
by combining the Jet Denture Repair Powder with the Jet Liquid (methyl methacrylate). A 
starting point is 350 µl of methyl methacrylate monomer added to 225 mg of powder. In some 
cases, the viscosity must be adjusted (by increasing or decreasing the amount of methyl 
methacrylate in the mixture) to properly secure the flexible device in place and/or mount the 
PCB in the headcap. ?CRITICAL STEP Adjusting the viscosity alters the working time of the 
cement. 
Virus Each type of virus has different handling instructions, but all must be stored on ice until 
immediately prior to the injection. In some cases, dilution of stock titers requires obtaining more 
of the reagent in which the viral prep was initially concentrated.  
ACSF If not purchased, the solution can be prepared following the recipes described elsewhere 
(2011; Zhang et al., 2010). 
 
EQUIPMENT SETUP 
Preparation of amplifier with proper heat sink The RF amplifier (1100/BBM2E4AJP, 
Empower RF Systems Inc.) requires an additional cooling system during operation. Thermal 
grease applied on top of the heat sink (LA 17/200 24V, Fischer Elektronik Inc.) facilities thermal 
contact with the amplifier, which is affixed to the sink using screws. The DC power supply 
operates both the amplifier and the fan attached to the heat sink, by supplying power with 
voltages of 24 V and 10 V, respectively. 
PROCEDURE 
Preparation of µ-ILEDs ) TIMING 7 d  
1 | Clean the wafer surface of GaN LED stacks (450 nm emission wavelength; p-type 
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GaN/multi-quantum well (MQW)/spacer/n-type GaN/undoped GaN) grown on sapphire 
substrate with 5 wt % diluted HCl for 5 min. ?CRITICAL STEP Proper cleaning enables 
reduced turn-on voltages and improved efficiencies, both of which minimize production of 
heat by the operating µ-ILEDs.  
2 | Deposit metals (Ni/Au, 15/15 nm) immediately after cleaning ?CRITICAL STEP The 
deposition should be carried out degree vacuum levels of ~10-6 torr or less.   
3 | Form L-shape patterned metals (Ni/Au) onto the p-type GaN semiconductor layer by 
photolithography and wet etching with Cr and Ni etchants followed by removal of the 
photoresist (PR) with acetone (Figure 3.1A).  
4 | Anneal the wafer for 10 min at 500 oC in 20% oxygen and 80% Argon atmosphere to 
generate p-ohmic contact. ?CRITICAL STEP The annealed metal layers should be semi-
transparent after this step.  
5 | Generate 40 x40 µm2 square hole patterns in a negative tone PR (AZ 2070 PR) and etch 
(chlorine gas based RIE etching) the p-GaN layer, MQW, spacer to open n-side GaN (Figure 
3.1B).  
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C D 
E F 
G H 
Deposit L-shape current    
spreading layer 
Etch n-side GaN  
Deposit p- and n-contact 
pads 
Etch space and fabricate   
complete µ-ILEDs on        
sapphire 
Deposit SiNx and bond  
to silicon wafer using In-
Pd bonding 
Laser lift off and remove    
sapphire 
Etch bonded metal layer Pick up µ-ILEDs using a     
structured PDMS slab 
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Figure 3.1 Fabrication procedure for injectable !-ILEDs. (A) L-shape current spreading layer 
(patterning of Ni/Au (15/15 nm) layers followed by 500 ºC annealing) is formed on GaN blue 
lighting LED stacks grown on sapphire. (B) In order to expose n-type GaN semiconductors, etch 
rectangular shape of p-type one, multi quantum well (MQW), and spacer layers by reactive ion 
etching. (C) Generation of n- and p-contact pads (Cr/Au (15/300 nm) 25 x25 µm2 squares) on n-
and p-type GaN sides. (D) Etch 20 µm width trench to define 100 x 100 µm2 or smaller than 100 
x 100 µm2 lateral dimensions. (E) Bonding !-ILEDs on sapphire with silicon wafer using In-Pd 
metallic alloy bond. (F) Expose laser on sapphire and mechanically remove sapphire from !-
ILEDs. (G) Wet etch the bonded metallic layer located on wafer. (H) Transfer of all !-ILEDs 
onto structured PDMS slabs and selectively pick up single !-ILEDs using a polydimethyl 
siloxane (PDMS) stamp. [Part d, f, g and h reproduced with permission from (Kim et al., 2012a) 
© 2012 Wiley] 
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6 | Generate 25 x25 µm2 square hole patterns in PR for n- and p-type metal contact pads and 
deposit Cr/Au (10/300 nm) using an electron beam evaporator. Then, remove PR (Figure 
3.1C).  
7 | Deposit a low stress layer (200 nm) of SiNx on the substrate, using plasma enhanced-
chemical vapor deposition (PE-CVD). Next, pattern a negative tone PR (AZ 2070) to serve 
as a mask for etching the SiNx and the GaN to define the lateral dimensions of array of µ-
ILEDs. Devices with dimensions of 100 x 100 µm2 or less are formed with 20 µm spacings 
(Figure 3.1D).  
8 | Deposit a layer of SiNx onto the µ-ILEDs to protect the devices and metal pads from further 
processes.  Bond the LED wafer to a silicon substrate using indium (In)-palladium (Pd) 
metallic alloy. This bonding uses Cr/Pd (15 /150 nm) on the LED substrate and Cr/Pd/In 
(15/150/900 nm) on the silicon. The bonding occurs on contact with a pressure of 400 bar 
and temperature of 220 oC for 2 hr (Figure 3.6E).  
9 | Use laser illumination through the sapphire to release the µ-ILEDs (Figure 3.1F). Details of 
this laser lift-off (LLO) technique appear elsewhere(Kim et al., 2012a; Wong et al., 2000). 
10 | Etch unalloyed metal by immersion in 5 wt% HCl for 30 min (Figure 3.1G).  
11 | Retrieve all µ-ILEDs onto substrate of PDMS with patterns of surface relief, in the geometry 
of cylindrical pillars with 3 µm diameter and 1.4 µm height and 5 µm spacing. Remove 
residual metals, including In-Pd alloy and Crare by Pd and Cr etchants (Figure 3.1H).  
12 | Prepare a PDMS stamp with a single relief feature consisting of a post with 100 x 100 µm2 
lateral dimensions and 100 µm height. Using a mask aligner for photolithography, retrieve a 
single µ-ILED with the stamp and transfer it to a needle shaped structure of PET adhered to a 
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thin layer of PDMS on a transparent temporary substrate (Figure 3.2A and B).  
13 | Remove passivation layer, SiNx (deposited in procedure 8) with RIE and spin coat a 
photosensitive benzocyclobutene (6 µm thick, BCB) onto the µ-ILED.  
14 | Pass ultraviolet (UV) light through the backside of the substrate and develop the BCB with 
BCB developer (Figure 3.2C) to obtain holes for n- and p-side contacts (Figure 3.2C, lower 
inset) !CAUTION Make sure that BCB covers the µ-ILED surface. Non-uniform coatings of 
BCB generate interference fringes that are readily visible. (Figure 3.2C, upper inset) After 
further curing BCB, anneal the samples at 250 oC on a hot plate for 3 hr. ?CRITICAL STEP 
The annealing should be carried out in Ar atmosphere to avoid high temperature damage to 
the BCB and polymeric layers. ?TROUBLESHOOTING 
15 | Deposit Cr/Au (15/300 nm) by sputtering, and form metal interconnects using positive tone 
PR (AZ 15198) followed by metal etching (Figure 3.2D).  
Deterministic device assembly by transfer printing and formation of electrical 
interconnects ) TIMING 1 d 
16 | Remove µ-ILEDs fabricated on each temporary substrate as shown in Figure 3.2A with 
water-soluble tape (Figure 3.2E). Remove water-soluble tapes in DI water (Fig. 2f) and 
place the devices on slabs of PDMS (Figure 3.2G). ?CRITICAL STEP Steps 16-20 describe 
device assembly for µ-ILEDs alone.  If you are assembling a multifunctional device, follow 
the instructions in Optional Section 3.1 before proceeding.  
17 | Connect each of the devices with anisotropic conductive film (ACF) cable to a PCB board 
(Figure 3.2H). * CRITICAL STEP Apply pressure and high temperature (~150 oC) during 
ACF cable bonding. ?TROUBLESHOOTING 
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Figure 3.2 Procedure for fabrication of injectable, multifunctional electronics. (A) Thin 
(~2.5 µm thick) needle-shaped polyethylene terephthalate (PET) is attached on temporary 
Polydimethylsiloxane (PDMS) coated glass substrate. (B) Schematic and photograph 
demonstrating the transfer printing of four µ-ILEDs onto the tip of the PET using a PDMS 
stamp. (C) Passivation approach with photocurable benzocyclobutene (BCB) polymer. The 
backside of BCB coated substrate is exposed to ultraviolet light. The wave pattern in the upper 
inset shows ununiformed coating of BCB. The lower inset shows successful uniformed coating. 
(D) The metal interconnection (Cr/Au) is generated by sputtering, photolithography and metal 
etching to electrically connect the four µ-ILEDs. (E) The connected device is picked up with 
water soluble tape. (F) The substrate is separated from the tape after the adhesive is dissolved in 
the water. The inset shows the µ-ILEDs on freestanding thin, flexible, needle-shaped PET. (G) 
The device is electrically connected to the ACF cable. The PDMS slabs on top and bottom are 
compressed using high temperature (~150ºC) to bond the ACF cable. (H) The other side of the 
ACF cable is connected to the PCB with pin connector for wireless or wired powering schemes. 
(I) The ACF cable and PCB is coated with PDMS for waterproofing. (J) Blue (450 nm) µ-ILEDs 
are powered. The µ-ILEDs and electrical connection should be checked prior to injection (K) 
The device is assembled with injection µ-needle using biodissolvable silk adhesive. (I) Image of 
a completed device ready for injection into brain tissue. 
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Figure 3.3 Multifunctional sensors and optoelectronics. (A) Representative scheme for 
multifunctional, injectable electronics formed on injectable needle. The devices include 
electrophysiological sensor (m-electrode); 1st layer), silicon photodiode (m -IPD; 2nd layer), four 
microscale inorganic light-emitting diodes (m-ILEDs; 3rd layer), and temperature sensor (m-
temp. sensor; 4th layer) based on platinum resistor are formed on injectable m-needle fabricated 
from epoxy polymer. (B) Side view of such a device reveals the ultrathin nature of the active 
components of the device. Scale bar applies to both panels and = 200 mm.  
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18 | Assemble all devices onto injection µ-needle formed in SU-8 epoxy. The entire region of  
injection device should be electrical insulated for in vivo use. Cover the flexible device with 
SU-8 polymer and the other parts with PDMS for waterproofing (Figure 3.2I). Temporarily 
fix the device to the PDMS slab. Drop PDMS solution (Sylgard 180, Dow corning, weight 
ratio=10:1 (silicone elastomer precursor: curing agent), see details at 
http://www.dowcorning.com/applications/search/default.aspx?r=131en) onto the ACF cable 
and PCB except for the pin connection area. After baking the PDMS in the oven at 70? for 
2 hrs, the entire area except pin adapter is electrically passivated by PDMS. 
19 | To check functionality, power the device by connecting to a power supply capable of 
delivering more than 1 mW (Figure 3.2J). Use silk adhesive to bond the devices to the 
injection µ-needle (Figure 3.2K and l).   
 
Fabrication of wireless power harvester and preparation of wireless operation?  TIMING 
1 d 
20 | Build either the robust, PCB-based (option A) or thin, flexible (option B) wireless power 
harvester. * CRITICAL STEP Both options perform equally, but each have advantages. The 
PCB-based option is more easily contrasted and more durable, but weighs more than the 
flexible version. We recommend using the PCB-based harvester for experiments that involve 
social interaction, while the flexible version is more ideal for experiments involving only a 
single animal. 
A)  Construction of the PCB-based wireless power harvester. 
i. Build the wireless power harvester from two stacked PCB circuits (Figure 3.4B); 
General Circuits Co., Ltd.). Each PCB includes top and bottom layers that are mostly 
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covered by solid copper ground planes.  
ii. Mount the electrical components on the PCB boards through soldering. The first PCB 
circuit (labeled as 5 in Figure 3.4B) contains a ceramic antenna (W3012, Pulse 
Electronics) operated at 915 MHz with a clearance space of 10.8&8.25 mm to the 
surrounding ground plane.  
iii. Connect a capacitor (8.2 pF in capacitance) between the feed line of the antenna and the 
ground plane to match the impedance of the antenna with the following circuit. A 
secondary PCB circuit (labeled as 6 in Figure 3.4B) contains a voltage multiplier circuit 
constructed with 6 pairs of capacitors (47 nF in capacitance) and Schottky diodes 
(MMDL301T1G) in cascaded connection (See Chapter 2) (Kim et al., 2013b).  
iv. Mount the connector that is used for the ?-LEDs to the secondary PCB circuit. Join the 
PCB circuits and the connector with flexible copper wires (Figure 3.4C), and bond 
together with resin epoxy (Figure 3.4D). Figure 3.3I shows a schematic illustration of 
the power harvester. The circuit parts, which are labeled with number 5 to 7, correspond 
to the same number shown in Figure 3.3B and 3.3E.  
B) Construction of the thin, flexible wireless power harvester. 
i. Fabricate the flexible PCB circuit on 75 µm thick Kapton film (Figure 3.4F). Coat the 
film with a 6 µm thick layer of copper using electron beam evaporation.  
ii. Pattern the copper to form pads for the electrical components and interconnection. Spin 
cast and pattern 1 µm thick polyimide film to expose the electrical contact pads, while 
passivating the interconnection (Figure 3.4F).  
iii. Attach a ground plane made of copper tape (Figure 3.4G) to the bottom of the Kapton 
film and connect with copper pattern on the top of the Kapton film through channels 
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filled with solder. A schematic illustration of the flexible PCB circuit appears in Figure 
3.4J      
21 | Setup the wireless power transmission system. The system consists of an RF signal generator 
(N5181A, Agilent Technologies, Inc.), an RF amplifier (1100/BBM2E4AJP, Empower RF 
Systems Inc.), a DC power supply (U8031A, Agilent Technologies, Inc.), an antenna (ARC-
PA0913B01, ARC Wireless), and a power meter (Thruline 43, bird electronic corp.) (Figure 
3.4A). Connect the amplifier to RF signal generator and an antenna using coaxial cables 
(SMA Male to N Male Precision Cable Using 160 Series Coax, Pasternack Inc.).The RF 
signal generator provides a 915 MHz RF signal with a power of -15 to -20 dBm. The signal 
is amplitude-modulated through the internal function of the generator to create a pulsed 
signal with frequency of 10 Hz, and a carrier frequency of 915 MHz. Alternatively, an 
external TTL function generator can be connected to the RF signal generator to modulate the 
pulse width and frequency. This signal is directed to the RF amplifier, which amplifies the 
signal to 30 to 33 dBm.  
22 | Connect the power supply to the RF amplifier and the exhaust fan of the heat sink of the 
amplifier (see EQUIPMENT SETUP) to provide DC voltages of 24 V and 10 V to the RF, 
respectively. Measure the intensity of the output power of the amplifier and then connect the 
amplifier to the antenna to RF power to power the ?-LEDs at a 1~2 meter distance (Figure 
3.4E and H).                                                
Injection of virus and µ-ILEDs into targeted brain structure ) TIMING 1 d 
23 | Mount the µ-ILED device in the custom-built cannula holder adapter or other electoral device 
holder (see EQUIPMENT SETUP) (Figure 3.5A and 3.6). To do so, grasp the exposed 
region of the µ-needle (Figure 3.5B). * CRITICAL STEP The device must be placed along 
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Figure 3.4 Wireless operation and equipment. (A) An experimental setup for wireless 
power transmission. The setup contains a RF signal generator (1), a RF power amplifier (2), a 
DC power supply (3), and a panel antenna (4). Components for the wireless power harvester 
for µ-ILED powering with stacked PCB circuits (5: circuit contains a ceramic antenna and a 
capacitor is connected between the feed line of the antenna and the ground plane to match the 
impedance of the antenna with the next circuit. 6: a second circuit contains a voltage 
multiplier constructed with 6 pairs of capacitors and Schottky diodes in a cascaded 
connection), before (B) and after (C) connecting with copper wire. A completed wireless 
power harvester alone (D) and with (E) connection to µ-ILED device (7) for wireless 
operation. Top (F) and side views (G) of a flexible wireless power harvester on Kapton film 
with similar components as the wireless harvester on PCB circuits. (H) A completed flexible 
wireless power harvester with connection to µ-ILED device for wireless operation. All scale 
bars are 5 mm. (I) A schematic of the PCB-based power harvester. The numbered circuit 
components correspond to the same number shown in Fig. 3b and 3e. (J) A schematic of the 
wireless power harvester. 
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the midline of the adapter to achieve proper spatial targeting. ? TROUBLESHOOTING 
24 | Anesthetize the mouse in an isoflurane induction chamber using 4% isoflurane and a flow 
rate of 1.5 L/min O2. * CRITICAL STEP Prior to beginning this protocol, all procedures 
should be approved by the Animal Care and Use Committee of the investigating institution 
and conform to US National Institutes of Health guidelines regarding animal research. * 
CRITICAL STEP Ensure that the animal is sufficiently anesthetized prior to transferring to 
the stereotaxic frame. The animal should have no response to a toe pinch and its breathing 
rate should reduce to ~1 Hz. 
25 | Transfer the animal to the stereotaxic frame, ensuring proper airflow of isoflurane to the nose 
cone (~2.5% isoflurane; 1.5 L/min O2). ? CRITICAL STEP Isoflurane levels should be 
monitored throughout the surgery to maintain sufficient anesthesia (no toe pinch response) 
and breathing (1 Hz). For longer duration surgery, isoflurane levels may be decreased to as 
low as 1%. Sterile, aseptic conditions should be used at all times to avoid infection.? 
CRITICAL STEP Proper placement in the stereotaxic frame is required for accurate injection 
of virus and devices. ? TROUBLESHOOTING  
26 | Apply ophthalmic ointment to protect the eyes during surgery. 
27 | Shave a 2 x 1 cm area on the animal’s scalp (Figure 3.5C). 
28 | Inject 0.1 mL of Enroflaxin into the hindlimb (i.m.) and 0.3 mL saline solution (0.9% (w/v), 
s.c.) to prevent infection and dehydration, respectively. 
29 | Using a cotton swab, apply 70% ethanol (vol/vol) and betadine to the shaved area. 
30 | Carefully grasp the tissue with the forceps and, using the scissors, make an incision the 
length of the shaved area of the animal’s scalp (Figure 3.5D). * CRITICAL STEP Ensure 
that all surgical instruments are sterilized prior to each animal surgery. 
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31 | After the skin separates, use the forceps and scissors to clean and remove any remaining 
periosteum on the skull surface.  
32 | Identify the skull sutures, lambda and bregma. Carefully level the skull according to the 
manufacturer’s recommend steps for your stereotaxic frame. For the KOPF Model 1900, use 
the stereotaxic alignment indicator. It is critical that both lambda and bregma be level, as 
well as achieving a level plane laterally across the skull. ? TROUBLESHOOTING  
33 | Once the skull is level, move the drill to the coordinates you have selected for anchor screw 
placement. Carefully drill a hole with a diameter just wide enough for the screws to catch and 
not so deep as to penetrate the skull (Figure 3.5E). * CRITICAL STEP Proper anchoring is 
crucial to ensure that the headcap remains affixed to the skull for the duration of the 
behavioral experiments. Generally, anchor screws should be placed on either side of the 
midline within 2 mm of the site of implantation. ? TROUBLESHOOTING  
34 | Use the forceps and microspatula to properly anchor the screws into the skull (Figure 3.5F)   
35 | Move the drill above the injection site. Drill a hole that penetrates the skull, but not the dura. 
* CRITICAL STEP Drilling through the dura can cause widespread damage, bleeding, and 
inflammation under the skull. 
36 | Align the infusion pump and lower the injection needle to the dorsal-ventral stereotaxic 
coordinates of the targeted structure of interest (Figure 3.5G). * CRITICAL STEP A 
beveled needle can penetrate the dura safely. If a blunt needle is used the dura should be 
pierced using a sharp, sterile needle. 
37 | Using the microcontroller, infuse the virus at a maximum rate of 100 nl/minute. Volume of 
virus will vary depending on the brain structure and serotype of virus used (Cardin et al., 
2010; Fenno et al., 2011; Gradinaru et al., 2010; Osakada and Callaway, 2013; Osakada et 
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al., 2011; Yizhar et al., 2011; Zhang et al., 2010). * CRITICAL STEP All viruses should be 
kept on ice prior, but special care should be taken with lentiviruses and herpes simplex 
viruses to prolonged exposure to temperatures above 4ºC. ? TROUBLESHOOTING  
38 | Once the infusion is complete, allow the injection needle to remain in place for one minute 
for every 100 nl of virus infused. Slowly remove the needle from the injection site. 
39 | Position the cannula holder above the drill hole (Figure 3.5H). Take care to orient the µ-
ILED/other functionalities in the direction suitable for the experiment in order to properly 
illuminate the opsin expressing brain region of interest. * CRITICAL STEP For injection 
into rodents, rinse with ethanol to sterilize the device prior to injection. For other mammals 
and primates it might be necessary to use room temperature Ethylene Oxide (EtO) gas 
sterilization (http://www.anpro.com/sterilizers/anprolene/indexanprolene.html) 
?TROUBLESHOOTING 
40 | Slowly lower the device into the brain to the desired dorsal-ventral coordinates. 
41 | Using a syringe needle, slowly apply ACSF to the skull to dissolve the silk-based adhesive. 
The brain tissue will dissolve the adhesive inside the skull. Wait at least ten minutes to allow 
for complete dissolution of the adhesive (Figure 3.5I). * CRITICAL STEP The adhesive 
must be completely dissolved prior to µ-needle removal. If not, the final placement of the 
flexible substrates will be affected.  
42 | Slowly remove the µ-needle. Monitor the position of the flexible substrates to ensure that 
zero movement occurs. If the adhesive is completely dissolved, the µ-needle will remove 
with ease and without movement (Figure 3.5J). 
43 | Prepare the dental cement according the REAGENT SETUP. 
44 | Using the microspatula, carefully apply a layer of dental cement directly to point of injection 
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to fully secure the placement of the device (Figure 3.4K). * CRITICAL STEP Allow this 
layer of cement to completely cure prior to building the structure of remaining headcap. 
45 | Once the initial layer of cement is fully cured, position the PCB-based connector in the 
desired orientation. Apply a small amount of dental cement to secure it to the base layer 
(Figure 3.5l). * CRITICAL STEP The orientation of the connector will determine the 
orientation of the RF headstage antenna. 
46 | Finish the headstage by completely encapsulating the device-related hardware in dental 
cement. Be sure to leave the pins of the connector exposed to allow for connections to RF or 
wired functional generator. (Figure 3.5M and N). ? TROUBLESHOOTING 
47 | Using a sterile spatula, detach any scalp skin from the cement. If the skin and the cement are 
connected, the headstage will be less stable over time. 
48 | Liberally apply (~1g) the antibiotic ointment and lidocaine ointment to the entire incision 
area. 
49 | Remove the animal from the stereotaxic frame and place it in a clean homecage position on 
top of a heating pad for recovery. The animal should recover rapidly (<15 minutes) and can 
be returned to its homecage once it displays normal, awake locomotor behaviors. Because the 
only exposed portion of the devices are the metal connector pins, the animals can be group-
housed for the duration of their experimental lifetime. However, if one chooses, the pins can 
be capped using a dummy connector.  
50 | The µ-needle should be clear of any components of the device. Remove from the cannula 
holder adapter and sterilize for re-use (Figure  3.5O) as described in Optional Section 2 and 
Figure 3.8.  
Preparation for behavioral testing ) TIMING ~5 days 
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51 | House mice until the time at which proteins would be expected to be expressed. The choice 
of viral expression system will determine expression time, and hence this wait time prior to  
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Figure 3.5 Surgical procedure for injection of virus and µ-ILED devices into mouse brain. 
(A) Custom-built adapter for accurate stereotaxic placement of device (see EQUIPMENT 
SETUP). (B) Mounted µ-ILED device, ready for injection into the animal. The exposed µ-needle 
is grasped with the adapter and a small piece of tape is used to secure the PCB during surgery. 
(C) A properly mounted mouse with head shaved and eyes-lubricated is ready for surgery. (D) 
Betadine and ethanol is used to prevent infection and the scalp is open to expose the skull. (E) 
After leveling the skull, the drill is used to create pilot holes for the bone screws. (F) Forceps and 
a spatula or jewelry screwdriver is used to drive the screws into the skull. (G) The syringe needle 
is lowered to the desired coordinates to deliver the virus containing the optogenetic construct. 
(H) A µ-ILED device prepared to be driven into the brain using the same craniotomy as the viral 
injection. Dashed lines outline the shape of the device for clarity. (I) The µ-ILED device is 
lowered into the tissue and ACSF is applied to the skull surface to dissolve any external silk 
adhesive. (J) After a 15 minute waiting period, the µ-needle is carefully retracted from the skull. 
(K) Dental cement is applied directly to the craniotomy site to secure the µ-ILED device in its 
targeted position. (L) The PCB connector is secured above the bone screws using a second layer 
of dental cement. (M,N) The PCB connector is completely encapsulated in dental cement, taking 
care to ensure that no bonds are made directly to the soft tissue. (O) The adapter is shown 
following surgery, containing only the µ-needle. All procedures were approved by the Animal 
Care and Use Committee of Washington University and conformed to US National Institutes of 
Health guidelines. 
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Figure 3.6 Machining of the cannula holder adapter. This adapter is specifically designed for 
use with the KOPF Model 1966 Cannula Holder. The adapter is fashioned from aluminum with 
an 8 mm stalk (3 mm in diameter) that can be held by the Model 1966. The main body of the 
adapter is 14 mm in length with a 7 mm diameter. There are two orthogonal bore holes through 
the body. The first is a 5 mm hole from which the center slit is created through to the tip of the 
adapter. The second is a 2 mm screw-hole so that a screw can be tightened to reduce the size of 
the center slit to hold the µ-needle. It is important that the center point of the adapter be in-line 
with the center point of the cannula holder itself to ensure accurate device injection. Note that 
this adapter is merely a suggestion, but we acknowledge there can be many other solutions to the 
problem of accurate injection of the devices. Most stereotaxic instrument manufacturers offer 
custom-built holders and it is likely that many standard electrode holders can be modified to suit 
the needs of the individual laboratory (e.g. KOPF Model 1768). 
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behavioral experimentation. This duration will vary from one to six weeks. For adeno-
associated viral expression typical wait times are 2-3 weeks for expression at cell bodies (See 
Chapter 2) (Cardin et al., 2010; Kim et al., 2013b; Lammel et al., 2012; Yizhar et al., 2011; 
Zhang et al., 2010). 
52 | At least five days before experimentation, handle animals to acclimate the animals to 
manipulation. In particular, connectors should be fitted to the headstage and any areas of the 
body that will be injected should be gently touched in order to habituate the animal to the 
manipulations they will experience during behavioral testing (e.g. the nape of the neck for 
subcutaneous, the abdomen for intraperitoneal, etc.). 
53 | Also habituate animals to the method of powering the devices. If a wired approach is used, 
animals should be connected to the wires and allowed to explore a homecage environment 
for at least 20 minutes once a day for three days. If a wireless approach is used, the RF 
headstage antenna should be connected in the homecage for the same duration. * 
CRITICAL STEP To eliminate locomotor confounds, the animals must be habituated to 
carrying the added weight of the antennas. 
54 | Perform wired (option A) or wireless (option B) behavioral tests.  ? CRITICAL STEP The t
iming of the photostimulation will depend on the parameters and goals of the study, but the p
ulse generation options are well suited for a wide variety of approaches. Any traditional funct
ion generator can either power the devices or provide TTL input into the RF signal generator 
to modulate the pulse width and frequency of the light pulses. If the photostimulation needs t
o be contingent on the animal’s behavior this can be achieved by using live video tracking co
nnected to a TTL output (Noldus Ethovision 9.0 with Trial and Hardware Control and I/O Bo
x or other) or triggering a TTL signal from infrared beam breaks (Med Associates or other).   
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A) Wired optogenetic behavioral control ) TIMING variable 
i. Once habituated to the connecting cables, power the devices using a traditional function 
generator. The pulse width and frequency of photostimulation should be determined and 
based on physiologically relevant conditions (Adamantidis et al., 2011; Jennings et al., 2013; 
Sparta et al.; Tye and Deisseroth, 2012; Tye et al., 2011). The timing of the photostimulation 
will greatly depend on the parameters and goals of the study. 
ii. Connect the cable to the function generator using the BNC-to-banana plug adapter.  
iii. Route the cabling. For most wired behaviors, the best approach is to route the cabling 
through an electrical rotary joint as described previously (du Hoffmann et al., 2011). 
iv. Carefully scruff the animal and connect the free end of the cable to the headstage of the 
animal. Place the animal in the behavioral apparatus (Figure 3.7A) and perform desired 
behavioral test. 
v. Following the behavioral test, scruff the animal, and remove the cable from the headstage. 
B)  Wireless optogenetic behavioral control ) TIMING variable 
i. Connect the function generator to the RF Signal generator, the RF signal generator to the RF 
power amplifier, and the RF power amplifier to the panel antenna. Be sure that the power 
supply is connected to the heat sink (see EQUIPMENT SETUP) to avoid damaging the 
amplifier. Connect the power supply to the RF amplifier. It is reasonable to assume that 
wireless operation of the devices would be compatible with any behavioral assay in which 
the behavioral apparatus itself does not interfere with the RF signal, but care should be taken 
to ensure proper powering of the devices in every behavioral apparatus used. CRITICAL 
STEP To avoid unnecessary powering of the devices, do not engage the power supply until 
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Figure 3.7 Expected results following viral and device injection. Once a device is 
injected, the standard connection allows for temporary coupling multiple means of powering 
in a variety of behavioral assays: (A) A mouse connected for wired powering in a standard 
operant behavioral chamber, (B) the same mouse prepared for wireless powering using the 
lightweight, flexible power scavenger in a conditioned place preference environment, (C) 
Two mice with implanted devices amongst cage mates. The mouse in the foreground has a 
PCB-style RF scavenger for powering in a homecage environment. All procedures were 
approved by the Animal Care and Use Committee of Washington University and conformed 
to US National Institutes of Health guidelines. 
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the beginning of the behavioral session. ? TROUBLESHOOTING.* 
ii. Carefully scruff the animal(s) and attach the RF scavenging antenna(s). Place the animal(s) in 
the behavioral apparatus and perform the behavioral test (Figure 3.7B and C).  
iii. Following the behavioral test, carefully scruff the animal and remove the scavenging 
antenna. 
iv. After the final behavioral session, if desired kill animals and use tissue for any manner of 
post-mortem evaluation (See Chapter 2) (Kim et al., 2013b). ? TROUBLESHOOTING 
 
Optional Section 1| Combining multifunctional sensors and optoelectronics 
One hallmark of these devices is their ability to both deliver light into the brain and record 
information from the brain. Depending on the experiment, users may wish to outfit the devices 
with a variety of multiple and optional modalities. Each different modality can be combined with 
any other modality; devices can have between one and four different modalities incorporated. 
However, if the electrophysiological sensor is incorporated it should be the outermost layer to 
have direct exposure to the tissue. The following steps provide information on adding functional 
layers to the devices. If these optional modalities are desired, Optional Section 1 should be 
completed prior to Step 16 of the main PROCEDURE. 
 
A) Fabrication of temperature sensors (4th layer shown in Figure 3.3) 
i. Generate PR patterns on a needle-shaped piece of PET (same substrates used in procedure 
12) and deposit platinum (Pt, 10 nm) by sputtering. Remove PR by acetone and generate 
Cr/Au (15/300 nm) metal lines that connect to the Pt resistor. 
ii. Calibrate the temperature sensor. Dip the temperature sensor into deionized (DI) water and 
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measure reference resistance using digital multimeter. With precisely controlled temperature 
of the DI water, measure the changes in resistance. Since the resistance change (!R) of the Pt 
resistor depends linearly on the temperature change (!T), the formula for estimated 
temperature is !!!! ! !! where k is constant. 
 
B) Fabrication of µ-IPDs  
CRITICAL (2nd layer shown in Figure 3.3), Additional details of this method are shown in a 
previous publication (Kim et al., 2008). 
i. Deposit SiO2 by PECVD on a silicon-on-insulator (SOI) wafer, with a top silicon layer 
thickness of approximately 1 µm.  
ii. Generate PR patterns to pattern the SiO2 using hydrofluoric acid (HF). 
iii. Remove PR and clean the wafer surface by RCA cleaning.  First perform SC (standard 
cleaning)-1 with 1:1:5 solution of ammonium hydroxide (NH4OH):Hydrogen 
peroxide(H2O2):DI water at 80 oC for 15 min. Second  remove  the SiO2 layer using 1:50 
solution of HF:DI water. Finally perform SC-2 with a 1:1:6 solution of hyrdrochloric acid 
(HCl):H2O2:DI water at 80 oC for 15 min (RCA Cleaning: 
http://inside.mines.edu/fs_home/cwolden/chen435/clean.htm). 
iv. Carry out solid state doping of the silicon to form a p-type region. 
v. Repeat above Steps 4 to 6 from for n-type doping. 
vi. Generate PR hole patterns on the entire wafer surface and etch the silicon layer, to define the 
lateral dimensions of the photodetectors. 
vii. Etch the buried oxide (BOx) layer using HF 
viii. Retrieve a ~1 µm thick thin Si membrane photodiode using a PDMS slab and release it onto 
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the needle-shaped PET substrate (described in PROCEDURE, Step12) 
ix. Form metal (Cr/Au, 15/300 nm) lines for interconnect. 
 
C) Fabrication of µ-electrode for electrophysiological sensor (1st layer shown in Figure 
3.3) 
i. Generate PR (AZ 2030) lift off patterns 
ii. Deposit Pt (30 nm) a needle-shaped piece of PET (described in PROCEDURE Step 12) by 
sputtering. Generate a pattern of SU-8 2 (2 µm thick) with 20 x 20 µm2 square opening. ?
CRITICAL STEP Additional oxygen descum to remove residual PR layer is recommended. 
The impedance of the Pt µ-electrode should be ~1.0 M$ at 1 kHz.    
 
Optional Section 2| Recycling the optoelectronic devices for re-use 
1 | After sacrificing the animal, use forceps to forcibly remove the headcap from the surface of 
the skull. Thoroughly remove any visible biological tissue or other build-up from the sides 
and bottom of the headcap. Take care not to damage the flexible aspect of the device. Once 
removed and cleaned, the headcap is ready for dissolution (Figure 3.8A). 
2 | Place the headcap into a glass beaker and add methyl methacrylate until the headcap is 
entirely submerged (Figure 3.8B). Cover the beaker with tin foil and place in a properly 
ventilated fume hood overnight. ! CAUTION Methyl Methacrylate Monomer is a flammable 
liquid. It may also cause skin irritation; avoid contact with skin, eyes, and clothing. Use with 
adequate ventilation.  
3 | Following overnight incubation, the dental cement should be completely dissolved. The 
device and bone screws should be clearly visible in the beaker (Figure 3.8C). Wearing 
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gloves and using forceps, remove these items from the beaker. The screws can be cleaned, 
sterilized, and used for another surgery. The device will normally become inactive after 
dissolution of the  
  
ACF cable 
Active device 
Check LEDs 
Reassembled !
with new ACF cable and PCB 
Bone screws 
A B 
C D 
E F 
G H 
Removed!
headcap Submerged!
headcap 
Disconnected 
Disconnected 
µ-needle 
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Figure 3.8 µ-ILED device recycling and re-fabrication for subsequent use. (A) The same 
headcap from Fig. 4, removed from the animal post-mortem and cleaned of biological material. 
(B) The headcap should then be fully submerged in methyl methacrylate. (C) Following 
overnight incubation in the stabilized methyl methacrylate monomer, the PCB, connector, µ-
ILED device, and bone screws will be freely available in the solution. (D,E) Both connections 
with the ACF cable will also dissolve, rendering the device non-functional. (F) The device 
should be checked for reuse. If non-functional, the device should be discarded and a new device 
should be fabricated. (G) The working device is reassembled with new ACF cable and PCB. (H) 
The electrical connection through the new ACF cable should be checked after the device is 
attached with injection µ-needle again. 
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4 | headcap due to concurrent dissolution of the adhesive connecting the ACF cable to both the 
device and the PCB (Figure 3.8D and E). Prior to proceeding to Step 4, use a multimeter to 
check that all µ-ILEDs still function properly (Figure 3.8F). If any of the µ-ILEDs have 
electrical failure, discard the device and begin the fabrication process anew.! ? 
TROUBLESHOOTING 
5 | Discard the original PCB, and reassemble the device as described in Step 17 (Figure 3.2G 
and H). 
6 | Apply PDMS to the entire device construction to provide passivation and waterproofing for 
operation in vivo as in Step 19 (Figure 3.2I). 
7 | Attach the µ-needle using the silk adhesive and test the device to ensure proper electrical 
connection as done previously in Steps 18 and 20 of the PROCEDURE (Figure 3.2J-L, 
3.8G, and H). The device is now ready for injection into a fresh animal starting at Step 24 of 
the PROCEDURE. 
 
? TROUBLESHOOTING 
Troubleshooting advice can be found in Table 3.1. 
 
) TIMING 
Steps 1–22, Preparation of µ-ILEDs, deterministic device assembly, and fabrication of wireless 
harvester: 9 d  
Steps 22-50, Viral and device injection: 1 d for procedure, 1–6 weeks for expression  
Steps 51-63, Behavioral experimentation: 5 d for preparation, variable by experiment  
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Optional Section 1, Combining multifunctional sensors and optoelectronics: 1-4 d depending on 
modalities 
Optional Section 2, Rescuing the optoelectronics for re-use: 2 d 
 
ANTICIPATED RESULTS 
Following successful fabrication and implementation of µ-ILEDs, wireless manipulation of 
intact mammalian neural circuitry is possible. While our group has demonstrated the feasibility 
of using these devices to investigate reward-related and anxiety-like behaviors (See Chapter 2) 
(Kim et al., 2013b), nearly any behavioral assay should be accessible with these devices. In 
particular, behaviors that require complete freedom of movement such as social interactions, 
wheel running, and homecage behaviors are now possible (Figure 3.7C). Users can expect 
injected devices to maintain function for many months, as we have tested devices up to six 
months following injection and observe that the devices retain their operational functionality 
(See Chapter 2) (Kim et al., 2013b). Furthermore, we show here that these devices can be reused 
in other animals to avoid the lengthy process of remaking new devices for each experiment. 
Depending on the nature of the experiment, a single panel antenna can power numerous 
headstage devices. If the stimulation parameters are the same across animals, this approach can 
greatly increase the experimental throughput for a variety of behavioral assays. Though not 
presented in detail here, a reasonable extension of this protocol would be to incorporate other 
existing microscale sensors such as pH, blood oxygen, glucose levels, or neurochemical 
detection onto µ-ILED devices (Clark et al., 2009; Kim et al., 2010b). In sum, the protocol 
described here should provide researchers the ability to use optogenetics to wirelessly control 
and study intact mammalian neural circuitry in a minimally invasive manner. 
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Table 3.1 ?TROUBLESHOOTING 
 
Step Problem Possible reason Possible solution(s) 
14 Electrical device failure Un-uniform coating of 
BCB passivation on µ-
ILED 
Spincoat BCB again and redo 
the process.   
17, 
Optional 
Section 2 
ACF cable bonding 
failure  
Insufficient 
temperature and/or 
pressure when bonding 
Be certain to apply enough 
pressure (~1 or 2 MPa) and 
temperature (150 ºC) 
24 Device is damaged prior 
to or during mounting for 
surgery 
The electrical 
components are 
grasped by the cannula 
holder adapter  
Only grasp the upper, 
exposed portion of the µ-
needle. No portion of the 
electrical components should 
be grasped with the cannula 
holder adapter. Be careful to 
apply appropriate pressure so 
as to avoid crushing the µ-
needle. 
25, 32 Inaccurate tissue targeting Improperly aligned 
skull 
Follow the instructions 
provided for your 
laboratory’s stereotaxic 
equipment for ear bar 
placement and skull leveling. 
Species-specific ear bars may 
be required. If the suture lines 
for identifying 
bregma/lambda on the skull 
are difficult to visualize, a 
surgical microscope and/or 
treating the skull with 
hydrogen peroxide can be a 
helpful addition. It may be 
necessary to wait longer after 
penetration prior to removal 
of the µ-needle. 
33, 36 Headcap falls off in 
homecage/during 
behavior 
Insufficient anchoring 
or cement application 
Dental cement is ideal for 
reusablility, but other 
adhesives such as VLC One 
Step Adhesive and C&B 
Metabond offer stronger 
bonds to the screws and skull 
surface. While two screws are 
normally sufficient, larger the 
PCB interfaces may require 
more anchor screws. 
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37, 63 Little or no expression of 
the viral construct 
Improper handling and 
injection of the virus 
Thaw virus as close in time to 
the surgery as possible. 
Maintain virus on ice until 
the time of injection. 
Depending on the promoter 
that drives expression, some 
systems will not provide 
sufficient opsin expression. 
This should be empirically 
determined prior to any 
attempted behavioral 
experiments. 
40 Dissolution of silk 
adhesive during 
sterilization 
Too much exposure to 
ethanol 
Most aqueous solutions will 
dissolve the silk adhesive. Do 
not soak the devices in 
ethanol as this will promote 
dissolution of the adhesive. 
In our experience, rinsing the 
device with ethanol for ~15 
seconds is sufficient to 
prevent widespread 
inflammation in mouse brain 
tissue (See Chapter 2) (Kim 
et al., 2013b). Care should be 
taken to use appropriate 
sterilization techniques in 
higher mammals to avoid 
immune responses, such as 
EtO gas sterilization.  
54Bi Insufficient RF power is 
reaching the headstage 
scavenger 
The behavioral 
apparatus is between 
the panel antenna and 
scavenger (in an 
enclosure) 
Connect a freestanding 
device to the scavenging 
headstage and place it in the 
behavioral enclosure. Using 
the gain on the RF signal 
generator adjust the RF 
power until sufficient power 
is available to power the µ-
ILEDs to the desired light 
output. If problems powering 
the device persist, consider 
reducing the distance 
between the panel antenna 
and the scavenger. 
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Optional 
Section 2 
Headcap does not fully-
dissolve 
Insoluble dental 
cement was used, not 
enough solvent, or 
extend duration of 
exposure to solvent 
Some dental cements will not 
dissolve in methyl 
methacrylate. Consider using 
the exact recommended 
cements where possible. If 
using Jet Denture Repair, add 
more solvent or wait a longer 
durations for cap to dissolve. 
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Chapter 4 
 
 
 
 
 
 
 
Wireless optofluidic systems for programmable in vivo 
pharmacology and optogenetics 
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 SUMMARY  
 In vivo pharmacology and optogenetics hold tremendous promise for dissection of neural 
circuits, cellular signaling and manipulating neurophysiological systems in awake, behaving 
animals. Existing neural interface technologies, such as metal cannulas connected to external 
drug supplies for pharmacological infusions and tethered fiber optics for optogenetics, are not 
ideal for minimally-invasive, untethered studies on freely behaving animals. Here we introduce 
wireless optofluidic neural probes that combine ultrathin, soft microfluidic drug delivery with 
cellular-scale inorganic light-emitting diode (µ-ILED) arrays. These probes are orders of 
magnitude smaller than cannulas and allow wireless, programmed spatiotemporal control of fluid 
delivery and photostimulation. We demonstrate these devices in freely moving animals to 
modify gene expression, deliver peptide ligands, and provide concurrent photostimulation with 
antagonist drug delivery to manipulate mesoaccumbens reward-related behavior. The minimally-
invasive operation of these probes forecasts utility in other organ systems and species, with 
potential for broad application in biomedical science, engineering, and medicine. 
INTRODUCTION 
 Fundamental insights into the function of the central and peripheral nervous system often 
follow from advances in tools and methodologies for neuroscience research. Technologies for 
deep brain optical manipulation of neural activity allow for many types of basic research into 
neural circuits (Tye and Deisseroth, 2012), intracellular signaling (Siuda et al., 2015; Zhang and 
Cui, 2015), gene expression (Konermann et al., 2013; Polstein and Gersbach, 2015) and other 
biological processes. Additional levels of control follow from combined use of such approaches 
with pharmacological delivery (Jennings et al., 2013; Stamatakis et al., 2013; Walsh et al., 2014). 
Furthermore, the potential of these combinatorial approaches for clinical impact was recently 
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demonstrated using combined optical and pharmacological intervention to inform and modify 
traditional, electrical deep brain stimulation to be more effective for off-label psychiatric 
disorders (Creed et al., 2015). A key technological challenge has been the development of 
miniaturized, self-contained systems that are capable of providing such functionality with 
wireless control in feely moving, awake animal models. Conventional methods rely on metal 
tubes (cannulas) and fiber optic cables to deliver drugs and light, respectively. Typically each 
modality requires connection to separately located light and fluid sources that physically tethers 
the animals and restricts their natural movement. Recent advances have combined cannulas and 
fiber optics into small, multifunctional fibers that have capabilities in fluid delivery and 
photostimulation, but which retain similar requirements for multiple, external connections 
(Canales et al., 2015). All these technologies use rigid materials as neural interfaces leading to 
adverse consequences for chronic use. The tissue benefit of mechanical compliance was recently 
demonstrated comparing standard systems against systems that combine soft electrodes and 
microfluidic structures in epidural implants (Minev et al., 2015) (See Table 4.1 for feature 
comparison). 
 The approach we report here describes complete platforms that include power supplies, 
control electronics, wireless interfaces, active fluidic handling systems and efficient light 
sources, into compact, head-mounted devices that interface with thin, mechanically compliant 
multifunctional neural probes. The result is a set of unique capabilities in programmed delivery 
of multiple types of pharmacological agents and monochromatic light to discretely targeted 
regions of the deep brain. These systems, which we refer to as wireless optofluidic neural probes, 
create important opportunities in neuroscience research that combines in vivo pharmacology with   
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 Optofluidic neural probes 
Electronic 
dura mater 
(Minev et al., 
2015) 
Multifunctional 
Fiber (Canales 
et al., 2015) 
NeuroMedicator 
(Spieth et al., 2012) 
Operation Wireless Tethered Tethered Tethered 
Modality Optical & Fluidic 
Fluidic & 
Electrical 
Optical, Fluidic 
& Electrical 
recording 
Fluidic only 
Programmable 
operation Yes No No Yes 
Mechanical 
property of the 
probe 
Soft, flexible Soft, flexible Flexible Rigid 
Modulus: 
~ 1 Mpa 
 
Modulus: 
 ~ 1 Mpa Not reported 
Modulus: 
 ~170 GPa 
Stiffness:  
13-18 N/m Not reported 
Stiffness: 107-
149 N/m Not reported 
Optical 
property 
Optically 
transparent 
Optically 
transparent Not transparent Not transparent 
Number of 
independent 
drug channels 
4 1 2 2 
Drug leakage No leakage No leakage No leakage Leakage by diffusion 
Dimensions 80 um in thickness 
200 um in 
thickness 
400-700 um in 
diameter (for 
multimodal 
fibers) 
250um in thickness 
 
Table 4.1. Comparison of various neural probes with related capabilities, related to Figure 
4.1.  
 
wireless optogenetics. Examples in awake, freely moving animals demonstrate the sophisticated 
levels of spatiotemporal control over neural circuit functions that are possible without physically 
contacting the animal. Specifically, optical manipulation of projections from the ventral 
tegmental area dopaminergic system into the nucleus accumbens can elicit place preference 
behaviors that can be blocked, in a temporally-precise programmable manner, by site-specific 
infusion of a dopamine receptor antagonist. These and related studies represent the sort of 
versatile, complex experimental options provided by the technology we report here. 
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RESULTS 
Ultrathin, Soft Neural Probes Have Wireless Capabilities For Programmed Drug Delivery 
and Photostimulation  
Figure 4.1 A-C show schematic illustrations and photographs of a multichannel, soft 
microfluidic system, in which two thin, narrow pieces of the elastomer polydimethylsiloxane 
(PDMS) bond together to form a set of four channels each with 10 & 10 µm2 cross-sectional 
areas in a platform that has a total thickness of 50 µm. This type of microfluidic probe (Figure 1, 
B and C) is transparent (> 95 % throughout across wavelengths from 400 nm to 700 nm) and 
mechanically soft (modulus ~1 MPa; bending stiffness 13-18 N/m), thereby enabling both 
optical access and minimally invasive use in soft neural tissue (see Chapter 2) (Canales et al., 
2015; Capadona et al., 2012; Jeong et al., 2015; Kim et al., 2013b; Kozai et al., 2012; Minev et 
al., 2015; Subbaroyan et al., 2005; Wu et al., 2013). The former characteristic facilitates 
integration of microscale inorganic light-emitting diodes (µ-ILEDs) on a filament of 
polyethylene terephthalate (PET) with thickness of 6 µm (Figure 4.1D). These µ-ILEDs (each 
with thicknesses of 6.54 µm and lateral dimensions of 100 & 100 µm2; Figure 4.1E) (see Chapter 
2) (Kim et al., 2013b) provide spatially- and temporally-precise delivery of light in regions 
adjacent to the outlets of the microfluidic channels. Active infusion of multiple drugs through 
these four individual channels (Figure 4.1F) can be controlled independently from the µ-ILEDs. 
This system allows for tandem pharmacological and optogenetic manipulation of neural 
circuitry, with potential for application in optopharmacology where the use of light to activate 
compounds requires high spatiotemporal control of both drug and light delivery (Kramer et al., 
2013) (Figure 4.1G). 
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Figures 4.1G, H and I provide comparisons of this type of compliant optofluidic probe to a 
standard metal cannula (see also Figure 4.2). The latter is hard, rigid, and displaces large 
amounts of brain tissue (diameter ~500 µm), whereas the former is soft, flexible, and minimally 
invasive (total thickness ~ 80 µm). The low bending stiffness (13-18 N/m, compared to > 5 
MN/m for the 26 gauge cannula) of the optofluidic probes (Figure 4.3) facilitates adaptation to 
the micromotions associated with movement, respiration, and blood flow (Gilletti and 
Muthuswamy, 2006). This probe property minimizes mechanically induced damage or irritation 
of the brain tissue in chronic applications (Lee et al., 2005). X-ray computed tomographic 
images of mice implanted with these two types of fluidic delivery systems highlight the notable 
differences in scale and impact on the tissue (Figures 4.1H and I).  
Thermo-mechanical-fluidic Characteristics of the Optofluidic Devices 
Figure 4.4A presents a schematic diagram of the overall system, with emphasis on the fluid-
controlling hardware. The schemes for fluid handling and pumping represent extensions of 
recently reported drug delivery systems that use rigid, single-channel and single-reservoir 
microfluidics and wired control interfaces (Spieth et al., 2012). Each of the four channels 
connects to a separate reservoir whose base consists of an active layer (2:1 mixture of PDMS and 
expandable microspheres, Expancel 031 DU 40, AkzoNobel) that initiates pumping through 
expansion induced by Joule heating in an underlying element (serpentine traces of gold with 
thickness of 185 nm). A dramatic increase in the volume of the active layer follows from 
thermally induced, irreversible expansion of hollow polymer microspheres that encapsulate 
hydrocarbon gas (Figure 4.4B). The supporting substrate (FR4) has a low thermal conductivity 
(0.4 W/m'K), thereby minimizing the electrical power needed to reach the temperatures required 
for this type of thermal actuation. The four reservoirs exist as molded features in a cyclic olefin 
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polymer (COP), chosen for its low water vapor permeability (0.023g'mm/m2'day). Thin copper 
membranes (thicknesses of 3 !m) seal the outlets of the reservoirs to prevent evaporation. This 
design allows delivery of multiple drugs without the repeated insertion of a delivery probe.  
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Figure 4.1 Ultrathin, Soft Neural Probes with Wireless Capabilities in Programmed Drug 
Delivery and Photostimulation (A) Schematic diagram of the assembly of a soft microfluidic 
probe. Bonding thin, molded (bottom) and unmolded (top) layers of PDMS together yields a 
system that includes four separately addressable microfluidic channels each with cross sections 
of 10 & 10 µm2, and a total thickness of 50 µm and width of 500 µm, as illustrated in the inset at 
the bottom right. (B) Optical micrograph of a microfluidic probe formed in this way. (Inset) 
Magnified view of the channels. Scale bar, 100 µm. (C) Picture that illustrates the soft, compliant 
mechanics of the device. (D) Schematic diagram of the integration of a soft microfluidic probe 
with a flexible array of µ-ILEDs (each with lateral dimensions of 100x100 µm2, and thicknesses 
of 6.54 µm) and metal interconnect traces on a film of PET (thickness of 6 µm). (E) Optical 
micrograph of an integrated probe, which we refer to as an optofluidic system. (Inset) Colorized 
SEM of a representative µ-ILED (contact electrodes, yellow; spreading layer, blue). Scale bar, 
100 µm. (F) Tilted view of an optofluidic probe that shows the tip end. (Inset) SEM of the outlets 
of the microfluidic channels. Scale bar, 50 µm. (G) Optofluidic neural probe during simultaneous 
drug delivery and photostimulation. (Insets) Comparison of such a device (top) and a 
conventional metal cannula (bottom; outer and inner diameters of ~500 and 260 µm, 
respectively). Scale bars, 1 mm. (H & I) X-ray computed tomographic images of the mouse 
models with (H) an optofluidic neural probe and (I) a metal cannula implanted into the brain. 
Both devices are colorized green. 
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Figure 4.2 Conventional cannulae to deliver drugs into the brain via an external pump. 
Related to Figure 4.1.  (A) Example of microinfusion pump system set up and connected to an 
awake behaving mouse. Scale bar, 10 cm. (B) Injector and metal cannula (500 µm diameter 
metal tube). Scale bar, 1 cm. (C) Connected injector/cannula (Note: 500 µm projection beyond 
cannula termination). Scale bar, 1 mm. (D) Mouse with cannula implanted into dorsal striatum, 
connected to microinfusion pump. Scale bar, 1 cm. (E) Top views of a metal cannula, an 
optofluidic probe, and an optical fiber. Metal cannula: 500 µm in diameter; Optofluidic probe: 
~80 µm in thickness; Optical fiber: 125 µm in diameter including a cladding. Scale bar, 1mm. 
Cannula!
Injector from pump!
A! B!
C! D!
10 cm!
Cannula! Optofluidic 
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Figure 4.3 Bending stiffness measurement of the optofluidic 
probe at physiological frequency range (respiration, heat beat, 
etc). Related to Figure 4.1. Dynamic mechanical analyzer (DMA 
Q800) in the single cantilever mode was used to measure the bending 
stiffness.  
 
 As illustrated in Figure 4.4C, activating a Joule heating element launches expansion of 
the corresponding active layer (Figure 4.4B). The resulting pressure in the reservoir ruptures the 
thin copper membrane and pumps the drug, with nearly 100% efficiency in volume delivery (0.5 
!l in this case; Figure 4.4D), through the respective microfluidic channel. Quantitative 
measurements and numerical modeling based on finite element analyses (FEA) capture the 
thermal and mechanical aspects of operation. Because the modulus of the COP material (~ 2.6 
GPa) is much higher than that of the expandable polymer (~ 3.0 MPa), deformations induced by 
thermal actuation are almost exclusively accommodated by the latter, as shown by both 
experimental and FEA results (Figure 4.4D and Figure 4.5, A-C). Quantitative studies (Figure 
4.4D) indicate a negligible amount (< 8.5%) of infusion for heating of the active layer to 
temperatures below ~75 oC, followed by a rapid increase above ~82 oC, finally reaching 
complete infusion (> 99.5% of the volume of the reservoir) at ~87 oC. This nonlinear behavior 
originates from the nonlinear thermal expansion properties (Figure 4.4B). FEA results for the 
spatiotemporal temperature distribution of isolated Joule heating elements agree with IR images, 
as shown in Figure 4.2E, thereby validating the use of computation in design optimization 
(Figure 4.5D). The increase in temperature decays rapidly along both the thickness and in-plane 
directions (Figure 4.4F and H), to allow efficient individual control of the reservoirs. Computed 
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and measured temperatures at representative locations for times before, during and immediately 
after actuation appear in Figure 4.4G. The average temperature of the drug in the reservoir 
remains in a range (< 60 ºC) compatible with many neuroactive compounds (Callahan et al., 
2001; Joyce et al., 1984; Steger et al., 1996). Calculations based on a simplified fluid dynamics 
model (see SI for details) indicate that the drug cools significantly as it flows down the 
microfluidic channels before reaching the outlets and penetrating the targeted tissue (< 0.1 oC 
higher than the temperature of the surroundings). 
Wireless Optofluidic Devices Can Deliver Multiple Fluids and Photostimulation 
Figure 4.6A (left) provides a schematic illustration of control hardware and associated 
electronics, along with the key components that directly support the array of µ-ILEDs and the 
soft microfluidic probe. A battery-powered infrared (IR) wireless module enables independent 
control of fluid delivery and optical activation. The system uses serial communication between a 
separate IR transmitter (950 nm wavelength) and the receiver, to provide programmable 
activation of individual heaters in the array (heater 1, 2, 3, or 4) and the µ-ILEDs (in this case 5, 
10, 20, or 40 Hz with 10 ms pulse width; Figure S4A). A thin, flexible printed circuit board 
(PCB) serves as a substrate for a microcontroller (556-ATTINY84-20MU, Atmel), transistors, 
and an IR detector with wide sensing angle (120˚; IR Sensor IC 38 kHz, Vishay 
Semiconductors). Two small, rechargeable lithium ion batteries (GM300910H, PowerStream 
Technology; Figure 4.7B) provide power. The entire collection of components (including the 
optofluidic probe, microfluidic reservoirs and actuators, the wireless module, and two batteries) 
is sufficiently lightweight (~ 1.8 g) to allow head mounting on adult mice and rats (Figure 
4.7C). The wireless module and rechargeable batteries release from the optofluidics to allow 
quick replacement, thus facilitating long-term operation in various behavioral experiments.  
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Figure 4.4 Thermo-Mechanical-Fluidic Characteristics of the Wireless Optofluidic System 
(A) Exploded view schematic diagram that illustrates an array of µ-ILEDs mounted on top of a 
soft microfluidic system that includes four separate microfluidic channels, each connected to a 
set of fluid reservoirs that include copper membranes as hermetic seals, expandable composite 
materials as mechanical transducers, and microscale Joule heating elements as actuators. (B) 
Characteristics of a thermally expandable composite material. (Left) Thickness variation of this 
material as a function of temperature. (Right) SEM images (scale bar, 100 µm) show the 
expansion of microspheres upon application of heat at ~110 ˚C. (C) Actuation principle for drug 
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delivery. Before actuation, drug remains in the reservoir (top). Upon activation of the Joule 
heater, the expandable composite layer increases in volume to push drug through the connecting 
microfluidic channel (bottom). (D) Dependence of the infused volume, as a percentage of the 
total volume of the reservoir, on temperature of the composite material. The dashed line indicates 
~100% infusion at 87 ºC. (Inset top) Cross sectional SEM image that shows complete filling of a 
reservoir with composite material by thermal expansion, for a state of 100% infused volume. 
(Inset bottom) Corresponding distribution of vertical displacements in the composite material 
under the deformed configuration. (E) Comparison of temperature distributions for the system 
with a bare heater in IR images (top) and FEA modeling results (bottom). The images show the 
temperature distribution after activating the heater for 20 s. (F) Calculated temperature 
distribution at the surface of the entire three-dimensional computational model (top), and that at 
the cross-section defined by the red plane in the top (bottom). (G) Computed (blue) and 
measured (red) temperature at the location of a thermal actuator, immediately before, during, and 
after operation. The violet, green and yellow curves correspond to calculations at the reservoir, 
the microfluidic inlet and outlet, respectively. (H) Temperature profile from the center of the 
powered heater to the center of adjacent, unpowered heater, corresponding to the FEA model in 
(E). The two red lines represent the boundaries of the two heaters.  
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Figure 4.5. Results of thermo-mechanical modeling on the actuation process. Related to 
Figure 4.4.  (A) Schematic of the full 3D model of FEA. (B) Distribution of the out-of-plane 
(i.e., the thickness direction) displacement in the structure, by applying a thermal strain of 22.4% 
to the area covered by the heater (corresponding to heating the thermal expandable layer to an 
average temperature of 87 oC). (C) The injected proportion of drug as a function of the thermal 
strain in the expandable layer. (D) Power analyses for a safe and sufficient injection. The 
minimum and maximum powers are plotted as functions of the heating time to complete the 
injection.  
  
C? D?
A? B?
0 5 10 15 20 25
0
20
40
60
80
100
In
jec
te
d 
pr
op
or
tio
n 
(%
)!
Thermal strain (%)!
0 10 20 30 40 50 60
0
50
100
150
200
Po
we
r (
m
W
)!
Heating time to complete injection (s)!
Theating!
= 37.3s!
Max power!
Min power!
Valid !
region!
158 
 Figure 4.6A (right) demonstrate wireless operation of drug delivery and optical 
stimulation with a compact, self-contained device in a 3D-printed enclosure. Upon wireless 
triggering, the microcontroller activates a selected heater for drug delivery. The infusion rates 
non-linearly increase up to ~ 5.2 !l/min, such that most of the fluid is delivered within 13 
seconds after initiating actuation (Figure 4.6B). The time dynamics of the expansion process and 
the geometries of the reservoirs and channels define these rates. Therefore, engineering the 
geometries of reservoirs and the dimensions of the channels can modulate the flow rate for 
different applications. Demonstration experiments using aqueous solutions of colored dyes and 
phantom brain tissue (0.6 % agarose gel) verify these operational characteristics, as shown in 
Figure 4.6C and D. Figure 4.6E shows results for total volumes of fluid delivered from a set of 
reservoirs in a representative device. 
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Figure 4.6 Wireless Optofluidic Devices Are Capable of Delivery of Multiple Fluids and 
Optical Manipulation. (A) Complete wireless optofluidic system. (Left) Schematic illustration 
of the electronics, power and wireless control system that plugs into the construct shown in 
Figure 2A. (Right) Demonstration of wireless drug delivery and optical stimulation by operation 
of the optofluidic system in a brain tissue phantom (0.6% agarose gel). (B) Flow rate in a 
microfluidic channel (blue) and total infused volume (red) as a function of time before, during 
and after actuation. (C) Time sequence of optical images that demonstrates delivery of liquid 
(aqueous solution with orange dye) into brain phantom tissue (0.6 % agarose gel) through a 
microfluidic channel: t1 = 0 s (onset of actuation), t2 = 3.1 s, t3 = 3.8 s, t4 = 15.2 s. (D) Images 
that show capabilities in separate delivery of different liquids (aqueous solutions with red, 
yellow, blue and green dyes) through four individual microfluidic channels. The image on the 
right provides a magnified view. (E) Total infusion volumes from each of four reservoirs in 
representative devices (average of three devices). 
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Figure 4.7 Design of wireless control system. Related to Figure 4.6 (A) Overall design of 
transmitter (remote controller) and receiver circuit. (B) Picture of optofluidic drug delivery 
device system components including a case, an optofluidic device, wireless control circuit, and 
lithium ion batteries. (C) Weight of an optofluidic system.  
B!
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Optofluidic Devices Are Suitable for Wireless Pharmacology and Optical Manipulation in 
Awake, Behaving Animals 
For application in vivo, the optofluidic drug delivery device can be chronically packaged with the 
platform for wirelessly triggered operation that includes infrared remote control, battery power, 
fluid reservoirs and pumps with associated control electronics, all contained in a small head stage 
(Figure 4.8A, Figure 4.9A and B). To extend the lifetime of operation and reduce the impact on 
smaller organisms, the packaged electronics for the optofluidic device can be acutely affixed to 
an awake animal for acute device operation (Figure 4.8B). Mice with the fully encapsulated, 
chronically implanted wireless optofluidic devices interfaced to the dorsal striatum perform the 
rotarod test of sensorimotor control equally as well as cannula-implanted controls (Figure 4.8C 
and Figure 4.9C). Furthermore when allowed to choose when and how to run on a wheel, 
optofluidic-implanted mice run equally as often and as much as cannula-implanted controls 
(Figure 4.8D and Figure 4.9D) and have equivalent baseline anxiety-like behavior in the open 
field test (Figure 4.8E). These results indicate that even small mammals such as mice tolerate 
the chronically implanted probes equally as well as mice with conventional cannulas targeting 
the same brain structure. It is important to note that the cannulated mice in these experiments 
were not connected to an external drug supply. Such tethering can restrict movement and impacts 
performance on all of these tests, while the optofluidic device-implanted mice are fully 
integrated with both the device and the fluid supply. In addition to comparable behavioral 
responses, the mechanical compliance and smaller overall tissue displacement of the microfluidic 
channels reduce lesioning and immunoreactive glial responses from deep brain implantation 
(Figure 4.8F-J). Additionally, the optofluidic devices provide access to four channels of drug, 
viral, or other fluid administration compared to a single channel for the cannula in a significantly 
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Figure 4.8 Optofluidic Devices Are Suitable for Wireless Pharmacology in Awake, 
Behaving Animals. (A & B) Images of a freely behaving (A) Sprague-Dawley rat and (B) a 
C57Bl6 mouse mounted with wireless power systems that are capable of drug delivery and 
photostimulation deep into brain tissue. All animals are healthy and freely moving, shown here 
one week following surgery. Scale bars, 1 cm. (C-E) Wild-type (C57Bl6) mice tolerate the 
microfluidic devices as well as traditional cannulas and do not exhibit any notable deficits in (C) 
motor coordination, (D) spontaneous locomotor activity, or (E) anxiety-like behavior. (F) 
Schematic and Mouse Brain Library atlas image of histological approach for inflammation and 
lesion study. Dashed circle indicates approximate injection site. Scale bar, 1 mm. (G) Mean ± 
SEM cross-sectional area of lesions from cannulas and optofluidic probes (Student’s T-Test, 
**p<0.01, n=3/group). (H) Representative linescan of fluorescence intensity from cannula (gray) 
and optofluidic probe (red) lesions. (I & J) Representative confocal fluorescence images of 30 
!m horizontal striatal slices show immunohistochemical staining for Nissl bodies (blue), 
astrocytes (GFAP, red) and activated microglia (Iba1, green) and overall lesion from a cannula 
(I) and an optofluidic device. All histological and confocal settings were kept consistent across 
groups. (J). In the rightmost panels, the shape and scale of the lesion from the cannula or 
optofluidic device is overlaid on the image of the other device (dashed lines). Scale bars, 100 
!m. 
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Figure 4.9 Demonstration of chronically implanted, fully enclosed and wireless microfluidic 
devices in various environments, related to Figure 4.8A-E. (A & B) Group-housed homecage 
environment. (C) Rotarod test. (D) Spontaneous run on a running wheel.  
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smaller cross-sectional area (Figure 4.8G) of the brain. These thin, flexible optofluidic neural 
probes are better tolerated by the brain than rigid implants, consistent with previous reports of 
ultrathin, flexible deep brain implants (see Chapter 2) (Canales et al., 2015; Capadona et al., 
2012; Kim et al., 2013b; Kozai and Kipke, 2009; Kozai et al., 2012). 
Wireless Virally-mediated Recombination and Visualization of Fluid Delivery  
 As a demonstration of the optofluidic probes’ ability to delivery multiple, independent 
fluids through a single implant in an awake, behaving animal we loaded two reservoirs with two 
different adeno-associated viruses to allow for recombination-dependent fluorescent 
visualization of successful fluid ejection. First, we delivered a virus expressing Cre recombinase 
(AAV5-PGK-Cre) into the dorsal striatum of a Cre-conditional tdTomato reporter mouse line 
developed by the Allen Institute for Brain Science (Figure 4.10A) (Madisen et al., 2010). We 
observed robust Cre-dependent expression of tdTomato in a distinct radius below the ventral tip 
of the microfluidic channels, thereby indicating efficient remote-controlled, virally-induced in 
vivo recombination (Figure 4.10A). When we counted the number of tdTomato+ cells emanating 
from the tip of the implant we found the majority of the Cre-induced fluorescent reporter 
expression to be within 500 !m of the injection site (Figure 4.10B). Next, in a separate group of 
animals, we delivered the same AAV5-PGK-Cre as well as a Cre-dependent eYFP reporter virus 
(AAV5-Ef1a-DIO-eYFP). In these animals we clearly observed co-expression of both tdTomato 
and eYFP (Figure 4.10C-E) indicating successful, combinatorial viral-mediated recombination 
in vivo. These are proof-of-principle experiments, but the same approach could be used to 
wirelessly alter gene expression at multiple timepoints without the need for multiple, disruptive 
surgeries or physical connection to viral infusion hardware. Together these results further 
demonstrate the optofluidic neural probes can be used for in vivo remote-controlled, independent 
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delivery of fluids within an isolated region through individual and distinct channels running 
along a single implant. 
 
 
  
B!
-750-500-250 0 250 500 7500
20
40
60
80
Distance from injection site (µm)
tdT
om
ato
+  n
eu
ro
ns
!
tdTomato!
A!
AAV5-Cre! AAV5-DIO-eYFP!
Ai9 tdTomato Reporter Mouse!
Nissl!
tdTomato! tdTomato!
eYFP!
eYFP!
tdTomato!
La
be
l 1
 c
el
ls
 a
ls
o 
ex
pr
es
si
ng
 L
ab
el
 2
 (%
)
0
20
40
60
80
100
eY
FP
 (1
)!
td
T 
(2
)!
td
T 
(1
)!
eY
FP
 (2
)!
D! E!
Figure 5!
Cre! 3?!5?!PGK!
AAV5 Viral infusion!
Ai9 mice 
STOP tdTomato CAG 
loxP!
tdTomato CAG 
Cre! 3?!5?!PGK!
loxP!
eYFP! 5?!
lox2722!
3?!EF1"!
3?!5 !EF1"!
tdTomato CAG 
Cre! 3?!5?!PGK!
Cre-dependent AAV5 Viral infusion!
eYFP! 3?!5?!EF1"!
C!
167 
Figure 4.10 Wireless Virally-mediated Recombination Visualizes the Spread of Fluid 
Delivery. (A) Schematic of viral delivery experiment depicting loading of two distinct viruses 
into a single microfluidic device, fluorescence image depicts bolus of Cre-mediated 
recombination (imaged as expressed tdTomato, red; Nissl, blue) near the tip of the implanted 
microfluidic device. Right, enlarged maximum projection of 35 confocal fluorescence images 
(tdTomato, red). Black scale bar, 1 mm; white scale bar, 25 !m. (B) Quantification of the spread 
of AAV5-PGK-Cre viral recombination. Cells counted in serial coronal slices from point of 
infusion (n=3 slices per brain from 3 brains). (C) Viral recombination scheme for the dual viral 
approach taken in (D & E). (D) Representative maximum projection of 35 confocal fluorescence 
images of 30 !m coronal striatal slices demonstrate efficient virally-induced gene expression 
(Left-tdTomato, red; middle - eYFP, green, Right-overlay) following wireless delivery of 
viruses. Chevron indicates example co-localization of tdTomato and eYFP. Scale bar, 25 !m. (E) 
Quantification of co-localization of tdTomato (tdT) and eYFP (n=3 slices per brain from 3 
brains).  
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Untethered, Programmed Pharmacological Infusion Alters the Behavior of Freely Moving 
Animals 
 The capability to load a single device with multiple fluids for independent, remote-
controlled delivery offers the user the advantage of either multiplexed therapeutic treatments or 
easily controlled within-subject study designs. As a demonstration of the latter, we implanted 
microfluidic devices unilaterally into the ventral tegmental area (VTA) of wild-type (C57Bl6) 
mice. Previous reports have demonstrated a remarkably stereotyped rotation behavior to 
unilateral !-opioid receptor (MOPR) activation in the VTA (Devine and Wise, 1994; Jenck et al., 
1988). As a proof-of-principle within-subject in vivo pharmacology experiment, two chambers of 
each device were loaded with different pharmacological agents; one with the synthetic opioid 
peptide and MOPR agonist, [D-Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO, 200 pmol, 
Tocris), and one with artificial cerebral spinal fluid (ACSF) as a vehicle control. In a counter-
balanced design, we then wirelessly delivered either the DAMGO or vehicle into the VTA of 
freely behaving animals over a distance of ~1 m away from the animal (Figure 4.11A and B). 
Consistent with previous reports (Calenco-Choukroun et al., 1991; Devine and Wise, 1994; 
Jenck et al., 1988; Latimer et al., 1987), when DAMGO was infused into the VTA the animals 
showed a robust increase in overall locomotor activity (Figure 4.11C-E). In particular, the 
unilateral administration causes stereotypical rotations contralateral to injection site that is 
completely absent when the same animals receive the wireless ACSF infusion (Figure 4.11B, C 
and E). This experiment demonstrates the utility of the optofluidic probes for self-contained, 
within-subject experiments to wirelessly deliver multiple chemicals into the brain without any 
physical contact with the animal for completely unconstrained freely moving behavior. 
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Figure 4.11 Untethered Delivery of Opioids into the Ventral Tegmental Area Causes 
Stereotypical, Repeated Rotation Behavior. (A) Schematic of the opioid peptide delivery 
experiment depicting loading of an agonist (200 pmol DAMGO, Tocris) and its vehicle into 
single microfluidic device. (B) Cartoon of wireless scheme for the DAMGO-induced rotation 
experiment. (C) Representative traces of movement from the same animal over the course of two 
minutes and one hour clearly show an increase in overall movement and rotations. (D-E) Within-
subject, counter-balanced experiments demonstrate robust wireless, DAMGO-induced changes 
in ambulatory behavior. Intra-VTA DAMGO causes a significant increase in (D) overall 
locomotion and (E) contraversive 360º rotations (n=7, Paired Student’s T-Test, **p<0.01).  
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Concomitant Wireless Photostimulation with Pharmacological Antagonism Modulates a 
Dopamine Receptor-1-sensitive Real-Time Place Preference 
 We next determined the in vivo optofluidic capabilities of these devices. Real-time place 
preference has become a common tool for neuroscientists to assess the behavioral valence of 
photostimulated neural circuits or cell bodies in a freely moving animal (Jennings et al., 2013; 
Kim et al., 2013a; Siuda et al., 2015; Stamatakis and Stuber, 2012; Stamatakis et al., 2013; Tan 
et al., 2012). In related behavioral models, phasic optogenetic activation of VTA dopaminergic 
(VTA-DA) neurons is rewarding (see Chapter 2) (Kim et al., 2012, 2013b; Tsai et al., 2009; 
Witten et al., 2011). However, we previously failed to observe that wireless phasic activation of 
VTA-DA cell bodies was sufficient for a real-time place preference (see Chapter 2) (Kim et al., 
2013b). Because of the pronounced heterogeneity of VTA projections (Gunaydin et al., 2014; 
Lammel et al., 2011, 2012, 2015; Stamatakis et al., 2013; Stuber et al., 2015), we sought to 
selectively target VTA-DA projections into the shell of the nucleus accumbens (NAcSh). To do 
this, we selectively targeted channelrhodopsin-2 fused with eYFP (AAV5-EF1a-ChR2(H134)-
eYFP) to VTA-DA neurons of TH-Cre mice and implanted an integrated optofluidic probe 
adjacent to the NAcSh (Figure 4.12A and B; Figure 4.13A-C). In this experiment, we found 
that photostimulation of the NAcSh-projecting VTA-DA fibers resulted in an increase in c-fos 
expression, a widely used biochemical marker of neuronal activation, in both the accumbens and 
the ventral tegmental area (presumably through antidromic activation) (Figure 4.13D and E). To 
test whether any of the observed behavioral phenotypes were dopamine-dependent, we filled one 
chamber of the optofluidic device with the selective dopamine receptor D1 (DRD1) antagonist 
SCH23390 (400 ng, Tocris) (Billard et al., 1984; Gunaydin et al., 2014; Hyttel, 1983). We found 
that phasic photostimulation (8 x 10 ms light pulses at 20 Hz every 5s) of VTA-NAcSh terminals 
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was able to drive a robust real-time place preference (Figure 4.12C and D). Importantly, in a 
counter-balanced design, this place preference was completely blocked by wireless 
pharmacological delivery of SCH23390 prior to photostimulation in the real-time place 
preference task, indicating that optogenetically-induced dopamine release into the NAcSh elicits 
the real-time place preference via DRD1 activation. There was no effect of either the 
photostimulation or the drug treatment on TH-Cre- control animals that did not express 
ChR2(H134)-eYFP (Figure 4.12E and F) and no treatment group displayed a significant effect 
on locomotor activity (Figure 4.12). These findings demonstrate that completely self-contained, 
remote-controlled optofluidic neural probes can be easily incorporated into optogenetic studies to 
introduce pharmacological agents into the immediate region of targeted photostimulation in a 
programmed fashion that is time-locked and dependent on the behavior. 
DISCUSSION 
 The wireless optofluidic neural probes presented here represent a compelling technology 
for programmable drug delivery and optical manipulation of deep brain tissue in freely moving 
animals. The resulting device platform has multifunctional capabilities in a single, soft implant 
that provides powerful options for in vivo pharmacology and wireless optogenetics, many of 
which would be impossible to reproduce with conventional metal cannulas and/or optical fibers. 
 A key advantage of these systems is the spatial specificity inherent in the multimodal 
brain/device interface. Previous demonstrations of wireless drug delivery have focused on defuse 
infusion of drug into the subcutaneous space of rats and, recently, humans (Farra et al., 2012; 
Hoare et al., 2009, 2011; Timko et al., 2014). While these devices are capable of on-demand 
fluid delivery, they are unable to couple to the types of microfluidic channels necessary for  
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Figure 4.12 Wireless DRD1 Antagonism in the NAcSh Blocks Photostimulation-induced 
Real-Time Preference of Freely Moving Animals. (A) Schematic of the optofluidic 
experiment. AAV5-EF1a-DIO-ChR2-eYFP was injected into the VTA and six weeks later an 
optofluidic probe loaded with SCH23390 (400 ng, Tocris) was implanted in the NAc of TH-Cre 
animals. (B) Representative confocal fluorescence images depicting cell-type specific expression 
of ChR2-eYFP in (right) dopaminergic, TH containing neurons of the VTA (TH, red; ChR2-
eYFP, green) and (left) their projections in the NAc (Nissl, blue; ChR2-eYFP, green). Triangular 
arrow indicates the ventral tip of the microfluidic channels and the chevron indicates the ventral 
tip of the optofluidic device. All scale bars for the figure are 100 µm. (C-G) Phasic 
photostimulation (8 pulses at 20 Hz, 10 ms pulse width upon entry and every 5 s the animal 
remains in the chamber) of NAc-projecting terminals from the VTA of TH-Cre animals drives a 
real-time place preference. (C) Representative traces of movement during the real-time place 
testing experiment of one TH-CreVTA:ChR2 animal show a SCH23390-sensitive preference for the 
photostimulation-paired chamber. (D) All TH-CreVTA:ChR2 animals show a real-time place 
preference that is significantly reduced following wireless intra-NAc delivery of SCH23390 
(n=9, Paired Student’s T-Test, ***p<0.001). (E) In Cre- control animals, neither the 
photostimulation or the SCH23390 treatment affects real-time preference behavior (n=8, Paired 
Student’s T-Test, p=0.6234). (F) Grouped analysis confirms that the SCH23390-sensitive place 
preference is selective for the TH-Cre+ animals (n=8-9/group, One-way ANOVA, Bonferroni 
Post-Hoc, **p<0.01, ****p<0.0001). (G) There is no significant difference between any groups 
for overall locomotor activity (n=8-9/group, One-way ANOVA). 
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Figure 4.13 Further analysis of optofluidic real-time place preference experiment, related 
to Figure 4.12 (A) Schematic of the optofluidic experiment. (B) Cartoon of wireless scheme for 
the RTPP experiment. (C) Hit map of optofluidic placements for the experiments in Figure 7. 
Blue lines represent the most ventral 1 mm of device in Cre+ animals, grey lines repersent the 
most ventral 1 mm of device in Cre- animals. (D) Antidromic c-fos expression in the VTA 
following 1 hour of photostimulation. Triangular arrow indicates example c-fos expression.  
Scale bar, 10 !m. (E) Orthodromic c-fos expression in the NAcSh following 1 hour 
photostimulation. Triangular arrow indicates example c-fos expression. Arrowhead indicates 
ventral tip of optofluidic device. Scale bar, 100 !m.  
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discrete, targeted fluid delivery into deep brain tissue. The wireless optofluidic probes reported 
here overcome this challenge with a single device that causes a single, static lesion to brain 
tissue, where fluids and photons arrive at precisely the same micro-region of the brain. This co-
localization targets the same cells with both drugs and photostimulation. One interesting 
possibility is in delivery of viral vectors for expression of exogenous receptors (light-sensitive 
ion channels, receptors, pumps, etc. or DREADD receptors), ligands for these or endogenous 
receptors, and photostimulation all to the same brain region and cell population. The compact, 
self-contained construction eliminates the repeated micro-lesions associated with internal 
cannulas and the angled lesions associated with exterior fiber optics dramatically reducing 
overall trauma to the brain (Figure 4.8F and G). This minimally invasive operation facilitates a 
within-subject experimental design, thereby reducing the number of animals one needs to 
account for the behavioral variability that arises from any significant disruption of brain tissue. 
The soft neural interfaces enabled by these ultrathin, compliant probes also create new 
opportunities for chronic neuroscience research and preclinical investigation, as demonstrated 
not only here but also in recent studies of other soft device technologies for use in the epidural 
space (Minev et al., 2015). Importantly, the materials and designs presented here represent 
significant advances over these and other neural interfaces, all of which rely on tethered 
operation and lack capabilities in both wireless operation and photostimulation (Table 
S1)(Canales et al., 2015; Minev et al., 2015; Spieth et al., 2012). An important perspective is that 
the platforms reported here can easily be adapted for a wide range of other types of passive or 
active electronics technologies, including electrical microstimulation. 
 For any configuration, the value of the technology to the community depends on the 
extent to which it can be widely adopted. In this context, a relevant consideration is that the 
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hardware for control and power management consists of readily available electronics hobbyist 
components. Aside from a simple IR remote control, the animal carries a small IR receiver 
system with little observable impact on its behavior (Figure 4.8). In fact, after the initial surgery 
to implant and secure the device to the skull, the experimental subject never needs to come in 
contact with a human again. Complete operation of these optofluidic neural probes, including 
delivery of up to four distinct pharmacological agents, viruses, or other fluids, as well as 
photostimulation can all be achieved wirelessly in any domain through which the IR signal can 
pass.  
 Areas for further improvement include dynamic control of fluid flow. While the reported 
devices provide for multiple delivery events, each operates with identical rates of infusion 
(Figure 4.6B). Engineered variations in the dimensions of the reservoirs and channels represent 
one means to define different flow conditions. Another limitation is in refilling devices. With the 
current layouts, reuse of the microfluidics reservoirs and channels can be challenging. To 
overcome these restrictions, implementing replaceable fluid-containing cartridges (analogous to 
ink jet printer cartridges) might represent an attractive future design feature.   
 Even in existing embodiments, the device capabilities allow previously intractable 
experiments such as altering gene expression in freely behaving animals while living in their 
native home cage environments (Figure 4.9 and 4.10). The optofluidic neural probes can also 
provide photostimulation and delivery of pharmacological agents in a closed-loop manner based 
on the animals’ behavior (Figure 4.12). Integration with real-time video acquisition of socially 
interacting animals (de Chaumont et al., 2012; Kunwar et al., 2015) would allow fully 
automated, programmed fluid delivery that could be tuned entirely to the social interactions of 
the animal.  Beyond the possibilities in optogenetics, all which require genetic modification, an 
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interesting application could be in optopharmacology. The use of photo-sensitive compounds 
that act as photo-switches or ligands that bind to channels or receptors upon photo-conversion 
(Kramer et al., 2013) could exploit the high spatiotemporal control of both fluid and light 
delivery afforded by these optofluidic probes. Optopharmacological agents have been 
enthusiastically received in neuroscience for in vitro applications (Banghart and Sabatini, 2012; 
Callaway and Katz, 1993; Carter and Sabatini, 2004; Matsuzaki et al., 2001), but their use in vivo 
has been limited. Although compelling findings exist addressing the external visual nervous 
system and the surface of the cortex (Mourot et al., 2012; Noguchi et al., 2011; Polosukhina et 
al., 2012; Tochitsky et al., 2014), optopharmacological application in the deep brain remains a 
significant challenge. Optofluidic devices that provide access to the UV spectrum with advanced 
µ-ILEDs could target these highly selective photosensitive tools to spatially isolated regions of 
the central nervous system in non-genetically altered mammals.  
 Beyond basic research, the operation and architecture of the probes reported here will 
allow for a smooth translation to non-human primate models as well as applications in clinical 
medicine. Therapeutic solutions for a diverse set of pathologies (e.g. local neurooncotherapy, 
pharmacologically-refined deep brain stimulation, delivery of agents to mitigate traumatic brain 
injury etc.) will benefit from the untethered and fully-contained, programmable operation of 
devices similar in design to these optofluidic neural probes. Such centrally targeted drug delivery 
holds the promise of more tissue- and cell-type selective therapies that avoid perturbing off-
target organ systems. With these exciting future directions in mind, the results of our studies 
establish strategies for minimally-invasive, ultrathin wireless optofluidic neural probes that can 
serve as a starting point for new generations of fluid neural interfaces. 
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MATERIALS AND METHODS 
Fabrication of Ultrathin, Flexible Optofluidic Probes 
 Fabrication of flexible microfluidic probes started with creating microfluidic channel 
patterns in a 25-µm-thick PDMS layer (Sylgard 184, Dow Corning) using a molding process. For 
fabrication of a mold, photo-curable epoxy (SU-8 10, Microchem Inc.) was spin-coated (3000 
rpm for 10 !m thickness) on a silicon wafer and UV-exposed (120 mJ/cm2) through a mask 
pattern. Removing the unexposed region by developing, followed by thermal annealing (95°C 
for 2 min) completed the mold for the fluidic channels. To facilitate release of patterned PDMS 
from the mold, the mold was chemically treated with evaporated anti-stiction agent 
(chlorotrimethylsilane, Sigma-Aldrich) for 20 min. PDMS was casted on the mold and pressed 
with a glass slide (5 & 3.5 cm2) that was treated with Pt inhibitor solution (5% AEAPS (3-(2-
Aminoethylamino) Propylmethyldimethoxysilane, Sigma-Aldrich) and 95% methanol) for 45 
min; this inhibitor treatment facilitated release of the thin PDMS layer from the glass slide by 
deactivating Pt at the glass-PDMS interface, which is a catalyst for polymerization of PDMS. 
The glass slide and the mold were clamped, and the PDMS between them was cured for 50 min 
at 70°C. Then, the glass slide with the patterned thin PDMS layer was carefully detached from 
the Si mold.  
 In the meantime, a flat, thin PDMS layer (20 !m thick) was prepared by spin-casting 
PDMS (2000 rpm for 60 s) on a polycarbonate (PC) membrane and cured at 70°C for 1 hour. 
The PC was chosen as a substrate for handling due to its surface property allowing easy release 
of PDMS. Both this flat PDMS layer on the PC membrane and the patterned PDMS layer on the 
glass slide were oxygen plasma–treated to activate their surfaces and bonded together to form 
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microfluidic probes. After removing the PC membrane, the microfluidic probes were released 
from the glass slide without damage due to the Pt inhibitor treatment of the glass surface.  
 The fabrication of the µ-ILED array on a thin PET layer (6 !m thick) was previously 
presented (see Chapters 2 & 3) (Kim et al., 2013b; McCall et al., 2013) (See SI for fabrication 
details). The !-ILED array was integrated onto the microfluidic probe using a double-sided 
adhesive (25 !m thick; ARclear 8154, Adhesives Research), and the fabrication was completed. 
The result was an ultra-thin (~80 !m thick), soft, and flexible optofluidic probe, suitable for 
long-term implantation in the soft brain tissue. 
Fabrication of Optofluidic Drug Delivery Devices With Thermal Actuators 
 Heater patterns were defined photolithographically on Cr/Au (5 nm/185 nm thick) 
deposited FR-4 substrates (G10 glass epoxy sheet, ePlastics). The expandable layer (250 !m 
thick) was prepared on top of heaters on the FR-4 substrate by spin-coating thermally expandable 
polymer (2:1 mixture of PDMS (elastomer:curing agent = 10:1) and expandable microspheres 
(Expancel 031 DU 40, AkzoNobel) and cured in a 70°C oven for 12 hours. Hemispherical 
reservoirs, which were patterned in cyclic olefin polymer, were aligned on the heaters and 
bonded using a double-sided adhesive (25 !m thick; ARclear® 8154, Adhesives Research). 
Then, parylene C (6 !m thick) was deposited on the inner walls of the reservoirs to further 
improve vapor impermeability as well as chemical resistance.  
 For drug loading, the reservoirs were first treated with oxygen plasma (March RIE) for 
30 seconds to make the inner surface hydrophilic. A syringe with a blunt needle was used to 
place the drug of interest into the reservoirs. To prevent fluid evaporation, the outlets of the 
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reservoirs were hermetically sealed with Cu membranes (3 !m thick) after drug loading. Then, 
the inlets of an optofluidic probe were aligned and bonded with the outlets of the reservoirs.  
Fabrication of µ-ILED Arrays on Flexible Microneedles  
 The fabrication of the µ-ILED was previously described (see Chapters 2 & 3) (Kim et al., 
2013; McCall et al., 2013). The GaN epi-layers, which were grown on a sapphire wafer (500 µm 
thick with 2” diameter, Cermet Inc.), consisted of undoped GaN (3.8 µm), n-GaN (2 µm), spacer 
(0.4 µm), multi-quantum well (0.14 µm), and p-GaN (0.2 µm). A sapphire surface were rinsed 
with diluted HCl (33 %) to remove GaN oxide layer followed by sputter deposition (AJA ATC 
2000) of current spreading layers of Ni/Au (15 nm/15 nm). Post-annealing at 500 oC for 5 min 
formed an Ohmic contact between the metal and the GaN. After etching n-type regions with 
inductively coupled plasma reactive ion etching (ICP RIE, Plasmatherm, SLR-770), n- and p- 
pads of 15 nm/300 nm of Cr/Au were deposited by electron beam evaporation (Temescal, FC-
1800). To define the entire LEDs with 100&100 µm2, ICP RIE was used to remove GaN down to 
the sapphire substrate, with negative photoresist (AZ 2070, Micorchem Inc) as an etching mask. 
A passivation layer of SiNx (200 nm) was deposited by plasma enhanced chemical vapor 
deposition (PECVD; STS, Mesc Multiple) followed by wafer bonding between a silicon wafer 
with Cr/Pd/In layers (15 nm/150 nm/900 nm) and a sapphire substrate to make metallic alloy. 
The LEDs were removed from a sapphire wafer by laser lift-off (KrF, intensity of ~0.9 J/cm2) 
and additional heating up to 70 oC for melting of In metal on a hot plate. Wet etching with HCl 
(5w%) removed the residual In layer, leaving porous structures of InPd alloy that acted as 
anchors to hold the LEDs to the silicon wafer during following etching processes with Pd and Cr 
metals. Entire LEDs were easily transferred onto PDMS slab which has micro-pillar (3 µm in 
diameter, 1.2 µm in height, and 5 µm in space) via the van der Waals forces. Finally, wet etching 
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of the residual Pd completed the fabrication of µ-ILEDs on PDMS, which were ready for transfer 
printing.  
 To transfer the µ-ILEDs, a PDMS stamp with micro-post (100 & 100 µm2 and heights of 
100 µm) was used to pick up the µ-ILED from a structured PDMS slab. The µ-ILED on the 
micro-post was integrated onto a thin UV curable adhesive (Kim et al., 2014) coated 6 µm-thick 
PET film which was micropatterned with a needle shape by using a mask aligner (Karl Suss, 
MJB). After transferring the µ-ILEDs, the SiNx passivation layer was removed by reactive ion 
etching (Plasmatherm 790). Photosensitive benzocyclobutene (6 µm thick) was spin-coated with 
2000 rpm for 30 sec followed by UV exposure from bottom side through the transparent glass 
substrate. UV light exposed all regions except the opaque n- and p- pads which are made of thick 
metals. Developing away (Advanced Developer, DS2100) the unexposed region completed the 
patterning process for via holes on to both pads. After fully curing in a glove box without 
water/oxygen gases at 210 oC for 2 hr, metal interconnections was deposited with 15 nm/300 nm 
of Cr/Au and patterned using photolithography and wet etching. Finally, the entire area except 
contact pads for connection was encapsulated with 2 µm-thick SU-8 and hard-cured for 
waterproof.  
Preparation of Releasable Metal Microneedles for Injection 
 To prepare injection metal microneedles, thin metal foil of Stainless steel (50 µm 
thickness) was purchased from Goodfellow Corporation. Needle shapes were designed with 500 
µm width / 6 mm length from the tip to the mid-point and 1 mm width / 7 mm length from the 
mid-point to the end. Metal foil was defined with laser mill which has focal point of 35 µm. 
Detaching of cut needles from the residual foil and cleaning with IPA completed the preparation.   
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 For bonding of an optofluidic probe to the injection microneedle, a thin layer of purified 
silk (7 wt%) or an adhesive from the water soluble PVA tape were used, to allow release after 
implantation – it takes about 5 min for resolution of the adhesives inside saline solution. 
Measurement of Device Temperature During Thermal Actuation 
 The temporal response of devices during thermal actuation was characterized by thermal 
imaging with an infrared camera (A655sc, FLIR Systems, Inc.), which has measurement 
accuracy at ±2% of the reading value.  
Thermal Characterization of Thermally Expandable Polymer  
 To measure the volumetric expansion dependent on temperature, we increased the 
temperature of the expandable polymer in an environmental chamber (Thermotron SM 1.0). The 
temperature was increased by 10°C per hour from 20°C to 130°C for 11 hours. The thermal 
expansion of the polymer was imaged with a camera (Logitech 720p Webcam C905), while the 
temperature was simultaneously recorded with a K-Type thermocouple probe (OMEGA®) 
connected to an analog channel of a NI DAQ board (myDAQ, National Instruments). 
The thermocouple probe was attached to the polymer with heat paste to enhance the thermal 
contact conductance. The images of the expanding polymer were analyzed by a custom code 
with Image Processing Tool Box of Matlab (MathWorks). 
Fluid Flow Rate Measurement  
 The flow rate was measured by tracking 2 µm green fluorescent microspheres (F-8827, 
Thermo Fisher Scientific) diluted to distilled water by 100:1. Before injecting the tracer, the 
microsphere solution was sonicated for 5 minutes to eliminate any aggregation. The video was 
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captured by a digital high speed camera (Phantom v7.3, Vision Research) and an inverted optical 
microscope (Leica) with a 20X objective (Leica) and wide-field fluorescence light source (X-
Cite 120Q, Excelitas Technologies) at the frame rate of 20,000 frames per seconds. The video 
was analyzed by Matlab (Mathworks) with an open source code for particle image velocimetry 
(http://www.fast.u-psud.fr/pivmat/) to calculate the microsphere displacement between the each 
frame. Then, the volumetric flow rate was calculated by multiplying the cross-section area with 
the flow speed. 
Delivered Fluid Volume Measurement  
 Delivered fluid volume was characterized by measuring device weight change per 
actuation with a high-precision analytical balance (XS105, Mettler Toledo) and converting it to 
volume.  
Thermo-Mechanical-Fluidic Simulation 
 Three dimensional (3D) finite element analysis (FEA) was carried out using the software 
ABAQUS to analyze the thermal conduction and mechanical deformation of the optofluidic drug 
delivery devices.  For a given power applied to the heater, the transient thermal analyses were 
carried out first to calculate the spatial and temporal variations of temperature in the device.  The 
thermal expansion of expandable polymer could be then determined based on the nonlinear 
thermal expansion curve (Figure 4.4B) and the increase of temperature obtained from thermal 
analyses.  In the subsequent simulation of mechanical deformations, the volume average of 
thermal expansion was applied as a uniform thermal expansion strain, to the area of expandable 
polymer underneath the operating heater for simplification.  The injected volume of drug could 
be then determined based on the deformed configuration of the entire device. 
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 In the thermal analyses, 8-node linear heat transfer elements were used, and the refined 
meshes were adopted to ensure the accuracy.  A volume heat source was applied within the 
operating heater.  The free surfaces of the device have natural convection with the surrounding 
air.  In the simulation of bare heater on the expandable polymer, the polymer was adhered to a 
plastic case that was put on a large petri-dish, and therefore a constant temperature (equal to 
room temperature) was applied to the bottom surface of plastic case.  In the simulation of entire 
operating device, the probe was inserted into a brain for interaction with neural tissues.  In this 
case, one side surface of device was in contact with the brain, and therefore should have a 
constant temperature approximately equal to the body temperature.  The material parameters 
used in the simulations are summarized in Supplementary Table 1.  The calculated temperature 
distributions are shown in Figure 4.4E for the bare-heater system, which agrees reasonably well 
with the corresponding experimental measurement.   
 In the mechanical analyses, 8-node 3D solid elements were used for all materials, with 
refined meshes to ensure the accuracy.  Since each reservoir is relatively far from each other, 
only one reservoir was modeled in the mechanics analyses, as schematically shown in Figure 
4.5A and B.  The physical contact between the top surface of adhesive layer and the spherical 
surface of reservior was taken into account during the thermal expansion.   The calculations 
show that the deformation induced by thermal actuation is mainly accommodated by the 
expandable layer, which is in agreement with the experiment results (Figure 4.4D).  For a given 
thermal expansion strain applied to the area of expandable polymer underneath the heater, the 
injected proportion of drug was obtained in Figure 4.5C, which shows a saturation in the 
injection for the thermal strain exceeding ~22%.   
185 
 Besides the thermal-mechanical simulations described above, a simplified computational 
fluid dynamics model was adopted to estimate the cooling of heated drug in the channel, before 
its reaction with neural tissues.  Here, FLUID 142 element (in the software ANSYS) was used to 
simulate the drug as a type of fluid flowed through the channel.  For simplification, the straight 
channel was assumed to be embedded in a cylindrical substrate that is sufficiently large.  A 
constant fluid temperature was adopted at the inlet of the channel, and the zero pressure 
condition was set at the outlet.  The free (i.e., outer) surface of the substrate have natural 
convection with the surrounding air.   The fludic parameters include the density (1060 kg/m3), 
the thermal conductivity (0.6 W/m/K), and the specific heat (4.184 kJ/kg/K).  The calculations 
show that the fluid temperature drops rapidly along the channel and the maximum temperature 
increase at the outlet is less than 0.1 oC. 
Table 4.2 The thermal and mechanical properties of various components in the 
microfluidic drug device, where E denotes the modulus, " is the Poisson ratio, and # is the 
density, cp is the specific heat and k is the thermal conductivity.  
 
Component " (kg/m3) cp (J/kg/K) k (W/m/K) E (MPa) # 
Silicone adhesive 1050 1100 0.18 1 0.49 
Expandable polymer 970 1460 0.24 3 0.48 
COP 1020 1000 0.14 2600 0.35 
Au heater 19280 129 318.00 78000 0.44 
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Substrate (FR-4) 1200 1750 0.45 24000 0.13 
 
Experimental subjects  
 Adult (25–35 g) male C57BL/6J and TH::IRES-Cre backcrossed to C57BL/6J mice were 
group-housed, given access to food pellets and water ad libitum and maintained on a 12 h:12 h 
light:dark cycle (lights on at 7:00 AM). All mice were held in a facility in the lab 1 week prior to 
surgery, post-surgery and throughout the duration of the behavioral assays to minimize stress 
from transportation and disruption from foot traffic. Adult (275-325g) male Lewis rats 
(LEW/CRL) were purchased from Charles River and housed in a climate-controlled facility with 
a 12:12-h light-dark cycle under standard conditions. All procedures were approved by the 
Animal Care and Use Committee of Washington University and conformed to US National 
Institutes of Health guidelines.  
Viral Preparation 
 Plasmids coding pAAV-EF1a-DIO-EFYP and pAAV-EF1a-double floxed-
hChR2(H134R)-EYFP-WPRE-HGHpA were obtained from Addgene (Addgene.org) originally 
from the Deisseroth Laboratory at Stanford University. The DNA was amplified with a Maxiprep 
kit (Promega) and packaged into AAV5 serotyped viruses by the WUSTL Hope Center Viral 
Core. AAV5-PGK-Cre was acquired from the UNC Vector Core.  
 
 
Table 4.3 Details on origin and titer of viral constructs used. 
187 
Plasmid Source Packaged by Serotype Titer 
pAAV-EF1a-
DIO-EFYP 
Deisseroth 
Laboratory 
(Stanford) 
WUSTL Hope 
Center Viral 
Core 
AAV5 5 x 10^12 vg/ml 
pAAV-EF1a-
double floxed-
hChR2(H134R)-
EYFP-WPRE-
HGHpA 
Deisseroth 
Laboratory 
(Stanford) 
WUSTL Hope 
Center Viral 
Core 
AAV5 2 x 10^13 vg/ml 
AAV5-PGK-Cre UNC Vector 
Core 
UNC Vector 
Core 
AAV5 3.2 x 10^12 
VM/mL 
 
 
Stereotaxic Surgery  
 After the mice were acclimatized to the holding facility for seven to nine days, they were 
anaesthetized in an induction chamber (4% Isolflurane) and placed in a stereotaxic frame (Kopf 
Instruments, Model 1900) where they were maintained at 1-2% isoflurane. For the baseline 
locomotor, anxiety, and inflammation assays, mice were implanted with the microfluidic device 
into the dorsal striatum (stereotaxic coordinates from bregma (mm): anterior-posterior (AP): 
+1.10, medial-lateral (ML): +/(1.50, dorsal-ventral (DV): (4.00). For the test of viral expression, 
mice were implanted with the microfluidic device into the dorsal striatum (stereotaxic 
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coordinates from bregma (mm): AP: +1.00, ML: +/(1.50, DV: (3.00). For the DAMGO-induced 
rotation experiment, mice were implanted with the microfluidic device above the VTA 
(stereotaxic coordinates from bregma (mm): AP:-3.10, ML: +/- 0.50, DV: -4.25). For the 
optofluidics experiment, a craniotomy was performed and TH-Cre mice were injected with 1 !l 
of AAV5-EF1a-ChR2(H134)-eYFP unilaterally into the VTA (stereotaxic coordinates from 
bregma (mm): AP:-3.20, ML:+/(0.50, DV: (4.90). Five weeks later, mice were then implanted 
with the optofluidic device adjacent to the NAcSh (stereotaxic coordinates from bregma: +1.30 
AP, +/(0.20 ML, (4.80 mm DV). A standard electrode holder (KOPF 1770) was adapted to 
implant the microfluidic and optofluidic devices. For biodissolvable samples, the device was 
implanted at the desired target, ACSF was applied to the portion of the device that remained 
outside of the skull to facilitate dissolution of the adhesive, and then the epoxy needle was 
removed after a delay of 15 minutes. The implants were secured using two bone screws (CMA, 
743102) and affixed with dental cement (Lang Dental). C57Bl6 mice were allowed to recover for 
5 days prior to behavioral testing. Ai9 mice were allowed to recover three weeks following 
surgery for viral expression. TH-Cre mice were allowed to recover one week following the final 
surgery (for a total of six weeks to (permit optimal AAV expression and Cre recombinase 
activity at VTA-NAc terminals). Post-surgery, all rats received subcutaneous injections of 
buprenorphine hydrochloride (0.05 mg/kg, Reckitt Benckiser Healthcare Ltd., USA) for pain 
management, and of ampicillin (50 mg/kg, Sage Pharmaceuticals, USA) to prevent infection at 
the implantation site. 
 
Immunohistochemistry  
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 Immunohistochemistry was performed as described (see Chapter 2) (Kim et al., 2013b) 
Briefly, mice were anesthetized with pentobarbital and intracardially perfused with ice-cold 4% 
paraformaldehyde in phosphate buffered saline (PBS). Brains were dissected, post-fixed for 24 
hr at 4 ºC and cryoprotected with solution of 30% sucrose in 0.1M PB at 4ºC for at least 24 hr, 
cut into 30 !m sections and processed for immunostaining. 30 !m brain sections were washed 
three times in PBS and blocked in PBS containing 0.5% Triton X-100 and 5 % normal goat 
serum. Sections were then incubated for ~16 hr at room temperature in rabbit anti c-fos antibody, 
guinea pig anti-GFAP, rabbit anti-Iba1 and/or chicken anti-TH. Following incubation, sections 
were washed three times in PBS and then incubated for 2 hr at room temperature in Alexa Fluor 
488 goat anti-rabbit IgG, Alexa Fluor 594 goat anti-rabbit IgG, Alexa Fluor 633 goat anti-
chicken, and/or goat anti-guinea pig Alexa Fluor 546, then washed three times in PBS, incubated 
for 1 hr in Neurotrace 435/455 Blue Fluorescent Nissl stain (1:400), then washed three times in 
PBS, and followed by three 1washes in PB and mounted on glass slides with HardSet 
Vectashield (Vector Labs). All sections were imaged on both epifluorescent and confocal 
microscopes. Gain and exposure time were constant throughout each experiment, and all image 
groups were processed in parallel using Adobe Photoshop CS5 (Adobe Systems). 
 
 
 
 
Table 4.4 Details on origin, species, and dilution of antibodies used. 
190 
Antibody Species Dilution Source 
GFAP Guinea Pig 1:500 Synaptic Systems 
Iba1 Rabbit 1:300 Wako Chemicals 
TH Chicken 1:2000 Aves Labs 
c-fos Rabbit 1:1000 Santa Cruz 
Alexa Fluor 488 anti-
rabbit IgG 
Goat 1:1000 Invitrogen 
Alexa Fluor 594 anti-
rabbit IgG 
Goat 1:1000 Invitrogen 
Alexa Fluor 633 anti-
chicken IgG 
Goat 1:1000 Invitrogen 
Alexa Fluor 546 anti-
guinea pig IgG 
Goat 1:1000 Invitrogen 
Alexa Fluor 594 anti-
chicken IgG 
Goat 1:1000 Invitrogen 
Neurotrace 435/455 N/A 1:400 Life Technologies 
 
Immuno-Glial Response in Implanted Tissues 
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 C57BL/6J mice (n=6) were implanted with microfluidic devices into the dorsal striatum 
and allowed to recover for four weeks before perfusion. Immunohistochemistry was performed 
as described.  
c-fos Expression 
 TH-Cre animals expressing AAV5-EF1a-ChR2(H134)-eYFP unilaterally in the VTA and 
implanted with optofluidic devices in the NAcSh were photostimulated at 10 Hz for 1 hour (see 
Chapter 2) (Kim et al., 2013b), animals were perfused immediately following, and 
immunohistochemistry was performed as above. 
Rotarod Assay 
 An accelerating Rotarod (Ugo Basile, Comerio, Italy) was used as described previously 
(Golden et al., 2013; Montana et al., 2009) to assess motor coordination C57Bl6 mice (cannulas 
or microfluidic devices were implanted in the dorsal striatum as described, n= 5/group) received 
two training sessions separated by 1 h. The first training session consisted of two trials of 120 s 
spent walking on the Rotarod at a fixed speed of 4 rpm. The second training session consisted of 
one trial of 120 s at 4 rpm. All mice completed the first training session without falling in five 
attempts or less; all mice completed the second training session in two attempts or less without a 
fall. One hour after the second training session, latency to fall as the Rotarod accelerated from 4 
to 40 rpm over 5 min was assessed. Five consecutive acceleration trials were performed, with 10 
min between each trial. 
Spontaneous Running Assay 
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 C57Bl6 mice (cannulas or microfluidic devices were implanted in the dorsal striatum as 
described, n=9-10/group) mice were habituated to locked low profile, wireless running wheels 
(ENV-044, Med Associates) for one hour. Following this habituation the wheels were unlocked 
and the animals were allowed to run freely for 2 hours. Revolutions of the wheel were counted as 
the primary means of assessing spontaneous running. 
Open Field Test 
 OFT testing was performed in a sound attenuated room maintained at 23ºC. Lighting was 
measured and stabilized at 2000 lux, and performed in the afternoon between 13:00–1600 hrs. 
The open field was a 50 x 50 cm square enclosure and was cleaned with 70% ethanol between 
testing trials. For testing, C57Bl6 mice (cannulas or microfluidic devices were implanted in the 
dorsal striatum as described, n=10/group) were placed in the center of the open field and allowed 
to roam freely for 30 min. Movements were video recorded and analyzed using Ethovision. The 
center was defined as a square comprised of 50% the total area of the OFT. Time in the center 
expressed as percentages total time was the primary measure of anxiety-like behaviors.  
Contraversive Rotation/Locomotor Testing Assay 
 C57Bl6 mice with microfluidic devices implanted above the VTA were placed in the 
center of the same arena used for the OFT and allowed to roam freely for 1 hr. Wireless infusion 
of vehicle or DAMGO was initiated and movements were video recorded and analyzed using 
Ethovision. Rotations were defined as full 360º revolutions in the path of movement. 
Real-Time Place Preference 
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 TH-CreVTA-NAc:ChR2 animals were placed in a custom-made unbiased, balanced two-
compartment conditioning apparatus (52.5 x 25.5 x 25.5 cm) as described previously (Jennings et 
al., 2013; Kim et al., 2013a; Stamatakis and Stuber, 2012; Stamatakis et al., 2013; Tan et al., 
2012). Mice were allowed to freely roam the entire apparatus for 20 min. Entry into one 
compartment triggered photostimulation (8, 10 ms light pulses at 20 Hz every 5s) while the 
animal remained in the light-paired chamber. Entry into the other chamber ended the 
photostimulation. The following day SCH23390 (400 ng, Tocris) was administered 10 minutes 
prior to the testing. Mice were counterbalanced so that ~50% received the SCH23390 on day 1, 
there was no difference between animals that received the drug on day 1 or day 2. The side 
paired with photostimulation was counterbalanced across mice and across sessions. Time spent 
in each chamber and total distance traveled for the entire 20-minute trial was measured using 
Ethovision 8.5 (Noldus Information Technologies, Leesburg, VA). The triggered wireless 
photostimulation was elicited using a Noldus I/O Box coupled to an Arduino microcontroller that 
controlled the output of the of IR remote control. 
Data Analysis/Statistics 
 Data are expressed as means ± SEM. Data were normally distributed, and differences 
between groups were determined using independent t-tests or one-way ANOVA followed by 
post hoc Bonferroni comparisons if the main effect was significant at p < 0.05. Paired t-tests 
were used in within subject design experiments. Statistical analyses were conducted using Prism 
5.0 (GraphPad). 
Genotyping of Mouse Lines  
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  DNA was isolated from tail tissue obtained from weanling mice (21-28 days of age), and 
PCR screening was performed using the following primers: Cre recombinase (forward: 5’- GCA 
TTA CCG GTC GAT GCA ACG AGT GAT GAG-3’ and reverse: 5’- GAG TGA ACG AAC 
CTG GTC GAA ATC AGT GCG-3’) yielding a 400-bp PCR product in Cre positive animals. 
Fatty acid-binding protein intestinal primers (forward: 5’- TGG ACA GGA CTG GAC CTC 
TGC TTT CCT AGA-3’ and reverse: 5’- TAG AGC TTT GCC ACA TCA CAG GTC ATT 
CAG-3’) were used as positive controls and yield a 200-bp PCR product. 
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SUMMARY 
 The locus coeruleus noradrenergic (LC-NE) system is one of the first systems engaged 
following a stressful event. While numerous groups have demonstrated that LC-NE neurons are 
activated by many different stressors, the underlying neural circuitry and the role of this activity 
in generating stress-induced anxiety has not been elucidated. Using a combination of in vivo 
chemogenetics, optogenetics, and retrograde tracing we determine that increased tonic activity of 
the LC-NE system is necessary and sufficient for stress-induced anxiety and aversion. Selective 
inhibition of LC-NE neurons during stress prevents subsequent anxiety-like behavior. 
Exogenously increasing tonic, but not phasic, activity of LC-NE neurons is alone sufficient for 
anxiety-like and aversive behavior. Furthermore, endogenous corticotropin releasing hormone+ 
(CRH+) LC inputs from the amygdala increase tonic LC activity, inducing anxiety-like 
behaviors. These studies position the LC-NE system as a critical mediator of acute stress-induced 
anxiety and offer a potential intervention for preventing stress-related affective disorders. 
INTRODUCTION 
 Anxiety is a complex set of behavioral and physiological responses that can be both 
beneficial and detrimental to an individual. In stressful conditions, acute anxiety helps to 
maintain the arousal and vigilance required to sustain attention, accomplish necessary tasks, and 
avoid repeated exposures to dangerous conditions (Gross and Hen, 2004). Recent basic 
neuroscience has elucidated circuits in the extended amygdala that are either natively anxiogenic 
or anxiolytic, building a circuit-based pathology that may yield more selective therapeutic 
approaches (Felix-Ortiz et al., 2013; Jennings et al., 2013; Kheirbek et al., 2013; Kim et al., 
2013a; Tye et al., 2011). However, the extended amygdala does not act alone in its control over 
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anxiogenesis, as elegant recent work reveals parallel systems for anxiety in the 
septohypothalamic circuitry related to persistent, stress-induced anxiety (Anthony et al., 2014; 
Heydendael et al., 2014). Additionally, the great majority of these studies propose mechanisms 
mediated by the fast-acting, small molecule neurotransmitters, GABA and glutamate. However, 
clinically, we know that neuromodulators such as norepinephrine and various neuropeptides play 
pivotal roles in long-term outcomes following stress exposure (Raskind et al., 2003, 2007, 2013). 
Here we propose a separate neuromodulatory system underlying immediate, acute stress-induced 
anxiety, which serves to alter risk aversion behavior immediately following a stressful event. 
 The locus coeruleus-noradrenergic system (LC-NE) is a small, tightly packed pontine 
brain region that sends numerous projections to the forebrain and spinal cord. The LC-NE 
system is involved in a broad number of physiological functions including arousal, memory, 
cognition, pain processing, behavioral flexibility, and stress reactivity (Berridge and Waterhouse, 
2003; Carter et al., 2010; Hickey et al., 2014; Snyder et al., 2012; Tervo et al., 2014; Valentino 
and Van Bockstaele, 2008; Vazey and Aston-Jones, 2014).. Numerous environmental stressors, 
including social and predator stress, activate the LC-NE system (Bingham et al., 2011; Cassens 
et al., 1981; Curtis et al., 1997, 2012; Francis et al., 1999; Lechner et al., 1997; Reyes et al., 
2008; Valentino and Van Bockstaele, 2008; Valentino et al., 1991). Thus, the LC system is 
thought to comprise a major component of the centrally mediated components of the classical 
fight-or-flight response The response of the LC-NE systems to stress is particularly important in 
the context of stress-induced human neuropsychiatric disorders such as posttraumatic stress 
disorder (PTSD) where both basic and clinical research have revealed noradrenergic antagonism 
to be a very promising therapeutic target (Olson et al., 2011; Raskind et al., 2003, 2007, 2013).  
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Noradrenergic neurons within the LC-NE system exhibit three distinct activation profiles: low 
tonic, high tonic, and phasic activity. It has been proposed that these neurons function differently 
to determine behavioral flexibility to various environmental challenges. Low tonic LC discharge 
(1-2 Hz) is thought to be consistent with an awake state (Aston-Jones and Bloom, 1981a; Bloom, 
1981; Carter et al., 2010, 2012) whereas phasic burst activity results from distinct sensory stimuli 
such as flashes of light, auditory tones, and brief touch  (Aston-Jones and Bloom, 1981b; Foote 
et al., 1980; Rasmussen et al., 1986). Stressful events and stimuli shift LC activity towards a high 
tonic mode of firing (3-8 Hz) and stress-related neuropeptide release, such as corticotropin-
releasing hormone (CRH) is thought to drive the high tonic state while simultaneously 
decreasing phasic firing events (Curtis et al., 1997, 2001, 2012; Jedema and Grace, 2004; Page 
and Abercrombie, 1999; Reyes et al., 2008; Snyder et al., 2012; Valentino and Foote, 1988). We 
were particularly interested in examining the role of this high tonic activity of LC-NE neurons 
during stress and defining the endogenous substrates that drive this increased LC-NE activity.  
 While phasic modulation of the LC is thought to be mediated by fast, small molecule 
neurotransmission, neuropeptide transmission is thought to control tonic LC-NE activity. 
Anatomical evidence suggests that neuropeptidergic inputs to the LC from the central nucleus of 
the amygdala (CeA), including those containing CRH, may become activated in response to 
stressors (Reyes et al., 2008; Valentino et al., 1992). Anatomical data support this notion using 
tract tracing studies and electron microscopy to suggest that CRH-containing amygdalar 
monosynaptic projections from the CeA terminate in the LC (Reyes et al., 2008). Given the 
importance of CRH in stress-induced behavioral responses such as dysphoria, anxiety, and 
aversion (Bruchas et al., 2009; Dunn et al., 2004; Francis et al., 1999; Gafford et al., 2012; 
Heinrichs et al., 1994; Koob, 1999; Land et al., 2008), these projections are situated to 
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significantly impact LC neuronal activity, yet the functional consequences of these inputs remain 
unresolved.  
 Here we dissect the locus coeruleus circuitry in the context of stress-induced negative 
affective behavior. In particular, we use chemogenetics and optogenetics to focus on the role of 
neural activity of locus coeruleus noradrenergic (LC-NE) neurons in generating these behaviors. 
We find that LC-NE neurons have increased activity during stress and that blocking this elevated 
activity suppresses acute stress-induced anxiety. Furthermore, optogenetic activation and release 
of endogenous amygdalar CRH into the LC promotes anxiety-like and aversive behavior. We 
conclusively show that LC and its afferent circuitry are critical for encoding and producing 
stress-induced anxiety. 
Results 
Selective inhibition of LC-NE neurons during stress suppresses subsequent anxiety 
 Numerous groups have reported that tonic activity of LC-NE neurons increases in 
response to stress (Bingham et al., 2011; Cassens et al., 1981; Curtis et al., 1997, 2012; Francis et 
al., 1999; Lechner et al., 1997; Reyes et al., 2008; Valentino and Van Bockstaele, 2008; 
Valentino et al., 1991), but it has previously been untenable to selectively inhibit the activity of 
only these NE neurons and assess their role in stress-induced behaviors. To examine the role of 
LC-NE neurons in stress-induced anxiety-like behavior in mice, we implemented a restraint 
stress paradigm (Chmielarz et al., 2013; Schaefer et al., 2000; Sim et al., 2013), which was 
immediately followed by anxiety testing in the open field test (OFT) (Figure 5.1A). Following 
30 minutes of restraint stress, wild-type (C57BL/6J) mice produce a robust stress-induced 
anxiety phenotype and have increased immediate early gene (cfos) expression, consistent with 
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increased activity of these neurons (Figure 5.1B-D, Figure 5.2A & B). To determine whether 
this increase in activity is necessary for the resultant anxiety-like behavior, we selectively 
targeted the inhibitory designer receptor exclusively activated by designer drug (Gai-coupled; 
hM4Di DREADD (Armbruster et al., 2007) to LC-NE neurons by injecting a Cre-dependent 
AAV into the LC of tyrosine hydroxylase-IRES-Cre mice (Th-Cre) (Figure 5.1E). When the 
receptor is activated with its ligand, Clozapine-n-oxide (CNO; 10 mg/kg (Li et al., 2013; Mahler 
et al., 2014; Penzo et al., 2015; Vazey and Aston-Jones, 2014)) prior to stress, there is a robust 
and significant decrease in stress-induced c-fos+ LC-NE neurons indicating the selective hM4Di 
DREADD approach is effective at reducing LC-NE neuronal activity (Figure 5.1F) during stress 
exposure.  
 Next, we used the Cre-dependent, AAV-hM4Di DREADD approach to test whether 
inhibition of LC-NE neurons during restraint stress can prevent subsequent stress-induced 
anxiety in the OFT (Figure 5.1G). Stressed control animals that do not express the Cre-
dependent hM4di (Th-CreLC:hM4Di-) show a significant stress-induced anxiety-like behavior 
compared to unstressed animals regardless of Cre-dependent hM4Di expression (Th-Cre LC:hM4Di- 
and Th-Cre LC:hM4Di+) seen in both time spent in the center and entries into the center of the OFT 
(Figure 5.1H & I). Stressed Th-Cre LC:hM4Di+ animals, however, did not exhibit anxiety-like 
behavioral responses and instead have behavior similar to and not statistically different from 
both non-stressed Th-Cr LC:hM4Di+ and Th-Cre LC:hM4Di- mice that did not experience the stressor 
(Figure 5.1H & I). Interestingly, hM4Di DREADD-mediated inhibition of LC-NE neurons prior 
to stress did not alter stress induced fecal output suggesting that the inhibition of LC-NE neurons 
suppresses acute stress-induced behavioral anxiety, but leaves other physiological responses 
intact (Figure 5.1J) (Bruchas et al., 2009; Konturek et al., 2011; Larauche et al., 2009). 
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Importantly, the hM4i DREADD manipulation has no effect on baseline anxiety levels (Figure 
5.1H, I, L) and none of the manipulations affected gross locomotor activity in the OFT (Figure 
5.1K). These findings suggest that stress-induced increases in LC-NE activity are required to 
produce an acute stress-induced anxiety state. 
Figure 5.1 Selective inhibition of LC-NE neurons prevents stress-induced anxiety. (A) 
Cartoon of experimental paradigm for restraint stress-induced anxiety. (B) Stressed animals 
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spend significantly less time exploring the center of the OFT than non-stressed controls (Data 
represented as mean ± SEM, n=7-8/group: Student’s t-test, p<0.001). (C and D) Representative 
immunohistochemistry and quantification show restraint stress increases c-fos immunoreactivity 
in LC neurons (Red=c-fos, green=tyrosine hydroxylase, arrows indicate example co-localization, 
scale bars= 100 µm; data represented as mean ± SEM, n=3 slices from 3 animals/group: 
Student’s t-test, p<0.0001). See locomotor activity data in Fig. S1. (E) Cartoon depicting viral 
strategy. (F and G) Representative immunohistochemistry and quantification show hM4Di 
inhibition of LC neurons decreases c-fos immunoreactivity in LC neurons (Red=c-fos, 
green=tyrosine hydroxylase, Scale bars= 100 µm; data represented as mean ± SEM, n=3 slices 
from 3 animals/group: One-Way ANOVA, Bonferroni post-hoc, No stress/Cre- vs. No 
stress/Cre+ **p<0.01, No stress/Cre- vs. Stress/Cre- ****p<0.0001, No stress/Cre- vs. Stress/Cre+ 
****p<0.0001, No stress/Cre+ vs. Stress/Cre- ****p<0.0001, No stress/Cre+ vs. Stress/Cre+, not 
significant). (G) Cartoon of experimental paradigm for LC-NE inhibition during restraint stress-
induced anxiety. (H and I) Inhibition of LC-NE neurons during stress blocks stress-induced 
anxiety. Data represented as mean ± SEM, n=8-13/group: One-Way ANOVA, Newman-Keuls 
post-hoc, No stress/Cre- vs. No stress/Cre+, not significant, No stress/Cre- vs. Stress/Cre- 
**p<0.01, No stress/Cre- vs. Stress/Cre+, not significant, No stress/Cre+ vs. Stress/Cre- **p<0.01, 
No stress/Cre+ vs. Stress/Cre+, not significant). (J) Inhibition of LC-NE neurons has no effect on 
stress-induced bowel motility. Data represented as mean ± SEM, n= n=8-13/group: One-Way 
ANOVA, Newman-Keuls post-hoc, No stress/Cre- vs. No stress/Cre+, not significant, No 
stress/Cre- vs. Stress/Cre- *p<0.05, No stress/Cre- vs. Stress/Cre+ *p<0.05, No stress/Cre+ vs. 
Stress/Cre-, not significant, No stress/Cre+ vs. Stress/Cre+, not significant). (K) Inhibition of LC-
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NE neurons has no effect on gross locomotor activity. Data represented as mean ± SEM. (L) 
Representative heat maps of activity during OFT. 
 
 
 
 
 
 
 
 
Figure 5.2 Restraint stress does not alter total locomotor activity in the OFT. Related data 
to Figure 5.1A-D (A) Restraint stress manipulation does not alter locomotor activity in the OFT. 
Data represented as mean ± SEM, n=7-8/group. (B) Representative heat maps of activity during 
OFT. 
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Optogenetic entrainment of high tonic LC-NE activity 
LC-NE neurons are reported to respond vigorously to stress with a robust increase in 
tonic firing rate (Valentino and Van Bockstaele, 2008). While this physiological response has 
been observed by many groups in variety of species the precise behavioral output of such an 
increase has been previously inaccessible. We selectively targeted channelrhodopsin-2 
(ChR2(H134)-eYFP) to LC-NE neurons of Th-Cre mice (Th-CreLC:ChR2) and observed restricted 
eYFP labeling to the membranes of noradrenergic neurons of the LC (Figure 5.3A-C). Slice 
recordings show that this targeting is sufficient to generate an inward photocurrent and 
physiologically normal action potentials in response to 470 nm blue light (Figure 5.3D & E). To 
determine whether this optogenetic strategy could be used to exogenously elevate the tonic firing 
of LC-NE neurons in a sustained fashion, we performed slice physiology experiments which 
demonstrated that LC-NE neurons can fire photostimulated-action potentials at 5 Hz for as long 
as 30 minutes (Figure 5.3F). Furthermore, in in vivo extracellular recordings using a fiber optic-
coupled multielectrode array (Sparta et al., 2011), we found that 5 Hz photostimulation produced 
responses similar to that evoked by stress (Bingham et al., 2011; Curtis et al., 2012) (Figure 
5.3G & H). Interestingly, putative LC neurons that did not appear to be directly photosensitive 
(>10 ms spike latency) still show increased firing over time, perhaps due to well-known, tightly 
coupled nature of neurons in this structure (Alvarez et al., 2002; Ballantyne et al., 2004) (Figure 
5.3I). Furthermore, indirect response of these neurons to photostimulation is highly correlated 
(r=0.89, p< 0.0001) to their baseline firing suggesting that some LC neurons are potentially more 
intrinsically excited by broader LC activity (Figure 5.3J). These findings indicate that 
optogenetic manipulation of LC-NE neurons can be used to sustain tonic firing of LC-NE that 
mimics their response to stress. 
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Figure 5.3 Optogenetic targeting to selectively increase tonic LC-NE activity. (A) Cartoon of 
viral strategy for slice experiments. (B and C) Representative immunohistochemistry show 
selective targeting of ChR2-eYFP to TH+ LC neurons (Red= tyrosine hydroxylase, green=ChR2-
eYFP, 4V = 4th ventricle, Scale bars= 100 and 50 µm, respectively). (D and E) Whole cell 
current and voltage-clamp recordings of an LC-NE neuron expressing ChR2. D, scale bar is 200 
pA x 100 ms and E, scale is 20 ms. (F) Slice recording of a single LC-NE neuron demonstrating 
action potentials over 30 min in response to 5 Hz 470 nm light pulses. (G) Cartoon of viral and 
multielectrode delivery for anesthetized, in vivo recordings. (H) Peristimulus time histogram 
(PSTH) showing increased LC neuron firing during a 20 s optical stimulation at 5 Hz. (I) Firing 
rate of n=16 cells before and during 5 Hz photostimulation (Paired Student’s t-test, p<0.01). (J) 
Correlation of baseline activity to activity during photostimulation (r=0.8938, p<0.0001). 
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Increased LC-NE tonic neuronal firing is acutely anxiogenic 
Using the same optogenetic strategy as above, we examined whether selectively increasing LC-
NE tonic firing is sufficient to mimic acute stress-induced anxiety-like behaviors. We 
photostimulated (5 Hz, 10 ms pulse width, 473 nm) LC-NE neurons during two well-established 
assays of anxiety-like behavior, OFT and elevated zero maze (EZM) (Choleris et al., 2001; 
Shepherd et al., 1994) (Figure 5.4A & B). In the OFT, photostimulated Th-CreLC:ChR2 mice spent 
significantly less time exploring the center of the arena than did fluorophore expressing controls 
(Th-CreLC:eYFP) (Figure 5.4C & D, Figure 5.5A & B). Importantly, 5 Hz photostimulation does 
not affect total locomotor activity (Figure 5.4E, Figure 5.5C), suggesting 5Hz LC-NE tonic 
activity selectively drives anxiety-like behavior. Furthermore, 5 Hz photostimulation in the EZM 
also induced anxiety-like behavior in Th-CreLC:ChR2 animals compared to Th-CreLC:eYFP controls.  
In the EZM, Th-CreLC:ChR2 spent less time in and entered the exposed areas of the EZM 
significantly less than Th-CreLC-eYFP controls (Figure 5.4F-H). These experiments demonstrate 
that increasing the tonic firing rate of LC-NE neurons in the absence of a physical stressor is 
sufficient to produce robust anxiety-like behavior. 
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Figure 5.4 High tonic LC-NE neuronal activity is sufficient to induce anxiety-like behavior. 
(A) Cartoon of viral and fiber optic delivery strategy. (B) Calendar of behavioral studies. (C) 
Representative heat maps of activity in the OFT. (D) 5 Hz photostimulation causes an anxiety-
like phenotype in OFT of Th-CreLC:ChR2 animals compared to Th-CreLC:eYFP controls (Data 
represented as mean ± SEM, n=10/group: 
Student’s t-test, p<0.01) with (E) no change in 
locomotor activity (Data represented as mean 
± SEM, n=10/group). See also Fig. S2. (F) 
Representative heat maps of activity in the 
EZM. (G and H) 5 Hz photostimulation 
causes an anxiety-like phenotype in EZM of 
Th-CreLC:ChR2 animals compared to Th-
CreLC:eYFP controls (Data represented as mean ± SEM, n=6-9/group; Student’s t-test, p<0.01). 
Figure 5.5 High   tonic   LC--NE   neuronal   activity   is   sufficient   to   induce   anxiety-
like behavior. Related data to Figure 
5.4.   (A)   Representative   immunohistochemistry   shows   selective   targeting   of   AAV5-DI
O-eYFP to DBH+ LC  neurons  of Th--CreLC:eYFP  controls 
(Red=  dopamine  beta  hydroxylase,  green=DIO-
-eYFP,  scale  bars=  100  µm.    (B)  Fiber  optic  tip  placements   for  the  OFT   and  EZM  exp
eriments.  Animals  were  excluded  if  the  tip  ended  >1   mm   dorsal   of   the   LC   or   any   
caused   significant   lesion   to   the   LC   or   4th   ventricle.  For  clarity,  only  hits  of  include
d  mice  for  this  experiment  are  shown.   (C)   There  is  also  no  change  in  mean  velocity  d
uring  the  photostimulation  in   the  OFT.  Data  represented  as  mean  ±  SEM,  n=10/group. 
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LC-NE tonic activity drives a frequency-dependent aversion 
 Following the observation that increased tonic activity of LC-NE neurons alone is 
capable of driving anxiety-like behaviors; we next sought to determine whether this activity 
produced place aversion in the animals. First we performed slice electrophysiology experiments 
that demonstrated dynamic control of LC-NE firing at increasing frequencies while maintaining 
spike fidelity (Figure 5.6A). We next sought to determine acute behavioral valence in Th-
CreLC:ChR2 and Th-CreLC:eYFP mice at a range of photostimulation frequencies. To assess the 
positive or negative valence of the photostimulation we employed a real-time place-testing 
(RTPT) assay that triggers photostimulation upon the animal’s entry into a chamber void of 
salient contextual stimuli (Figure 5.6B). This assay assesses native behavioral preference to 
photostimulation; regimes with a negative valence will cause an aversion from and those with a 
positive valence will drive a preference for the chamber paired with photostimulation (see 
Chapter 4) (Jennings et al., 2013; Kim et al., 2013a; Stamatakis and Stuber, 2012; Stamatakis et 
al., 2013; Tan et al., 2012). Without photostimulation and at low tonic firing rates similar to alert, 
awake LC activity (1 and 2 Hz) (Aston-Jones and Bloom, 1981a; Bloom, 1981; Carter et al., 
2010, 2012) there was no observable shift in chamber preference compared to baseline or Th-
CreLC:eYFP control animals (Figure 5.6C). However, when we increased the frequency of 
photostimulation to induce a higher tonic firing rate of LC-NE neurons (5 and 10 Hz), we 
observed a significant frequency-dependent shift away from the photostimulation-paired 
chamber (Figure 5.6C). These data suggest that acutely increasing tonic firing of LC-NE 
neurons elicits a negative valence that is capable of biasing behavior to avoid the increased 
neuronal activity. Again, as we found in the anxiety-like behavioral assays, there was no change 
in gross locomotor activity during any of the frequencies tested (Figure 5.6D & E, Figure 5.7A 
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& B). To determine whether this negative valence was specifically due to increased tonic 
activity, we implemented the same RTPT assay using two different phasic photostimulation 
regimes (3 or 10 (10 ms) pulses at 10 Hz upon entry and every 30 s the mouse remains in the 
chamber). In the phasic photostimulation paradigm, we did not observe any negative or positive 
valence associated with phasic burst activity (Figure 5.6F, Figure 5.7C & D) in either regime. 
This finding is in line with the evidence that suggests phasic responses of LC-NE neurons are 
elicited by salient stimuli rather than stressful events (Aston-Jones and Bloom, 1981b; Bouret et 
al., 2012; Sara and Bouret, 2012). 
 While the RTPT assay provides clear evidence that increased tonic, but not phasic, 
activity of LC-NE neurons is acutely aversive, it does not provide information as to whether this 
activity is encoded and can be later retrieved to inform future behavior. A natural response to a 
stressful experience would be to avoid the context in which the stress occurred (Knoll and 
Carlezon, 2010; Ungless et al., 2010). To test whether increased tonic activity of LC neurons 
produces a learned change in behavior, we employed a Pavlovian conditioned place aversion 
(CPA) assay (Bruchas et al., 2009; Al-Hasani et al., 2013; Land et al., 2008, 2009).  In this assay, 
Th-CreLC:ChR2 and Th-CreLC:eYFP animals are exposed to two distinct visual contexts that have no 
initial bias. During two conditioning days, animals do not receive any optical stimulation in one 
context and receive high tonic stimulation (5 Hz, 10 ms pulse widths) in the other context 
(Figure 5.6G). When allowed to freely explore both chambers following conditioning, the Th-
CreLC:ChR2 animals spent significantly less time in the chamber that was paired with high tonic 
photostimulation (Figure 5.6H). In contrast, Th-CreLC:eYFP controls did not show a change in 
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Figure 5.6 LC-NE photostimulation drives both real-time and learned aversions. (A) 
Current clamp whole cell recording with spike fidelity at 2, 3, 5 and 8 Hz. (B) Cartoon of viral 
and fiber optic delivery strategy and calendar of behavioral studies. (C) Frequency response of 
RTPT and (D) locomotor activity at 0, 1, 2, 5, and 10 Hz. Data represented as mean ± SEM, n=6-
7/group: Two-Way ANOVA, Bonferroni post-hoc, 5 Hz ChR2 vs. 5 Hz eYFP *p<0.05, 10 Hz 
ChR2 vs. 10 Hz eYFP  ***p<0.001. (E) Representative traces of behavior at different 
frequencies. (F) Phasic stimulation does not drive aversion, n=6/group. (G) Time line and 
cartoon of 5 Hz CPA experiment. (H) Mean preference (s) ± SEM, post-test minus pre-test (n=7-
9; Student’s t-test, p<0.05). (I) No locomotor effect in either pre- or post-test. (J) Representative 
traces of behavior in the pre- and post-test. See also Figure 5.7. 
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Figure 5.7 LC-NE photostimulation drives both real-time and 
learned aversions. Related data to Figure 5.6 (A) Representative 
traces of behavior at different frequen- cies for the Th-CreLC:eYFP 
animals. (B) Fiber optic tip placements for the RTPT frequency-
response experiment. Animals were excluded if the tip ended >1 mm dorsal of the LC or any 
caused significant lesion to the LC or 4th ventricle. For clarity, only hits of included mice for this 
experiment are shown. (C) Phasic stimulation does not significantly alter locomotor activity, 
n=6/group. (D) Representative traces of behavior for the phasic regimes. (E) Representative 
traces of of Th-CreLC:eYFP behavior for the CPA assay in the pre- and post-test. 
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behavior from their initial exploration and neither group showed altered locomotor activity 
(Figure 5.6I & J, Figure 5.7E). These results suggest that the negative valence and anxiety-like 
behaviors previously observed during high tonic photostimulation of LC-NE neurons are capable 
of being learned and influencing future behavior; and suggest that, the high tonic state of LC-NE 
firing can inform behavior to avoid repeated exposure to conditions associated with stress-like 
conditions. 
Photostimulation of galanin-containing LC-NE neurons is also sufficient to elicit aversion 
 In addition to the catalytic enzymes necessary for catecholamine production, a majority 
of LC-NE neurons are also known to produce the neuropeptide galanin and galanin 
immunoreactivity is widely used as an LC neuronal marker (Holets et al., 1988; Le Maître et al., 
2013; Melander et al., 1986). Therefore, to further corroborate the results we observed using Th-
Cre mice, we also used mice expressing Cre recombinase under the promoter for Galanin (Gal-
Cre) (Gong et al., 2003, 2007; Wu et al., 2014). To validate and confirm loci of Galanin 
expression we first crossed these mice to a Cre-conditional tdTomato reporter line developed by 
the Allen Institute for Brain Science (Ai9) (Madisen et al., 2010). As predicted, we see dense, 
localized expression in the LC as well as the hypothalamus and brainstem (Figure 5.7A & B). 
We also observed some tdTomato+ cells in regions that do not have mRNA for galanin in the 
adult mouse (cortex, hippocampus, thalamus, and amygdalar structures) (Lein et al., 2007). In 
each of these regions we identify transient mRNA expression throughout development (Figure 
5.9) which would be sufficient to cause the recombination event needed to chronically express 
the reporter.  However, this Cre driver remains a viable tool for selective targeting of the LC 
(Figure 5.7C), as seen when we selectively targeted ChR2(H134)-eYFP to LC-NE neurons of 
Gal-Cre mice (Gal-CreLC:ChR2) there was restricted eYFP labeling to the membranes of 
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noradrenergic neurons of the LC (Figure 5.7D, Figure 5.10). We found that eFYP expression 
was selective for LC-NE neurons (100% of eYFP expressing LC neurons were positive for the 
NE marker, dopamine beta hydroxylase (DBH+)).  However, we found that only 61.48% of LC-
NE neurons expressed ChR2(H134)-eYFP in this model – significantly fewer than those targeted 
using the Th-Cre line (Figure 5.7E, Figure 5.10).  To test whether tonic photostimulation of this 
subpopulation of galanin-containing, LC-NE neurons also produces aversion, the Gal-CreLC:ChR2 
animals were tested in RTPT with and without photostimulation at 5 Hz.  In these experiments, 
we found that increased tonic LC-NE stimulation in Gal-CreLC:ChR2 animals produced significant 
avoidance behavior,  consistent with the behavior we observed under the same conditions in the 
Th-CreLC-ChR2 mice (Figure 5.7F & G). Using multiple, distinct in vivo LC-NE targeting 
strategies, these experiments further corroborate our findings that high tonic stimulation of LC-
NE neurons drives an aversive behavioral response and further suggest that increased activity of 
the entire population of LC neurons may not be necessary to elicit aversive behavior. 
CRH+ neurons from the central amygdala send dense projections to the LC 
 Following multiple observations that exogenously increasing tonic firing of LC-NE 
neurons is sufficient to drive anxiety-like and aversion behaviors in the absence of stress, we 
sought to determine the endogenous substrate for such a change in firing. Previously, CRH has 
been suggested as a potential mechanism for stress-induced increases in LC activity (Curtis et al., 
1997, 2001, 2012; Jedema and Grace, 2004; Page and Abercrombie, 1999; Reyes et al., 2008; 
Snyder et al., 2012; Valentino and Foote, 1988). Consistent with these studies, we found that 
systemic antagonism (Antalarmin HCl, 10 mg/kg, i.p.) of endogenous CRH action on CRHR1 
receptors is sufficient to prevent stress-induced anxiety (Figure 5.11A-D) (Gafford et al., 2012; 
Heinrichs et al., 1994).  We next sought to determine whether the action of CRH locally within 
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Figure 5.8 Galanin containing LC-NE neurons are sufficient to drive place aversion. (A and 
B) Galanin labeling in Gal-Cre x Ai9-tdTomato compared to in situ images from the Allen 
Institute for Brain Science in a sagittal section highlighting presence of galanin in the LC. All 
images show tdTomato (red) and Nissl (blue) staining. See also Figure 5.9. (C) Cartoon of viral 
and fiber optic delivery strategy for Gal-Cre experiment. (D) Image of ChR2-eYFP targeting to 
DBH+ LC neurons. Scale bar=100 !m. (E) Quantification of Cre-dependent eYFP viral 
expression in the LC of Th-Cre and Gal-Cre mouse lines. Data represented as mean ± SEM, n=3 
slices from 3 animals/group: Student’s t-test, p<0.0001. See also Figure 5.10. (F) 5 Hz 
stimulation ofLC-Gal neurons drives aversion (n=6, Paired Student’s t-test, p<0.01). (G) 
Representative traces of behavior at different frequencies. 
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Figure 5.9 Cre-dependent tdTomato expression in adult Ai9 X Gal-Cre mice. Related data 
to Figure 5.8A & B. (A) Images  show   Cre-dependent  reporter  expression  in  adultAi9  X  
Gal-Cre  mice  (left  panel),  in  situ  hybridization  for  Gal  in  adult  WT   mice  from  the  
Allen   Institute  (middle  panel),  and  in  situ  hybridization  for  Gal  in  P14  WT   mice  from  
the  Allen  Institute  (right  panel)  for  the  (A)  locus  coeruleus,   (B)  hippocampus,  (C)  
anteroventral  thalamus,  and  (D)  basolateral  and  basomedial  amygdala.  We  did  observe  
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any  regions  that contain Cre-dependent  reporter  expression  that  were  not  positive  for  Gal  
mRNA  at  some  stage  in development  or  in  the  adult  animal. 
Figure 5.10 Gal-Cre mice can be used to effectively target a subset of LC neurons. Related 
data to Figure 5.8D & E. (A) Representative   immunohstochemistry   show   selective   
targeting   of   ChR2--eYFP   to   DBH+  LC   neurons   in   Th-Cre   mice   (Red=  tyrosine   
hydroxylase, green = ChR2-eYFP, Scale bar = 100 µm). (B) Representative   
immunohistochemistry   show   selective   targeting   of   ChR2--eYFP   to   a   subset   of   
DBH+   LC   neurons   in   Gal-Cre mice (Red=  tyrosine   hydroxylase, green = ChR2-eYFP, 
Scale bar = 100 µm). (C) High--power   confocal micrograph depicting  ChR2--eYFP  
membrane  labeling  in  Gal-Cre DBH+ neurons.   
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the LC is responsible for CRH-dependent anxiety-like behavior. To do so, we utilized two 
retrograde tracing approaches to examine the potential sources of CRH input into the LC. First, 
we injected the tracer Fluorogold into the LC of wild-type mice (Figure 5.11E\). Consistent with 
previous studies, this non-selective retrograde tracing approach revealed known inputs into the 
LC from the cortex, hypothalamus, and central amygdala - a known input and source of 
extrahypothalamic CRH (Bouret et al., 2003; Dimitrov et al., 2013; Reyes et al., 2008, 2011) 
(Figure 5.11F, Figure 5.12). We next used a dual injection strategy to anatomically isolate LC-
projecting, CRH+ neurons. To do so, we used mice expressing Cre under the promoter for CRH 
(Crh-Cre) mice (Taniguchi et al., 2011). We simultaneously injected a red-labeled retrograde 
tracer, Cholera Toxin Subunit B (CTB-594) (Conte et al., 2009), to the LC and the green-labeled 
AAV5-DIO-Ef1"-ChR2(H134)-eYFP to the CeA of these mice (Crh-CreCeA:ChR2; Figure 
5.11G). From this approach we visualized Crh+ neurons in the CeA project to the LC by 
observing significant colocalization of both fluorophores in single CeA neurons, indicating that 
these neurons project to the LC (Figure 5.11H & I). Finally, to examine CRH+ terminal 
innervation of the LC, we only injected the Cre-dependent reporter AAV5-DIO-Ef1"-eYFP in 
the CeA of Crh-Cre mice (Figure 5.11J). We clearly observed projections from the CeA to the 
LC in both transverse and coronal sections (Figure 5.11K-M). These anatomical studies identify 
a discrete projection of Crh+ neurons from the CeA to the LC that could act to provide the 
hypothesized CRH-induced increase in tonic LC activity. 
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Figure 5.11 Identifying a CRH+ CeA input to the LC. (A) Calendar of pharmacological 
experiment. (B) CRF-R1 antagonism blocks stress-induced anxiety-like behavior (C) with no 
significant effect on locomotor activity (n=6-8/group, Student’s t-test, *p<0.05). (D) 
Representative heat maps show behavior in the OFT, hotter colors indicate more time spent in a 
position. (E) Cartoon depicting fluorgold tracing strategy. (F) Representative image shows 
robust retrograde labeling of the CeA (Fluorgold pseudocolored red, Nissl=grey). See also F 
Figure 5.12 (G) Cartoon depicting dual injection tracing strategy for CTB-594 and DIO-ChR2-
eYFP. (H) Representative image shows retrograde labeling in CeA of CTB-594 (red) and 
anterograde labeling of CRH+ cells (green). Arrow indicates example co-localization. (I) ~25% 
of each label co-labels with the other. (J) Cartoon depicting anterograde tracing strategy. (K) 71º 
off of sagittal, transverse slice of Crh-Cre mouse expressing DIO-eYFP in the CeA. Image 
shows intact projections from CeA to LC. Arrow indicates fiber optic placement. (L and M) 
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Coronal images depict robust eYFP labeling in the CeA and LC of the same mouse. All scale 
bars are 100 !m. + is in 4th ventricle. 
 
Figure  5.12  Retrograde  fluorogold  labeling  in  various  forebrain  regions.  Related   data 
 to Figure 5.11 E & F. 
(A)  Cartoon  depicting  fluorgold  tracing  strategy.  Representative   images  shows 
retrograde  labeling  throughout  in  the  (B)  lateral  hypothalamus  (LH),  (C)  
paraventricular   nucleus   of   the   hypothalamus   (PVN),   (D)   auditory   cortex   (Aud   Ctx),  
and  (E)  frontal  association  (FrA)  and  prelimbic  cortex  (PrL  Ctx)  paraventricular  nucleus  
of   the   hypothalamus.   In   all   images,   fluorogold   is   psuedocolored   red   and   Nissl   is   
in   grey.  All  scale  bars  are  100  µm. 
Photoactivation of CRH+ terminals in the LC causes increased tonic firing of LC neurons 
LV
LCCeA
!"#$%&'()
*+,-.-/-+0)123-)%!
4155+
*+,-.-/-+0
%6
7,0)!38 *.7)9):.%)!38
:;4
!
"
#
$
%
&'()*+,-./,0+1*2(*34+,56)2*2(264,637+6'8(,'8,93*'2):,52*+7*3'8,*+('28:;,0+631+4,
4313,12,&'()*+,.%<&,<!=)!>.3--2)0?@1A312/)B+,-./-+0)3.>A12/)53.>3?/CD)E?@.?5?23>31F?)
1G>/?5)5H-I5).?3.-/.>0?)+>J?+12/)3H.-,/H-,3)12)3H?)<"=)+>3?.>+)HC@-3H>+>G,5)<%6=K)<$=))))
@>.>F?23.1A,+>.) 2,A+?,5) -B) 3H?) HC@-3H>+>G,5) <:;4=K) <#=) >,013-.C) A-.3?8) <7,0)!38=K))
>20)<%=)B.-23>+)>55-A1>31-2)<*.7=)>20)@.?+1GJ1A)A-.3?8)<:.%)!38=)@>.>F?23.1A,+>.)2,A+?,5)
-B) 3H?)HC@-3H>+>G,5D) L2)>++) 1G>/?5K) B+,-.-/-+0) 15)@5,?0-A-+-.?0) .?0)>20)4155+) 15) 12)
/.?CD)7++)5A>+?)J>.5)>.?)MNN)OGD)
226 
 After identifying the CRH+ projection from the CeA to the LC, we sought to determine 
the effects of stimulating these terminals locally within the LC. In Crh-CreCeA-LC:ChR2 mice, we 
implanted multi-electrode arrays coupled to fiber optics into the LC and recorded LC activity 
before, during, and after photostimulation (Figure 5.13A). The CeA has been reported to 
spontaneously fire from 2-20 Hz (Ciocchi et al., 2010; Veinante and Freund-Mercier, 1998), so 
we used a 10 Hz photostimulation paradigm to maintain a physiologically-relevant frequency at 
the terminals. In recordings of 35 putative LC neurons from 5 different animals, we found a 
heterogeneous population of responses including increased firing in a significant proportion of 
cells (42.8% of observed putative LC units) (Figure 5.13B-F, Figure 5.14A). While the overall 
sample of neurons significantly increased firing (Figure 5.13E & F), we did observe a subset 
that decreased firing rate during photostimulation (Figure 5.13H). In cases where the firing rate 
increased the mean latency to increase was 344.6 ms, suggesting a neuromodulatory influence of 
the photostimulation (Figure 5.13F & G). Likewise, in cases where the firing rate decreased the 
mean latency to decrease was 360.0 ms (Figure 5.13H & I). Similarly to what we observed with 
direct LC-NE photostimulation (Figure 5.3J), we also observed that the increasing firing rates to 
Crh-CreCeA-LC:ChR2 photostimulation, are correlated (r=.70, p< 0.0001) to the baseline state of 
each neuron, again indicating that some LC neurons are innately more excitable by this 
projection than others. (Figure 5.13J). Importantly, the observed increase in firing following this 
selective photostimulation approach is consistent with other reports following either stress or 
exogenous application of CRH (Curtis et al., 1997; Jedema and Grace, 2004; Page and 
Abercrombie, 1999). 
Stimulation of CRH+ CeA terminals in the LC is aversive and anxiogenic 
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 After identifying the CeA terminals to the LC as a projecting source of CRH+ LC inputs, 
which are capable of increasing tonic activity, we next sought to test whether stimulation of these 
terminals would drive similar behavioral profiles to direct LC-NE stimulation or stress alone. In 
these experiments we used Crh-CreCeA-LC:ChR2 and Crh-CreCeA-LC:eYFP animals with fiber optic 
implants over the LC (Figure 5.13K). Using the same stimulation procedure we used during in 
vivo recordings  (10 Hz, 10 ms pulse width), we first observed that in the CPA assay (Figure 
5.13K) photostimulation of CeA-LC CRH+ terminals conditions a place aversion in Crh-CreCeA-
LC:ChR2 compared to Crh-CreCeA-LC:eYFP controls (Figure 5.13L & M). We next determined 
whether this stimulation was sufficient to induce anxiety-like behaviors in the EZM (Figure 
5.13N). In Crh-CreCeA-LC:ChR2 animals, acute photostimulation produced significant anxiety-like 
behavior compared to Crh-CreCeA-LC:eYFP controls (Figure 5.13O, Figure 5.14B & C). This 
anxiety-like behavior is similar to both direct LC-NE stimulation (Figure 5.3) or stress (Figure 
5.1A-D and Figure 5.11A-D). Importantly, when we locally antagonize  CRHR1 directly into 
the LC prior to photostimatulation ("-helical CRF 1 !g, intra-LC) this effect is completely 
reversed, suggesting that CRH release from CeA-LC terminals is the substrate responsible for the 
photostimulation-induced anxiety-like behavior (Figure 5.13O, Figure 5.14B & C). 
Furthermore, systemic antagonism of CRHR1 (Antalarmin HCl, 10 mg/kg, i.p.) prior to 
photostimulation of Crh-CreCeA-LC:ChR2 animals also prevents the induced anxiety-like behavior  
(Figure 5.13P). Taken together, these results suggest that the CRH+ projection from the CeA to 
the LC carries both an aversive and anxiogenic component mediated through CRH+ activation of 
CRHR1 in the LC. This is the first functional identification that CeA CRH projections to the LC 
can induce the negative affective behaviors associated with stress.
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Figure 5.13 CRH+ CeA-LC terminals increase LC activity and drive anxiety through 
CRFR1 activation. (A) Cartoon of viral and multi-electrode array delivery for anesthetized, in 
vivo recordings. (B and C) Representative PSTHs of putative LC neurons responding to 20s of 
10 Hz, 10 ms pulse width photostimulation (473 nm, ~10 mW). (D) Representative principal 
component analysis plot showing the first two principal components with clear clustering of 
units. (E) Total recorded sample shows significant increase in firing rate to 10 Hz 
photostimulation (n=35, Paired Student’s t-test, p<0.01). (F) n=15 units increase firing rate by 
>10% during 10 Hz photostimulation (Paired Student’s t-test, p<0.01). (G) Response latency 
following onset of photostimulation for cells that increase firing. (H) n=15 units decrease firing 
rate by >10% during 10 Hz photostimulation (Paired Student’s t-test, p<0.01). See also Fig. S7A. 
(I) Response latency following onset of photostimulation for cells that increase firing. (J) 
Correlation of baseline activity to activity during photostimulation (r=0.7029, p<0.0001). (K) 
Cartoon of viral and fiber optic delivery strategy and calendar of CPA behavior. (L and M) Crh-
CreCeA-LC:ChR2 show a significant CPA compared to Crh-CreCeA-LC:eYFP controls. Representative 
traces of behavior in the pre- and post-test and mean preference (s) ± SEM, post-test minus pre-
test (n=10-12/group; Student’s t-test, p<0.05). (N) Cartoon of viral, cannula, and fiber optic 
delivery strategy and calendar of EZM behavior. (O) 10 Hz photostimulation causes an anxiety-
like phenotype in EZM of Crh-CreCeA-LC:ChR2 animals compared to Crh-CreCeA-LC:eYFP controls, 
which is reversed by intra-LC "-helical-CRF ("HCRF) pretreatment  (Data represented as mean 
± SEM, n=7/group: One-Way ANOVA, Newman-Keuls, Crh-CreCeA-LC:eYFP vs. Crh-CreCeA-
LC:ChR2 *p<0.05, CreCeA-LC:eYFP vs. Crh-CreCeA-LC:ChR2+AHCRF **p<0.01, CreCeA-LC:ChR2 vs. Crh-
CreCeA-LC:ChR2+AHCRF ***p<0.001). See also Fig. S7B&C. (P) Systemic CRHR1 antagonism 
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reverses photostimulation-induced anxiety-like behavior (n=6-8/group, Student’s t-test, 
p<0.001). (Q) Model and summary of results. See also Fig. S7D. 
 
 
 
 
 
 
 
 
Figure 5.14 CRH+ CeA-LC terminals increase LC activity and drive anxiety through 
CRFR1 activation. Related data to Figure 5.13. (A) n=5 units that did not increase or decrease 
firing by >10% during 10 Hz photostimulation. (B) Representative heat maps of activity in the 
EZM. (C) Cannula and fiber optic placements for the EZM experiments with Crh-CreCeA-LC 
animals. Animals were excluded if the fiber tip ended >1 mm dorsal of the LC or caused 
significant lesion to the LC or 4th ventricle. Additionally, cannulated mice were excluded if the 
final injection placement appeared to be >0.5mm from the LC. (D) Hypothetical model of 
downstream LC-NE influence on anxiety-like behaviors. Anterograde tracing of eYFP+ fibers 
from Th-CreLC-eYFP mice reveals dense innervation in the CeA, BLA, and LS (red=Nissl, green – 
DIO-eYFP, scale bars =100 µm). 
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DISCUSSION 
 The LC-NE system has long been implicated as a key mediator of the central stress 
response (Koob, 1999). Observational electrophysiological studies across many species have 
identified that LC-NE neurons respond vigorously to stress and behavioral pharmacology has 
revealed a potential role for endogenous CRH in the generation of this response (Bingham et al., 
2011; Cassens et al., 1981; Curtis et al., 1997, 2012; Francis et al., 1999; Lechner et al., 1997; 
Jedema and Grace, 2004; Page and Abercrombie, 1999; Reyes et al., 2008; Snyder et al., 2012; 
Valentino et al., 1991; Valentino and Foote, 1988; Valentino and Van Bockstaele, 2008). The 
current study, however, is the first to selectively manipulate LC-NE neurons in the context of 
stress and its resulting anxiety-like behaviors. Here, we report that the activity of LC-NE neurons 
is necessary to elicit acute stress-induced anxiety. Furthermore, selectively increasing the firing 
of LC-NE neurons is itself anxiogenic in the absence of stress. This same high tonic state has 
negative valence that can inform future behavior through learned association. Finally, 
optogenetic stimulation of CRH+ CeA terminals into the LC replicates both the cellular profile 
and acute anxiogenic and aversive behavioral state of direct LC-NE high tonic stimulation 
(Figure 5.13Q).  
LC activity during stress is necessary for acute stress-induced anxiety 
 While the observation of the LC response to stress has implicated the LC-NE system in 
negative affect associated with stress, it is only now, using a chemogenetic approach, that we can 
conclude that this activity is required for stress-induced anxiety. Many studies have indicated 
that noradrenergic tone is important for processing stressful stimuli, encoding fearful events, 
deciphering threatening versus non-threatening signals (Aston-Jones et al., 1999; Snyder et al., 
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2012). The finding that activity of LC-NE neurons is necessary to transmit this information and 
produce stress-induced anxiety-like behavior extends our understanding of this system’s role in 
the stress and the canonical “fight or flight” response. Interestingly, inhibition of the LC-NE 
system without stress did not affect baseline anxiety levels, suggesting that less LC activity is not 
necessarily anxiolytic. Furthermore, inhibiting LC-NE neurons during stress did not prevent 
other physiological readouts of stress, such as fecal output. It will be interesting to dissect 
whether other stress-induced behaviors such as analgesia (Bannister et al., 2009; Butler and Finn, 
2009; Hickey et al., 2014) and reinstatement to drug seeking (Al-Hasani et al., 2013; Shaham et 
al., 2000) require intact LC-NE activity during stress. 
 The chemogenetic inhibition approach used here is temporally restricted due to the 
kinetics of CNO activity, and the neuromodulatory function of the DREADD receptors. 
Therefore it is difficult to precisely hypothesize when it would be crucial to inhibit LC-NE 
activity to prevent a stress-induced anxiety event. However, this initial study provides a clearer 
picture of how LC-NE activity during stress alters subsequent behavior. Additionally, it is quite 
possible that only a subset of LC-NE neurons are required for stress-induced anxiety and 
previous studies have indicated that the dorsal-ventral axis of the LC can have diverse actions 
(Hickey et al., 2014). Future studies will be necessary to elucidate whether the microanatomy 
and local neural circuits within the LC play an important role in stress-induced anxiety.  
High tonic LC-NE neuronal activity can initiate anxiety-like behavior 
 Several recent studies have used optogenetics to generate binary control of acute anxiety 
(see Chapter 2) (Felix-Ortiz et al., 2013; Heydendael et al., 2014; Jennings et al., 2013; Kheirbek 
et al., 2013; Kim et al., 2013a, 2013b; Sidor et al., 2015; Tye et al., 2011). The circuits of the 
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extended amygdala and some of their projections into the mesolimbic dopamine system have 
demonstrated rapid onset and offset of anxiety that is likely mediated by small-molecule 
neurotransmission. Here, we demonstrate anxiety-like behavior generated by increasing the tonic 
activity of the neuromodulatory LC-NE system. While this activity generates anxiety on a short 
timescale (seconds to minutes), it is unlikely that the immediate (subsecond timescale) result of 
high tonic activity is anxiety. Rather, it is plausible that the LC serves to integrate information 
from numerous forebrain and sensory inputs and, over time, the persistent high tonic state feeds 
forward onto previously established anxiety circuits. This integration of information may serve 
to adjust the gain on these downstream systems to ultimately drive anxiety, an idea consistent 
with previous hypotheses on LC function (Koob, 1999). The extended amygdala is a potential 
candidate region where feed-forward, gain modulation could exist as there are reciprocal 
connections between the LC and multiple divisions of the amygdala (Bouret et al., 2003; 
Buffalari and Grace, 2007; Samuels and Szabadi, 2008) (Figure 5.14D). Importantly, this 
hypothetical model of LC modulation of anxiety circuitry is likely an endogenous mechanism 
given than the removal of the LC-NE system prevents stress-induced anxiety. 
 Furthermore, the LC is the primary source of norepinephrine for the mammalian 
forebrain (Berridge and Waterhouse, 2003; Sara, 2009). It is unlikely that increased 
noradrenergic tone throughout the brain and spinal cord is what mediates the transition to 
anxiety-like behavior. Rather, we suspect that particular efferent LC-NE projections likely 
mediate particular behavioral outcomes. For example, the LC projects into the basolateral 
amygdala and the lateral septum, both of which have been demonstrated to play a key role in the 
regulation of stress and anxiety-like behaviors (Anthony et al., 2014; Felix-Ortiz et al., 2013; Tye 
et al., 2011) (Figure 5.14D). This circuit-based theory of LC function is a helpful framework 
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towards understanding other LC functions such as attention, arousal, and as presented here, 
aversion.   
High tonic LC-NE activity has a negative valence that can inform future behavior 
 The same optogenetic manipulation that incites anxiety also elicits aversive behaviors in 
both real-time and conditioned assays. These findings demonstrate that exogenously increasing 
LC tonic activity carries a significant negative valence. Mimicking the neuronal response to 
stress in these cells produces behavior similar to exposure to stressful stimuli. While previous 
studies have identified that the LC has increased immediate early gene expression during various 
forms of aversion (Sandner et al., 1993), this is the initial attempt to examine, in real-time, 
whether increased LC-NE activity is sufficient for these behaviors. In fact, we observe that high 
tonic stimulation of LC-NE neurons is aversive in both real-time and a Pavlovian conditioning 
paradigm. While this negative valence aligns with the previously discussed anxiogenic results, it 
elucidates three key components of the system. First, in the real-time aversion assay, the 
observed aversion behavior is frequency-dependent. In other words, low tonic stimulation that is 
similar to baseline awake LC activity (1-2 Hz) (Aston-Jones and Bloom, 1981a; Bloom, 1981; 
Carter et al., 2010, 2012) does not provide negative valence signals to the animal, but higher 
tonic states, similar to those evoked by stress (5-10 Hz) (Bingham et al., 2011; Cassens et al., 
1981; Curtis et al., 1997, 2012; Francis et al., 1999; Lechner et al., 1997; Reyes et al., 2008; 
Valentino and Van Bockstaele, 2008; Valentino et al., 1991), drive aversion. Furthermore, phasic 
paradigms mimicking the intrinsic phasic bursting activity of LC neurons (Aston-Jones and 
Bloom, 1981b; Bouret et al., 2003, 2012; Tervo et al., 2014; Valentino and Foote, 1988), and 
similar to paradigms used to evoke real-time behavior in other catecholaminergic systems (see 
Chapters 2 & 4) (Adamantidis et al., 2011; Chaudhury et al., 2013; Kim et al., 2013b; Lammel et 
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al., 2012; Stamatakis and Stuber, 2012; Tsai et al., 2009; Tye et al., 2013; Witten et al., 2011), do 
not carry the same aversive signals to the animal. Finally, it appears that higher tonic frequencies 
potentially produce anxiety through negative affect. While it is generally thought that anxiety 
and aversion are both negative affective states, the two behavioral outputs are neurobiologically 
distinct in numerous systems (Kim et al., 2013a; Land et al., 2008) and can each exist without 
the other. In the case of the LC system, however, the observed anxiety-like behavior does seem 
to be driven by the aversive nature of the stimulation. 
Galaninergic locus coeruleus neurons are sufficient to drive aversion 
 Previous studies have identified galanin as a common neuropeptide co-transmitter in the 
LC (Holets et al., 1988; Le Maître et al., 2013; Melander et al., 1986). This selective co-
localization allows for a second means of genetically targeting LC neurons. While the Gal-Cre 
experiments support the findings targeting LC-NE neurons in Th-Cre mice, they also importantly 
show that a smaller subset of LC neurons can still maintain the same behavior. This observation 
suggests possible heterogeneity within the LC. It is now possible to directly compare Gal+ and 
Gal- neurons using a Cre-OFF and Cre-ON system to express optogenetic or chemogenetic 
constructs in clearly segregated populations of LC neurons (Fenno et al., 2014; Saunders et al., 
2012). Future work using these and other intersectional targeting strategies will help further 
dissect the role of this important structure in behavior.  
 The Gal-Cre experiments also point to a gap in our knowledge of the downstream 
substrate beyond LC-NE neurons. As previously discussed, it seems likely the LC operates with 
circuit-selectivity to mediate various behaviors, however, postsynaptic cellular mechanisms 
allow for orders of magnitude of more complexity. With at least nine different adrenergic 
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receptors and three different galanin receptors, that have nearly all been indicated in anxiety-like 
behaviors (Brunner et al., 2014; Dixit et al., 2014; Hanke et al., 2012; Kuteeva et al., 2008; Le 
Maître et al., 2013; Mantsch et al., 2010; Raskind et al., 2007; Wohleb et al., 2011), the 
combined circuit- and cellular-level dynamics of this system will provide significant challenges 
for the next series of studies. 
CRH+ CeA-LC terminals increase activity and drive anxiety through CRFR1 activation 
 Anatomical studies first identified the projection from the CeA to the LC (Van 
Bockstaele et al., 1996, 1998) and recent work has helped understand the molecular profile of 
these projections suggesting that CeA-LC projections are potentially glutamatergic and carry the 
neuropeptides dynorphin and CRH (Kravets et al., 2015; Reyes et al., 2008, 2011). Here, we 
identify that CRH+ neurons represent a clear subset of LC-projecting neurons that aligns with 
electron microscopy data from the terminal populations in the LC (Kravets et al., 2015; Reyes et 
al., 2008, 2011). Importantly, CRH+ CeA neurons have been shown to be a part of the protein 
kinase C d- subpopulation (Haubensak et al., 2010) of CeA neurons that have recently been 
shown to be distinct from those CeA neurons involved in conditioned fear and have a possible 
role in driving food consumption (Cai et al., 2014; Haubensak et al., 2010). This CRH+ 
projection into the LC has been of particular interest for the possibility that this is a source of 
extrahypothalamic CRH that increases tonic LC firing during stress. Here, we see the overall 
population of recorded LC neurons does increase tonic firing following photostimulation of 
CRH+ CeA-LC terminals. Unsurprisingly, however, this increase in activity was not ubiquitous. 
The diversity of observed responses likely represents an anatomical differentiation of LC 
neurons. It is quite possible that non-responding neurons do not receive innervation from the 
CeA and the difference in increased or decreased responses could be explained by a varied 
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expression of cell-surface receptors on the postsynaptic neurons. While the literature is clear that 
monosynaptic connections exist in this circuit (Kravets et al., 2015; Reyes et al., 2008, 2011), 
none of our recorded cells suggest any fast-acting neurotransmission. While this could be due to 
the potential for selection bias inherent in in vivo recordings (only firing neurons can be 
observed) or an artifact of slower acting neuropeptide/G-protein coupled receptor-mediated 
transmission, we cannot rule out the possibility of a polysynaptic mechanism.  Future work to 
extensively investigate local GABAergic influence and other LC microcircuits will be necessary 
(Aston-Jones et al., 2004). 
 Importantly, however, spatially-isolated photostimulation of these terminals in the LC 
recapitulates the aversion and anxiety-like behaviors observed with both stress and direct LC 
photostimulation. Furthermore, the anxiety-like behavior can be prevented by local antagonism 
of CRHR1 in the LC. This finding suggests that photostimulation-induced release of CRH 
mediates these behaviors through action in the LC. In addition, the same behavior can be blocked 
by systemic antagonism of CRHR1. This systemic approach has previously been shown to be 
anxiogenic in the absence of stress (Heinrichs et al., 1994), but here, still in the absence of stress, 
the pharmacological manipulation is anxiolytic – reversing the photostimulation-induced anxiety. 
 Understanding the place of the LC in broader brain networks related to anxiety is crucial 
to understanding anxiogenesis and determining potential points for therapeutic intervention. 
While recent focus has been on fast-acting small-molecule transmission (glutamate/GABA) in 
the generation of anxiety states, the role of stress and neuromodulatory fight-or-flight systems 
has yet to be fully vetted. Understanding how the vast efferent projection network of the LC 
facilitates this anxiogenesis will be an important next step. While Anthony and colleagues 
(Anthony et al., 2014), clearly demonstrate the role of Crfr2+ neurons of the lateral septum (LS) 
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in prolonged stress-induced anxiety, future work will be needed to investigate whether the 
known LC inputs into the LS acutely modulate this system and produce prolonged 
anxiety (Antonopoulos et al., 2004; Berridge et al., 1996; Bondi et al., 2007; Risold and 
Swanson, 1997). Additionally, the LC also has many known projections to other anxiogenic 
centers such as the amygdala including the basolateral amygdala and reciprocal projections back 
to the CeA which merit similar future investigation (Bouret et al., 2003; Buffalari and Grace, 
2007; Samuels and Szabadi, 2008)( Figure 5.14D). Nevertheless, we report here that stress-
induced increases in LC activity are both necessary and sufficient for anxiety-like behavior, 
collectively affirming the LC-NE system as a critical mediator of the acute behavioral stress 
response. Taken together, this study provides fundamental framework for understanding the 
mammalian brain circuitry responsible for the innate anxiety response. 
MATERIALS AND METHODS 
Experimental subjects  
 Adult (25–35 g) male C57BL/6J, TH-IRES-Cre, Crh-IRES-Cre, and Gal-Cre (all 
backcrossed to C57BL/6J mice for ~10 generations) were group-housed, given access to food 
pellets and water ad libitum and maintained on a 12 h:12 h light:dark cycle (lights on at 7:00 
AM). All animals were held in a sound attenuated holding room facility in the lab 1 week prior 
to surgery, post-surgery and throughout the duration of the behavioral assays to minimize stress 
from transportation and disruption from foot traffic.  All mice were handled and, where 
appropriate, connected to fiber optics and/or headstages two times a day for one week prior to 
experimental testing. All procedures were approved by the Animal Care and Use Committee of 
Washington University and conformed to US National Institutes of Health guidelines.  
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Viral preparation 
 Plasmids coding pAAV-EF1"-DIO-EFYP and pAAV-EF1"-double floxed-
hChR2(H134R)-EYFP-WPRE-HGHpA, were obtained from Addgene (Addgene.org) originally 
from the Deisseroth Laboratory at Stanford University. The DNA was amplified with a Maxiprep 
kit (Promega) and packaged into AAV5 serotyped viruses by the WUSTL Hope Center Viral 
Core. The final viral concentration was 2-5 x 1012 genome vg/mL for the adeno-associated 
viruses. AAV5-EF1"-DIO-HM4Di-mCherry was purchased directly from the UNC Vector Core. 
Table 5.1 Viral vectors used. 
Plasmid Source Packaged by Serotype Titer 
pAAV-EF1"-
DIO-EFYP 
Deisseroth 
Laboratory 
(Stanford) 
WUSTL Hope 
Center Viral 
Core 
AAV5 5 x 10^12 vg/ml 
pAAV-EF1"-
double floxed-
hChR2(H134R)-
EYFP-WPRE-
HGHpA 
Deisseroth 
Laboratory 
(Stanford) 
WUSTL Hope 
Center Viral 
Core 
AAV5 2 x 10^13 vg/ml 
AAV5-EF1"-
DIO-HM4Di-
mCherry 
Roth Laboratory 
(UNC) 
UNC Vector 
Core 
AAV5 3x10^12 VM/mL 
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Stereotaxic surgery  
 After the animals were acclimated to the holding facility for seven to nine days, they 
were anaesthetized in an induction chamber (4% Isolflurane) and placed in a stereotaxic frame 
(Kopf Instruments, Model 1900) where they were maintained at 1-2% isoflurane. A craniotomy 
was performed and mice were injected with 500 nl of AAV5-DIO-HM4Di, AAV5-DIO-ChR2 or 
AAV5-DIO-eYFP, Fluorogold, or CTB-594 unilaterally into the LC (stereotaxic coordinates 
from bregma: -5.45 anterior-posterior (AP), +/(1.25 medial-lateral (ML), (4.00 mm dorsal-
ventral (DV)), or the CeA (-1.25 AP, +/- 2.75 ML, -4.75 DV). Mice were then implanted with 
metal cannula (PlasticsOne; coordinates adjusted from viral injection 0.00 AP, +/- 0.25 ML, 
+1.00 DV) or fiber optic implants (coordinates adjusted from viral injection 0.00 AP, +/- 0.25 
ML, +1.00 DV)(Carter et al., 2010). Custom adapters (WUSTL Instrument Machine Shop) for 
the Kopf cannula holder (Model 1966) were used to implant the fiber optics(Sparta et al., 2011). 
The implants were secured using two bone screws (CMA, 743102) and affixed with dental 
cement (Lang Dental). Mice were allowed to recover for 3-6 weeks prior to behavioral testing; 
this interval also permitted optimal AAV expression and Cre recombinase activity.  
Immunohistochemistry  
 Immunohistochemistry was performed as described (see Chapter 2) (Al-Hasani et al., 
2013; Kim et al., 2013b). Briefly, mice were anesthetized with pentobarbital and transcardially 
perfused with ice-cold 4% paraformaldehyde in phosphate buffer (PB). Brains were dissected, 
post-fixed for 24 hr at 4 ºC and cryoprotected with solution of 30% sucrose in 0.1M PB at 4ºC 
for at least 24 hr, cut into 30 !m sections and processed for immunostaining. 30 !m brain 
sections were washed three times in PBS and blocked in PBS containing 0.5% Triton X-100 and 
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5% normal goat serum. Sections were then incubated for ~16 hr at room temperature in rabbit 
anti c-fos antibody (1:500, Santa Cruz), rabbit anti-DBH (1:2000, Millipore) and/or chicken anti-
TH (1:2000, Aves Labs). Following incubation, sections were washed three times in PBS and 
then incubated for 2 hr at room temperature in Alexa Fluor 488 goat anti-mouse IgG (1:500, 
Invitrogen), Alexa Fluor 594 goat anti-rabbit IgG (1:500, Invitrogen), and/or goat anti-chicken 
Alexa Fluor 633(1:500, Invitrogen) were then washed three times in PBS and followed by three 
10-min rinses in PB and mounted on glass slides with Hardset Vectashield (Vector Labs) for 
microscopy. All sections were imaged on both epifluorescent and confocal microscopes. Gain 
and exposure time were constant throughout each experiment, and all image groups were 
processed in parallel using Adobe Photoshop CS5 (Adobe Systems). IHC was quantified as 
previously described (see Chapter 2) (Al-Hasani et al., 2013; Kim et al., 2013b). Briefly, 
channels were separated, an exclusive threshold was set, and positive staining for each channel 
was counted in a blind-to-treatment fashion using Metamorph. The counts from each channel 
were then overlaid and percent of co-labeled cells were reported. 
Antibody Species Dilution Source 
TH Chicken 1:2000 Aves Labs 
c-fos Rabbit 1:500 Santa Cruz 
DBH Rabbit 1:2000 Millipore 
Alexa Fluor 488 
anti-mouse IgG 
Goat 1:500 Invitrogen 
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Alexa Fluor 594 
anti-rabbit IgG 
Goat 1:500 Invitrogen 
Alexa Fluor 633 
anti-chicken IgG 
Goat 1:500 Invitrogen 
Alexa Fluor 594 
anti-chicken IgG 
Goat 1:500 Invitrogen 
Table 5.2 Antibodies used. 
Anatomical tracing  
 For retrograde tracing experiments (Fluorogold and CTB-594), the tracer was injected 
and the animal was allowed to recover for six days before perfusion. For anterograde viral 
tracing, the virus was injected and the animal was allowed to recover for six weeks before 
perfusion. 
Stress-induced anxiety paradigm 
 Mice assigned to stress groups were restrained in 50 ml disposable conical tubes that 
were adapted for this purpose by drilling holes to permit air circulation and for the tail to be 
extended. For acute stress-induced anxiety-like behavior, mice were immobilized in the tube 
once for 30 minutes. Immediately following stress, animals were transferred to the open field 
(see below). Fecal boli were collected from both the tube and the open field. For the hM4Di 
experiments, mice were injected with CNO (10 mg/kg, i.p., 30 min prior to exposure to the 
restraint tube) (Armbruster et al., 2007; Li et al., 2013; Mahler et al., 2014; Penzo et al., 2015; 
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Vazey and Aston-Jones, 2014). For the CRF antagonism experiment, mice were injected with 
Antalarmin HCl (10 mg/kg, i.p., 30 min prior to exposure to the restraint tube).  
Open Field Test (OFT) 
 OFT testing was performed in a square enclosure (50 x 50 cm) within a sound attenuated 
room maintained at 23ºC. Lighting was measured and stabilized at ~25 lux. For stress-induced 
experiments, we followed the above paradigm immediately prior to a 20 minute test. For 
optogenetic experiments, we connected Th-CreLC:ChR2 or Th-CreLC:eYFP mice to fiber optic cables 
and placed them in the center of the open field and allowed them to roam freely for 21 min. 
Photostimulation alternated between off and on states in 3 min time segments, beginning with 3 
min of no stimulation. For the photostimulated time segments, animals received 5 Hz (10 ms 
width) photostimulation (~10 mW light power). The open field was cleaned with 70% ethanol 
between each trial. Movements were video recorded and analyzed using Ethovision 8.5 (Noldus 
Information Technologies, Leesburg, VA). The center was defined as a square comprised of 50% 
the total area of the OFT. Time in the center was the primary measure of anxiety-like behaviors.  
Slice preparation and solutions (experiments by performed by Chris Ford, PhD) 
 Following anesthesia, horizontal midbrain slices containing the LC (240 !m) were cut in 
ice-cold sucrose cutting solution that contained (mM): 75 NaCl, 2.5 KCl, 6 MgCl2, 0.1 CaCl2, 
1.2 NaH2PO4, 25 NaHC03, 2.5 D-glucose, 50 sucrose; bubbled with 95% O2/5% CO2.  Slices 
were incubated post-cutting at 35°C in oxygenated 95% O2/5% CO2 ACSF solution that 
contained (mM): 126 NaCl, 2.5 KCl, 1.2 MgCl2, 2.5 CaCl2, 1.2 NaH2PO4, 21.4 NaHCO3, 11.1 
D-glucose for 45 minutes before recording.  During incubation, 10 !M MK-801 was included to 
reduce excitotoxicity and increase slice viability.  Following incubation, slices were placed in a 
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recording chamber and constantly perfused with warm ACSF (34 ± 2°C) containing 100 !M 
picrotoxin, 10 !M DNQX and 1 !M idazoxan at 2 ml/min. Neurons were visualized with a 
BXWI51 microscope (Olympus) with infrared custom-built gradient contrast optics. 
Slice electrophysiology (experiments by performed by Chris Ford, PhD) 
 Whole-cell current-clamp recordings were made as described (Courtney and Ford, 2014; 
Ford et al., 2009) using an Axopatch 200B amplifier (Molecular Devices).  Patch pipettes (1.5-2 
M$) were pulled from borosilicate glass (World Precision Instruments). The intracellular pipette 
solution contained 115 (mM): 115 K-methylsulphate, 20 NaCl, 1.5 MgCl2, 10 HEPES(K), 10 
BAPTA-tetrapotassium, 1mg/ml ATP, 0.1 mg/ml GTP, and 1.5 mg/ml phosphocreatine (pH 7.4, 
275 mOsm).  Data were acquired using an ITC-18 interface (Instrutech) and Axograph X 
(Axograph Scientific) at 10 KHz and filtered to 2KHz for voltage-clamp recordings. Widefield 
activation of ChR2 was activated with collimated light from a LED (470 nm) through the 40x 
water immersion objective. 
In vivo electrophysiology 
 For light modulated responses, an array of 16 (35-µm tungsten wires, 150-µm spacing 
between wires, 150-µm spacing between rows, Innovative Physiology) was epoxied to a fiber 
optic and lowered into the LC of a lightly (<1% isoflurane) anesthetized, Th-CreLC:ChR2 (Figure 
5.3) or Crh-CreCeA-LC:ChR2 animals (Figure 5.13). Two skull screws were arbitrarily placed 
anterior to bregma on either side of the midline and used to ground the electrode array. In either 
approach, voltage readings from each electrode were bandpass-filtered with activity between 250 
and 8,000 Hz analyzed as spikes. LC cells were selected based on their stereotaxic position, 
baseline activity, and response to a toe pinch. The signal was amplified and digitally converted 
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using commercially available hardware and software (Omniplex and PlexControl, Plexon). 
Spikes were sorted using principal component analysis and/or evaluation of t-distribution with 
expectation maximization (Offline sorter, Plexon). Sorted units were analyzed using 
NeuroExplorer 3.0 and timestamps were exported for further analysis in Microsoft Excel and 
Matlab 7.12. 
Elevated Zero Maze (EZM) 
 EZM testing was performed in a sound attenuated room maintained at 23ºC at 200 lux 
(see Chapter 2) (Bruchas et al., 2009; Kim et al., 2013b), and trials were performed in the 
afternoon between 13:00–16:00 hr. The EZM (Harvard Apparatus, Holliston, MA) had the 
following dimensions: 200 cm in circumference comprised of four 50 cm sections: two opened 
and two closed. The maze was elevated 50 cm above the floor, with a path width of 4 cm and a 
0.5 cm lip on each open section. The maze was cleaned with 70% ethanol between trials. Prior to 
testing, Th-CreLC:ChR2, Th-CreLC:eYFP, Crh-CreCeA-LC:ChR2, or Crh-CreCeA-LC:eYFP  were connected 
to the fiber optic and placed at the threshold of a closed section facing the open section and 
allowed to roam freely for 7 min. Th-Cre animals received 5 Hz (10 ms width) and Crh-Cre 
animals received 10 Hz (10 ms width) photostimulation (~10 mW light power). For the CRFR1 
antagonism experiments, mice were injected into the LC with "-helical CRF (1 !g, intra-LC, one 
hour prior to behavior, Tocris) or Antalarmin HCl (10 mg/kg, i.p., 30 min prior to behavior, 
Sigma). Movements were video recorded and analyzed using Ethovision 8.5 (Noldus 
Information Technologies, Leesburg, VA). Open section time and entries into the open section 
following a one-minute habituation were the primary measures of anxiety-like behaviors.  
Conditioned Place Aversion 
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 Th-CreLC:ChR2, Th-CreLC:eYFP, Crh-CreCeA-LC:ChR2, or Crh-CreCeA-LC:eYFP animals were 
trained in an unbiased, balanced three-compartment conditioning apparatus as described 
(Bruchas et al., 2009; Al-Hasani et al., 2013; Land et al., 2008, 2009). Briefly, mice were pre-
tested by placing individual animals in the small central compartment and allowing them to 
explore the entire apparatus for 30 min. Time spent in each compartment was recorded with a 
video camera (ZR90; Canon) and analyzed using Ethovision 8.5 (Noldus). Mice were randomly 
assigned to photostimulation and no-photostimulation compartments and received no 
photostimulation in the morning and photostimulation (Th-CreLC:ChR2: 5 Hz, 10 ms pulses; Crh-
CreCeA-LC:ChR2: 10 Hz, 10 ms pulses) in the afternoon at least 4 h after the morning training on 
two consecutive days. CPA was assessed on day 4 by allowing the mice to roam freely in all 
three compartments and recording the time spent in each. Scores were calculated by subtracting 
the time spent in the photostimulation-paired compartment post-test minus the pre-test. 
Real-time Place Testing 
 Th-CreLC:ChR2, Th-CreLC:eYFP, Gal- CreLC:ChR2, Crh-CreCeA-LC:ChR2, or Crh-CreCeA-LC:eYFP 
animals were placed in a custom-made unbiased, balanced two-compartment conditioning 
apparatus (52.5 x 25.5 x 25.5 cm) as described previously (see Chapter 4) (Jennings et al., 2013; 
Kim et al., 2013a; Stamatakis and Stuber, 2012; Stamatakis et al., 2013; Tan et al., 2012). Mice 
were allowed to freely roam the entire apparatus for 20 min. Entry into one compartment 
triggered photostimulation of various frequencies (0, 1, 2, 5, 10 Hz, etc.) while the animal 
remained in the light-paired chamber. Entry into the other chamber ended the photostimulation. 
The side paired with photostimulation was counterbalanced across mice and across session. Time 
spent in each chamber and total distance traveled for the entire 20-minute trial was measured 
using Ethovision 8.5 (Noldus Information Technologies, Leesburg, VA). 
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Data Analysis/Statistics 
 All data expressed as mean ± SEM. Data were normally distributed, and differences 
between groups were determined using independent t-tests or one-way ANOVA, or two-way 
ANOVAs followed by post hoc Bonferroni comparisons if the main effect was significant at 
p<0.05. Statistical analyses were conducted using Prism 5.0 (GraphPad). 
Genotyping of mouse lines  
  DNA was isolated from tail tissue obtained from weanling mice (21-28 days of age), and 
PCR screening was performed using the following primers: Cre recombinase (forward: 5’- GCA 
TTA CCG GTC GAT GCA ACG AGT GAT GAG-3’ and reverse: 5’- GAG TGA ACG AAC 
CTG GTC GAA ATC AGT GCG-3’) yielding a 400-bp PCR product in Cre positive animals. 
Fatty acid-binding protein intestinal primers (forward: 5’- TGG ACA GGA CTG GAC CTC 
TGC TTT CCT AGA-3’ and reverse: 5’- TAG AGC TTT GCC ACA TCA CAG GTC ATT 
CAG-3’) were used as positive controls and yield a 200-bp PCR product. 
REFERENCES 
Adamantidis, A.R., Tsai, H.-C., Boutrel, B., Zhang, F., Stuber, G.D., Budygin, E.A., Touriño, C., 
Bonci, A., Deisseroth, K., and de Lecea, L. (2011). Optogenetic interrogation of dopaminergic 
modulation of the multiple phases of reward-seeking behavior. J. Neurosci. Off. J. Soc. Neurosci. 
31, 10829–10835. 
Alvarez, V.A., Chow, C.C., Van Bockstaele, E.J., and Williams, J.T. (2002). Frequency-
dependent synchrony in locus ceruleus: role of electrotonic coupling. Proc. Natl. Acad. Sci. U. S. 
A. 99, 4032–4036. 
Anthony, T., Dee, N., Bernard, A., Lerchner, W., Heintz, N., and Anderson, D. (2014). Control 
of Stress-Induced Persistent Anxiety by an Extra-Amygdala Septohypothalamic Circuit. Cell 
156, 522–536. 
248 
Antonopoulos, J., Latsari, M., Dori, I., Chiotelli, M., Parnavelas, J.G., and Dinopoulos, A. 
(2004). Noradrenergic innervation of the developing and mature septal area of the rat. J. Comp. 
Neurol. 476, 80–90. 
Armbruster, B.N., Li, X., Pausch, M.H., Herlitze, S., and Roth, B.L. (2007). Evolving the lock to 
fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. 
Proc. Natl. Acad. Sci. U. S. A. 104, 5163–5168. 
Aston-Jones, G., and Bloom, F.E. (1981a). Activity of norepinephrine-containing locus 
coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J. 
Neurosci. Off. J. Soc. Neurosci. 1, 876–886. 
Aston-Jones, G., and Bloom, F.E. (1981b). Norepinephrine-containing locus coeruleus neurons 
in behaving rats exhibit pronounced responses to non-noxious environmental stimuli. J. 
Neurosci. Off. J. Soc. Neurosci. 1, 887–900. 
Aston-Jones, G., Rajkowski, J., and Cohen, J. (1999). Role of locus coeruleus in attention and 
behavioral flexibility. Biol. Psychiatry 46, 1309–1320. 
Aston-Jones, G., Zhu, Y., and Card, J.P. (2004). Numerous GABAergic afferents to locus 
ceruleus in the pericerulear dendritic zone: possible interneuronal pool. J. Neurosci. Off. J. Soc. 
Neurosci. 24, 2313–2321. 
Ballantyne, D., Andrzejewski, M., Mückenhoff, K., and Scheid, P. (2004). Rhythms, synchrony 
and electrical coupling in the Locus coeruleus. Respir. Physiol. Neurobiol. 143, 199–214. 
Bannister, K., Bee, L.A., and Dickenson, A.H. (2009). Preclinical and early clinical 
investigations related to monoaminergic pain modulation. Neurother. J. Am. Soc. Exp. 
Neurother. 6, 703–712. 
Berridge, C.W., and Waterhouse, B.D. (2003). The locus coeruleus-noradrenergic system: 
modulation of behavioral state and state-dependent cognitive processes. Brain Res. Brain Res. 
Rev. 42, 33–84. 
Berridge, C.W., Bolen, S.J., Manley, M.S., and Foote, S.L. (1996). Modulation of Forebrain 
Electroencephalographic Activity in Halothane-Anesthetized Rat via Actions of Noradrenergic 
#-Receptors within the Medial Septal Region. J. Neurosci. 16, 7010–7020. 
Bingham, B., McFadden, K., Zhang, X., Bhatnagar, S., Beck, S., and Valentino, R. (2011). Early 
adolescence as a critical window during which social stress distinctly alters behavior and brain 
norepinephrine activity. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 
36, 896–909. 
249 
Bloom, F.E. (1981). ACTIVITY OF NOREPINEPHRINE-CONTAINING NEURONS IN 
BEHAVING RATS ANTICIPATES THE SLEEP-WAKING CYCLE ’ LOCUS COERULEUS 
FLUCTUATIONS IN. 1, 876–886. 
Van Bockstaele, E.J., Chan, J., and Pickel, V.M. (1996). Input from central nucleus of the 
amygdala efferents to pericoerulear dendrites, some of which contain tyrosine hydroxylase 
immunoreactivity. J. Neurosci. Res. 45, 289–302. 
Van Bockstaele, E.J., Colago, E.E., and Valentino, R.J. (1998). Amygdaloid corticotropin-
releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional 
and cognitive limbs of the stress response. J. Neuroendocrinol. 10, 743–757. 
Bondi, C.O., Barrera, G., Lapiz, M.D.S., Bedard, T., Mahan, A., and Morilak, D.A. (2007). 
Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and 
modulation by chronic treatment with desipramine. Prog. Neuropsychopharmacol. Biol. 
Psychiatry 31, 482–495. 
Bouret, S., Duvel, A., Onat, S., and Sara, S.J. (2003). Phasic activation of locus ceruleus neurons 
by the central nucleus of the amygdala. J. Neurosci. Off. J. Soc. Neurosci. 23, 3491–3497. 
Bouret, S., Ravel, S., and Richmond, B.J. (2012). Complementary neural correlates of motivation 
in dopaminergic and noradrenergic neurons of monkeys. Front. Behav. Neurosci. 6, 40. 
Bruchas, M.R., Land, B.B., Lemos, J.C., and Chavkin, C. (2009). CRF1-R activation of the 
dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like 
behavior. PloS One 4, e8528. 
Brunner, S.M., Farzi, A., Locker, F., Holub, B.S., Drexel, M., Reichmann, F., Lang, A.A., Mayr, 
J.A., Vilches, J.J., Navarro, X., et al. (2014). GAL3 receptor KO mice exhibit an anxiety-like 
phenotype. Proc. Natl. Acad. Sci. U. S. A. 111, 7138–7143. 
Buffalari, D.M., and Grace, A.A. (2007). Noradrenergic modulation of basolateral amygdala 
neuronal activity: opposing influences of alpha-2 and beta receptor activation. J. Neurosci. Off. J. 
Soc. Neurosci. 27, 12358–12366. 
Butler, R.K., and Finn, D.P. (2009). Stress-induced analgesia. Prog. Neurobiol. 88, 184–202. 
Cai, H., Haubensak, W., Anthony, T.E., and Anderson, D.J. (2014). Central amygdala PKC-++ 
neurons mediate the influence of multiple anorexigenic signals. Nat. Neurosci. 17, 1240–1248. 
Carter, M.E., Yizhar, O., Chikahisa, S., Nguyen, H., Adamantidis, A., Nishino, S., Deisseroth, 
K., and de Lecea, L. (2010). Tuning arousal with optogenetic modulation of locus coeruleus 
neurons. Nat. Neurosci. 13, 1526–1533. 
250 
Carter, M.E., Brill, J., Bonnavion, P., Huguenard, J.R., Huerta, R., and de Lecea, L. (2012). 
Mechanism for Hypocretin-mediated sleep-to-wake transitions. Proc. Natl. Acad. Sci. U. S. A. 
109, E2635–E2644. 
Cassens, G., Kuruc, A., Roffman, M., Orsulak, P.J., and Schildkraut, J.J. (1981). Alterations in 
brain norepinephrine metabolism and behavior induced by environmental stimuli previously 
paired with inescapable shock. Behav. Brain Res. 2, 387–407. 
Chaudhury, D., Walsh, J.J., Friedman, A.K., Juarez, B., Ku, S.M., Koo, J.W., Ferguson, D., Tsai, 
H.-C., Pomeranz, L., Christoffel, D.J., et al. (2013). Rapid regulation of depression-related 
behaviours by control of midbrain dopamine neurons. Nature 493, 532–536. 
Chmielarz, P., Ku,mierczyk, J., Parlato, R., Schütz, G., Nalepa, I., and Kreiner, G. (2013). 
Inactivation of Glucocorticoid Receptor in Noradrenergic System Influences Anxiety- and 
Depressive-Like Behavior in Mice. PLoS ONE 8, e72632. 
Choleris, E., Thomas,  a W., Kavaliers, M., and Prato, F.S. (2001). A detailed ethological 
analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely 
low frequency pulsed magnetic field. Neurosci. Biobehav. Rev. 25, 235–260. 
Ciocchi, S., Herry, C., Grenier, F., Wolff, S.B.E., Letzkus, J.J., Vlachos, I., Ehrlich, I., Sprengel, 
R., Deisseroth, K., Stadler, M.B., et al. (2010). Encoding of conditioned fear in central amygdala 
inhibitory circuits. Nature 468, 277–282. 
Conte, W.L., Kamishina, H., and Reep, R.L. (2009). Multiple neuroanatomical tract-tracing 
using fluorescent Alexa Fluor conjugates of cholera toxin subunit B in rats. Nat. Protoc. 4, 1157–
1166. 
Courtney, N.A., and Ford, C.P. (2014). The timing of dopamine- and noradrenaline-mediated 
transmission reflects underlying differences in the extent of spillover and pooling. J. Neurosci. 
Off. J. Soc. Neurosci. 34, 7645–7656. 
Curtis,  a L., Lechner, S.M., Pavcovich, L. a, and Valentino, R.J. (1997). Activation of the locus 
coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: 
effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic 
activity. J. Pharmacol. Exp. Ther. 281, 163–172. 
Curtis,  a L., Bello, N.T., and Valentino, R.J. (2001). Evidence for functional release of 
endogenous opioids in the locus ceruleus during stress termination. J. Neurosci. Off. J. Soc. 
Neurosci. 21, RC152. 
Curtis, A.L., Leiser, S.C., Snyder, K., and Valentino, R.J. (2012). Predator stress engages 
corticotropin-releasing factor and opioid systems to alter the operating mode of locus coeruleus 
norepinephrine neurons. Neuropharmacology 62, 1737–1745. 
251 
Dimitrov, E.L., Yanagawa, Y., and Usdin, T.B. (2013). Forebrain GABAergic projections to 
locus coeruleus in mouse. J. Comp. Neurol. 521, 2373–2397. 
Dixit, M.P., Thakre, P.P., Pannase, A.S., Aglawe, M.M., Taksande, B.G., and Kotagale, N.R. 
(2014). Imidazoline binding sites mediates anticompulsive-like effect of agmatine in marble-
burying behavior in mice. Eur. J. Pharmacol. 732, 26–31. 
Dunn, A.J., Swiergiel, A.H., and Palamarchouk, V. (2004). Brain circuits involved in 
corticotropin-releasing factor-norepinephrine interactions during stress. Ann. N. Y. Acad. Sci. 
1018, 25–34. 
Felix-Ortiz, A.C., Beyeler, A., Seo, C., Leppla, C.A., Wildes, C.P., and Tye, K.M. (2013). BLA 
to vHPC inputs modulate anxiety-related behaviors. Neuron 79, 658–664. 
Fenno, L.E., Mattis, J., Ramakrishnan, C., Hyun, M., Lee, S.Y., He, M., Tucciarone, J., 
Selimbeyoglu, A., Berndt, A., Grosenick, L., et al. (2014). Targeting cells with single vectors 
using multiple-feature Boolean logic. Nat. Methods 11, 763–772. 
Foote, S.L., Aston-Jones, G., and Bloom, F.E. (1980). Impulse activity of locus coeruleus 
neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc. Natl. 
Acad. Sci. U. S. A. 77, 3033–3037. 
Ford, C.P., Phillips, P.E.M., and Williams, J.T. (2009). The time course of dopamine 
transmission in the ventral tegmental area. J. Neurosci. Off. J. Soc. Neurosci. 29, 13344–13352. 
Francis, D.D., Caldji, C., Champagne, F., Plotsky, P.M., and Meaney, M.J. (1999). The role of 
corticotropin-releasing factor–norepinephrine systems in mediating the effects of early 
experience on the development of behavioral and endocrine responses to stress. Biol. Psychiatry 
46, 1153–1166. 
Gafford, G.M., Guo, J.-D., Flandreau, E.I., Hazra, R., Rainnie, D.G., and Ressler, K.J. (2012). 
Cell-type specific deletion of GABA(A)"1 in corticotropin-releasing factor-containing neurons 
enhances anxiety and disrupts fear extinction. Proc. Natl. Acad. Sci. U. S. A. 109, 16330–16335. 
Gong, S., Zheng, C., Doughty, M.L., Losos, K., Didkovsky, N., Schambra, U.B., Nowak, N.J., 
Joyner, A., Leblanc, G., Hatten, M.E., et al. (2003). A gene expression atlas of the central 
nervous system based on bacterial artificial chromosomes. Nature 425, 917–925. 
Gong, S., Doughty, M., Harbaugh, C.R., Cummins, A., Hatten, M.E., Heintz, N., and Gerfen, 
C.R. (2007). Targeting Cre Recombinase to Specific Neuron Populations with Bacterial 
Artificial Chromosome Constructs. J. Neurosci. 27, 9817–9823. 
Gross, C., and Hen, R. (2004). The developmental origins of anxiety. Nat. Rev. Neurosci. 5, 
545–552. 
252 
Hanke, M.L., Powell, N.D., Stiner, L.M., Bailey, M.T., and Sheridan, J.F. (2012). Beta 
adrenergic blockade decreases the immunomodulatory effects of social disruption stress. Brain. 
Behav. Immun. 26, 1150–1159. 
Al-Hasani, R., McCall, J.G., Foshage, A.M., and Bruchas, M.R. (2013). Locus Coeruleus Kappa 
Opioid Receptors modulate Reinstatement of Cocaine Place Preference through a Noradrenergic 
Mechanism. Neuropsychopharmacology. 
Haubensak, W., Kunwar, P.S., Cai, H., Ciocchi, S., Wall, N.R., Ponnusamy, R., Biag, J., Dong, 
H.-W., Deisseroth, K., Callaway, E.M., et al. (2010). Genetic dissection of an amygdala 
microcircuit that gates conditioned fear. Nature 468, 270–276. 
Heinrichs, S.C., Menzaghi, F., Pich, E.M., Baldwin, H.A., Rassnick, S., Britton, K.T., and Koob, 
G.F. (1994). Anti-stress action of a corticotropin-releasing factor antagonist on behavioral 
reactivity to stressors of varying type and intensity. Neuropsychopharmacol. Off. Publ. Am. Coll. 
Neuropsychopharmacol. 11, 179–186. 
Heydendael, W., Sengupta, A., Beck, S., and Bhatnagar, S. (2014). Optogenetic examination 
identifies a context-specific role for orexins/hypocretins in anxiety-related behavior. Physiol. 
Behav. 130, 182–190. 
Hickey, L., Li, Y., Fyson, S.J., Watson, T.C., Perrins, R., Hewinson, J., Teschemacher, A.G., 
Furue, H., Lumb, B.M., and Pickering, A.E. (2014). Optoactivation of locus ceruleus neurons 
evokes bidirectional changes in thermal nociception in rats. J. Neurosci. Off. J. Soc. Neurosci. 
34, 4148–4160. 
Holets, V.R., Hökfelt, T., Rökaeus, Å., Terenius, L., and Goldstein, M. (1988). Locus coeruleus 
neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent 
projections to the spinal cord, cerebral cortex and hypothalamus. Neuroscience 24, 893–906. 
Jedema, H.P., and Grace, A.A. (2004). Corticotropin-releasing hormone directly activates 
noradrenergic neurons of the locus ceruleus recorded in vitro. J. Neurosci. Off. J. Soc. Neurosci. 
24, 9703–9713. 
Jennings, J.H., Sparta, D.R., Stamatakis, A.M., Ung, R.L., Pleil, K.E., Kash, T.L., and Stuber, 
G.D. (2013). Distinct extended amygdala circuits for divergent motivational states. Nature 496, 
224–228. 
Kheirbek, M.A., Drew, L.J., Burghardt, N.S., Costantini, D.O., Tannenholz, L., Ahmari, S.E., 
Zeng, H., Fenton, A.A., and Hen, R. (2013). Differential control of learning and anxiety along 
the dorsoventral axis of the dentate gyrus. Neuron 77, 955–968. 
253 
Kim, S.-Y., Adhikari, A., Lee, S.Y., Marshel, J.H., Kim, C.K., Mallory, C.S., Lo, M., Pak, S., 
Mattis, J., Lim, B.K., et al. (2013a). Diverging neural pathways assemble a behavioural state 
from separable features in anxiety. Nature 496, 219–223. 
Kim, T., McCall, J.G., Jung, Y.H., Huang, X., Siuda, E.R., Li, Y., Song, J., Song, Y.M., Pao, 
H.A., Kim, R.-H., et al. (2013b). Injectable, Cellular-Scale Optoelectronics with Applications for 
Wireless Optogenetics. Science 340, 211–216. 
Knoll, A.T., and Carlezon, W.A. (2010). Dynorphin, stress, and depression. Brain Res. 1314, 56–
73. 
Konturek, P.C., Brzozowski, T., and Konturek, S.J. (2011). Stress and the gut: pathophysiology, 
clinical consequences, diagnostic approach and treatment options. J. Physiol. Pharmacol. Off. J. 
Pol. Physiol. Soc. 62, 591–599. 
Koob, G.F. (1999). Corticotropin-releasing factor, norepinephrine, and stress. Biol. Psychiatry 
46, 1167–1180. 
Kravets, J.L., Reyes, B. a. S., Unterwald, E.M., and Van Bockstaele, E.J. (2015). Direct targeting 
of peptidergic amygdalar neurons by noradrenergic afferents: linking stress-integrative circuitry. 
Brain Struct. Funct. 220, 541–558. 
Kuteeva, E., Wardi, T., Lundström, L., Sollenberg, U., Langel, U., Hökfelt, T., and Ogren, S.O. 
(2008). Differential role of galanin receptors in the regulation of depression-like behavior and 
monoamine/stress-related genes at the cell body level. Neuropsychopharmacol. Off. Publ. Am. 
Coll. Neuropsychopharmacol. 33, 2573–2585. 
Lammel, S., Lim, B.K., Ran, C., Huang, K.W., Betley, M.J., Tye, K.M., Deisseroth, K., and 
Malenka, R.C. (2012). Input-specific control of reward and aversion in the ventral tegmental 
area. Nature 491, 212–217. 
Land, B.B., Bruchas, M.R., Lemos, J.C., Xu, M., Melief, E.J., and Chavkin, C. (2008). The 
dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J. 
Neurosci. Off. J. Soc. Neurosci. 28, 407–414. 
Land, B.B., Bruchas, M.R., Schattauer, S., Giardino, W.J., Aita, M., Messinger, D., Hnasko, 
T.S., Palmiter, R.D., and Chavkin, C. (2009). Activation of the kappa opioid receptor in the 
dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc. 
Natl. Acad. Sci. U. S. A. 106, 19168–19173. 
Larauche, M., Kiank, C., and Tache, Y. (2009). Corticotropin releasing factor signaling in colon 
and ileum: regulation by stress and pathophysiological implications. J. Physiol. Pharmacol. Off. 
J. Pol. Physiol. Soc. 60 Suppl 7, 33–46. 
254 
Lechner, S.M., Curtis,  a L., Brons, R., and Valentino, R.J. (1997). Locus coeruleus activation by 
colon distention: role of corticotropin-releasing factor and excitatory amino acids. Brain Res. 
756, 114–124. 
Lein, E.S., Hawrylycz, M.J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A.F., Boguski, 
M.S., Brockway, K.S., Byrnes, E.J., et al. (2007). Genome-wide atlas of gene expression in the 
adult mouse brain. Nature 445, 168–176. 
Li, H., Penzo, M.A., Taniguchi, H., Kopec, C.D., Huang, Z.J., and Li, B. (2013). Experience-
dependent modification of a central amygdala fear circuit. Nat. Neurosci. 16, 332–339. 
Madisen, L., Zwingman, T.A., Sunkin, S.M., Oh, S.W., Zariwala, H.A., Gu, H., Ng, L.L., 
Palmiter, R.D., Hawrylycz, M.J., Jones, A.R., et al. (2010). A robust and high-throughput Cre 
reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133–140. 
Mahler, S.V., Vazey, E.M., Beckley, J.T., Keistler, C.R., McGlinchey, E.M., Kaufling, J., 
Wilson, S.P., Deisseroth, K., Woodward, J.J., and Aston-Jones, G. (2014). Designer receptors 
show role for ventral pallidum input to ventral tegmental area in cocaine seeking. Nat. Neurosci. 
17, 577–585. 
Le Maître, E., Barde, S.S., Palkovits, M., Diaz-Heijtz, R., and Hökfelt, T.G.M. (2013). Distinct 
features of neurotransmitter systems in the human brain with focus on the galanin system in 
locus coeruleus and dorsal raphe. Proc. Natl. Acad. Sci. U. S. A. 110, E536–E545. 
Mantsch, J.R., Weyer, A., Vranjkovic, O., Beyer, C.E., Baker, D. a, and Caretta, H. (2010). 
Involvement of Noradrenergic Neurotransmission in the Stress- but not Cocaine-Induced 
Reinstatement of Extinguished Cocaine-Induced Conditioned Place Preference in Mice: Role for 
beta-2 Adrenergic Receptors. Neuropsychopharmacol. Off. Publ. Am. Coll. 
Neuropsychopharmacol. 35, 2165–2178. 
Melander, T., Hökfelt, T., and Rökaeus, A. (1986). Distribution of galaninlike immunoreactivity 
in the rat central nervous system. J. Comp. Neurol. 248, 475–517. 
Olson, V.G., Rockett, H.R., Reh, R.K., Redila, V.A., Tran, P.M., Venkov, H.A., DeFino, M.C., 
Hague, C., Peskind, E.R., Szot, P., et al. (2011). The Role of Norepinephrine in Differential 
Response to Stress in an Animal Model of Posttraumatic Stress Disorder. Biol. Psychiatry 70, 
441–448. 
Page, M.E., and Abercrombie, E.D. (1999). Discrete local application of corticotropin-releasing 
factor increases locus coeruleus discharge and extracellular norepinephrine in rat hippocampus. 
Synap. N. Y. N 33, 304–313. 
255 
Penzo, M.A., Robert, V., Tucciarone, J., De Bundel, D., Wang, M., Van Aelst, L., Darvas, M., 
Parada, L.F., Palmiter, R.D., He, M., et al. (2015). The paraventricular thalamus controls a 
central amygdala fear circuit. Nature advance online publication. 
Raskind, M.A., Peskind, E.R., Kanter, E.D., Petrie, E.C., Radant, A., Thompson, C.E., Dobie, 
D.J., Hoff, D., Rein, R.J., Straits-Tröster, K., et al. (2003). Reduction of nightmares and other 
PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am. J. Psychiatry 
160, 371–373. 
Raskind, M.A., Peskind, E.R., Hoff, D.J., Hart, K.L., Holmes, H.A., Warren, D., Shofer, J., 
O’Connell, J., Taylor, F., Gross, C., et al. (2007). A parallel group placebo controlled study of 
prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic 
stress disorder. Biol. Psychiatry 61, 928–934. 
Raskind, M.A., Peterson, K., Williams, T., Hoff, D.J., Hart, K., Holmes, H., Homas, D., Hill, J., 
Daniels, C., Calohan, J., et al. (2013). A Trial of Prazosin for Combat Trauma PTSD With 
Nightmares in Active-Duty Soldiers Returned From Iraq and Afghanistan. Am. J. Psychiatry 
170, 1003–1010. 
Rasmussen, K., Strecker, R.E., and Jacobs, B.L. (1986). Single unit response of noradrenergic, 
serotonergic and dopaminergic neurons in freely moving cats to simple sensory stimuli. Brain 
Res. 369, 336–340. 
Reyes, B. a S., Drolet, G., and Van Bockstaele, E.J. (2008). Dynorphin and stress-related 
peptides in rat locus coeruleus: contribution of amygdalar efferents. J. Comp. Neurol. 508, 663–
675. 
Reyes, B. a. S., Carvalho, A.F., Vakharia, K., and Van Bockstaele, E.J. (2011). Amygdalar 
peptidergic circuits regulating noradrenergic locus coeruleus neurons: linking limbic and arousal 
centers. Exp. Neurol. 230, 96–105. 
Risold, P.Y., and Swanson, L.W. (1997). Chemoarchitecture of the rat lateral septal nucleus. 
Brain Res. Brain Res. Rev. 24, 91–113. 
Samuels, E.R., and Szabadi, E. (2008). Functional Neuroanatomy of the Noradrenergic Locus 
Coeruleus: Its Roles in the Regulation of Arousal and Autonomic Function Part I: Principles of 
Functional Organisation. Curr. Neuropharmacol. 6, 235–253. 
Sandner, G., Oberling, P., Silveira, M.C., Di Scala, G., Rocha, B., Bagri, A., and Depoortere, R. 
(1993). What brain structures are active during emotions? Effects of brain stimulation elicited 
aversion on c-fos immunoreactivity and behavior. Behav. Brain Res. 58, 9–18. 
Sara, S.J. (2009). The locus coeruleus and noradrenergic modulation of cognition. Nat. Rev. 
Neurosci. 10, 211–223. 
256 
Sara, S.J., and Bouret, S. (2012). Orienting and reorienting: the locus coeruleus mediates 
cognition through arousal. Neuron 76, 130–141. 
Saunders, A., Johnson, C.A., and Sabatini, B.L. (2012). Novel recombinant adeno-associated 
viruses for Cre activated and inactivated transgene expression in neurons. Front. Neural Circuits 
6, 47. 
Schaefer, M.L., Wong, S.T., Wozniak, D.F., Muglia, L.M., Liauw, J.A., Zhuo, M., Nardi, A., 
Hartman, R.E., Vogt, S.K., Luedke, C.E., et al. (2000). Altered Stress-Induced Anxiety in 
Adenylyl Cyclase Type VIII-Deficient Mice. J. Neurosci. 20, 4809–4820. 
Shaham, Y., Highfield, D., Delfs, J., Leung, S., and Stewart, J. (2000). Clonidine blocks stress-
induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus 
noradrenergic neurons. Eur. J. Neurosci. 12, 292–302. 
Shepherd, J.K., Grewal, S.S., Fletcher, A., Bill, D.J., and Dourish, C.T. (1994). Behavioural and 
pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety. 
Psychopharmacology (Berl.) 116, 56–64. 
Sidor, M.M., Spencer, S.M., Dzirasa, K., Parekh, P.K., Tye, K.M., Warden, M.R., Arey, R.N., 
Enwright, J.F., Jacobsen, J.P.R., Kumar, S., et al. (2015). Daytime spikes in dopaminergic 
activity drive rapid mood-cycling in mice. Mol. Psychiatry 5. 
Sim, H.-R., Choi, T.-Y., Lee, H.J., Kang, E.Y., Yoon, S., Han, P.-L., Choi, S.-Y., and Baik, J.-H. 
(2013). Role of dopamine D2 receptors in plasticity of stress-induced addictive behaviours. Nat. 
Commun. 4, 1579. 
Snyder, K., Wang, W.-W., Han, R., McFadden, K., and Valentino, R.J. (2012). Corticotropin-
releasing factor in the norepinephrine nucleus, locus coeruleus, facilitates behavioral flexibility. 
Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 37, 520–530. 
Sparta, D.R., Stamatakis, A.M., Phillips, J.L., Hovelsø, N., van Zessen, R., and Stuber, G.D. 
(2011). Construction of implantable optical fibers for long-term optogenetic manipulation of 
neural circuits. Nat. Protoc. 7, 12–23. 
Stamatakis, A.M., and Stuber, G.D. (2012). Activation of lateral habenula inputs to the ventral 
midbrain promotes behavioral avoidance. Nat. Neurosci. 15, 1105–1107. 
Stamatakis, A.M., Jennings, J.H., Ung, R.L., Blair, G.A., Weinberg, R.J., Neve, R.L., Boyce, F., 
Mattis, J., Ramakrishnan, C., Deisseroth, K., et al. (2013). A unique population of ventral 
tegmental area neurons inhibits the lateral habenula to promote reward. Neuron 80, 1039–1053. 
Tan, K.R., Yvon, C., Turiault, M., Mirzabekov, J.J., Doehner, J., Labouèbe, G., Deisseroth, K., 
Tye, K.M., and Lüscher, C. (2012). GABA neurons of the VTA drive conditioned place 
aversion. Neuron 73, 1173–1183. 
257 
Taniguchi, H., He, M., Wu, P., Kim, S., Paik, R., Sugino, K., Kvitsiani, D., Kvitsani, D., Fu, Y., 
Lu, J., et al. (2011). A resource of Cre driver lines for genetic targeting of GABAergic neurons in 
cerebral cortex. Neuron 71, 995–1013. 
Tervo, D.G.R., Proskurin, M., Manakov, M., Kabra, M., Vollmer, A., Branson, K., and Karpova, 
A.Y. (2014). Behavioral Variability through Stochastic Choice and Its Gating by Anterior 
Cingulate Cortex. Cell 159, 21–32. 
Tsai, H.-C., Zhang, F., Adamantidis, A., Stuber, G.D., Bonci, A., de Lecea, L., and Deisseroth, 
K. (2009). Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. 
Science 324, 1080–1084. 
Tye, K.M., Prakash, R., Kim, S.-Y., Fenno, L.E., Grosenick, L., Zarabi, H., Thompson, K.R., 
Gradinaru, V., Ramakrishnan, C., and Deisseroth, K. (2011). Amygdala circuitry mediating 
reversible and bidirectional control of anxiety. Nature 471, 358–362. 
Tye, K.M., Mirzabekov, J.J., Warden, M.R., Ferenczi, E.A., Tsai, H.-C., Finkelstein, J., Kim, S.-
Y., Adhikari, A., Thompson, K.R., Andalman, A.S., et al. (2013). Dopamine neurons modulate 
neural encoding and expression of depression-related behaviour. Nature 493, 537–541. 
Ungless, M.A., Argilli, E., and Bonci, A. (2010). Effects of stress and aversion on dopamine 
neurons: implications for addiction. Neurosci. Biobehav. Rev. 35, 151–156. 
Valentino, R.J., and Van Bockstaele, E. (2008). Convergent regulation of locus coeruleus 
activity as an adaptive response to stress. Eur. J. Pharmacol. 583, 194–203. 
Valentino, R.J., and Foote, S.L. (1988). Corticotropin-releasing hormone increases tonic but not 
sensory-evoked activity of noradrenergic locus coeruleus neurons in unanesthetized rats. J. 
Neurosci. Off. J. Soc. Neurosci. 8, 1016–1025. 
Valentino, R.J., Page, M.E., and Curtis,  a L. (1991). Activation of noradrenergic locus coeruleus 
neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain 
Res. 555, 25–34. 
Valentino, R.J., Page, M., Van Bockstaele, E., and Aston-Jones, G. (1992). Corticotropin-
releasing factor innervation of the locus coeruleus region: distribution of fibers and sources of 
input. Neuroscience 48, 689–705. 
Vazey, E.M., and Aston-Jones, G. (2014). Designer receptor manipulations reveal a role of the 
locus coeruleus noradrenergic system in isoflurane general anesthesia. Proc. Natl. Acad. Sci. 
111, 3859–3864. 
Veinante, P., and Freund-Mercier, M.-J. (1998). Intrinsic and extrinsic connections of the rat 
central extended amygdala: an in vivo electrophysiological study of the central amygdaloid 
nucleus. Brain Res. 794, 188–198. 
258 
Witten, I.B., Steinberg, E.E., Lee, S.Y., Davidson, T.J., Zalocusky, K.A., Brodsky, M., Yizhar, 
O., Cho, S.L., Gong, S., Ramakrishnan, C., et al. (2011). Recombinase-driver rat lines: tools, 
techniques, and optogenetic application to dopamine-mediated reinforcement. Neuron 72, 721–
733. 
Wohleb, E.S., Hanke, M.L., Corona, A.W., Powell, N.D., Stiner, L.M., Bailey, M.T., Nelson, 
R.J., Godbout, J.P., and Sheridan, J.F. (2011). #-Adrenergic receptor antagonism prevents 
anxiety-like behavior and microglial reactivity induced by repeated social defeat. J. Neurosci. 
Off. J. Soc. Neurosci. 31, 6277–6288. 
Wu, Z., Autry, A.E., Bergan, J.F., Watabe-Uchida, M., and Dulac, C.G. (2014). Galanin neurons 
in the medial preoptic area govern parental behaviour. Nature 509, 325–330. 
  
259 
 
Chapter 6 
 
 
 
 
 
 
 
Determining the downstream receptor and projection 
targets that mediate locus coeruleus-induced negative 
affective behaviors 
 
 
 
This chapter contains components of a manuscript currently in preparation: 
J.G. McCall*, E.R. Siuda*, Z.A. McElligot, S.L. Anderson, G.D. Stuber, M.R. Bruchas. 
Activation of locus coeruleus projections to the basolateral amygdala induce anxiety and 
condition aversion (in preparation). 
 
 
Author contributions for the above citation: 
*co-first author J.G.M, E.R.S., and M.R.B. designed all of the experiments and wrote the 
paper. J.G.M. performed all of the experiments except for the fast scan cyclic voltammetry 
(FSCV). E.R.S. and S.L.A. performed the immunohistochemistry. J.G.M and E.R.S. performed 
the in vivo electrophysiology experiments together and E.R.S analyzed the in vivo 
electrophysiology data. E.R.S. analyzed the behavior for Figures 6.6 & 6.7. Z.A. McElligot 
performed and analyzed the FSCV. G.D.S. supervised the FSCV. M.R.B. oversaw all of the 
work and helped write the paper. A similar, though distinct, chapter is contained in the 
dissertation of E.R.S. E.R.S. made the layouts for Figures 6.2-6.7. 
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SUMMARY 
 
 Increased tonic activity of locus coeruleus noradrenergic (LC-NE) neurons induces 
anxiety-like and aversive behavior. While some information is known about the afferent circuitry 
that endogenously drives this neural activity and behavior, the downstream receptors and 
anatomical projection targets that mediate these behaviors remain unresolved. Here we use a 
combination of in vivo optogenetics, behavioral pharmacology, single-unit electrophysiology and 
fast scan cyclic voltammetry to determine the neural substrates downstream of LC-NE activity.  
We show that !-adrenergic receptors mediate the anxiety-like phenotype of increased tonic LC-
NE activity, while "1-adrenergic receptors mediate the real-time place aversion. Additionally, 
we demonstrate that norepinephrine release in the basolateral amygdala (BLA) alters BLA 
activity and increases anxiety-like and conditioned aversive behaviors, but not real-time place 
preference. These studies begin to illustrate how the complex efferent system of the LC-NE 
system selectively mediates different behaviors through distinct receptor and projection-selective 
mechanisms. 
INTRODUCTION 
 After determining that increased tonic activity of LC-NE neurons drives negative 
affective behaviors in Chapter 5, we next sought to determine the downstream components of 
this system towards driving anxiety. Though Chapter 5 investigated the circuitry upstream of 
the LC, we were careful to make our conclusions based on LC-NE cell activity rather than on 
downstream effectors (e.g. receptors, anatomical targets). With at least nine different adrenergic 
receptors and three different galanin receptors, that have nearly all been indicated in anxiety-like 
behaviors (Brunner et al., 2014; Dixit et al., 2014; Hanke et al., 2012; Kuteeva et al., 2008; Le 
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Maître et al., 2013; Mantsch et al., 2010; Raskind et al., 2007; Wohleb et al., 2011) and a 
widespread projection network through the brain and spinal cord (Berridge and Waterhouse, 
2003; Sara, 2009), the downstream targets for these behaviors could quickly become 
complicated. The LC sends dense neuronal projections to the amygdala and extended amygdala, 
which are thought to be responsible for the widely known role of norepinephrine (NE) in 
affective behaviors (Berridge and Waterhouse, 2003; Davis, 1992; Valentino and Aston-Jones, 
2010). In particular, noradrenergic cell firing in the LC has been shown to increase in the context 
of stressful stimuli (Abercrombie and Jacobs, 1987a, 1987b; Aston-Jones et al., 1999; Mana and 
Grace, 1997). While the anatomical projections from the LC and their cell types have been 
studied for several years, the precise mechanisms by which the LC generates its influence over 
basolateral amygdala (BLA) function remain undefined. In particular, how the LC-BLA 
projection integrates affective behavioral responses via specific receptor systems and cell activity 
is unknown. 
 To determine what downstream receptor systems might be involved in the anxiety-like 
and aversive behavior induced by high tonic LC-NE activity, we replicated experiments from 
Chapter 5 (Figure 5.4 and 5.6) with systemic antagonism of either !-adrenergic receptors or 
"1-adrenergic receptors. These pilot experiments unexpectedly reveal that the observed anxiety-
like and real-time aversion behaviors are mediated through different receptor systems. To 
determine the role of noradrenergic influence on BLA function and negative affective behavior 
we utilized optogenetic control of LC-NE inputs into the BLA. Here we directly tested whether 
NE release from LC terminals into the BLA can drive anxiety-like and aversive behavioral 
responses. We demonstrate that photostimulation of LC projections to the amygdala releases NE 
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to cause localized excitability. This increased noradrenergic tone is sufficient to produce anxiety-
like and conditioned aversive behaviors. 
RESULTS 
The anxiety-like component of increased LC-NE tonic neuronal firing is mediated through 
!-adrenergic receptor activation 
 Using the same optogenetic strategy described in Chapter 5 (Figure 5.4), we tested 
whether systemic antagonism could block the anxiogenic behavioral response induced by 
selectively increasing LC-NE tonic firing. 30 minutes prior to behavioral testing, we pre-treated 
animals with either the non-selective !-adrenergic receptor antagonist Propranolol HCl (10 
mg/kg, i.p., Tocris) (Al-Hasani et al., 2013), the "1-adrenergic antagonist Prazosin HCl (1 
mg/kg, Sigma) (Bortolozzi and Artigas, 2003), or a vehicle control. We next photostimulated (5 
Hz, 10 ms pulse width, 473 nm) LC-NE neurons during access to elevated zero maze (EZM) 
(Choleris et al., 2001; Shepherd et al., 1994) (Figure 6.1A & B). As we saw in Chapter 5, 5 Hz 
photostimulation in the EZM induced anxiety-like behavior in Th-Cre+ animals expressing ChR2 
in the LC compared to Th-Cre- control animals that do not express ChR2 (Figure 6.1C). Th-Cre+ 
animals that were pre-treated with Propranolol were not significantly different from controls, 
indicating that !-adrenergic antagonism blocked the effect of LC-NE photostimulation (Figure 
6.1C). Importantly, this was not the case in the animals treated with Prazosin (Figure 6.1C). The 
blockade of "1-adrenergic receptors trended towards a more anxiogenic baseline state in the 
controls and a potentiation of the photostimulation-induced effect in the Cre+ animals, but this 
trend was not significant. These experiments demonstrate that the anxiogenic state that is driven 
by increasing tonic firing of LC-NE neurons is meditated by !-adrenergic receptor activation. 
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Figure 6.1 The anxiety-like and real-time place aversion behaviors induced by high tonic 
LC-NE activity are mediated by separate receptor systems.  (A) Cartoon of viral and fiber 
optic delivery strategy. (B) Calendar of behavioral studies. (C) 5 Hz photostimulation causes an 
anxiety-like phenotype in EZM of Th-Cre+ animals expressing ChR2 in the LC compared to Th-
Cre- control animals that do not express ChR2. This effect is reversed by Propranolol pre-
treatment, but not by Prazosin (Data represented as mean ± SEM, n=6-11/group; One-Way 
ANOVA, Bonferonni post-hoc, **p<0.01, *p<0.05, ns=no significance). (D) 5 Hz 
photostimulation causes a real-time place aversion in RTPT of Th-Cre+ animals expressing ChR2 
in the LC compared to Th-Cre- control animals that do not express ChR2. This effect is not 
reversed by Propranolol pre-treatment, but is by Prazosin (Data represented as mean ± SEM, 
n=6-10/group; One-Way ANOVA, Bonferonni post-hoc, ****p<0.0001, **p<0.01, ns=no 
significance). 
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The negative valence elicited by high tonic LC-NE activity is mediated by "1-adrenergic 
receptors 
 We next sought to determine whether this same systemic antagonism of !-adrenergic 
receptors could prevent the acute negative behavioral valence seen in the real-time place testing 
(RTPT) assay from Chapter 5 (Figure 5.6). This assay assesses native behavioral preference to 
photostimulation (see Chapters 4 & 5) (Jennings et al., 2013; Kim et al., 2013a; Stamatakis and 
Stuber, 2012; Stamatakis et al., 2013; Tan et al., 2012). We previously demonstrated that 5 Hz 
photostimiluation of LC-NE neurons in this assay causes an aversion from the chamber paired 
with photostimulation (Figure 5.6). Similarly, when we replicated this experiment with vehicle 
controls, we see the same behavioral phenotype as before – Th-Cre+, ChR2-expressing animals 
have an aversion from the photostimulation-paired chamber compared to controls (Figure 6.1D). 
Surprisingly pre-treatment with Propranolol did not block this effect (Figure 6.1D). Even more 
unexpected, however, we found that pre-treatment with Prazosin did block the real-time place 
aversion (Figure 6.1D). These data suggest that the negative affective behaviors elicited by 
elevating LC tonic activity are separable behavior phenomenon. At the least the anxiety-like and 
real-time aversive components of these behaviors are mediate by different downstream receptor 
systems (anxiety-like behavior through !-adrenergic receptors and real-time aversion through 
"1-adrenergic receptors). Whether there is also a circuit-based mechanism for this segregation 
remains to be seen. 
Optogenetic targeting of LC- NE neurons and their inputs to the BLA 
 After gaining some insight into the receptors through which increased tonic LC-NE 
activity induces behavioral responses, we next sought to test whether these same behaviors can 
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be generated by releasing NE at localized LC projection in the BLA. Using the same Th-Cre 
mice as above to genetically isolate LC-NE neurons, we injected Cre-dependent virus expressing 
channelrhodopsin-2 (AAV5-EF1"-DIO-ChR2-eYFP) into the LC and allowed six weeks for 
ChR2 expression to reach terminals within the BLA (LC-BLATh-Cre; Figures 6.2 A-D and 6.3 
A,B). 
 
 
Figure 6.2 Expression of AAV5-EF1"-DIO-ChR2-eYFP in Th-Cre+ mice. (A) Cartoon of 
viral injection and fiber optic implantation. (B) ChR2-eYFP (yellow), Nissl (blue), and tyrosine 
hydroxylase (TH; red) (inset, TH (red), scale bar = 25 µm) expression in LC (scale bar = 50 µm). 
(C) ChR2-eYFP (yellow) and Nissl (blue) in locus coeruleus (scale bar = 100 µm). (D) LC 
terminals expressing ChR2-eYFP (yellow) amongst BLA neurons (Nissl (blue)) (scale bar = 20 
µm). 
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Figure 2.1. Expression of AAV5-EF1!-DIO-ChR2-eYFP in tyrosine hydroxylase 
(TH)-Cre+ mice. (A) Viral injection and fiber optic. (B) ChR2-eYFP and TH (inset, TH, 
scale bar = 25 !m) expression in LC (scale bar = 50 !m). (C) ChR2-eYFP in locus 
coeruleus (scale bar = 100 !m).  (D) LC terminals expressing ChR2-eYFP in BLA (scale 
bar = 20 !m).  
 
DIO-ChR2-eYFP) into the LC and allowed 6-7 weeks for ChR2 expression to reach 
terminals within the BLA (LC-BLATHcre; Figures 2.1 A-D and 2.2 A,B).   
 To determine if photostimulation of LC-BLATHcre projections resulted in NE 
release at terminals, we first performed fast-scan cyclic voltammetry (FSCV) in acute 
brain slices of LC-BLATHcre animals. A carbon fiber microelectrode was positioned in the 
amygdala and slices were stimulated with a 473 nm LED for 30x, 5-ms pulses at 10 Hz 
(Figure 2.3 A). Oxidative and reductive currents were observed following 
photostimulation displaying characteristic catecholamine cyclic voltammograms and 
uptake similar to NE (t1/2 = 2.0 ± 0.2 s, Figure 2.3 B). Following 20 minutes of consistent 
baseline NE oxidative current, 1 !M reserpine (an inhibitor of vesicular monoamine 
transporters) was perfused on the slices to deplete catecholamine from the terminals 
projecting from the LC (Dahlström et al., 1965). Reserpine treatment significantly 
depleted evoked terminal NE (31.6 +\- 1.0 % of baseline, Figures 2.3 C,D) confirming 
optically-evoked NE release in this isolated LC-BLATHcre projection. To further validate  
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Figure 6.3 Viral expression and fiber optic hit maps in the LC and BLA, respectively, of 
Th-Cre+ mice (a) Unilateral ferrule implant placement for AAV5-EF1"-DIO-ChR2-eYFP 
(black) and AAV5-EF1"-DIO-eYFP (grey) in BLA for 6 individual animals each. (b) Unilateral 
viral expression of AAV5-EF1"-DIO-ChR2-eYFP (blue) and AAV5-EF1"-DIO-eYFP (green) 
in locus coeruleus for 6 individual animals each. Numbers indicate individual animals and viral 
label was generally present throughout the intended target. 
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Figure 2.2. Expression of AAV5-EF1!-DIO-ChR2-eYFP in tyrosine hydroxylase 
(TH)-Cre+ mice. (a) Unilateral ferrule implant placement for AAV5-EF1!-ChR2-eYFP 
(black) and AAV5-eYFP (grey) in BLA for 6 individual animals each. (b) Unilat ral viral 
expression of AAV5-EF1!-ChR2-eYFP (blue) and AAV5-eYFP (green) in locus 
coeruleus for 6 individual animals each. Numbers indicate individual animals and viral 
label was generally present throughout the intended target. 
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Photostimulation of LC-BLA terminals releases NE 
 In Chapter 5, we demonstrated optogenetic control of LC-NE neurons (Figure 5.3). 
However, these studies did not examine where the observed spiking activity caused release of 
neurotransmitters, particularly NE. To test whether photostimulation of LC-BLATh-Cre projections 
resulted in NE release at terminals, we collaborated with the Stuber lab at the University of 
North Carolina (UNC). After injecting LC-BLATh-Cre mice with AAV5-EF1"-DIO-ChR2-eYFP, 
we sent the animals to UNC for Zoe McElligot to acutely slice for fast-scan cyclic voltammetry 
(FSCV). A carbon fiber microelectrode was positioned in the amygdala and slices were 
stimulated with a 473 nm LED for 30x, 5-ms pulses at 10 Hz (Figure 6.4A). Oxidative and 
reductive currents were observed following photostimulation displaying characteristic 
catecholamine cyclic voltammograms and uptake similar to NE (t1/2 = 2.0 ± 0.2 s, Figure 6.4B). 
Following 20 minutes of consistent baseline NE oxidative current, 1 µM reserpine (an inhibitor 
of vesicular monoamine transporters) was perfused on the slices to deplete catecholamine from 
the terminals projecting from the LC (Dahlström et al., 1965). Reserpine treatment significantly 
depleted evoked terminal NE (31.6 +\- 1.0 % of baseline, Figures 6.4C & D) confirming 
optically-evoked NE release in this isolated LC-BLATh-Cre projection. This study demonstrates 
that long-range BLA projections from the LC can be photostimulated to induce NE release. 
Photostimulation of LC-BLA terminals modulates 
 BLA neurons have well reported responses to exogenous application of NE (Buffalari and 
Grace, 2007). We next sought to determine if the optically-evoked endogenous NE release would 
mimic the responses of BLA neurons to exogenous NE. To do so, we examined BLA single-unit 
activity in LC-BLATh-Cre mice using 16-channel microelectrode arrays coupled to a fiber optic 
implant (optrode arrays) (Sparta et al., 2011). These optrode arrays were used to isolate and  
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Figure 6.4 Photostimulation of locus coeruleus terminals in the BLA releases 
norepinephrine. (A) Fast scan cyclic voltammetry schematic. (B-C) Oxidative and reductive 
currents (with representative voltammograms below) in response to photostimulation are 
attenuated by reserpine (1 µM). (D) Attenuation in NE oxidative current in response to reserpine 
(1 µM; **p < 0.01; paired Student’s t-tests to baseline; n = 3 pairs; mean ± S.E.M).  
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Figure 2.3. Photostimulation of locus coeruleus terminals in the BLA releases 
norepinephrine. (A) Fast scan cyclic voltammetry schematic. (B-D) Oxidative and 
reductive currents (with representative voltammograms) in response to photostimulation 
are attenuated by reserpine (1 !M). (H) Attenuation in NE oxidative current in respon e 
to reserpine (1 !M; **p < 0.01; paired Student’s t-tests to baseline; n = 3 pairs; mean ± 
S.E.M). CONTRIBUTION: Data collected and analyzed by Zoe A. McElligott, PhD 
(UNC Chapel Hill). 
 
local BLA ChR2 activation, and downstream modulation of the BLA in LC-BLATHcre mice 
in vivo, we used 16-channel microelectrode arrays coupled to a fiber optic implant 
(optrode arrays) (Sparta et al., 2012) to isolate and record BLA single-unit activity 
resulting from photostimulation of LC-BLATHcre projections (473 nm, 5 Hz, 10 ms pulse 
width) (Figure 2.3A).   
 In these experiments photostimulation of LC-BLATHcre terminals caused a 
significant increase in firing frequency in 58% of units recorded in the BLA, while some  
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Figure 2.4. Photostimulation of LC terminals in the BLA alters neuronal 
excitability. (A) Schematic illustrating single unit extracellular recording paradigm of 
BLA neurons presynaptically activated by ChR2 expressing locus coeruleus terminals. 
(B) Distribution of differential firing rates present in photostimulated BLA neurons. (C) 
Photostimulation (5 Hz) of LC terminals in the BLA shows neurons that either increase 
(excitatory; blue; n = 12; **p < 0.01, paired Student’s t-test), decrease (inhibitory; grey; n 
= 5; *p < 0.05, paired Student’s t-test), or show no change (black; n = 3) in firing rate. 
Representative histograms (1 sec bin) of isolated single units showing increase (D), 
decrease (E), or no change (F), in neuronal firing in response to photostimulation (473 
nm, 5 Hz, 3 min). (G) Representative histogram (1 sec bin) of isolated single-unit shows 
an increase in neuronal firing in response to constant photostimulation (473, constant 
light, 20 sec, 5 mW). (H) Neuronal firing rate increases in response to 20 sec (473 nm, 
constant light) photostimulation and returns to baseline values in the absence of light (** 
p < 0.01, ***p < 0.001, One-Way Repeated Measures ANOVA followed by Bonferroni 
post hoc comparison test). 
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Figure 6.5. Photostimulation of LC terminals in the BLA alters neuronal excitability. (A) 
Schematic illustrating single-unit extracellular recording paradigm of BLA neurons 
presynaptically modulated by ChR2-expressing LC-BLA terminals. (B) Distribution of 
differential firing rates present in BLA neurons following LC-BLA terminal photostimlation. (C) 
Photostimulation (5 Hz) of LC terminals in the BLA shows neurons that either increase 
(excitatory; blue; n = 12; **p < 0.01, paired Student’s t-test), decrease (inhibitory; grey; n = 5; 
*p < 0.05, paired Student’s t-test), or show no change (black; n = 3) in firing rate. Representative 
histograms (1 sec bin) of isolated single-units showing increase (D), decrease (E), or no change 
(F), in neuronal firing in response to photostimulation (473 nm, 5 Hz, 3 min). (G) Representative 
histogram (1 sec bin) of isolated single-unit shows an increase in neuronal firing in response to 
constant photostimulation (473, constant light, 20 sec, 5 mW). (H) Neuronal firing rate increases 
in response to 20 sec (473 nm, constant light) photostimulation and returns to baseline values in 
the absence of light (** p < 0.01, ***p < 0.001, One-Way Repeated Measures ANOVA followed 
by Bonferroni post hoc comparison test). 
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record BLA single-unit activity before, during, and after photostimulation of LC-BLATh-Cre 
projections (473 nm, 5 Hz, 10 ms pulse width) (Figure 6.5A). In these experiments 
photostimulation of LC-BLATh-Cre terminals caused a significant increase in firing frequency in 
58% of units recorded in the BLA, while some cells showed inhibitory responses (26%), and 
some showed no response (16%) (Figures 6.5B-F). Responses are also shown from isolated 
units receiving constant light stimulation (Figures 6.5G,H). Together, these heterogeneous firing 
properties are consistent with previous studies using iontophoresis of norepinephrine to the 
region, and further highlight the complex pharmacological activity of NE in this structure 
(Buffalari and Grace, 2007; Ferry et al., 1997; Huang et al., 1996). These results demonstrate 
that photostimulation of LC terminals in the BLA causes varied responses in BLA firing rate, 
with a majority of observed units increasing in response the terminal photostimulation.  
Optogenetic targeting of LC-NE projections to the BLA promotes anxiety-like behavior 
 After identifying the LC terminals to the BLA as a projecting source of NE, which is 
capable of increasing BLA activity, we next sought to test whether stimulation of these terminals 
would drive similar behavioral profiles to direct LC-NE stimulation. Fiber optics were implanted 
at LC-NE terminal sites in the BLA of LC-BLATh-Cre mice (Figures 6.6A and 6.3A & B). 
Photostimulation of LC-BLATh-Cre terminals using the parameters that induce anxiety-like 
behavior at LC-NE cell bodies in Chapter 5 (5 Hz) resulted in a significant decrease in time 
spent in the open area of the elevated zero maze (EZM) (Figures 6.6B & C) with no significant 
change in general locomotor activity (Figures 6.6D-F). This experiment shows stimulation of a 
subset of LC-NE fibers, only those projecting to the BLA, is sufficient to induce anxiety-like 
behavior. 
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Figure 6.6. Photostimulation of LC terminals in the BLA induces anxiety-like behavior. (A) 
Viral injection and fiber optic implants in LC-BLATh-Cre mice. (B) Colorized heat maps of 
elevated zero maze activity (EZM) of control and ChR2 animals. (C) Cumulative open arm time 
course of photostimulated ChR2 (blue, n = 8) and control animals (black; n = 7) (5 Hz, 10 ms 
pulses; * p < 0.05, ** p < 0.01, via multiple Student’s t-tests; mean ± SEM). Control (black; n = 
6) and ChR2 (blue; n = 8) expressing animals: travel similar distances (D), have similar 
velocities (E), and make similar number of entries (F) into open arms of EZM. 
  
 
 
21 
 
Figure 2.5. Photostimulation of LC terminals in the BLA induces anxiety-like 
behavior. (A) Viral injection and fiber optic implants in tyrosine hydroxylase (TH)-Cre+ 
mice. (B) Colorized heat maps of elevated zero maze activity (EZM) of control and 
ChR2 animals. (C) Cumulative open arm time course of photostimulated ChR2 (blue, n 
= 8) and control animals (black; n = 7) (5 Hz, 10 ms pulses; * p < 0.05, ** p < 0.01, via 
multiple Student’s t-tests; mean ± SEM). Control (black; n = 6) and ChR2 (blue; n = 8) 
expressing animals: travel similar distances (D), have similar velocities (E), and make 
similar number of entries (F) into open arms of EZM. CONTRIBUTION: Data collected 
and analyzed by Jordan McCall. 
 
 Furthermore, photoactivation of LC-BLATHcre terminals (5 Hz, 10 ms) caused 
significant conditioned place aversion (CPA, -165 ± 45 s) to the chamber paired with 
photostimulation in ChR2-eYFP expressing LC-BLATHcre mice following two days of 
conditioning (Figures 2.6 A-C), but not in control mice and without altering locomotor 
activity (Figure 2.6 D). However, real-time place aversion (RTPA) to photostimulation of 
LC-BLATHcre terminals, was not aversive at either 5 Hz (Figures 2.6 E,F) or 60 Hz 
273 
LC-BLATh-Cre terminal stimulation is sufficient to condition place aversion, but does not 
drive a real-time place aversion 
 Following the observation that stimulation of LC-BLA fibers alone is capable of driving 
anxiety-like behaviors, we next tested whether this same stimulation produces a learned change 
in behavior. Similarly to Chapter 5, (Figure 5.6) we employed a Pavlovian conditioned place 
aversion (CPA) assay (Bruchas et al., 2009; Al-Hasani et al., 2013; Land et al., 2008, 2009). 
When allowed to freely explore both chambers following two conditioning days of 
photostimulation of LC-BLATh-Cre terminals (5 Hz, 10 ms), the animals expressing ChR2-eYFP 
spent significantly less time in the chamber that was paired with photostimulation compared to 
eYFP-expressing controls (Figure 6.7A-C). Neither group of mice had significant changes in 
locomotor activity before, during, or after conditioning (Figure 6.7D). These results suggest that 
the negative affect produced by LC-BLATh-Cre photostimulation is capable of being learned and 
biasing behavior away from contexts in which the experience took place. This finding is also 
consistent with prior work showing a role for noradrenergic influence in fear-related memory 
formation (Debiec and Ledoux, 2004). 
 These experiments, however, do not assess whether or not the stimulation itself has a 
negative valence. Surprisingly, when LC-BLATh-Cre animals are tested in the RTPT paradigm 
there was no aversion at either 5 Hz (Figures 6.7E & F) or 60 Hz photostimulation (Figures 
6.7G & H). This finding is particularly interesting in light of the systemic pharmacology 
experiments (Figure 6.1) and suggests that perhaps the negative valence of LC-NE stimulation is 
produced via another circuit. It is also possible that the neuromodulatory effects on this circuit 
potentially require a learning component compared to acute activation of similar 
neurotransmitter pathways (GABA/Glutamate) (Haubensak et al., 2010; Kim et al., 2013a).  
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Figure 6.7. Photostimulation of LC terminals in the BLA induces aversive behavior. (A) 
Conditioned place aversion (CPA) behavioral diary. (B) Representative CPA traces. (C) ChR2 
(blue; n = 9) show an aversive response to chamber paired with photostimulation compared to 
controls (black; n = 8) (*p < 0.05; unpaired t-test) following two days of conditioning with (D) 
no differences in locomotor behavior during conditioning day 1 (CD1) and or conditioning day 2 
(CD2) in CPA. (E) ChR2 (blue; n = 9) and viral control mice (black; n = 9) do not show real-
time place aversion to a photostimulation (5 Hz) paired chamber and (F) do not show any 
difference in distance traveled during real time place aversion. (G) ChR2 (blue; n = 5) and viral 
control mice (black; n = 4) do not show real time place aversion to a photostimulation (60 Hz) 
paired chamber. (H) ChR2 (blue; n =5) travel less distance than viral control mice (black; n = 4) 
in real-time place aversion with 60 Hz photostimulation. 
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Figure 2.6. Photostimulation of LC terminals in the BLA induces aversive 
ehavior. (A) Conditioned place aversion (CPA) b havioral diary. (B) Representative 
CPA traces. (F) ChR2 (blue; n = 9) show an aversive response to chamber paired with 
phot timulation compared to controls (black; n = 8) (*p < 0.05; unpaired -test  
following two days of conditioning with no differences in locomotor behavior during 
c nditioning day 1 (CD1) and or conditioni g day 2 (CD2) in CPA (D). (E) ChR2 (blue; n 
= 9) and viral control mice (black; n = 9) do not show real-time place aversion to a 
photostimulation (5 Hz) pair d chamber and (F) d  not show any difference in distance 
traveled during real time place aversion. (G) ChR2 (blue; n = 5) and viral control mice 
(black; n = 4) do ot show real time place aversion to a photostimulation (60 Hz) paired 
chamber. (H) ChR2 (blue; n =5) travel less distance than viral control mice (black; n = 4) 
in real-time pl c av rsion with 60 Hz photostimulation. CONTRIBUTION: Data 
collected and analyzed by Jordan McCall. 
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 Taken together these data suggest that LC-BLA projections release NE into the BLA, 
which can cause increased neuronal excitability and facilitate condition aversive and anxiety-like 
behavioral responses. It is possible that the neuronal activity responses and behavior are 
mediated by !-adrernergic receptors and unlikely to be mediated by "1-adrenergic receptors. 
These data provide a critical framework for understanding the downstream influence of the LC-
NE system in the BLA as it relates to anxiety-like and aversive behavioral states. 
DISCUSSION 
 Though LC-NE neurons contain numerous co-transmitters (Berridge and Waterhouse, 
2003), NE is considered the primary effector released from these neurons. Here we show that NE 
activates multiple receptors for the generation of unique negative affective behaviors. The 
observation that these behaviors segregate by receptor system foreshadows an elegant, but 
complicated future in dissecting the role of the LC-NE system in behavior. 
 The BLA is an important component in the neural circuitry of negative affective behavior 
(Davidson, 2002; Davis, 1992). Activation of BLA cell bodies and their projections to the ventral 
hippocampus mediate anxiety-like behavior (Felix-Ortiz et al., 2013; Tye et al., 2011). The BLA 
receives noradrenergic input from the LC (Asan, 1998; Fallon et al., 1978) and NE increases in 
the BLA following stress events (Galvez et al., 1996; Hatfield et al., 1999). Here we use FSCV 
to show that Th+ positive neurons from the LC release NE in the amygdala. Previous studies 
have demonstrated that noradrenergic cell firing in the LC increases tonic drive (5-8Hz) 
following stressful stimuli (see Chapter 5) (Abercrombie and Jacobs, 1987a, 1987b; Aston-
Jones et al., 1999; Mana and Grace, 1997). We also demonstrate that selective activation of 
terminals from these neurons (5Hz) increases the excitatory drive of BLA neurons in vivo. 
Additionally, we show that stimulation of LC terminals in the BLA causes robust increases in 
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anxiety-like and conditioned aversive behavior suggesting a strong role of NE in mediating these 
behaviors. However, given that the LC terminals likely release more than NE, the postsynaptic 
neuronal responses and their subsequent behavioral outputs may potentially be mediated through 
a different mechanism of action. While there is some concern that photostimulation of LC-
BLATh-Cre causes backpropagating action potential to LC-NE cell bodies, the observation that this 
stimulation does not replicate all of the behavioral phenotypes seen in Chapter 5 (i.e. no RTPT) 
suggests there is at least some degree of circuit isolation in these studies. Future work should 
strive to account for such a possibility either by genetically isolating the projection (Fenno et al., 
2014) or pharmacologically inactivating backpropagation (Stuber et al., 2011).  
 To further solidify the role of NE in mediating anxiogenic behavior, future studies should 
combine photostimulation of LC-BLATh-Cre with local infusion of adrenergic antagonists in the 
BLA. However, these data could prove difficult to interpret as antagonists would not target 
specific cell types and could “spill over” from the predominately glutamatergic BLA to the 
neighboring GABAergic CeA (Carlsen, 1988; McDonald, 1982; Smith and Paré, 1994). These 
experiments represent an ideal application of optofluidic neural probes (Chapter 4), where 
spatial restriction of both pharmacological agents and photostimulation will be required. While 
isolation of the specific contributions of different receptor subtypes to NE- mediated anxiety-like 
behavior and aversion could be challenging via classical pharmacological methods, other modern 
techniques, such as DREADD and optically-sensitive GPCRs, show potential in dissecting these 
contributions. 
 Taken together, our results demonstrate that LC-NE downstream influence on negative 
affective behaviors is an elegant and complex system likely involving many different 
postsynaptic receptor systems and anatomical projection targets. These findings have broad 
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implications for our understanding of the mechanisms of stress-induced and anxiety disorders 
and suggest that further study of these noradrenergic circuits and signaling pathways should 
greatly advance our current understanding of these pathologies. 
 
MATERIALS & METHODS 
Animals 
 Adult (25–35 g) male C57BL/6J and TH::IRES-Cre backcrossed to C57BL/6J mice were 
group-housed, given access to food and water ad libitum and maintained on a 12 h:12 h 
light:dark cycle. All animals were held in a facility in the lab 1 week prior to surgery, post-
surgery and throughout the duration of the behavioral assays to minimize stress from 
transportation and disruption from foot traffic. All procedures were approved by the Animal Care 
and Use Committee of Washington University and conformed to US National Institutes of 
Health guidelines. 
Viral preparation 
 Plasmids encoding pAAV-EF1"-DIO-eYFP [final titer 5 x 1012 vg/ml], pAAV-EF1"-
double floxed-hChR2(H134R)-eYFP-WPRE-HGHpA [final titer 2 x 1013 vg/ml], were obtained 
from Addgene (Addgene.org) originally from the Deisseroth Laboratory at Stanford University. 
The DNA was amplified with a Maxiprep kit (Promega) and packaged into AAV5 serotyped 
viruses by the WUSTL Hope Center Viral Core. 
Stereotaxic surgery 
  Mice were anaesthetized in an induction chamber (5% isoflurane) and placed in a 
stereotaxic frame (Kopf Instruments, Model 1900) where they were maintained at 1-2% 
isoflurane throughout the procedure. A craniotomy was performed and mice were injected as 
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follows. For locus coeruleus terminal studies, 1 µl of AAV5- DIO-ChR2 or AAV5-DIO-eYFP 
was injected unilaterally into the locus coeruleus at stereotaxic coordinates from bregma: -5.45 
mm anterior-posterior (AP), ± 1.25 mm medial-lateral (ML), -3.65 mm dorsal-ventral (DV). 
Mice were then implanted with chronic fiber optic implants with coordinates adjusted from viral 
injection to 0.00 mm 30(AP), ± 0.25 mm (ML), and +1.00 mm (DV). The fiber optic implants 
were secured using two bone screws (CMA, 743102) and affixed with TitanBond (Horizon 
Dental Products) and dental cement (Lang Dental) (McCall et al., 2013). Mice were allowed to 
recover for at least 3-6 weeks prior to behavioral testing; this interval also permitted optimal 
AAV expression and Cre recombinase activity. 
General Behavior Notes 
 Behavioral assays were performed in a sound attenuated room maintained at 23°C. 
Lighting was measured and stabilized at ~ 4 lux for anxiety tests and ~200 lux for place testing. 
All behavioral apparatuses were cleaned with 70% ethanol in between animals. In each assay, 
animals received constant photostimulation throughout the entire trial. AAV5-DIO-ChR2 and 
AAV5-DIO-eYFP animals received 5 ms pulses of 10 Hz photostimulation (473 nm). 
Movements were video recorded and analyzed using Ethovision Software. 
Elevated Zero Maze (EZM) 
 The EZM (Harvard Apparatus) was made of grey plastic, 200 cm in circumference, 
comprised of four 50 cm sections (two opened and two closed). The maze was elevated 50 cm 
above the floor and had a path width of 4 cm with a 0.5 cm lip on each open section. Animals 
were connected to cables coupled to a function generator, positioned head first into a closed arm, 
and allowed to roam freely for 6 min. Mean open arm time was the primary measure of anxiety-
like behavior. 
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Conditioned Place Aversion (CPA) 
 Mice were trained in an unbiased, balanced three compartment conditioning apparatus as 
previously described (Al-Hasani et al., 2013; Kim et al., 2013b). Briefly, mice were pre-tested by 
placing individual animals in the small central compartment and allowing them to explore the 
entire 31apparatus for 30 min. Time spent in each compartment was recorded with a video 
camera (ZR90; Canon) and analyzed using Ethovision 8.5 (Noldus). Mice were randomly 
assigned to light and no-light compartments and received no light in the morning and light (5 Hz 
for LC-BLA) in the afternoon at least 4 h after the morning training on two consecutive days. 
CPA was assessed on day 4 by allowing the mice to roam freely in all three compartments and 
recording the time spent in each. Scores were calculated by subtracting the time spent in the light 
stimulus-paired compartment post-test minus the pre-test. 
Real Time Place Testing (RTPT) 
  Mice were placed into a custom-made unbiased, balanced two-compartment conditioning 
apparatus (52.5 x 25.5 x 25.5 cm) as previously described (Stamatakis and Stuber, 2012) and 
allowed to freely roam the entire apparatus for 20 min. Entry into one compartment triggered 
constant photostimulation (5 Hz for LC-BLA; ~10 mW light power) while the animal remained 
in the light-paired chamber. Entry into the other chamber ended the photostimulation. The side 
paired with photostimulation was counterbalanced across mice. Time spent in each chamber and 
total distance traveled for the entire 20 min trial was measured using Ethovision 8.5 (Noldus). 
Data are expressed as mean +/- S.E.M percent time spent in photostimulation-paired chamber. 
Voltammetry  
 Slice voltammetry experiments were performed as previously described (Stamatakis et al., 
2013). Briefly, mice were anesthetized (Euthasol) and perfused with ice-cold sucrose aCSF (in 
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mM: 225 sucrose, 119 NaCl, 1.0 NaH2PO4, 4.9 MgCl2, 0.1 CaCl2, 26.2 NaHCo3, 1.25 
glucose). Following rapid decapitation, slices were prepared 32 on a vibratome (VT-1000, Leica 
Microsystems) and allowed to rest for at least 30 min in oxygenated aCSF (in mM: 119 NaCl, 
2.5 KCl, 1.0 NaH2PO4, 1.3 MgCl2, 2.5 CaCl2, 26.2 NaHCO3, and 11 glucose) at 35oC prior to 
placement in the recording chamber where slices were perfused with oxygenated aCSF at 37oC 
at a rate of 2 ml/min. Carbon fiber microelectrodes (CFME, 75 µm in length) were lowered into 
300 µM coronal slices and placed where the densest ChR2-eYFP expression was observed 
(CeA/BLA border) of THLC::ChR2 mice. To detect NE, the CFME was ramped from -0.4 V to 
1.3 V versus a Ag/AgCl reference electrode (in the bath) at a rate of 400 V/s at 10 Hz. Slices 
were stimulated with 30 pulses of a blue LED (Thorlabs, 473 nm, 5 ms pulse width, 1 mW) via a 
40X objective at 10 Hz every 5 minutes to release NA. Electrochemical data was collected and 
analyzed via custom software (Tar Heel CV, HD CV, Labview). Following collection, 
background subtracted cyclic voltammograms (CVs) were transformed with a Fast Fourier 
Transformation (Bucher et al., 2013). CVs had characteristic oxidation and reduction peaks 
coinciding with catecholamine detection (ox: 600-700 mV red: -200-300 mV). Oxidative 
currents were analyzed at the peak of the oxidative potential for individual experiments. 
Clearance half-life (t1/2) was measured in Clampfit 10.2 (Molecular devices) as previously 
described (McElligott et al., 2013). 
In vivo electrophysiology 
  Spontaneous single unit activity was recorded as previously described (Kim et al., 2013b; 
Sparta et al., 2011). Briefly, mice were lightly anesthetized (1% isoflurane), placed in a 
stereotactic frame and two skull screws were placed on either side of the midline to ground the 
electrode array. The recording apparatus consisted of a 16-channel (35-µm tungsten wires, 150-
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µm spacing between wires, 150-33 µm spacing between rows, Innovative Physiology) electrode 
array. This array was epoxied to a fiber optic and lowered into the BLA (stereotaxic coordinates 
from bregma: -1.3 mm (AP), ± 2.9 mm (ML) and -4.9 mm (DV). Extracellular recordings were 
taken from LC-BLATh-Cre mice and its corresponding viral control mice. Spontaneous and 
photostimulated neuronal activity was recorded from each electrode, bandpass-filtered with 
activity between 250 and 8,000 Hz, and analyzed as spikes. Voltage signals were amplified and 
digitally converted using OmniPlex and PlexControl (Plexon). For LC-BLATh-Cre recordings, 3 
min of baseline recordings were made followed by 3 min of 5 Hz photostimulation (10 ms 
pulses, 10 mW) and then another 3 min post- stimulation (off, on, off). Principle component 
analysis and/or evaluation of t-distribution with expectation maximization was used to sort 
spikes using Offline Sorter (Plexon). 
Statistics/Data Analysis  
 All data are expressed as mean ± SEM. Statistical significance was taken as *p < 0.05, **p 
< 0.01, ***p < 0.001, as determined by the Student’s t-test (paired and unpaired): One-Way 
Analysis of Variance (ANOVA) or One-Way Repeated Measures ANOVA, followed by 
Dunnett’s or Bonferroni post hoc tests as appropriate. Statistical analyses were performed in 
GraphPad Prism 5.0. 
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PART 1: The development and application of cellular-scale optoelectronic devices for 
wireless manipulation of intact mammalian neural circuitry 
 To date, the primary implementation of the technologies presented in Part 1 has been in 
“proof-of-principle” experiments. Initially, Tae-il Kim and I devised a means to combine many 
different functional electronic modalities into a single, ultrathin device (Chapter 2, Figure 2.1). 
These ultrathin (~20 µm), flexible devices allow for electrophysiological, optical, and thermal 
observation of brain tissue as well as wireless photostimulation. We devised a means to implant 
this thin interface into the brain using a removable insertion needle that temporarily binds to the 
flexible device with a biodissolvable adhesive (Figure 2.1D). By utilizing the well-established 
reward-related circuitry of the ventral tegmental area dopamine (VTA-DA) system, we were able 
to demonstrate that these devices can safely and effectively integrate with awake, behaving 
animals as small as a C57Bl/6 mouse (Figure 2.1G). Furthermore, we for the first time, directly 
addressed the role of tonic VTA-DA activity in anxiety-like behavior (Figure 2.28).  
 In an effort to facilitate the widespread distribution of this new technology Tae-il, 
Gunchul Shin, and I prepared a detailed protocol explaining every step of the fabrication and use 
these first generation devices (Chapter 3). Though this protocol is specific to these devices, the 
principles of both the materials science and the neuroscience approaches presented are portable 
to other endeavors such as the fabrication of other flexible optoelectronic technologies (Figure 
3.1-3.3) and/or the general stereotaxic surgery (Figure 3.5). 
 Though the devices detailed in Chapters 2 & 3 enable previously impossible 
experimental power for wireless photostimulation, they are limited greatly in their scope for 
other wireless perturbations such as local pharmacological manipulations in the deep brain. 
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Local pharmacology is a powerful tool in dissecting both neural circuits and endogenous 
receptor/ligand systems (Parker et al., 2010; Stachniak et al., 2014). However, to date, localized 
fluid delivery has relied exclusively on tethered approaches. Together, Jaewoong Jeong and I 
achieved wireless fluid delivery that can be paired with photostimulation (Chapter 4). These 
optofluidic neural probes can deliver up to four different fluids (Figure 4.1 & 4.6) and we have 
shown utility in viral gene transfer (Figure 4.10), local pharmacology (Figure 4.11), and paired 
optogenetic and pharmacological manipulation (Figure 4.12). Here we again returned to the 
well-established VTA-DA system to demonstrate the latter combinatorial approach. Following 
the extensive progress that had recently been made in the VTA-DA field (Gunaydin et al., 2014; 
Kim et al., 2012, 2013; Lammel et al., 2011, 2012, 2015; Stamatakis et al., 2013; Stuber et al., 
2015; Tsai et al., 2009; Witten et al., 2011), we isolated a distinct projection to photostimulate 
and antagonize dopamine D1 receptors  (DRD1) (Figure 4.12). The isolation of this projection 
greatly increased the selectivity of our approach in Chapter 2 (Figure 2.11) and revealed a role 
for this particular projection in the real-time place preference assay (Figure 4.12).  
  All of the devices presented in Part 1 represent first forays into new technology. 
Following the initial proof-of-principle experiments presented here, there are myriad of ways to 
expand application of the technology.  
Enhanced spatial targeting using independently-controlled !-ILEDs 
 A major motivation and primary strength of the !-ILED approach to photostimulation is 
the ability to spatially restrict the path of light (Figure 2.23) (Kim et al., 2013). At the time that 
we began work on these devices the most celebrated approach to directing the light path was 
feeding a fiber optic cable through a beveled cannula (Tye et al., 2011). Contemporaneous 
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development of optical waveguide-based probes (Zorzos et al., 2010, 2012) achieved marked 
success in spatial targeting of light, but failed to implement these impressive devices into 
experiments with behaving animals. While these waveguides provide impressive optical abilities, 
their rigid design and cumbersome optical coupling have limited their use in the field. !-ILED 
devices, however, should be capable of spatial targeting beyond what we have so far presented. 
The initial devices used an array of four !-ILEDs all under the same control. Gunchul Shin has 
since developed !-ILED devices that have two !-ILEDs separated by 1 mm that can be 
independently controlled. These “bidirectional” devices provide a first concept towards enhanced 
spatial targeting with !-ILEDs and we have demonstrated their utility dissecting the 
microanatomy of the nucleus accumbens. Ream Al-Hasani and I have recently identified a 
functional anatomical segregation within dynorphin-expressing neurons of the nucleus 
accumbens (Appendix 1). Here we show that activation of dynorphin neurons in the dorsal shell 
of the nucleus accumbens (NAcSh) drives a preference behavior and activation of dynorphin 
neurons in the ventral NAcSH drives an aversion behavior. Using Gunchul’s devices we were 
able to demonstrate that this behavioral diversity can be elicited in the same animal by shifting 
the spatial targeting of photostimulation between dorsal to ventral (Figure A1.3 and A1.4).  
 While the dynorphin experiments show the promise of spatial selectivity using !-ILEDs, 
there likely remain greater spatial targeting achievements. One can imagine flexible devices that 
insert between the hippocampus and cortex of mouse brain or along sulci in higher mammals that 
would allow spatially segregated targeting of different regions. Other possible schemes could 
involve flexible net-like devices that could overlay the cortex (Viventi et al., 2010, 2011), 
providing numerous independently-addressable !-ILEDs. One such exciting application that 
exploits the spatial properties of independently-addressable !-ILEDs is using optogenetics for 
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cochlear stimulation. Preliminary studies have already shown that such an approach is feasible 
with !-ILEDs (Hernandez et al., 2014), but soft, flexible devices with independently-addressable 
!-ILEDs that could wrap along the cochlea similar to traditional cochlear implants could help 
refine the sensitivity of such prosthetics (Clark, 2015). Such devices could greatly aid study of 
larger network dynamics with the fine control of optogenetics. Furthermore, the independently-
addressable !-ILEDs could also access different wavelengths to either provide combined 
stimulation/inhibition or to activate discrete opsins targeted to distinct cell-types along a similar 
projection (Chuong et al., 2014; Klapoetke et al., 2014; Lin et al., 2013).  
Miniaturization of the harvesting antenna 
 The initial power harvesting antennas that we presented were relatively large (~2 g) and 
most of this weight resulted from a reliance on a standard, commercially available rigid printed 
circuit board. By printing the same circuitry on flexible Kapton film we were able to reduce the 
weight of the harvester to ~700 mg. These lightweight devices, however, still require external 
mounting and would interfere with more ethologically-relevant behaviors such as social 
interaction. Following our work from Chapter 2 (Kim et al., 2013), Sung il Park in the Rogers 
group has worked diligently to reduce the size of the power harvester needed to power the 
µ#ILEDs. The ultimate goal of this work is to achieve a miniaturized power harvester capable of 
being embedded completely under the scalp of an animal. Sung il achieved an order of 
magnitude reduction in weight by increasing the operating frequency of the harvesters (Park, 
2013). The original harvesters operated at ~900 MHz and an increase to 1.5 GHz, resulted in 
substantially smaller harvesters (Figure 7.1A & B). These devices were operational and proved 
sufficient for Ed Siuda and myself to demonstrate that wireless activation of Gs-signaling in 
CAMKII"+ neurons the BLA is sufficient for anxiety-like behavior in the light-dark box assay 
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(Figure 7.1C-F). Importantly, this assay involves the animal entering an enclosed environment 
and would be incompatible with tethered fiber optic system. After this initial reduction in size, 
Sung il once again increased the operating frequency to allow for further miniaturization of the 
harvesters. Now with harvesters optimized near 2.4 GHz, the devices are an order of magnitude 
lighter ~60 mg and can easily be implanted under the scalp (Figure 7.1G). Proof of principle 
experiments  
 
 
 
 
 
Figure 7.1: Ongoing work to reduce the size of the RF energy harvester. (A) Circuit diagram 
of an energy harvester operating at 1.5 Ghz. It consists of antenna, impedance matching circuits, 
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Cockcroft-Walton multiplier, and micro-LEDs. (B) Radiofrequency power harvester with µ-
LEDs. µ-LEDs are detachable from the harvester as shown in the inset. Scale bars = 5 mm.  (C) 
Viral injection site, unilateral !-ILED implant and brief overview of wireless transmission 
system. (D) Representative traces of individual control (black) and individual opto-!2AR (blue) 
animal in light dark box behavioral assay. (E) Wireless photostimulation of mice expressing 
opto-!2AR (blue; n = 7) in the BLA enter the dark box faster than viral controls (black; n = 11) 
(* p < 0.05; log-rank (Mantel-Cox) Test) (inset * p < 0.05; Students’ unpaired t-test). (F) Opto-
!2AR animals (blue) spend more time in the dark box than viral controls (black) (*p < 0.05; 
multiple Student’s unpaired t-tests). All data expressed as mean ± SEM.  All light pulses are 473 
nm, 1 W/cm2. (G) Demonstration of subcutaneous implantation of 2.4 GHz RF harvesters. (A & 
B) Data generated by Sung il Park, Rogers Group, University of Illinois at Urbana-Champaign 
(C-F) Data generated and analyzed by Edward R. Siuda, Jordan G. McCall, and Martin J. 
Schmidt. (G) Data generated by Jordan G. McCall. 
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using these devices are underway, but these miniaturized harvesters may prove difficult to 
implement with freely behaving animals due to the limitations of RF power harvesting. 
Limitations of radiofrequency power scavenging 
 The wireless capabilities of the devices presented in Chapters 2 & 3 (Kim et al., 2013; 
McCall et al., 2013) are all based on the concept of radiofrequency power harvesting from 
intentionally broadcasted sources. This powering scheme is advantageous because it allows the 
user to wirelessly operate the devices while foregoing both an onboard battery and a processor of 
some kind to determine the parameters of photostimulation (the latter is avoided by manipulating 
the broadcasted RF signal). However, the intentionally broadcasted RF signal is linearly 
polarized. This polarization limits the angle at which the broadcasted signal can be efficiently 
harvested for power of the µ#ILEDs. Practically speaking, this property can greatly limit the 
ability to deliver effective wireless photostimulation. As discussed briefly in Chapter 3 (McCall 
et al., 2013), the use of multiple broadcast antennas arranged purposefully can overcome some of 
these polarity issues. However, the increase in operating frequency that allows for 
miniaturization of the harvester makes these devices inherently more prone to polarity issues. 
These issues can be problematic. Despite the use of multiple broadcasting antennas, there can 
often be numerous “dead zones” or areas where there is insufficient RF radiation to power the 
devices in a behavioral arena. This likely did not affect our behavioral results in (Figure 7.1C-F) 
as we were using an optically-sensitive GPCR with a activation time that outlasts the period of 
photostimulation (Airan et al., 2009), but users wishing to use a faster acting channel or pump 
(Mattis et al., 2012) may face hurdles. This limitation is likely a greater concern in the 2.4 GHz 
subcutaneous versions of the harvesters. 
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 Despite the limitations introduced by the higher operating frequency, the goal of 
miniaturization is a worthy target. One possible solution is to use the implanted nature of these 
devices to harness the tissue of the animal as a greater harvesting platform (Peyman et al., 2001; 
Poon et al., 2010). Such an approach would allow smaller harvesters that are not nearly as 
effected by the head direction of the animal (as the whole body of the animal could be used to 
help capture RF energy). Another approach would be to supplement the small-scale harvesters 
with a small battery that engages when power is lost. This would eliminate dead zones, but the 
battery and its interface to the harvester may prove too large to have the device remain 
subcutaneous. It is also possible that such a strategy would need a miniaturized microcontroller 
to ensure proper control of the photostimulation. Finally, and perhaps most promising, is the 
prospect of moving away from high frequency RF scavenging altogether. Lower frequency RF 
(~13 MHz) such as that used for Near Field Communication (NFC) can similarly be used for 
energy transfer from an initiator antenna to power a passive target, in this case an µ#ILED array 
(S.n et al., 2012). A similar approach was recently demonstrated using a resonant cavity to 
broadcast circularly polarized RF signals to nearby RF harvesting coils for wireless 
photostimulation in mice (Ho et al., 2015). In that particular case, the resonant cavity inherently 
restricts the operating distance and types of behavior accessible to this technology. The NFC 
initiator-based approach also sacrifices the distance at which the devices can be wirelessly 
powered (high frequency RF can operate µ#ILEDs at ~2 m, low frequency is likely close to 10 
cm). However, the NFC initiator can be many different shapes and could presumably be form-
fitted to any behavioral environment. Assuming three-dimensional access to the environment in 
which the subject was freely moving, it should be possible to maintain efficient photostimulation 
without limitations of polarity or “dead spot” areas in the field using an NFC initiator approach. 
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Furthermore, NFC should easily accommodate underwater scenarios that are difficult with high 
frequency RF or battery-based systems (Zoksimovski et al.) and the technology is already being 
used for bidirectional information exchange which would easily enable physiological monitoring 
systems  such as electroencephalography (Bertrand, 2015). 
Increasing the functionality and accessibility of optofluidic neural probes 
 The optofluidic neural probes presented in Chapter 4 foreshadow a number of parallel 
advances in wireless neural interface technologies including therapeutic approaches accessing 
the peripheral nervous system (Minev et al., 2015), the expansion of in vivo photoconversion of 
caged ligands (Kramer et al., 2013; Polosukhina et al., 2012; Tochitsky et al., 2014), and 
improved wireless photostimulation schemes based on battery-powered microprocessors (Iwai et 
al., 2011; Lee et al., 2015). The designs we present in Chapter 4 can be modified to address 
each one of these exciting new directions. Local delivery of drugs into the spinal cord and 
peripheral nervous system could provide opportunities for better pain management and/or aid in 
regeneration of damaged nerves (Minev et al., 2015; Richards and McMahon, 2013; Scheib and 
Höke, 2013). Such delivery may be more readily achieved using these thin, flexible microfluidic 
channels. Likewise, the integration of the optofluidic neural probes with UV spectrum (~405 nm) 
!-ILEDs that Gunchul Shin has recently developed will hopefully expand the applicability of 
these devices to wild-type animals and increase the chance of therapeutic translation using caged 
compounds (Banghart and Sabatini, 2012; Kramer et al., 2013). Finally, it is worth noting that 
the wireless scheme presented in Chapter 4 is unique from those presented in Chapters 2 & 3. 
Using a battery-powered microprocessor insures equivalent efficiency of the !-ILEDs regardless 
of the position or orientation of the animal in space, thus providing another solution to the 
polarity issues discussed above. While these battery-powered designs are larger (~1.8 g) than the 
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current generation of RF harvesters, size reduction for devices intended exclusively for 
photostimulation are immediately possible. The power requirements for the µ#ILED is 
substantially less than that of the Joule heaters needed for fluid delivery, so such a device would 
only need a single battery. Furthermore, control of the pulse paradigm for photostimulation could 
be removed from the on-board microcontroller and instead controlled remotely by pulsing the IR 
signal. In other words, if the microcontroller was reduced to serve as an I/O gate to the µ#ILEDs 
then the IR signal could be pulsed to any desired parameters. Such modifications could likely 
make a wireless photostimulation device weighing less than 500 mg that would not suffer any 
orientation limitations. 
 Unlike the ultrathin, flexible multimodal µ#ILED devices presented in Chapters 2 & 3 
(Kim et al., 2013; McCall et al., 2013), the optofluidic neural probes presented in Chapter 4 are 
fabricated from readily available and/or 3D-printable materials in a standard lab environment. 
However, accessibility to these devices is limited to how the fluid chambers are filled (see 
Chapter 4 Materials & Methods). The current design only allows each set of four chambers to 
be filled a single time. Ideally, access to the fluidic channels would be limitless. In tethered 
approaches, fluid supply is never an issue and certainly not the limiting step towards adopting the 
technique. Development of a cartridge system that could reversibly connect to the microfluidic 
channels is one possibility for overcoming this hurdle. In this case, fluid could be filled into 
limitless disposable cartridges and once the fluid is dispensed from all chambers in the cartridge, 
the entire cartridge is replaced. The primary challenge with this idea will be the creation of fluid 
interconnects that remain patent between cartridges, but such a goal should be achievable.  
 Even though each device and technology platform introduced in Part 1 has room for 
improvement and modification, each device design is ready to address new biological questions. 
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In large part, these tools were developed to help us answer previously intractable questions 
concerning the locus coeruleus noradrenergic system. Though application of these technologies 
to locus coeruleus circuitry has begun (Figure 2.23, Figure 7.1C-F), much more work will be 
needed to better understand how this system regulates such a broad range of behaviors. In Part 
2, we began a relatively gross modern dissection of LC-NE circuitry in negative affect. With the 
help of the technology from Part 1, we can uncover more of the fundamental nature of LC-NE 
mediated behaviors. 
PART 2: Dissecting the role of locus coeruleus circuitry in negative affective behaviors 
 The locus coeruleus noradrenergic (LC-NE) system has been known to be involved in 
central stress response for many decades (Koob, 1999). While numerous groups have observed 
that the LC-NE electrophysiological activity increases in response to stressors (Bingham et al., 
2011; Cassens et al., 1981; Curtis et al., 1997, 2012; Francis et al., 1999; Lechner et al., 1997; 
Jedema and Grace, 2004; Page and Abercrombie, 1999; Reyes et al., 2008; Snyder et al., 2012; 
Valentino et al., 1991; Valentino and Foote, 1988; Valentino and Van Bockstaele, 2008), the 
underlying circuitry and cellular dynamics of this response have not previously been fully 
elucidated. Recent advances in cell-type selective control of neural circuitry, namely 
optogenetics and chemogenetics, provide an ideal toolbox for furthering our understanding of 
this small, pontine brain structure. Indeed, one of the earliest in vivo optogenetics studies 
targeted the LC-NE cell bodies to understand this structure’s role in arousal (Carter et al., 2010). 
The bidirectional control of arousal through LC-NE cell bodies by Carter et al., 2010 
demonstrated the powerful command this small brainstem structure can have on gross behavioral 
states. This early observation, though striking, left much unexplored territory for the LC which is 
known have roles in stress responses (Koob, 1999), attention (Sara, 2009; Sara and Bouret, 
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2012), and descending pain modulation (Jones, 1991) among other behavioral outputs (Berridge 
and Waterhouse, 2003; Sara, 2009). In order to better understand how the LC-NE system 
mediates these and other behaviors, more detailed studies were necessary to dissect the 
underlying circuitry. The studies presented in Chapters 5 & 6 are the first to selectively 
manipulate LC-NE neurons in the context of stress and the resulting anxiety-like behaviors and 
are the first to explore afferent and efferent projections from this structure with regard towards 
negative affective behavior.  
 In Chapter 5, we report that the activity of LC-NE neurons is necessary to elicit acute 
stress-induced anxiety (Figure 5.1). Furthermore, selectively increasing the firing of LC-NE 
neurons is itself anxiogenic in the absence of stress (Figure 5.4). This same high tonic state has 
negative valence that can be learned to influence future behavior (Figure 5.6). Interestingly, this 
negative valence can be generated by a subset of LC-NE neurons that express the neuropeptide 
Galanin (Figure 5.8). In an effort to understand the endogenous afferent circuitry that mediates 
these effects we traced CRH+ inputs from the central amygdala (CeA) to the LC (Figure 5.11). 
Optogenetic stimulation of CRH+ CeA terminals into the LC replicates both the cellular activity 
profile and acute anxiogenic and aversive behavioral state of direct LC-NE high tonic 
stimulation (Figure 5.13).  
 Following these experiments, we sought to determine what downstream brain regions and 
receptor systems could be targets to drive the negative affective behaviors mediated by the LC. 
In Chapter 6, I observed that the anxiogenic and aversive components of LC activation may be 
mediated through two different adrenergic receptor systems (Figure 6.1). In an effort to 
understand where these effects are mediated, Ed Siuda and I identified an anxiogenic and 
aversive efferent projection from the LC to the basolateral amygdala (BLA) (Figure 6.6 and 
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6.7). Increased tonic stimulation of this projection releases norepinephrine (NE) into the BLA 
(Figure 6.4) and alters BLA single unit activity similarly to exogenously applied NE (Figure 
6.5) (Buffalari and Grace, 2007). In the behaving animal, stimulation of these LC-BLA terminals 
drives similar anxiety-like behavior and conditions an aversion similar to direct LC-NE cell body 
stimulation (Figure 6.6, Figure 7.2A). Together these findings suggest a critical amygdalar-
coerulear network in the mediation of stress-induced anxiety (Figure 7.2 B). Understanding 
these circuits in the context of natural behaviors will require further study, but there is 
undoubtedly a wealth of knowledge to be gained by further circuit dissection of the LC-NE 
system. 
 
 
 
Figure 7.2 Possible models for LC-NE mediated stress-induced negative affective 
behaviors. (A) Chapter 6 indicates that LC-BLA projections likely mediate acute stress-induced 
anxiety, possibly through local !-adrenergic receptors. (B) Proposed model of feed-forward 
circuit between the LC and the amygdala that could possibly drive persistent and/or chronic 
anxiety. (C) Anthony et al. 2014 presented the lateral septum (LS) as a region mediating 
persistent stress-induced anxiety, the LC sends projections to this region which could play a role 
in sustained stress-induced anxiety. 
Considerations when using Cre-driver lines for cell-type selective targeting 
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 Much of the data presented in this dissertation was gathered using various Cre-driver 
lines (e.g. Th-Cre, CRH-Cre, Gal-Cre, Dyn-Cre, etc.). While these mouse lines can enable cell-
type selective expression of constructs using Cre-dependent viral vectors, it is important to 
consider the limitations of these animals. Recent work highlighted various Cre-driver lines 
commonly used to target VTA-DA neurons may target slightly different populations within and 
near this brain region (Lammel et al., 2015). While there is significant controversy concerning 
this work (Stuber et al., 2015), it is important to appreciate that no Cre-driver system is likely 
perfect. In our hands with the Gal-Cre mouse, using a Cre-dependent reporter mouse, we 
observed Cre-dependent activity in brain regions that should be absent of Galanin in the adult 
(Figure 5.9). After a thorough investigation using the Allen Brain Atlas of the Developing 
Mouse Brain, we determined that the ectopic reporter expression was due to recombination from 
transient Galanin (and therefore Cre) expression during development. After histological 
evaluation in the adult mouse, we believe that this appearance of “leaky” Cre expression is likely 
an artifact brought on through development. Such developmental changes of Cre expression have 
been observed before (Bruchas et al., 2011) and the extent to which they can bias results will 
depend on each mouse line and each experiment. Importantly, following histological 
examination in all of the mouse lines we used in Part 1 and Part 2, we do no believe there is 
cause for concern in interpreting our data. 
 
Single-unit electrophysiology qualifications and future alternatives 
 The single-unit electrophysiological studies of LC neurons presented in Chapters 5 & 6 
were all performed in isofluorane-anesthetized animals. While the LC is still active under light 
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(<~1%) isofluorane anesthesia, its activity is significantly reduced and can be dampened 
completely with higher levels of isofluorane (Gompf et al., 2009). Conversely, significant LC 
activation can reverse the effects of isofluorane anesthesia (Vazey and Aston-Jones, 2014). 
Significant effort was taken to perform these experiments at the lowest possible level of 
anesthetic that still maintains an anesthetized state of the animal (~0.7%). That being said, the 
basal activity of LC neurons and the likelihood of observing an LC neuron were both likely 
decreased in all of the recording experiments. This side effect of the experimental preparation 
introduces an inherent selection bias as one can only record from neurons that are observably 
active. Though attempts were made to record from the LC of awake, behaving animals the 
signal-to-noise ratio was not ideal to isolate single LC neurons. An important future step in 
understanding LC-NE function will be to observe the activity of these neurons during naturalistic 
behaviors (e.g. during the stress experience and/or the expression of anxiety-like behaviors. One 
possible approach would be to visualize the LC-NE neurons using a genetically targeted 
fluorescent Ca2+ indicator paired with a deep brain implanted gradient-index (GRIN) lens and 
miniature fluorescent microscope (Hamel et al., 2015; Jennings et al., 2015; Ziv et al., 2013). 
While the temporal resolution of in vivo Ca2+ imaging is much slower than single-unit 
electrophysiology, there should be valuable information gained from the visualization of these 
neurons in awake, behaving animals. Even at a reduced temporal resolution, gross alterations in 
LC-NE activity should be observable with in vivo Ca2+ imaging. Such observational studies 
would greatly inform how the LC processes stressful events and induces negative affective 
behavior. 
 The implementation of deep brain microendoscopy can be challenging, however, due to 
the invasive nature of the implanted GRIN lens. Fiber photometry represents a less invasive 
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opportunity to resolve population activity with genetically targeted fluorescent Ca2+ indicators 
(Cui et al., 2013, 2014). While this approach likely does not yield much greater information that 
multiunit activity would at cell bodies, the technique can be used to observe Ca2+ activity in 
terminal fields (Gunaydin et al., 2014). This feature of the technology would be very powerful in 
understanding the dynamics of long-range projections into and out of the LC. Furthermore, it is 
possible that the flexible photodetector presented in Chapters 2 & 3 could be adapted for similar 
purposes (Figure 2.1, Figure 3.3). 
Temporal limitations and the implications for persistent and chronic stress-induced anxiety 
 While these studies are the first of their kind to dissect LC function with cell-type- and 
projection-selective targeting, there remain many limitations in the interpretation of the data. The 
necessity of the LC-NE system in stress-induced anxiety was shown by cell-type selective 
chemogenetic inhibition of LC-NE neurons (Figure 5.1). This approach is somewhat temporally 
ambiguous due to the onset kinetics of CNO and the Gi-coupled DREADD receptor. We chose 
this tool purposefully as it should enable inhibition of LC activity for an extended period of time 
(~1 hour). However, because LC activity was likely dampened during both the stressor and the 
test of stress-induced anxiety-like behavior, it is difficult to know the contribution of increased 
LC activity to either.  Inhibitory optogenetic constructs are much more temporally precise, 
however achieving equivalent inhibition via illumination across a large area can be problematic. 
Not only are there concerns of tissue heating (Yizhar et al., 2011), but the first generation 
optogenetic constructs can lead to altered cell activity after the inhibition has ceased (Raimondo 
et al., 2012).  
304 
 Similar to the temporal concerns of the inhibition experiments, all of our studies in 
Chapters 5 & 6 relate only the acute phase of stress-induced anxiety. While we suggest that LC 
activity may work in a feed-forward loop through the amygdala to promote an anxiety-like state 
it is unclear at this time if LC-NE activity alone can sustain such a loop. Experiments that acutely 
increase LC tonic activity prior to anxiety testing (rather than during) and those addressing 
chronic LC activation (see below) can help address these outstanding questions. Recent evidence 
has shown that persistent stress-induced anxiety is mediated through CRFR2+ cells in the lateral 
septum (Anthony et al., 2014). It is possible that the LC mediates acute anxiety-like behavior 
through a projection to the BLA (Figure 7.2A), while modulating more long-term stress-induced 
anxiety through inputs into the lateral septum (Figure 5.14, Figure 7.2C). 
Do diverging projections explain diverging behaviors? 
 A central question underlying LC-NE research is how a small structure with such 
ubiquitous innervation of the forebrain can selectively contribute to a wide array of physiological 
and behavioral functions as it does? Our work here (Chapters 5 & 6) begins to illustrate a 
circuit-based mechanism for this diversity. First, in Chapter 5 we demonstrate that only a subset 
of neurons are required to sufficiently drive a real-time place aversion (Figure 5.8) and that 
sparse innervation from the CeA is sufficient for both learned aversion and anxiety-like behavior 
(Figure 5.13). Next, in Chapter 6 we show that anxiety-like and real-time place aversion are 
mediated by two separate downstream adrenergic receptor systems (Figure 6.1) and that the 
anxiety-like behavior is likely mediated through !-adrenergic receptors activated by LC 
projections to the BLA (Figures 6.1, 6.4, 7.1, 7.2A). This divisibility of behavioral output 
suggests that subsets of LC neurons with different efferent projection targets can drive distinct 
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LC-mediated behaviors. It will be important to extend these findings to other behaviors, 
particularly other stress-induced behaviors as described below.  
 The next generation of functional circuit dissection should access finer selectivity than 
the research presented here. Combinatorial approaches that utilize intersectional genetics as well 
as projection-selective viral gene transfer will greatly enhance our ability to decipher complex 
circuitry in vivo (Fenno et al., 2014; Madisen et al., 2015; Saunders et al., 2012; Stamatakis et 
al., 2013). We previously suggested that a similar approach be taken using the Gal-Cre mice to 
selectively target LC-NE neurons that do not express Galanin (i.e. using the Cre-OFF system 
(Saunders et al., 2012), but such an approach could be used in combination with retrograde viral 
targeting to yield, projection- and perhaps synapse-selective cell-type selective control of 
neuronal subtypes (Goshen et al., 2011; Krashes et al., 2014; Ogawa et al., 2014; Watabe-Uchida 
et al., 2012). 
Exploring LC-NE activity in other stress-related behaviors 
 Stress-induced anxiety and aversion represents only a subset of known behavioral 
responses to stress (Bruchas et al., 2011; Butler and Finn, 2009; Weninger et al., 1999). Several 
stress-induced behaviors are known to be influenced or mediated by NE, including stress-
induced relapse to drug seeking (Weinshenker and Schroeder, 2007) and stress-induced analgesia 
(Butler and Finn, 2009). Exploring the possibility of these behaviors being mediated by LC 
efferent projections is a compelling next step.  
Stress-induced relapse 
 While it is possible the NE involved in other stress-induced behaviors could come from 
the other A1/A2 noradrenergic neurons of the brainstem (Erb et al., 2000; Shaham et al., 2000), 
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preliminary data indicates that tonic activation of the LC-NE system is sufficient for 
reinstatement of a cocaine place preference (Appendix 2, Figure A2.1). While these data need 
to be extended and replicated, the findings represent an interesting observation that goes against 
the accepted dogma in the addiction field (Weinshenker and Schroeder, 2007). The LC-NE 
system has not been considered a mediator of stress-induced relapse since an early 
pharmacological study asserted that the mechanism was independent of LC activity (Shaham et 
al., 2000). While this study and others (Delfs et al., 2000) clearly demonstrated the involvement 
of A1/A2 noradrenergic neurons in these behaviors, the data are not sufficient to rule out a role 
for the LC-NE system. Furthermore, our lab has recently shown that the LC does have an 
important role in kappa opioid-induced reinstatement to cocaine place preference (Al-Hasani et 
al., 2013). Future studies will be necessary to determine if the reinstatement behavior induced by 
tonic activation of LC-NE cell bodies is truly mirroring stress-induced reinstatement. However, 
the tools now exist for elegant dissection of this behavior to demonstrate both the necessary and 
sufficient components of the system paralleling the approach used in Chapter 5.  
 Beyond using selective modulation of LC-NE cell bodies in drug seeking behavior, it will 
also be important to investigate the underlying circuit mechanisms of such behavior. For 
example, the efferent projections from the LC that mediate reinstatement behavior may not be 
the same as those that mediate anxiety-like or aversion behaviors. While it is possible that the 
negative affective behaviors induced by tonic activation of the LC fibers in the BLA can drive 
reinstatement behavior (Bruchas et al., 2009, 2011; Land et al., 2009), it is also possible that the 
LC-NE system can mitigate reinstatement from direct activation of the VTA-DA system (Mejías-
Aponte et al., 2009; Velásquez-Martinez et al., 2012) (Figure 7.3A). Furthermore, the afferent 
circuitry that activates the LC-NE system during such behavior could be independent of the 
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amygdala as the VTA-DA system (among many others) has direct input into the LC as well 
(Deutch et al., 1986). 
 
 
 
 
Figure 7.3 Possible models for the role of LC-NE in other stress-induced behaviors. (A) 
Stress-induced reinstatement of drug seeking could possible be mediated in part by LC 
projection into the VTA that activates "1-adrenergic receptors or by activating the anxiety-
related circuits in Figure 7.2. (B) Stress-induced analgesia may be mediated by descending 
projections into the spinal cord via "1-adrenergic andor "2-adrenergic receptors. 
Stress-induced analgesia 
 The LC-NE system has a well-established role in the descending modulation of pain 
(Jones, 1991; Liu et al., 2008; Millan, 2002; Ossipov et al., 2010; Tsuruoka et al., 2010). 
Furthermore, NE and its receptor systems are known mediators of stress-induced analgesia 
(Buerkle and Yaksh, 1998; Butler and Finn, 2009; Howe et al., 1983). The link between these 
two observations, however, has yet to be clearly made. Recently both our group (Appendix 2, 
Figure A2.2) and another (Hickey et al., 2014) have demonstrated that increased tonic LC-NE 
activity can drive antinociception in both mice and rats, respectively. This selective increased 
activity mimics stress-induced anxiety (Figure 5.4), but whether the same can be said for stress-
induced analgesia remains to be seen. Selective inhibition of LC-NE neurons during stress will 
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be important to determine whether there is physiological relevance to the findings in Figure 
A2.2 and Hickey et al., 2014.  
 The study of descending modulation of pain by the LC-NE system is clear example of a 
case where integration between Part 1 and Part 2 of this dissertation would be fruitful (Figure 
7.3B). As previously discussed, integration of the optofluidic neural probes (Chapter 4) with the 
spinal cord is a promising future direction. In the case of descending LC-NE projections, the 
ability to optically stimulate LC-NE terminals within the spinal cord would provide direct 
evidence that the analgesic effect of LC-NE stimulation is via descending projections rather than 
through central modulation in the amygdala or elsewhere. Furthermore, local pharmacology in 
the spinal cord could help to resolve the receptor systems mediating any observed effects. 
Beyond local modulation in the spinal cord, Hickey et al., 2014 presented evidence of a dorsal-
ventral shift between pronociception and antinociception in the LC. Using independently-
addressable !-ILEDs such as those used in Appendix 1, could help decipher the contribution and 
significance of this anatomical functional segregation within the LC proper. 
Stress-induced arousal disorders 
 The LC-NE system is intimately involved in the regulation of arousal states (Aston-Jones 
and Bloom, 1981; Carter et al., 2010, 2012; Foote et al., 1980; Sara and Bouret, 2012). While the 
awake state seems to be mediated by the presence of any tonic activity (Aston-Jones and Bloom, 
1981; Bloom, 1981; Carter et al., 2010), we now know that increased tonic activity mimics the 
behavioral phenotypes of stress (Figures 5.4, 5.6, 5.8, 5.13, 6.1, 6.6). The connection between 
stress, anxiety, arousal and the LC-NE system is likely a continuum: the more LC-NE activity, 
the more arousal, the more anxiety-like behavior. While we believe that LC activation likely 
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adjusts the gain on downstream anxiety systems (e.g. BLA activity), we have not examined the 
long-term consequences of exogenously increasing LC activity. Chapters 5 & 6 only test acute 
anxiety-like and aversive states. It is possible that chronic, long-term activation of LC-NE cell 
bodies would produce a state of hyperarousal a known symptom of post-traumatic stress disorder 
(Krystal and Neumeister, 2009). Once again, utilizing some of the technology presented in Part 1 
can now more directly test such a hypothesis. Wireless !-ILED devices that utilize RF power 
harvesting are suitable for long-term photostimulation in a homecage environment. Thus, one 
could directly test the behavioral effects of chronic LC stimulation. Wireless optogenetics, 
however, are not necessary for such a design. It would also be possible to mimic chronic 
activation of the LC by targeting the Gq-coupled DREADD receptor to LC-NE neurons and 
deliver CNO via an osmotic pump. While the time-frame of this design would be limited by the 
CNO exposure, it would certainly allow for long-term activation of LC-NE neurons.  
Closing thoughts 
 While both Part 1 and Part 2 of this dissertation provide new tools for interrogating 
neural function and insight into the role of LC-NE system in stress-induced behaviors, each Part 
is only a very early step in these processes. Flexible, wireless neural probes ultimately have the 
potential clinical translation. Perhaps not with optogenetics in mind, but less invasive and less 
cumbersome medical devices are promising future applications of these kinds of technology. 
With a clearer understanding of the function of the LC-NE system in stress-induced behaviors, it 
is even possible that such technologies could be used to ameliorate psychiatric disorders, relieve 
pain, or prevent the deleterious effects of chronic stress and axnxiety. 
MATERIALS & METHODS 
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Stereotaxic surgery 
 Mice were anaesthetized in an induction chamber (5% isoflurane) and placed in a 
stereotaxic frame (Kopf Instruments, Model 1900) where they were maintained at 1-2% 
isoflurane throughout the procedure. Following craniotomy mice were injected bilaterally with 
1.2 !l of either lenti-EF1"-GFP or lenti-CaMKII"-opto!2AR-mCherry in the basolateral 
amygdala at stereotaxic coordinates from bregma: -1.3 mm (AP), ± 2.9 mm (ML) and  -4.9 mm 
(DV). For wireless !-ILED BLA studies, animals were injected unilaterally, not bilaterally. Mice 
were then implanted with chronic fiber optic implants or !-ILED wireless devices with 
coordinates adjusted from viral injection to 0.00 mm (AP), ± 0.00 mm (ML), and +1.00 mm 
(DV). For bio-dissolvable samples, the device was implanted at the desired target, ACSF was 
applied to the portion of the device that remained outside of the skull to facilitate dissolution of 
the adhesive, and then the epoxy needle was removed after a delay of 15 min (Kim et al., 2013; 
McCall et al., 2013). The fiber optic implants and wireless !-ILED devices were secured using 
two bone screws (CMA, 743102) and affixed with TitanBond (Horizon Dental Products) and 
dental cement (Lang Dental) (McCall et al., 2013). Mice were allowed to recover for at least 3-6 
weeks prior to behavioral testing; this interval also permitted optimal viral expression. 
Wireless powering and RF powering scavenger for wireless optogenetics 
 Wireless powering of the !-ILED devices was adapted as previously described (Kim et 
al., 2013; McCall et al., 2013). The wireless power transmitter includes an RF signal generator 
(Agilent N5181A), a power supply (Agilent U8031A), a RF power amplifier (Empower RF 
Systems 1119-BBM3K5KHM), an RF signal splitter (RF Lambda RFLT2W0727GN), and two 
panel antennas (ARC Wireless ARC-PA2419B01).  The RF signal generator is internally 
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modulated to delivery sufficient power to light the !-iLEDs at the given stimulation protocol (10 
Hz, 50 ms pulse widths).  The RF power amplifier that is powered by the power supply enlarges 
the modulated RF signal from the RF signal generator.  The RF power is then transmitted from 
the panel antenna to the headstage power harvesters.  The RF signal generator has a power 
output from -10 to 0 dBm at 1.5 GHz, optimized daily to ensure equivalent light power 
throughout the space of the LDB assay. Mice with chronically implanted µ-ILED devices were 
acutely connected to the headstage power harvesters immediately prior to any wireless 
photostimulation. 
Behavior – Light/Dark Box (LDB) 
 Behavioral assays were performed in a special sound attenuated room maintained at 
23°C. Lighting was measured and stabilized at ~ 4 lux for anxiety tests and ~200 lux for place 
testing. All behavioral apparatuses were cleaned with 70% ethanol in between animals. In each 
assay, animals received constant photostimulation throughout the entire trial. For all behavioral 
experiments, lenti-EF1"-GFP and lenti-CaMKII"-opto!2AR-mCherry received 5 sec of constant 
photostimulation (473 nm) followed by 5 sec of no light throughout the entire trial.  Movements 
were video recorded and analyzed using Ethovision Software. The LDB was a 50 x 50 cm square 
plexiglass enclosure with a 16.5 cm x 49 cm dark insert. For testing, animals were connected to 
wireless harvester and placed into the corner of the open enclosure and allowed to roam freely 
for 10 min. 
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SUMMARY 
 Both the nucleus accumbens (NAc) and the dynorphinergic system are widely implicated 
in motivated behaviors. Prior studies have shown that activation of the dynorphin-kappa opioid 
receptor (KOR) system can lead to aversive, dysphoria-like behavior. However, the endogenous 
sources of dynorphin in these circuits remain unknown. We investigated whether dynorphinergic 
neuronal firing in the NAc is sufficient to induce aversive behaviors. We found that 
photostimulation of dynorphinergic cells in the dorsal NAc shell induces robust place preference 
and is positively reinforcing in an operant paradigm, whereas activation of dynorphin neurons in 
the ventral NAc shell elicits robust conditioned and real-time aversive behavior via KOR 
activation. These results show a previously unknown, discrete NAc subregion of dynorphin-
containing cells in the ventral shell that selectively drive aversive behavior. Understanding the 
regional specificity by which NAc dynorphinerigic cells regulate aversion provides valuable 
insight into the motivated behaviors dysregulated in stress and psychiatric disease. 
INTRODUCTION 
 It is now widely thought that many mood disorders are associated with major disruption 
of the brain’s reward circuitry (Nestler and Carlezon, 2006). The nucleus accumbens (NAc) is a 
key region within this circuitry with major projections from the ventral tegmental area (VTA), 
medial prefrontal cortex (mPFC), basolateral amygdala (BLA) and the hippocampus (Russo and 
Nestler, 2013). Recent studies have identified the striatum as crucial for integrating behavioral 
responses to both positive and negative reinforcement (Castro and Berridge, 2014; Everitt and 
Robbins, 2005; Kravitz et al., 2012). Furthermore, it is thought that negative emotional states are 
what mediate and perpetuate the phases of depression as well as increase susceptibility to drug 
abuse. NAc neuronal activity is consistently reduced in major depression in humans (Drevets et 
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al., 1992; Mayberg et al., 2000) and is thought to reflect loss of reward function that drives 
common symptoms such as anhedonia (Russo and Nestler, 2013). In order to better understand 
these processes, it is important to dissect how neuromodulator systems within specific 
subregions of the brain function to influence negative emotional states, represented by changes in 
motivated behavior.  
 The kappa opioid receptor (KOR) system has recently been identified as one such 
prominent neuromodulator system for regulating motivated behavior and is highly implicated in 
stress-induced dysphoria and vulnerability to drug abuse. Its peptide dynorphin (Dyn), which is 
cleaved from the precursor prodynorphin, endogenously activates KORs (Chavkin et al., 1982). 
Dyn is known to mediate negative emotional states, with KOR agonists inducing place aversions, 
depression-like behavior, and dysphoria in human and animal models (Mucha et al., 1985; 
Pfeiffer et al., 1986; Shippenberg et al., 2007). Notably, direct infusion of KOR agonists into the 
NAc mediates conditioned place aversion (Bals-Kubik et al., 1989), and local antagonism of 
KOR in this region prevents depression-like behavioral responses (Land et al., 2009; Shirayama 
et al., 2004). Furthermore, Dyn-containing axon terminals and cell bodies are located in the NAc 
(Van Bockstaele et al., 1995). Additionally, a number of studies have shown recruitment of the 
Dyn/KOR system in the NAc following compulsive drug taking (Daunais et al., 1993; Fagergren 
et al., 2003; Hurd et al., 1992; Lindholm et al., 2000; Schlussman et al., 2005; Solecki et al., 
2009). It is thought that monoamine output within the NAc is tightly regulated via presynaptic 
KORs on serotonergic and dopaminergic cells in the region, ultimately acting to suppress release 
of dopamine and serotonin. However, the mechanisms and role of Dyn-containing circuits in the 
regulation of KOR-mediated negative affective behaviors remain unresolved (Bruchas et al., 
2010, 2011).  
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 Here we directly ascertained the sufficiency of local Dyn release within the NAc shell to 
drive aversive behavior. We hypothesized that photostimulation of Dyn-containing cells in the 
NAc shell will drive an aversion behavior in a real-time place testing paradigm using a new form 
of birdirectional wireless !-ILED optogenetic technology, a conditioned place testing paradigm 
and an operant self-stimulation paradigm. We report a distinct subpopulation of ventral NAc 
Dyn-containing cells that when activated produce robust aversive behavioral responses, whereas 
stimulation of a nearby dorsal NAc site engages positively reinforced motivated behaviors. 
RESULTS 
Activation of dynorphinergic cells in the NAc shell drives both aversion and reward 
 To determine key sites of Dyn influence throughout the brain we generated a Dyn-
tdTomato-reporter mouse by crossing preprodynorphin-IRES-Cre (Dyn-IRES-Cre) mice to Allen 
Institute for Brain Science tdTomato flox-stop reporter line (Ai9) (Madisen et al., 2010) (Figure 
A1.1A, Figure A1.2). This new mouse line (Dyn-CretdTomato) is useful for Cre-dependent 
expression/excision in selected Dyn-circuits and provides a representative map of Dyn 
expressing cells, Dyn axon projections, and terminal fields. We first characterized Dyn 
expression across the full brain of these mice, comparing our Dyn-CretdTomato expression side-by-
side with in situ hybridization data (Figure A1.1B) to confirm soma specific labeling in well 
known Dyn enriched regions. Using Dyn-CretdTomato mice we visualized an abundance of Dyn-
containing cells within the NAc, in direct line with current literature (Figure A1.1C). In 
addition, we found robust Dyn-induced tdTomato expression in the hippocampus, bed nucleus of 
the stria  
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Figure A1.1: Photostimulation of dynorphinergic cells in the NAc shell drives and aversion 
and reward. A. Dyn labeling in Dyn-IRES-cre x Ai9-tdTomato compared to in situ images from 
the B. Allen Institute for Brain Science in a sagittal section highlighting presence of Dyn in the 
striatum, the hippocampus, BNST, amygdala, hippocampus and substantia nigra. All images 
show tdTomato (red) and Nissl (blue) staining. C. Coronal section highlighting dynorphinergic 
cell labeling in the NAc as compared to the Allen Institute for Brain Science. D. Cartoon 
depicting virus and fiber optic placement. E. Whole cell slice recording showing that 
dynorphinergic cells in the NAc shell fire optically stimulated action potentials from 5-40 Hz. F. 
Cartoon of real time place testing set up and a frequency response curve showing two distinct 
groups ‘preferers’ and ‘averters’ spend significantly more time in the stimulated and non-
stimulated side, respectively, following 10, 20 and 40 Hz stimulation (Data represented as mean 
± SEM, n=6: Two-Way ANOVA, interaction effect between groups and frequency, p<0.0001) in 
a real-time place testing paradigm G. At 10 Hz preferers and averters show a significant 
preference or aversion compared to one another and controls (Data represented as mean ± SEM, 
n=5-8: One-Way ANOVA, Bonferroni post-hoc, control vs preferers ****p<0.0001, control vs 
averters **p<0.01, preferers vs averters ####p<0.0001). H. At 20 Hz preferers and averters show 
a significant preference or aversion compared to one another and controls (Data represented as 
mean ± SEM, n=6: One-Way ANOVA, Bonferroni post-hoc, control vs preferers ****p<0.0001, 
control vs averters ***p<0.001, preferers vs averters ####p<0.0001). I. Scatter plot for preferers 
and averters at following 10Hz photostimulation, with representative IHC showing that preferers 
show dorsal ChR2 expression whereas averters show ventral ChR2 expression (n=7-10). 
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Figure A1.2 Additional Dyn labeling in Dyn-IRES-cre x Ai9-tdTomato throughout the 
brain. A. Bregma 1.94, coronal section including the cortex and NAc. B. Bregma -2.18, coronal 
section including the hippocampus and tracts through the cerebral peduncle. C. Bregma -3.08, 
coronal section including the substantia nigra and the VTA. D. Bregma -5.34, coronal section 
including the parabrachial nucleus and the colliculus E. Dynorphinergic labeling in the dopamine 
rich areas of the ventral tegmental area and the substantia nigra. F. Dynorphinergic labeling in 
the locus coeruleus and G. the dorsal raphe.  Images are representative of three separate brains 
imaged in their entirety. 
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terminalis, basolateral amygdala, central nucleus of the amygdala, throughout the cortex, caudate 
putamen, globus pallidus, the dopamine rich areas of the ventral tegmental area and the substania 
nigra, dorsal raphe and locus coeruleus (Figure A1.1A, Figure A1.2A-G). 
 To dissect the role of NAc Dyn-containing cells, we utilized in vivo optogenetics to 
selectively target these neurons and assess their ability to be photostimulated (Figure A1.1D). 
However, due to the novelty of this Dyn-Cre mouse line we first determined whether 
photostimulation of Dyn-containing cells could elicit action potentials at multiple frequencies in 
slice. We injected AAV5-DIO-ChR2-eYFP into the NAc of Dyn-Cre mice and performed 
whole-cell electrophysiology. We found robust intact spike fidelity at frequencies of 5 Hz, 10Hz 
and 20Hz (1 ms pulse width), which was not maintained at 40 Hz (Figure A1.1E).  
 Prior reports have suggested that the Dyn/KOR system mediates negative emotional 
states through increased Dyn expression in the NAc, contributing to the dysphoria associated 
with depression and drug dependence. However, the endogenous source of Dyn in these 
responses has not been previously shown (Britton et al., 1982; Bruchas et al., 2010; Knoll et al., 
2011; Lindholm et al., 2000; Mucha et al., 1985; Pfeiffer et al., 1986; Rylkova et al., 2009; 
Schlosburg et al., 2013; Shippenberg et al., 2007). Given the location of Dyn-containing cells in 
the NAc, we first hypothesized that photostimulation of NAc-Dyn neurons will produce aversive 
behaviors. To test this hypothesis we injected AAV5-DIO-ChR2-eYFP,chronically implanted a 
fiber optic into the NAc shell of Dyn-Cre positive and Dyn-Cre negative mice and used a real-
time place-testing paradigm (RTPT) (Figure A1.1F). During this 20 min behavioral test, 
photostimulation occurs in real-time only upon entry into the counterbalanced designated 
chamber (Carter et al., 2010; Stamatakis and Stuber, 2012; Tan et al., 2012). Behavioral data are 
then calculated as time spent in the photostimulation- paired chamber, expressed as a percentage 
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of total time. In this experiment we also assessed the efficacy of photostimulated cell firing in 
vivo in producing real-time behavioral responses, as compared to the in vitro whole-cell 
recordings. In accordance with our hypothesis, we show that photostimulation of Dyn-containing 
cells in the NAc shell over the same range of frequencies, 5Hz, 10Hz and 20Hz produces a 
significant real-time aversion behavior, that plateaued at 40Hz, correlating with the in vitro 
whole-cell recordings (Figure A1.1E). However a subgroup of mice showed a robust preference 
behavior when compared to controls. We therefore defined these two groups as real time 
‘averters’ or ‘preferers’. Our data show a significant interaction between the preferers, averters, 
controls and the frequency of photostimulation (Figure A1.1F). In addition, in vivo 10Hz and 
20Hz stimulation produced a significant real-time place-preference and aversion in the preferers 
as well as the averters, respectively, compared either to control or to one another (Figure A1.1 G 
and H). To investigate what may drive these opposing behavioral states between preferers and 
averters we carefully examined the anatomical distribution of viral expression within the NAc 
shell of each individual mouse and group. Interestingly, we identified that mice which exhibited 
a preference behavior, showed isolated dorsal viral expression in the NAc shell whereas mice 
which exhibited an aversion behavior showed a more ventral pattern of viral expression (Figure 
A1.1I). These results suggest that photostimulation of Dyn-containing cells in discrete 
subregions within the NAc shell can drive opposing behaviors with distinct positive or negative 
valence. These data indicate that photostimulation of Dyn-containing cells in the dorsal NAc 
drives a real-time place preference whereas photostimulation of Dyn-containing cells in the 
ventral NAc drives a real-time place aversion.  
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Spatially discrete targeting of NAc dyn-containing cells engages both preference and 
aversion in the same animal 
 To further investigate the subregional distinction in behavior within the NAc shell and to 
enable precise, discrete spatial targeting we used a novel modified form of our recently 
developed wireless µ-ILED devices (Kim et al., 2013; McCall et al., 2013). We reconfigured the 
original wireless !-ILED devices to produce a device that allows isolated and directionally 
controlled light to specific NAc subregions. In this case we positioned one !-ILED to target the 
dorsal NAc and the other the ventral NAc shell (Figure A1.3A, Figure A1.4), separated by a 
distance of 1 mm. These devices are wirelessly controlled using an RF power source, which can 
either stimulate each !-ILED independently or both together simultaneously (Figure A1.3B, 
Figure A1.4). These devices provide discrete spatial targeting and importantly allow us to 
photostimulate each region to drive opposing behaviors within the same individual mouse. 
Following viral injections of AAV5-DIO-ChR2-eYFP into the NAc shell of Dyn-Cre positive 
and Dyn-Cre negative mice, with expression spanning both dorsal and ventral co-ordinates, 
devices were implanted into mice and used in the real-time place preference paradigm (Figure 
A1.3C). Here we show that within the same mouse we can selectively photostimulate the ventral 
NAc, to produce a real time aversion or we can photostimulate the dorsal NAc to drive a real 
time preference (Figure A1.3D, E & F). In addition, photostimulation of Dyn-containing cells in 
either the dorsal or the ventral NAc shell does not induce any significant changes in locomotor 
activity compared to controls (Fig 2F). In addition, we wanted to investigate if targeting these 
distinct regions in the NAc induced anxiety behavior, since recent reports have implicated the 
KOR/Dyn system in anxiety-like behavioral responses (Bruchas et al., 2009; Knoll et al., 2011).   
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Figure A1.3 Discrete spatial targeting drives preference and aversion in the same animal. 
A. Directionally-controlled light spread of !-iLED devices has advantages over fiber optics for 
isolating subregions of NAc as demonstrated in the fluorescein images. B. Images of an ultrathin 
(~10-50 !m), flexible integrated system. Light can be isolated to either dorsal or ventral NAc C. 
Behavioral calendar outlining the design of the experimental procedure. D. Examples of real-
time mouse behavioral traces following no stimulation, ventral or dorsal wireless 
photostimulation. E. An aversion and preference real-time behavior following stimulation of the 
ventral and dorsal NAc shell within each individual mouse (Data represented as mean ± SEM, 
n=5: Student’s t-test, p=0.05). F. Stimulation with dorsal LED drives a real-time place 
preference but stimulation with ventral LED drives an aversion, which are significantly different 
from one another (Data represented as mean ± SEM, n=6: One-Way ANOVA, Bonferroni post-
hoc **p<0.01) G. No significant difference in locomotor activity measured during a 20 min trial 
between all groups (Data represented as mean ± SEM, n=6).  
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Figure A1.4 Fabrication details for the bidirectional !-iLED devices. A. Circuit diagram of 
wireless energy harvester operating at 1.5Ghz and 2.4 GHz. It consists of antennas, impedance 
matching circuits, Cockcroft-Walton multiplier, and  
blue-LED. B. An image showing the device plus the harvester that wirelessly powers the device. 
C. An image of the !-iLED connected to the harvester that can power either the dorsal or ventral 
!-iLED at different carrier frequencies. D. Light emission spectrum of blue LED which has the 
peak wavelength of 465 nm E. Light output-Current-Voltage (L-I-V) characteristics of injectable 
LED device. F. No significant difference in mean velocity measured during a 20 min trial 
between all groups (Data represented as mean ± SEM, n=6).  
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 Together, these data support the hypothesis that activation of Dyn-containing cells in the 
ventral NAc shell drives an aversion behavior. These novel devices also demonstrate that within 
the same animal we can cause a preference behavior by stimulating Dyn-containing cells in the 
dorsal NAc shell. Bidirectional µ-ILED control adds confidence to the current findings and 
suggests that stimulation of the subsets of neurons within the NAc dynorphinergic system is 
capable of dynamic engagement of either positive or negative behavioral valence. Furthermore, 
because these devices are ultrathin, minimally invasive, (Kim et al., 2013) and target both dorsal 
and ventral NAc, there is limited likelihood that dorsal lesions from our earlier fiber optic 
implantation (Figure A1.1) influence the observed behavioral responses.  
Aversion following photostimulation of Dyn-containing neurons in the ventral NAc shell 
requires KOR activity 
 Current research indicates a role for NAc KORs in aversive negative affective behaviors 
involved in stress, dysphoria and drug abuse (Bals-Kubik et al., 1989; Land et al., 2009; Mucha 
et al., 1985; Shippenberg et al., 2007; Solecki et al., 2009). Therefore, we hypothesized that 
activation of kappa opioid receptors following the photostimulated-release of Dyn in the ventral 
NAc is one of the key underlying mechanisms for the observed aversion behavior.  
 From this point onward we modified our virus volume and co-ordinates to specifically 
target either the dorsal or ventral NAc shell. We also injected Cre-negative control mice in either 
the dorsal and ventral NAc and saw no effect of photostimulation in either group. Based on the 
results from our whole cell slice recordings and in vivo frequency response data we 
photostimulated at 10 Hz with a 10 ms pulse width to elicit action potential firing, evoke release 
of Dyn, remain physiologically-relevant and to maintain spike fidelity. We first assessed how 
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photostimulation of Dyn-containing cells in the ventral NAc shell drives an aversion in a 
conditioned place preference paradigm.  This behavioral model is a form of pavlovian 
conditioning used to measure the motivational or aversive effects of an associated experience. 
The key component of this model is the learning aspect, which was absent in our RTPT 
paradigm (Figure A1.1). We showed that in a y-maze conditioning paradigm (Figure A1.5A) 
we are able to condition mice to the photostimulation of Dyn-containing cells in the ventral Nac 
to drive an aversion behavior, which is consistent with our earlier findings. In addition, 
conditioned photostimulation of dorsal Nac shell was able to drive a significant preference 
behavior when compared to controls and to each other (Figure A1.5B, C & D).  
 To test the hypothesis that the aversion behavior is driven by the release of Dyn from 
cells within the ventral NAc shell acting on KOR we locally infused the long acting KOR 
antagonist NorBNI (2.5µg/1µl) (Bruchas et al., 2007; Al-Hasani et al., 2013; Melief et al., 2010) 
into the ventral NAc shell, 14 days after site specific viral (AAV5-DIO-ChR2-eYFP) injection in 
to the ventral NAc (Figure A1.5A). Importantly, injection of NorBNI into the ventral NAc shell 
was able to significantly block the aversion seen following photostimulation of Dyn-containing 
cells (Figure A1.5B, C, D) with no observed change in locomotor activity (Figure A1.5E). 
These findings identify the aversion behavior mediated following photostimulation of Dyn-
containing cells in the ventral NAc as KOR-mediated, acting locally within the NAc itself, 
consistent with prior studies using exogenous ligand infusions within this region (Castro and 
Berridge, 2014; Land et al., 2009; Shippenberg et al., 2007).  
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Figure A1.5 Aversion following photostimulation of Dyn-containing neurons in the ventral 
NAc shell requires KOR activity. A. Calendar outlining experimental procedure for the Y-
maze paradigm. B. Representative heat map of activity during post-test day 5. C. Mice injected 
and photostimulated in the dorsal NAc show a significant increase in % time spent in 
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conditioned arm of the Y-maze whereas mice stimulated in the ventral NAc show an aversion 
(Data represented as mean ± SEM, n=8-13: One-Way ANOVA, Bonferroni post-hoc, control vs 
dorsal **p<0.01, Control vs ventral *p<0.05, dorsal vs ventral ****p<0.0001, dorsal vs ventral 
NorBNI ##p<0.01, ventral vs ventral NorBNI #p<0.05. D. Change from baseline measured 
across all 5 days of the y-maze paradigm (Data represented as mean ± SEM, n=8-13, Two-Way 
ANOVA, interaction effect between groups and days, p<0.0001) E. No significant difference in 
locomotor activity measured during a 20 min trial between all groups (Data represented as mean 
± SEM, n=8-13). F. Calendar outlining experimental procedure for the operant self-stimulation 
paradigm. G. No significant difference in active nose pokes for food reward between all groups 
(Data represented as mean ± SEM, n=6-7). H. Data showing number of nose pokes across 5 days 
of operant self-stimulation. Dorsally injected mice show significantly increased active nose 
pokes, compared to controls and ventrally injected mice, which show a significant reduction in 
nose pokes following photostimulation (Data represented as mean ± SEM, n=6-7: Two Way 
repeated measures ANOVA, Bonferroni post-hoc; dorsal vs controls, ventral and ventral NorBNI 
on day 1,2,3 ****p<0.0001, dorsal vs control and ventral on day 4 *p<0.05, control vs ventral on 
day 1 **p<0.01, ventral vs ventral NorBNI ***p<0.001. I. Significant differences in total nose 
pokes on day and day 2 following photostimulation (Data represented as mean ± SEM, n=6-7: 
One-Way ANOVA, bonferroni post-hoc, control vs dorsal ****p<0.0001, control vs ventral 
*p<0.05, dorsal vs ventral ****p<0.0001, dorsal vs ventral NorBNI ****p<0.0001, ventral vs 
ventral NorBNI **p<0.01. J. Representative 60 min trials for each group.  
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Distinct NAc dynophin populations in operant stimulation produce positive and negative 
responses 
 The operant self-stimulation paradigm is unique in that it demonstrates the ability of a 
mouse to establish response habits similar to those exhibited to natural rewards. Here we 
assessed the contribution of dorsal and ventral NAc shell Dyn-containing neurons in self-
stimulation. Importantly, all groups of mice, whether injected with AAV5-DIO-ChR2-eYFP in 
Dyn-Cre mice, in either the dorsal or ventral NAc, were able to learn to poke for a food reward 
(Figure A1.5F and G). Following food training the food pellet was replaced with a 2s (10Hz, 
10ms pulse width) photo-stimulation, which was delivered following a nose poke. The dorsally 
injected mice continued to show positive reinforcement behavior but the number of nose pokes 
increased 5-fold following photostimulation, emphasizing the highly rewarding nature of self-
stimulation of this NAc shell subregion (Figure A1.5G, H, I). However, both the controls and 
the ventrally-injected mice decreased their number of nose pokes following photostimulation. 
While both were significantly different compared to the dorsally injected mice, the ventrally 
injected mice showed a significant decrease in the number of nose pokes compared to controls 
(Figure A1.5G, H, I). The aversive nature of the photostimulation in the ventral NAc shell mice 
suggest that it is strong enough to mute the extinction burst seen during the first day of 
photostimulation and accelerate extinction following food training. The extinction burst is 
characteristic in the operant model but in the case of this experiment is highly interesting as the 
ventrally-injected mice show an acceleration in extinction and overall reduced nose pokes for 
photostimulation whereas the dorsal mice maintain an increased number of nose pokes due to the 
rewarding nature of the stimulation (Figure A1.1G, H, I). These operant self-stimulation data 
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further suggest that there is a dynamic relationship between the positively reinforcing and 
aversive nature of stimulating distinct subpopulations of NAc shell Dyn-containing cells. 
DISCUSSION 
 In the present study we identify that photostimulation of Dyn-containing cells in discrete 
subregions within the NAc shell drive opposing motivational behavioral states. We show that 
photostimulation of Dyn cells in the ventral NAc shell drives aversion behavior whereas 
photostimulation in the dorsal NAc shell drives a preference/reward behavior. This is the first 
study to our knowledge to report a distinction in aversion and reward behavior within the NAc 
shell via dynorphin-containing cells and here we demonstrate this using three different 
behavioral paradigms; real-time place testing using bidirectional wireless !-ILED technology, 
conditioned place testing and operant self-stimulation.  
 Previous studies reported that the Dyn/KOR system mediates negative emotional states 
through increased Dyn expression in the NAc, contributing to the dysphoria associated with 
depression, drug dependence and withdrawal but the mechanisms for engagement of dynorphin 
circuitry are unknown (Britton et al., 1982; Bruchas et al., 2009; Knoll et al., 2011; Lindholm et 
al., 2000; Mucha et al., 1985; Pfeiffer et al., 1986; Rylkova et al., 2009; Schlosburg et al., 2013; 
Shippenberg et al., 2007). In this study we are able to show that activation of Dyn-containing 
cells within a distinct region of the NAc shell, the ventral NAc shell, drives an aversion behavior, 
as demonstrated in a real-time place preference paradigm. Few reports have extensively 
investigated regional distinctions within the NAc that might mediate differences in aversion and 
reward behaviors. However, it has recently been shown that the rostrodorsal quadrant of the 
medial NAc shell contains a specialized opioid hedonic hotspot in rats, which traditionally 
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mediates an increase in “liking” following mu opioid receptor (MOR) activation, however a role 
has also been identified for both delta opioid receptors (DOR) and KOR (Castro and Berridge, 
2014). Within this recent body of work, a separate suppressive cold spot in the caudal half of the 
shell was identified in which each opioid stimulation oppositely reduced sucrose positive 
“liking” reactions (Castro and Berridge, 2014). In addition to these interesting findings this 
group also identified several anatomical differences between NAc opioid control of “liking” 
verses “wanting” of feeding (Castro and Berridge, 2014). These results highlight anatomical 
heterogeneity of the NAc, but also show that this is localized to opioid reward related functions 
in the medial shell that includes a role for KOR system. While using different species and 
behavioral model we report here a consistent heterogeneity within the NAc shell, where selective 
photostimulation of the endogenous Dyn-containing cells in the dorsal NAc shell drives a 
preference/reward behavior but photostimulation of Dyn neurons in the ventral shell drives an 
aversion behavior. Further, a recent study has found that prodynorphin content specifically in the 
ventral NAc shell is dramatically increased following 12 hour long access heroin self-
administration, and that escalation of this drug-seeking behavior was suppressed following 
treatment with the long acting KOR antagonist NorBNI (Schlosburg et al., 2013). These recent 
findings further support our present data, and suggest that the release of Dyn in distinct 
subregions within the NAc shell drives opposing motivated behavioral states.  
 To discretely isolate these small subregions of the accumbens within a single animal, we 
modified our original wireless, spatially-targeted !-ILED devices (Kim et al., 2013; McCall et 
al., 2013) to enable independent illumination of either the ventral or dorsal region of the NAc 
within the same mouse. A device with these capabilities has not been previously used, but here 
we generated a modified version of them to directly test the question of spatial segregation of 
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reward and aversion within the NAc shell. Here we adapted the connection and powering 
schemes of the !-ILED devices to provide multiple channels of independent optical control. 
Using these devices we were able to drive a real-time aversion and reward behavior within the 
same mouse confirming that engaging Dyn neurons in these discrete regions mediates opposing 
behaviors. Importantly, we also found that stimulating these distinct regions does not mediate an 
anxiety-like behavior, consistent with previous reports that identify the basolateral amygdala and 
the central nucleus of the amygdala as the key KOR site involved in the mediation of anxiety-
like behaviors (Bruchas et al., 2009; Knoll et al., 2011). 
 These !-ILED devices could be easily modified for other potential uses, for example the 
!-ILEDs can be differentially spaced and/or oriented to target different regions or subregions 
within the brain. Additional !-ILEDs can be added to the device to target larger brain regions or 
multiple subregions in a dorsal-ventral axis, such as layers of the cortex, or other similar 
structures. !-ILEDs of different wavelengths could also be added enabling photoactivation or 
inhibition of various opsin constructs within the same structure. The wireless capabilities also 
enable us to carry out optogenetic experiments within the home cage itself, which are more 
difficult using traditional fiber optic tethering.  
 Looking closely at the neurobiological sources of Dyn and KOR in the NAc, it is widely 
known that Dyn is predominantly expressed in medium spiny neurons within the NAc that 
coexpress dopamine D1 receptors (Ghazarossian et al., 1980; Raynor et al., 1994); however, 
there are also input projections from other structures that could also release Dyn, for example the 
ventral pallidum and the lateral hypothalamus (Baldo et al., 2003; Groenewegen et al., 1999; 
Haber et al., 1985; Peyron et al., 1998). It is reported that postsynaptic KOR in the NAc are on 
dendrites of most medium spiny neurons but reside predominantly on the dopamine D2 
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expressing medium spiny neurons (Svingos et al., 1999).  KORs are also widely known to be 
expressed on presynaptic terminals of glutamate, serotonin and dopamine projections into the 
NAc (Bruchas et al., 2011; Hjelmstad and Fields, 2001; Land et al., 2009; Schindler et al., 2012; 
Svingos et al., 1999). In light of this we hypothesized that the Dyn-mediated aversion in the 
ventral NAc is driven by activation of KOR locally in the NAc. In both a conditioned place 
preference and an operant self-stimulation paradigm we show that NorBNI is able to block the 
aversion behavior following photostimulation of Dyn neurons in the ventral NAc shell, thereby 
identifying that aversion behavior in the ventral NAc is mediated by a local KOR dependent 
mechanism.  
 Photostimulation of Dyn-containing cells in the dorsal NAc drives a preference/reward 
behavior in all of the three paradigms. Interestingly, Berridge’s group are the first to report 
positive rewarding effects for kappa activation but this was restricted to the rostrodorsal shell 
hotspot as all other areas produced negative effects (Castro and Berridge, 2014). They suggest 
that the anatomical specificity gates the valence of KOR effects in the NAc. Though this is 
certainly a consideration in the present study it is important to note that the Dyn-containing cells 
we are photostimulating also express dopamine D1 receptors so it is certainly likely that upon 
photostimulation we are in fact likely mimicking D1 receptor activation which would in turn 
induce a preference/reward behavior. In fact, optogenetic stimulation of the direct pathway, 
Dyn/Dopamine receptor-1 (D1-R) containing neurons in the dorsal striatum has been shown to 
be rewarding in several contexts (Kravitz et al., 2012). Here we have shown that we can produce 
the same behavior but by targeting a more discrete region dorsal NAc. Further investigation is 
warranted to identify whether the preference behavior is KOR-dependent or more likely 
consistent with the well-established D1 receptor mediated effect.  
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 The key finding of the present study is that we have identified two distinct subregions 
within the NAc shell that drive opposing behavioral valences. The elegant work of Thompson 
and Swanson (2010) identified that within the NAc network nodes exist which are localized and 
restricted to specific subdivisions within a region, which is why regions such as the hedonic 
hotspot have been considered important (Thompson and Swanson, 2010). Furthermore, it is the 
distinct projections to and from these discrete regions that will help us to understand what is 
driving the unique behavioral outputs in this present study. To begin investigating these 
projections we will use a combination of the Dyn-reporter mouse (Dyn-CretdTomato) generated and 
viral tracing approaches.  We have characterized Dyn expression across the full brain of these 
mice, comparing our results with data freely available from the Allen Institute for Brain Science 
(Lein et al., 2007). This mouse line is useful for Cre-dependent expression/excision in selected 
Dyn-circuits, provides us with a new map of Dyn expressing cells, and a simple way to easily 
trace dynorphinergic axon projections and terminal fields.  
 Here we identified two distinct subregions within the NAc shell, which drive opposing 
behaviors through activation of the KOR/Dyn system. Photostimulation of Dyn-containing 
neurons in the ventral NAc shell causes a KOR dependent aversive behavior whereas 
photostimulation of Dyn-containing neurons in the dorsal NAc shell causes preference. 
Understanding the circuitry that mediate motivated behaviors is critical in furthering our 
understanding of positive and negative affective states that contribute to mood disorders, 
addiction and depression. 
MATERIALS & METHODS 
Experimental subjects  
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 Adult (25–35 g) male preprodynorphin-IRES-Cre (Dyn-Cre) mice were group-housed, 
given access to food pellets and water ad libitum and maintained on a 12 h:12 h light:dark cycle 
(lights on at 7:00 AM). All animals were kept in a sound attenuated, isolated holding facility in 
the lab one week prior to surgery, post-surgery and throughout the duration of the behavioral 
assays to minimize stress. All procedures were approved by the Animal Care and Use Committee 
of Washington University and conformed to US National Institutes of Health guidelines.  
Generation and breeding of Pdyn-IRES-Cre mice and Ai9-x Pdyn-IRES-Cre 
 Pdyn-IRES-Cre mice were kindly provided by Bradford Lowell’s lab (Krashes et al., 
2014) see for details. The mice were bred in our facilities by crossing the pdyn-IRES-Cre mice 
with C57BL/6 wildtype mice and backcrossed for seven generations. These mice were then 
crossed to Ai9-tdtomato mice on C57BL/6 background, bred and backcrossed for seven 
generations.  
Stereotaxic viral injection surgery  
 After the animals were acclimatized to the holding facility for seven to nine days, the 
mice were anaesthetized in an induction chamber (4% Isoflurane) and placed into a stereotaxic 
frame (Kopf Instruments, Model 1900) where they were maintained at 1-2% isoflurane. We 
performed a craniotomy and unilaterally injected, using a blunt needle (86200, Hamilton 
Company, Reno, NV), 300 nl of AAV5-DIO-ChR2-eYFP or AAV5-DIO-eYFP (Hope Center 
Viral Vector Core, viral titre 2 x 10^13 vg/ml) into either the dorsal NAc (stereotaxic coordinates 
from bregma: +1.30 anterior-posterior (AP), +/(0.5 medial-lateral (ML), (4.25 mm dorsal-
ventral (DV)) or ventral NAc (stereotaxic coordinates from bregma: +1.30 (AP), +/(0.5 (ML), 
(4.75 mm (DV), followed by fiber optic implantation (Sparta et al., 2012). We secured the 
344 
implants using two bone screws and constructed a chronic headcap using dental cement (Lang 
Dental, Wheeling, IL). Mice were allowed to recover for three weeks prior to behavioral testing, 
permitting optimal expression of ChR2 in the Dyn-Cre cell bodies. 
NorBNI local Infusion: Two weeks post viral injection the mice were locally injected with 
NorBNI in the ventral NAc (2.5µg/1µl) (co-ordinates stated above) followed by the optic fiber 
implantation to allow optimal expression of both ChR2 and NorBNI. All mice were allowed at 
least one week to recover post surgery before beginning experimentation, well within the ideal 
limits of norBNI antagonism and ChR2 expression. 
Slice electrophysiology 
 We performed whole-cell electrophysiology experiments similar to those published 
(Sparrow et al., 2012). Briefly, mice were rapidly decapitated under isoflurane anesthesia, and 
300uM coronal slices containing the NAc were prepared on a vibratome (Leica VT1200). The 
brains were removed and placed in ice-cold modified high sucrose artificial cerebrospinal fluid 
(aCSF) (see supplemental experimental procedures for details). Slices were then transferred to 
normal aCSF (see supplemental experimental procedures for details) maintained at 
approximately 30 degrees (Warner Instruments, Hamden, Connecticut). Slices were placed in a 
holding chamber (Warner Instruments, Hamden, CT), and were allowed to rest for one hour, and 
remained there until used. Slices were continuously bubbled with a 95% O2 / 5% CO2 mixture 
throughout slicing and experiments. Thin-walled borosilicate glass capillary recording electrodes 
(3–6 M$) were pulled on a Flaming-Brown Micropipette Puller (Sutter Instruments). Following 
rupture of the cell membrane, cells were allowed to rest and equilibrate to the intracellular 
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recording solutions (below). Input resistance was monitored continuously throughout the 
experiment, and when input resistance deviated by more than 20% the experiment was discarded. 
 All brains were checked for light-evoked action potentials in the NAc using a potassium-
gluconate based internal (see supplemental experimental procedures for details). Those brains in 
which action potentials were not obtained or injections were missed were discarded and not used 
for further experimentation. Action potentials were light evoked (1msec stimulation) at 
frequencies from 5-40 Hz to check spike fidelity of light-evoked responses. 
Real-time Place Testing 
 We used custom-made unbiased, balanced two-compartment conditioning apparatus 
(52.5 x 25.5 x 25.5 cm) as described previously (Jennings et al., 2013; Stamatakis and Stuber, 
2012). Mice were allowed to freely roam the entire apparatus for 20 min. Entry into one 
compartment triggered constant photostimulation at either 5Hz, 10Hz, 20Hz or 40Hz (473 nm, 
10 ms pulse width, ~10 mW light power) while the animal remained in the light-paired chamber. 
Entry into the other chamber ended the photostimulation. The side paired with photostimulation 
was counterbalanced across mice. Time spent in each chamber and total distance traveled for the 
entire 20-minute trial was measured using Ethovision 8.5 (Noldus Information Technologies, 
Leesburg, VA). 
Wireless Powering and RF Powering Scavenger 
 Wireless powering of the µ-ILED devices was adapted as previously described (Kim et 
al., 2013; McCall et al., 2013) The RF scavenger consists of antennas, impedance matching 
circuits and Cockcroft-Walton voltage multiplier. The wireless power transmitter includes an RF 
signal generator (Agilent N5181A), a power supply (Agilent U8031A), a RF power amplifier 
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(Empower RF Systems 1119-BBM3K5KHM), an RF signal splitter (RF Lambda 
RFLT2W0727GN), and two panel antennas (ARC Wireless ARC-PA2419B01). The RF signal 
generator is internally modulated to delivery sufficient power to light the µ-ILEDs at the given 
stimulation protocol (10 Hz, 50 ms pulse widths). The RF power amplifier that is powered by the 
power supply enlarges the modulated RF signal from the RF signal generator. The RF power is 
then transmitted from the panel antenna to the headstage power harvesters. The RF signal 
generator has a power output from -10 to 0 dBm at 1.5 GHz & 2.4 GHz for each LEDs, 
optimized daily to ensure equivalent light power throughout the space of the LDB assay. Mice 
with chronically implanted µ-ILED devices were acutely connected to the headstage power 
harvesters immediately prior to any wireless photostimulation. 
Y-Maze Conditioned Place Testing 
 Mice were placed in a 3-chambered environment compatible with fiber-optics coupled to 
473 nm laser as previous described (Kim et al., 2013). Initially, on day one the mice have free 
access to all chambers without stimulation (pre-test) to show no bias between the 2 larger, cue-
distinct environments. This is followed by three conditioning days where upon entry into one 
chamber photostimulation (10 Hz, 10 ms pulse width) occurs in real-time and when the animal 
leaves this compartment photostimulation ends. On post-test day 5 mice have free access to all 
chambers without stimulation to assess whether a preference or aversion association has been 
made with the paired context. Data were calculated as time spent in each chamber and entries 
into the photostimulation- paired chamber with control animals showing equal time spent in each 
chamber and an aversive response being time reduced from 50%. 
Operant Self-Stimulation 
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 Mice are initially food deprived to 90% of their body weight and trained to nose-poke for 
food pellets for 4 days in a modular test chamber for mice (17.8 cm x 15.2 cm x 18.4 cm) (Med 
Associates Inc., St. Albans, VT). This was used in conjunction with either Ethovision (Noldus, 
Leesburg, VA) or Med Associates program. This was followed by operant self-stimulation where 
upon an active nose poke the mice receive a 2 second photo-stimulation (10 Hz, 10 ms pulse 
width stimulation) on a fixed ratio-1 schedule for a 1 hour session. For operant self-stimulation 
the mice are connected to a laser via a tether than runs through the top of the chamber. An 
Arduino (Arduino, http://www.arduino.cc) is programed and connected to the laser and chamber 
so upon nose poking the 2 second 10 Hz, 10 ms pulse width photostimulation is administered. 
This was paired with a cue light and a tone. A poke at the inactive nose poke resulted in no 
stimulation, cue light or tone. The data were calculated as total number of nosepokes at the active 
and inactive for each day over the course of 5 days.  
 For all behavioral experiments at the end of each study, animals were perfused with 4% 
paraformaldehyde followed by anatomical analysis to confirm injection sites and cell type-
specific expression. 
Statistics 
All data are expressed as mean ± SEM. Statistical significance was taken as *p < 0.05, **p < 
0.01, ***p < 0.001, ****p < 0.0001 as determined by a One-Way Analysis of Variance 
(ANOVA) or a Two-Way Repeated Measures ANOVA followed by a Bonferroni post hoc tests 
as appropriate. Statistical analyses were performed in GraphPad Prism 5.0.  
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Appendix 2 
 
 
 
 
 
 
 
 
 
Supplementary locus coeruleus experiments 
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SUMMARY 
 Stress-induced anxiety and aversion represents only a subset of known behavioral 
responses to stress (Bruchas et al., 2011a; Butler and Finn, 2009; Weninger et al., 1999). Several 
stress-induced behaviors are known to be influenced or mediated by NE, including stress-
induced relapse to drug seeking (Weinshenker and Schroeder, 2007) and stress-induced analgesia 
(Butler and Finn, 2009). Exploring the possibility of these behaviors being mediated by LC 
efferent projections is a compelling next step. This appendix contains two sets of preliminary 
data evoking a high tonic (5 Hz) state of LC. In all cases the LC is targeting using Th-Cre mice 
and AAV5-EF1"-DIO-ChR2-EYFP. The controls are AAV5-EF1"-DIO-EYFP The first is a 
study of reinstatement of a cocaine conditioned place preference, the second is battery pain-
related assays. 
Potential role of LC-NE neurons in reinstatement of cocaine place preference 
 Mice were trained in an unbiased, balanced three-compartment conditioning apparatus as 
described (Land et al., 2009; Bruchas et al., 2011). On pre-conditioning day, day 1, mice were 
allowed free access to all three chambers for 30 min. Time spent in each compartment was 
recorded with a video camera (ZR90; Canon) and analyzed using Ethovision 8.5 (Noldus). Mice 
were randomly assigned to saline and drug compartments and received a saline injection in the 
morning (10 ml/kg, s.c.) and a cocaine injection (15 mg/kg, s.c.) in the afternoon, at least 4 h 
after the morning training on 3 consecutive days (days 2-4). To test for cocaine place preference 
(day 5) the mice were allowed free access to the three chambers. Scores were calculated by 
subtracting the time spent in the drug-paired compartment post-test minus the pre-test. This was 
followed by 3 days of extinction training (days 6–8) during which saline (10 ml/kg, s.c.) was 
355 
injected in both the morning and afternoon prior to placement into isolated conditioning 
compartments. Mice were tested for extinction of place preference on day 9 with free access to 
all three chambers. Mice were considered to have extinguished cocaine preference if scores fell 
within 15% of their initial preference scores. Mice that did not meet these criteria were excluded 
from the study. Mice that extinguished continued on to the reinstatement phase. On day 10, mice 
were exposed to five minutes of 5 Hz, 10 ms photostimulation.  
Reinstatement was measured as time (s) in drug-paired chamber on day 10 minus time 
spent in drug-paired chamber following extinction training. Mice that did not reinstate to 
photostimulation were exposed on the following day to a priming injection of cocaine (15 mg/kg, 
s.c.) and placed in the apparatus and allowed free access to all compartments (data not shown). 
Reinstatement scores were calculated by subtracting the time spent in the cocaine side post-test 
minus the extinction test as previously described (Bruchas et al., 2011, Land et al, 2009).  
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Figure A2.1 Potential role of LC-NE neurons in reinstatement of cocaine place preference. 
(A) Time line of CPP/reinstatement experiment (B) Data represent the mean preference (s) ± 
SEM, n=4/group. All included animals reached extinction criteria on Day 9 and received 5 
minutes of 5 Hz stimulation prior to post-test on Day 10. 
High tonic LC-NE activity is antinociceptive 
Plantar test (Hargreaves Method) 
 Mice were acclimated to a 30ºC glass platform for two hours prior to testing. Radiant 
heat was applied to each hindpaw and withdrawal latency was measured over 5 trials (15 min 
ITI). Conditions were counterbalanced to get baseline withdrawal latency for each mouse. 5 Hz 
photostimulation began 5 s before the first trial. 
Hot plate test 
 Mice were habituated to the testing room for two hours prior to testing. The hot plate was 
heated to 55ºC. 5 s before the trial, 5 Hz photostimulation began. The animal was placed on the 
hot plate and a timer started. Time ended with any of the following behaviors: animal lifts 
hindpaw and clearly licks, animal jumps off plate, or timer reaches 30 s. Only one trial per 
animal was recorded. 
Von Frey test 
 Calibrated Von Frey filaments were used to assess formalin-induced mechanical 
hypersensitity as previously described (Kolber et al., 2010). 
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Figure A2.2 High tonic LC-NE activity is antinocieptive. 5 Hz stimulation blunts thermal 
nociception in the (A) plantar and (B) hot plate tests. 5 Hz stimulation of LC-NE cell bodies 
reverse mechanical hypersensitivity in (C) the Von Frey test. Data shown as mean +/- SEM. 
n=6/group. **p<0.01, *p<0.05 Student’s t-test. 
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